AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|All other|2010
0-19|~|~|~|Malignant|~|40652257|Female|All other|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|All other|2011
0-19|~|~|~|Malignant|~|40557037|Female|All other|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|All other|2012
0-19|~|~|~|Malignant|~|40480081|Female|All other|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|All other|2013
0-19|~|~|~|Malignant|~|40460487|Female|All other|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|All other|2014
0-19|~|~|~|Malignant|~|40479388|Female|All other|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|All other|2015
0-19|~|~|~|Malignant|~|40552408|Female|All other|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|All other|2016
0-19|~|~|~|Malignant|~|40654446|Female|All other|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|All other|2017
0-19|~|~|~|Malignant|~|40708069|Female|All other|2017
0-19|0.0|0.1|0.1|Benign/Borderline|27|40711461|Female|All other|2018
0-19|0.3|0.4|0.3|Malignant|127|40711461|Female|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|40|40657090|Female|All other|2019
0-19|0.4|0.5|0.4|Malignant|167|40657090|Female|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|193|201507280|Female|All other|2019-2023
0-19|0.5|0.5|0.5|Malignant|996|201507280|Female|All other|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|33|40488555|Female|All other|2020
0-19|0.3|0.5|0.4|Malignant|158|40488555|Female|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|35|40157719|Female|All other|2021
0-19|0.4|0.5|0.4|Malignant|168|40157719|Female|All other|2021
0-19|0.1|0.1|0.1|Benign/Borderline|36|40107942|Female|All other|2022
0-19|0.5|0.7|0.6|Malignant|226|40107942|Female|All other|2022
0-19|0.1|0.2|0.1|Benign/Borderline|49|40095974|Female|All other|2023
0-19|0.6|0.8|0.7|Malignant|277|40095974|Female|All other|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004
0-19|0.1|0.2|0.1|Malignant|47|39865121|Female|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|40|40652257|Female|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|39|40557037|Female|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Anaplastic astrocytoma|2012
0-19|0.0|0.1|0.1|Malignant|24|40480081|Female|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Anaplastic astrocytoma|2013
0-19|0.1|0.2|0.1|Malignant|51|40460487|Female|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Anaplastic astrocytoma|2014
0-19|0.1|0.1|0.1|Malignant|40|40479388|Female|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|35|40552408|Female|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|31|40654446|Female|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Anaplastic astrocytoma|2017
0-19|0.0|0.1|0.1|Malignant|27|40708069|Female|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Anaplastic astrocytoma|2018
0-19|0.0|0.1|0.1|Malignant|24|40711461|Female|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Anaplastic astrocytoma|2019
0-19|0.0|0.1|0.1|Malignant|28|40657090|Female|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Anaplastic astrocytoma|2019-2023
0-19|0.0|0.0|0.0|Malignant|79|201507280|Female|Anaplastic astrocytoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|22|40488555|Female|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Anaplastic astrocytoma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Anaplastic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Anaplastic astrocytoma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Anaplastic astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|40652257|Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|40557037|Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|40480081|Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|40460487|Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|40479388|Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|40552408|Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|40654446|Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Anaplastic oligodendroglioma|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Anaplastic oligodendroglioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Anaplastic oligodendroglioma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Anaplastic oligodendroglioma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.2|Malignant|92|39865121|Female|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|93|39998876|Female|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.2|Malignant|90|40165421|Female|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|86|40382360|Female|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|87|40576293|Female|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|97|40670476|Female|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.2|Malignant|90|40652257|Female|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Astrocytoma, NOS|2011
0-19|0.2|0.2|0.2|Malignant|80|40557037|Female|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Astrocytoma, NOS|2012
0-19|0.2|0.3|0.2|Malignant|83|40480081|Female|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|100|40460487|Female|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|105|40479388|Female|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Astrocytoma, NOS|2015
0-19|0.1|0.2|0.2|Malignant|76|40552408|Female|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Astrocytoma, NOS|2016
0-19|0.2|0.3|0.2|Malignant|86|40654446|Female|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Astrocytoma, NOS|2017
0-19|0.2|0.3|0.2|Malignant|83|40708069|Female|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Astrocytoma, NOS|2018
0-19|0.2|0.3|0.2|Malignant|87|40711461|Female|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Astrocytoma, NOS|2019
0-19|0.2|0.2|0.2|Malignant|78|40657090|Female|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Astrocytoma, NOS|2019-2023
0-19|0.1|0.2|0.1|Malignant|287|201507280|Female|Astrocytoma, NOS|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Astrocytoma, NOS|2020
0-19|0.1|0.2|0.1|Malignant|54|40488555|Female|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|69|40157719|Female|Astrocytoma, NOS|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Astrocytoma, NOS|2022
0-19|0.1|0.2|0.1|Malignant|52|40107942|Female|Astrocytoma, NOS|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Astrocytoma, NOS|2023
0-19|0.1|0.1|0.1|Malignant|34|40095974|Female|Astrocytoma, NOS|2023
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Choroid plexus|2004
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|39998876|Female|Choroid plexus|2005
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005
0-19|0.0|0.1|0.1|Benign/Borderline|27|40165421|Female|Choroid plexus|2006
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|31|40382360|Female|Choroid plexus|2007
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008
0-19|0.0|0.1|0.1|Benign/Borderline|24|40670476|Female|Choroid plexus|2009
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009
0-19|0.0|0.1|0.1|Benign/Borderline|29|40652257|Female|Choroid plexus|2010
0-19|~|~|~|Malignant|~|40652257|Female|Choroid plexus|2010
0-19|0.0|0.1|0.1|Benign/Borderline|27|40557037|Female|Choroid plexus|2011
0-19|~|~|~|Malignant|~|40557037|Female|Choroid plexus|2011
0-19|0.0|0.1|0.1|Benign/Borderline|27|40480081|Female|Choroid plexus|2012
0-19|~|~|~|Malignant|~|40480081|Female|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|30|40460487|Female|Choroid plexus|2013
0-19|~|~|~|Malignant|~|40460487|Female|Choroid plexus|2013
0-19|0.0|0.1|0.1|Benign/Borderline|21|40479388|Female|Choroid plexus|2014
0-19|~|~|~|Malignant|~|40479388|Female|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|32|40552408|Female|Choroid plexus|2015
0-19|~|~|~|Malignant|~|40552408|Female|Choroid plexus|2015
0-19|0.0|0.1|0.1|Benign/Borderline|23|40654446|Female|Choroid plexus|2016
0-19|~|~|~|Malignant|~|40654446|Female|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|35|40708069|Female|Choroid plexus|2017
0-19|~|~|~|Malignant|~|40708069|Female|Choroid plexus|2017
0-19|0.0|0.1|0.1|Benign/Borderline|27|40711461|Female|Choroid plexus|2018
0-19|~|~|~|Malignant|~|40711461|Female|Choroid plexus|2018
0-19|0.0|0.1|0.1|Benign/Borderline|25|40657090|Female|Choroid plexus|2019
0-19|~|~|~|Malignant|~|40657090|Female|Choroid plexus|2019
0-19|0.1|0.1|0.1|Benign/Borderline|125|201507280|Female|Choroid plexus|2019-2023
0-19|0.0|0.0|0.0|Malignant|39|201507280|Female|Choroid plexus|2019-2023
0-19|0.0|0.1|0.1|Benign/Borderline|28|40488555|Female|Choroid plexus|2020
0-19|~|~|~|Malignant|~|40488555|Female|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|21|40157719|Female|Choroid plexus|2021
0-19|~|~|~|Malignant|~|40157719|Female|Choroid plexus|2021
0-19|0.0|0.1|0.1|Benign/Borderline|23|40107942|Female|Choroid plexus|2022
0-19|~|~|~|Malignant|~|40107942|Female|Choroid plexus|2022
0-19|0.0|0.1|0.1|Benign/Borderline|28|40095974|Female|Choroid plexus|2023
0-19|~|~|~|Malignant|~|40095974|Female|Choroid plexus|2023
0-19|0.2|0.3|0.2|Benign/Borderline|85|39865121|Female|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|77|40165421|Female|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007
0-19|0.1|0.2|0.2|Benign/Borderline|68|40576293|Female|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009
0-19|0.2|0.3|0.2|Benign/Borderline|96|40652257|Female|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|40652257|Female|Craniopharyngioma|2010
0-19|0.2|0.3|0.2|Benign/Borderline|87|40557037|Female|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|40557037|Female|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|78|40480081|Female|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|40480081|Female|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|89|40460487|Female|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|40460487|Female|Craniopharyngioma|2013
0-19|0.2|0.3|0.2|Benign/Borderline|95|40479388|Female|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|40479388|Female|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|82|40552408|Female|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|40552408|Female|Craniopharyngioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|69|40654446|Female|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|40654446|Female|Craniopharyngioma|2016
0-19|0.2|0.2|0.2|Benign/Borderline|80|40708069|Female|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Craniopharyngioma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|56|40711461|Female|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Craniopharyngioma|2018
0-19|0.2|0.3|0.2|Benign/Borderline|87|40657090|Female|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Craniopharyngioma|2019
0-19|0.2|0.2|0.2|Benign/Borderline|378|201507280|Female|Craniopharyngioma|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Craniopharyngioma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|72|40488555|Female|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Craniopharyngioma|2020
0-19|0.2|0.2|0.2|Benign/Borderline|80|40157719|Female|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Craniopharyngioma|2021
0-19|0.1|0.2|0.2|Benign/Borderline|69|40107942|Female|Craniopharyngioma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Craniopharyngioma|2022
0-19|0.1|0.2|0.2|Benign/Borderline|70|40095974|Female|Craniopharyngioma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Craniopharyngioma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|19|40670476|Female|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Diffuse astrocytoma|2010
0-19|0.0|0.1|0.0|Malignant|19|40652257|Female|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Diffuse astrocytoma|2011
0-19|~|~|~|Malignant|~|40557037|Female|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Diffuse astrocytoma|2012
0-19|~|~|~|Malignant|~|40480081|Female|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Diffuse astrocytoma|2013
0-19|~|~|~|Malignant|~|40460487|Female|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|40479388|Female|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|40552408|Female|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|40654446|Female|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Diffuse astrocytoma|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Diffuse astrocytoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Diffuse astrocytoma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Diffuse astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Diffuse astrocytoma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Diffuse astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004
0-19|0.5|0.6|0.5|Malignant|214|39865121|Female|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005
0-19|0.4|0.5|0.5|Malignant|184|39998876|Female|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006
0-19|0.4|0.6|0.5|Malignant|204|40165421|Female|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007
0-19|0.5|0.6|0.5|Malignant|218|40382360|Female|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009
0-19|0.4|0.6|0.5|Malignant|204|40670476|Female|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Embryonal/primitive/medulloblastoma|2010
0-19|0.4|0.5|0.4|Malignant|173|40652257|Female|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Embryonal/primitive/medulloblastoma|2011
0-19|0.4|0.6|0.5|Malignant|197|40557037|Female|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Embryonal/primitive/medulloblastoma|2012
0-19|0.4|0.5|0.4|Malignant|181|40480081|Female|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Embryonal/primitive/medulloblastoma|2013
0-19|0.4|0.5|0.5|Malignant|188|40460487|Female|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Embryonal/primitive/medulloblastoma|2014
0-19|0.5|0.6|0.5|Malignant|213|40479388|Female|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Embryonal/primitive/medulloblastoma|2015
0-19|0.4|0.6|0.5|Malignant|193|40552408|Female|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Embryonal/primitive/medulloblastoma|2016
0-19|0.4|0.5|0.4|Malignant|174|40654446|Female|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Embryonal/primitive/medulloblastoma|2017
0-19|0.4|0.5|0.4|Malignant|169|40708069|Female|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Embryonal/primitive/medulloblastoma|2018
0-19|0.3|0.5|0.4|Malignant|156|40711461|Female|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Embryonal/primitive/medulloblastoma|2019
0-19|0.2|0.4|0.3|Malignant|119|40657090|Female|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Embryonal/primitive/medulloblastoma|2019-2023
0-19|0.3|0.3|0.3|Malignant|574|201507280|Female|Embryonal/primitive/medulloblastoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Embryonal/primitive/medulloblastoma|2020
0-19|0.3|0.4|0.3|Malignant|136|40488555|Female|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Embryonal/primitive/medulloblastoma|2021
0-19|0.3|0.4|0.3|Malignant|126|40157719|Female|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Embryonal/primitive/medulloblastoma|2022
0-19|0.2|0.3|0.3|Malignant|97|40107942|Female|Embryonal/primitive/medulloblastoma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Embryonal/primitive/medulloblastoma|2023
0-19|0.2|0.3|0.2|Malignant|96|40095974|Female|Embryonal/primitive/medulloblastoma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|40652257|Female|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|21|40557037|Female|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|40557037|Female|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|16|40480081|Female|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|40480081|Female|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|17|40460487|Female|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|40460487|Female|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|40479388|Female|Ependymoma variants|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|40552408|Female|Ependymoma variants|2015
0-19|0.0|0.1|0.0|Benign/Borderline|16|40654446|Female|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|40654446|Female|Ependymoma variants|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|40708069|Female|Ependymoma variants|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|40711461|Female|Ependymoma variants|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|40657090|Female|Ependymoma variants|2019
0-19|0.0|0.0|0.0|Benign/Borderline|69|201507280|Female|Ependymoma variants|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Ependymoma variants|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|40488555|Female|Ependymoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|16|40157719|Female|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|40157719|Female|Ependymoma variants|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Ependymoma variants|2022
0-19|~|~|~|Malignant|~|40107942|Female|Ependymoma variants|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Ependymoma variants|2023
0-19|~|~|~|Malignant|~|40095974|Female|Ependymoma variants|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|112|39998876|Female|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.3|Malignant|101|40165421|Female|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007
0-19|0.1|0.2|0.2|Malignant|72|40382360|Female|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008
0-19|0.2|0.2|0.2|Malignant|78|40576293|Female|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.2|Malignant|93|40652257|Female|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.2|Malignant|97|40557037|Female|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.2|Malignant|89|40480081|Female|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.2|Malignant|89|40460487|Female|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.2|Malignant|92|40479388|Female|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.2|Malignant|88|40552408|Female|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.3|0.2|Malignant|82|40654446|Female|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.3|0.2|Malignant|98|40708069|Female|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Ependymoma/anaplastic ependymoma|2018
0-19|0.1|0.2|0.2|Malignant|70|40711461|Female|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Ependymoma/anaplastic ependymoma|2019
0-19|0.1|0.2|0.2|Malignant|72|40657090|Female|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Ependymoma/anaplastic ependymoma|2019-2023
0-19|0.1|0.2|0.2|Malignant|306|201507280|Female|Ependymoma/anaplastic ependymoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Ependymoma/anaplastic ependymoma|2020
0-19|0.1|0.2|0.2|Malignant|71|40488555|Female|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Ependymoma/anaplastic ependymoma|2021
0-19|0.1|0.2|0.2|Malignant|68|40157719|Female|Ependymoma/anaplastic ependymoma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Ependymoma/anaplastic ependymoma|2022
0-19|0.1|0.2|0.1|Malignant|54|40107942|Female|Ependymoma/anaplastic ependymoma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Ependymoma/anaplastic ependymoma|2023
0-19|0.1|0.1|0.1|Malignant|41|40095974|Female|Ependymoma/anaplastic ependymoma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004
0-19|0.1|0.1|0.1|Malignant|43|39865121|Female|Germ Cell Tumors|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Germ Cell Tumors|2006
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Germ Cell Tumors|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|18|40576293|Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.1|Malignant|29|40576293|Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.0|Benign/Borderline|20|40670476|Female|Germ Cell Tumors|2009
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|21|40652257|Female|Germ Cell Tumors|2010
0-19|0.1|0.2|0.1|Malignant|53|40652257|Female|Germ Cell Tumors|2010
0-19|0.0|0.1|0.1|Benign/Borderline|23|40557037|Female|Germ Cell Tumors|2011
0-19|0.1|0.1|0.1|Malignant|37|40557037|Female|Germ Cell Tumors|2011
0-19|0.0|0.1|0.0|Benign/Borderline|17|40480081|Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Malignant|21|40480081|Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|21|40460487|Female|Germ Cell Tumors|2013
0-19|0.1|0.2|0.1|Malignant|48|40460487|Female|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|23|40479388|Female|Germ Cell Tumors|2014
0-19|0.1|0.1|0.1|Malignant|34|40479388|Female|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|18|40552408|Female|Germ Cell Tumors|2015
0-19|0.1|0.2|0.1|Malignant|46|40552408|Female|Germ Cell Tumors|2015
0-19|0.0|0.1|0.1|Benign/Borderline|27|40654446|Female|Germ Cell Tumors|2016
0-19|0.1|0.2|0.1|Malignant|58|40654446|Female|Germ Cell Tumors|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Germ Cell Tumors|2017
0-19|0.1|0.2|0.1|Malignant|46|40708069|Female|Germ Cell Tumors|2017
0-19|0.0|0.1|0.1|Benign/Borderline|24|40711461|Female|Germ Cell Tumors|2018
0-19|0.1|0.1|0.1|Malignant|44|40711461|Female|Germ Cell Tumors|2018
0-19|0.0|0.1|0.0|Benign/Borderline|17|40657090|Female|Germ Cell Tumors|2019
0-19|0.1|0.2|0.1|Malignant|50|40657090|Female|Germ Cell Tumors|2019
0-19|0.0|0.0|0.0|Benign/Borderline|75|201507280|Female|Germ Cell Tumors|2019-2023
0-19|0.1|0.1|0.1|Malignant|230|201507280|Female|Germ Cell Tumors|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Germ Cell Tumors|2020
0-19|0.1|0.2|0.1|Malignant|50|40488555|Female|Germ Cell Tumors|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Germ Cell Tumors|2021
0-19|0.1|0.1|0.1|Malignant|44|40157719|Female|Germ Cell Tumors|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Germ Cell Tumors|2022
0-19|0.1|0.1|0.1|Malignant|35|40107942|Female|Germ Cell Tumors|2022
0-19|0.0|0.1|0.0|Benign/Borderline|18|40095974|Female|Germ Cell Tumors|2023
0-19|0.1|0.2|0.1|Malignant|51|40095974|Female|Germ Cell Tumors|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006
0-19|0.1|0.1|0.1|Malignant|43|40165421|Female|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007
0-19|0.1|0.2|0.1|Malignant|58|40382360|Female|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009
0-19|0.1|0.1|0.1|Malignant|38|40670476|Female|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Glioblastoma|2010
0-19|0.1|0.2|0.1|Malignant|51|40652257|Female|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Glioblastoma|2011
0-19|0.1|0.2|0.2|Malignant|75|40557037|Female|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Glioblastoma|2012
0-19|0.1|0.2|0.2|Malignant|76|40480081|Female|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Glioblastoma|2013
0-19|0.1|0.2|0.2|Malignant|70|40460487|Female|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|69|40479388|Female|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Glioblastoma|2015
0-19|0.1|0.2|0.2|Malignant|68|40552408|Female|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Glioblastoma|2016
0-19|0.1|0.2|0.1|Malignant|54|40654446|Female|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|70|40708069|Female|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Glioblastoma|2018
0-19|0.1|0.2|0.1|Malignant|60|40711461|Female|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Glioblastoma|2019
0-19|0.1|0.2|0.1|Malignant|54|40657090|Female|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Glioblastoma|2019-2023
0-19|0.1|0.1|0.1|Malignant|180|201507280|Female|Glioblastoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Glioblastoma|2020
0-19|0.1|0.1|0.1|Malignant|35|40488555|Female|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Glioblastoma|2021
0-19|0.1|0.1|0.1|Malignant|44|40157719|Female|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Glioblastoma|2022
0-19|0.1|0.1|0.1|Malignant|32|40107942|Female|Glioblastoma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Glioblastoma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Glioblastoma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004
0-19|0.5|0.7|0.6|Malignant|235|39865121|Female|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005
0-19|0.5|0.7|0.6|Malignant|235|39998876|Female|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006
0-19|0.6|0.7|0.6|Malignant|249|40165421|Female|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007
0-19|0.6|0.8|0.7|Malignant|268|40382360|Female|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008
0-19|0.6|0.8|0.7|Malignant|281|40576293|Female|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009
0-19|0.7|0.8|0.7|Malignant|299|40670476|Female|Glioma malignant, NOS|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Glioma malignant, NOS|2010
0-19|0.6|0.7|0.7|Malignant|266|40652257|Female|Glioma malignant, NOS|2010
0-19|0.0|0.1|0.0|Benign/Borderline|20|40557037|Female|Glioma malignant, NOS|2011
0-19|0.7|0.9|0.8|Malignant|318|40557037|Female|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|18|40480081|Female|Glioma malignant, NOS|2012
0-19|0.5|0.7|0.6|Malignant|234|40480081|Female|Glioma malignant, NOS|2012
0-19|0.0|0.1|0.0|Benign/Borderline|16|40460487|Female|Glioma malignant, NOS|2013
0-19|0.7|0.9|0.8|Malignant|310|40460487|Female|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.0|Benign/Borderline|19|40479388|Female|Glioma malignant, NOS|2014
0-19|0.6|0.8|0.7|Malignant|276|40479388|Female|Glioma malignant, NOS|2014
0-19|0.0|0.1|0.0|Benign/Borderline|16|40552408|Female|Glioma malignant, NOS|2015
0-19|0.6|0.8|0.7|Malignant|287|40552408|Female|Glioma malignant, NOS|2015
0-19|0.0|0.1|0.1|Benign/Borderline|25|40654446|Female|Glioma malignant, NOS|2016
0-19|0.7|0.9|0.8|Malignant|325|40654446|Female|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|26|40708069|Female|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|332|40708069|Female|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.1|Benign/Borderline|23|40711461|Female|Glioma malignant, NOS|2018
0-19|0.6|0.7|0.6|Malignant|258|40711461|Female|Glioma malignant, NOS|2018
0-19|0.0|0.1|0.0|Benign/Borderline|19|40657090|Female|Glioma malignant, NOS|2019
0-19|0.5|0.7|0.6|Malignant|238|40657090|Female|Glioma malignant, NOS|2019
0-19|0.0|0.1|0.1|Benign/Borderline|115|201507280|Female|Glioma malignant, NOS|2019-2023
0-19|0.6|0.6|0.6|Malignant|1171|201507280|Female|Glioma malignant, NOS|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Glioma malignant, NOS|2020
0-19|0.5|0.7|0.6|Malignant|242|40488555|Female|Glioma malignant, NOS|2020
0-19|0.0|0.1|0.0|Benign/Borderline|17|40157719|Female|Glioma malignant, NOS|2021
0-19|0.6|0.8|0.7|Malignant|270|40157719|Female|Glioma malignant, NOS|2021
0-19|0.0|0.1|0.1|Benign/Borderline|29|40107942|Female|Glioma malignant, NOS|2022
0-19|0.5|0.7|0.6|Malignant|240|40107942|Female|Glioma malignant, NOS|2022
0-19|0.1|0.1|0.1|Benign/Borderline|40|40095974|Female|Glioma malignant, NOS|2023
0-19|0.4|0.5|0.5|Malignant|181|40095974|Female|Glioma malignant, NOS|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004
0-19|0.0|0.1|0.0|Benign/Borderline|19|39998876|Female|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006
0-19|0.0|0.1|0.1|Benign/Borderline|21|40382360|Female|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|17|40670476|Female|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|40652257|Female|Hemangioblastoma|2010
0-19|0.0|0.1|0.0|Benign/Borderline|19|40557037|Female|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|40557037|Female|Hemangioblastoma|2011
0-19|0.0|0.1|0.0|Benign/Borderline|19|40480081|Female|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|40480081|Female|Hemangioblastoma|2012
0-19|0.0|0.1|0.1|Benign/Borderline|21|40460487|Female|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|40460487|Female|Hemangioblastoma|2013
0-19|0.1|0.1|0.1|Benign/Borderline|33|40479388|Female|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|40479388|Female|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|18|40552408|Female|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|40552408|Female|Hemangioblastoma|2015
0-19|0.0|0.1|0.1|Benign/Borderline|24|40654446|Female|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|40654446|Female|Hemangioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Hemangioblastoma|2017
0-19|0.0|0.1|0.0|Benign/Borderline|20|40711461|Female|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Hemangioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Hemangioblastoma|2019
0-19|0.0|0.0|0.0|Benign/Borderline|77|201507280|Female|Hemangioblastoma|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Hemangioblastoma|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|19|40488555|Female|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Hemangioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Hemangioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Hemangioblastoma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Hemangioblastoma|2022
0-19|0.0|0.1|0.0|Benign/Borderline|16|40095974|Female|Hemangioblastoma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Hemangioblastoma|2023
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Hemangioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|25|39998876|Female|Hemangioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|35|40165421|Female|Hemangioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006
0-19|0.1|0.1|0.1|Benign/Borderline|33|40382360|Female|Hemangioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|50|40576293|Female|Hemangioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|54|40670476|Female|Hemangioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|47|40652257|Female|Hemangioma|2010
0-19|~|~|~|Malignant|~|40652257|Female|Hemangioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|73|40557037|Female|Hemangioma|2011
0-19|~|~|~|Malignant|~|40557037|Female|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|69|40480081|Female|Hemangioma|2012
0-19|~|~|~|Malignant|~|40480081|Female|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|65|40460487|Female|Hemangioma|2013
0-19|~|~|~|Malignant|~|40460487|Female|Hemangioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|66|40479388|Female|Hemangioma|2014
0-19|~|~|~|Malignant|~|40479388|Female|Hemangioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|76|40552408|Female|Hemangioma|2015
0-19|~|~|~|Malignant|~|40552408|Female|Hemangioma|2015
0-19|0.1|0.2|0.1|Benign/Borderline|58|40654446|Female|Hemangioma|2016
0-19|~|~|~|Malignant|~|40654446|Female|Hemangioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|57|40708069|Female|Hemangioma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Hemangioma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|59|40711461|Female|Hemangioma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Hemangioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|54|40657090|Female|Hemangioma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|288|201507280|Female|Hemangioma|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Hemangioma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|68|40488555|Female|Hemangioma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Hemangioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|59|40157719|Female|Hemangioma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Hemangioma|2021
0-19|0.1|0.2|0.1|Benign/Borderline|58|40107942|Female|Hemangioma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Hemangioma|2022
0-19|0.1|0.2|0.1|Benign/Borderline|49|40095974|Female|Hemangioma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Hemangioma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|40652257|Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|40557037|Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|40480081|Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|40460487|Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|40479388|Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|40552408|Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|40654446|Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|40708069|Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|40711461|Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|40657090|Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Local Extensions from Regional Tumors|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Local Extensions from Regional Tumors|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|40488555|Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|40157719|Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Malignant|~|40107942|Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Local Extensions from Regional Tumors|2023
0-19|~|~|~|Malignant|~|40095974|Female|Local Extensions from Regional Tumors|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|40652257|Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|40557037|Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|40480081|Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|40460487|Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|40479388|Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Malignant|~|40552408|Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|40654446|Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|40708069|Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|40711461|Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|40657090|Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
0-19|0.0|0.0|0.0|Malignant|16|201507280|Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|40488555|Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|40157719|Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Malignant|~|40107942|Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Lymphomas and Hematopoietic Neoplasms|2023
0-19|~|~|~|Malignant|~|40095974|Female|Lymphomas and Hematopoietic Neoplasms|2023
0-19|0.1|0.2|0.1|Benign/Borderline|48|39865121|Female|Meningioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165421|Female|Meningioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007
0-19|0.1|0.2|0.2|Benign/Borderline|63|40576293|Female|Meningioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|61|40670476|Female|Meningioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|60|40652257|Female|Meningioma|2010
0-19|~|~|~|Malignant|~|40652257|Female|Meningioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|69|40557037|Female|Meningioma|2011
0-19|~|~|~|Malignant|~|40557037|Female|Meningioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|66|40480081|Female|Meningioma|2012
0-19|~|~|~|Malignant|~|40480081|Female|Meningioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|77|40460487|Female|Meningioma|2013
0-19|~|~|~|Malignant|~|40460487|Female|Meningioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|75|40479388|Female|Meningioma|2014
0-19|~|~|~|Malignant|~|40479388|Female|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|72|40552408|Female|Meningioma|2015
0-19|~|~|~|Malignant|~|40552408|Female|Meningioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|76|40654446|Female|Meningioma|2016
0-19|~|~|~|Malignant|~|40654446|Female|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|67|40708069|Female|Meningioma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Meningioma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|74|40711461|Female|Meningioma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Meningioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|80|40657090|Female|Meningioma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Meningioma|2019
0-19|0.2|0.2|0.2|Benign/Borderline|364|201507280|Female|Meningioma|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Meningioma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|64|40488555|Female|Meningioma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Meningioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|93|40157719|Female|Meningioma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Meningioma|2021
0-19|0.1|0.2|0.2|Benign/Borderline|67|40107942|Female|Meningioma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Meningioma|2022
0-19|0.1|0.2|0.1|Benign/Borderline|60|40095974|Female|Meningioma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Meningioma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Mixed glioma|2010
0-19|~|~|~|Malignant|~|40652257|Female|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Mixed glioma|2011
0-19|~|~|~|Malignant|~|40557037|Female|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Mixed glioma|2012
0-19|~|~|~|Malignant|~|40480081|Female|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Mixed glioma|2013
0-19|~|~|~|Malignant|~|40460487|Female|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Mixed glioma|2014
0-19|~|~|~|Malignant|~|40479388|Female|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Mixed glioma|2015
0-19|~|~|~|Malignant|~|40552408|Female|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Mixed glioma|2016
0-19|~|~|~|Malignant|~|40654446|Female|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Mixed glioma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Mixed glioma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Mixed glioma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Mixed glioma|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Mixed glioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Mixed glioma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Mixed glioma|2021
0-19|~|~|~|Malignant|~|40157719|Female|Mixed glioma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Mixed glioma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Mixed glioma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Mixed glioma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Mixed glioma|2023
0-19|0.1|0.1|0.1|Benign/Borderline|34|39865121|Female|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|56|39998876|Female|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|18|39998876|Female|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165421|Female|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|28|40165421|Female|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|54|40382360|Female|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.2|Benign/Borderline|77|40576293|Female|Neoplasm, unspecified|2008
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008
0-19|0.1|0.2|0.2|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009
0-19|0.2|0.3|0.2|Benign/Borderline|91|40652257|Female|Neoplasm, unspecified|2010
0-19|~|~|~|Malignant|~|40652257|Female|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|69|40557037|Female|Neoplasm, unspecified|2011
0-19|0.0|0.1|0.0|Malignant|18|40557037|Female|Neoplasm, unspecified|2011
0-19|0.2|0.2|0.2|Benign/Borderline|78|40480081|Female|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|23|40480081|Female|Neoplasm, unspecified|2012
0-19|0.1|0.2|0.2|Benign/Borderline|76|40460487|Female|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.1|Malignant|24|40460487|Female|Neoplasm, unspecified|2013
0-19|0.2|0.3|0.2|Benign/Borderline|83|40479388|Female|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.0|Malignant|19|40479388|Female|Neoplasm, unspecified|2014
0-19|0.2|0.3|0.2|Benign/Borderline|83|40552408|Female|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|17|40552408|Female|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.1|Benign/Borderline|58|40654446|Female|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|24|40654446|Female|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.2|Benign/Borderline|62|40708069|Female|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.0|Malignant|20|40708069|Female|Neoplasm, unspecified|2017
0-19|0.1|0.2|0.2|Benign/Borderline|74|40711461|Female|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.1|Malignant|27|40711461|Female|Neoplasm, unspecified|2018
0-19|0.1|0.2|0.1|Benign/Borderline|48|40657090|Female|Neoplasm, unspecified|2019
0-19|~|~|~|Malignant|~|40657090|Female|Neoplasm, unspecified|2019
0-19|0.1|0.1|0.1|Benign/Borderline|256|201507280|Female|Neoplasm, unspecified|2019-2023
0-19|0.0|0.1|0.1|Malignant|117|201507280|Female|Neoplasm, unspecified|2019-2023
0-19|0.1|0.2|0.1|Benign/Borderline|54|40488555|Female|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|25|40488555|Female|Neoplasm, unspecified|2020
0-19|0.1|0.2|0.2|Benign/Borderline|61|40157719|Female|Neoplasm, unspecified|2021
0-19|0.0|0.1|0.1|Malignant|27|40157719|Female|Neoplasm, unspecified|2021
0-19|0.1|0.2|0.1|Benign/Borderline|49|40107942|Female|Neoplasm, unspecified|2022
0-19|0.0|0.1|0.1|Malignant|26|40107942|Female|Neoplasm, unspecified|2022
0-19|0.1|0.1|0.1|Benign/Borderline|44|40095974|Female|Neoplasm, unspecified|2023
0-19|0.0|0.1|0.1|Malignant|25|40095974|Female|Neoplasm, unspecified|2023
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005
0-19|0.3|0.5|0.4|Benign/Borderline|164|40165421|Female|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006
0-19|0.3|0.4|0.3|Benign/Borderline|137|40382360|Female|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|150|40576293|Female|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|40652257|Female|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|40652257|Female|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.3|Benign/Borderline|139|40557037|Female|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|40557037|Female|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|147|40480081|Female|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|40480081|Female|Nerve sheath, benign and malignant|2012
0-19|0.3|0.5|0.4|Benign/Borderline|158|40460487|Female|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|40460487|Female|Nerve sheath, benign and malignant|2013
0-19|0.2|0.3|0.3|Benign/Borderline|112|40479388|Female|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|40479388|Female|Nerve sheath, benign and malignant|2014
0-19|0.3|0.5|0.4|Benign/Borderline|160|40552408|Female|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|40552408|Female|Nerve sheath, benign and malignant|2015
0-19|0.3|0.4|0.3|Benign/Borderline|132|40654446|Female|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|40654446|Female|Nerve sheath, benign and malignant|2016
0-19|0.3|0.4|0.3|Benign/Borderline|138|40708069|Female|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|40708069|Female|Nerve sheath, benign and malignant|2017
0-19|0.2|0.2|0.2|Benign/Borderline|82|40711461|Female|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|40711461|Female|Nerve sheath, benign and malignant|2018
0-19|0.2|0.2|0.2|Benign/Borderline|82|40657090|Female|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|40657090|Female|Nerve sheath, benign and malignant|2019
0-19|0.2|0.2|0.2|Benign/Borderline|403|201507280|Female|Nerve sheath, benign and malignant|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Nerve sheath, benign and malignant|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|78|40488555|Female|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|40488555|Female|Nerve sheath, benign and malignant|2020
0-19|0.2|0.3|0.2|Benign/Borderline|86|40157719|Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|40157719|Female|Nerve sheath, benign and malignant|2021
0-19|0.1|0.2|0.2|Benign/Borderline|76|40107942|Female|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Malignant|~|40107942|Female|Nerve sheath, benign and malignant|2022
0-19|0.2|0.2|0.2|Benign/Borderline|81|40095974|Female|Nerve sheath, benign and malignant|2023
0-19|~|~|~|Malignant|~|40095974|Female|Nerve sheath, benign and malignant|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|40652257|Female|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|40557037|Female|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|40480081|Female|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|40460487|Female|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|40479388|Female|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|40552408|Female|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|40654446|Female|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|40708069|Female|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|40711461|Female|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|40657090|Female|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Neuroepithelial|2019-2023
0-19|0.0|0.0|0.0|Malignant|25|201507280|Female|Neuroepithelial|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|40488555|Female|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|40157719|Female|Neuroepithelial|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Neuroepithelial|2022
0-19|~|~|~|Malignant|~|40107942|Female|Neuroepithelial|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Neuroepithelial|2023
0-19|~|~|~|Malignant|~|40095974|Female|Neuroepithelial|2023
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|21|39865121|Female|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.3|Benign/Borderline|137|39998876|Female|Neuronal/glial, neuronal|2005
0-19|0.0|0.1|0.1|Malignant|27|39998876|Female|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.3|Benign/Borderline|127|40165421|Female|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Neuronal/glial, neuronal|2006
0-19|0.3|0.4|0.3|Benign/Borderline|140|40382360|Female|Neuronal/glial, neuronal|2007
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Neuronal/glial, neuronal|2007
0-19|0.3|0.4|0.3|Benign/Borderline|135|40576293|Female|Neuronal/glial, neuronal|2008
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009
0-19|0.3|0.4|0.4|Benign/Borderline|143|40652257|Female|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|19|40652257|Female|Neuronal/glial, neuronal|2010
0-19|0.3|0.4|0.4|Benign/Borderline|154|40557037|Female|Neuronal/glial, neuronal|2011
0-19|~|~|~|Malignant|~|40557037|Female|Neuronal/glial, neuronal|2011
0-19|0.3|0.5|0.4|Benign/Borderline|157|40480081|Female|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.0|Malignant|19|40480081|Female|Neuronal/glial, neuronal|2012
0-19|0.3|0.5|0.4|Benign/Borderline|166|40460487|Female|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|22|40460487|Female|Neuronal/glial, neuronal|2013
0-19|0.3|0.5|0.4|Benign/Borderline|165|40479388|Female|Neuronal/glial, neuronal|2014
0-19|0.0|0.1|0.1|Malignant|26|40479388|Female|Neuronal/glial, neuronal|2014
0-19|0.4|0.5|0.4|Benign/Borderline|176|40552408|Female|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.0|Malignant|17|40552408|Female|Neuronal/glial, neuronal|2015
0-19|0.4|0.5|0.5|Benign/Borderline|191|40654446|Female|Neuronal/glial, neuronal|2016
0-19|0.0|0.1|0.1|Malignant|29|40654446|Female|Neuronal/glial, neuronal|2016
0-19|0.4|0.5|0.4|Benign/Borderline|182|40708069|Female|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.1|Malignant|24|40708069|Female|Neuronal/glial, neuronal|2017
0-19|0.3|0.5|0.4|Benign/Borderline|160|40711461|Female|Neuronal/glial, neuronal|2018
0-19|0.0|0.1|0.1|Malignant|29|40711461|Female|Neuronal/glial, neuronal|2018
0-19|0.3|0.4|0.4|Benign/Borderline|154|40657090|Female|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|22|40657090|Female|Neuronal/glial, neuronal|2019
0-19|0.4|0.4|0.4|Benign/Borderline|775|201507280|Female|Neuronal/glial, neuronal|2019-2023
0-19|0.0|0.1|0.1|Malignant|102|201507280|Female|Neuronal/glial, neuronal|2019-2023
0-19|0.3|0.5|0.4|Benign/Borderline|159|40488555|Female|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.1|Malignant|28|40488555|Female|Neuronal/glial, neuronal|2020
0-19|0.3|0.4|0.3|Benign/Borderline|140|40157719|Female|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|16|40157719|Female|Neuronal/glial, neuronal|2021
0-19|0.3|0.5|0.4|Benign/Borderline|166|40107942|Female|Neuronal/glial, neuronal|2022
0-19|0.0|0.1|0.0|Malignant|17|40107942|Female|Neuronal/glial, neuronal|2022
0-19|0.3|0.5|0.4|Benign/Borderline|156|40095974|Female|Neuronal/glial, neuronal|2023
0-19|0.0|0.1|0.0|Malignant|19|40095974|Female|Neuronal/glial, neuronal|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|24|39998876|Female|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|30|40382360|Female|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008
0-19|0.0|0.1|0.0|Malignant|17|40576293|Female|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|24|40652257|Female|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|20|40557037|Female|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|22|40480081|Female|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|16|40460487|Female|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|19|40479388|Female|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|18|40552408|Female|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Oligodendroglioma|2016
0-19|0.0|0.1|0.1|Malignant|21|40654446|Female|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Oligodendroglioma|2017
0-19|~|~|~|Malignant|~|40708069|Female|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Oligodendroglioma|2018
0-19|~|~|~|Malignant|~|40711461|Female|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Oligodendroglioma|2019
0-19|~|~|~|Malignant|~|40657090|Female|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|201507280|Female|Oligodendroglioma|2019-2023
0-19|0.0|0.0|0.0|Malignant|55|201507280|Female|Oligodendroglioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Oligodendroglioma|2020
0-19|~|~|~|Malignant|~|40488555|Female|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Oligodendroglioma|2021
0-19|0.0|0.1|0.0|Malignant|16|40157719|Female|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Oligodendroglioma|2022
0-19|~|~|~|Malignant|~|40107942|Female|Oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Oligodendroglioma|2023
0-19|~|~|~|Malignant|~|40095974|Female|Oligodendroglioma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|19|40165421|Female|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006
0-19|0.0|0.1|0.1|Benign/Borderline|21|40382360|Female|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|20|40576293|Female|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008
0-19|0.1|0.1|0.1|Benign/Borderline|31|40670476|Female|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|27|40652257|Female|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|40652257|Female|Other mesenchymal|2010
0-19|0.0|0.1|0.1|Benign/Borderline|29|40557037|Female|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|40557037|Female|Other mesenchymal|2011
0-19|0.1|0.2|0.1|Benign/Borderline|56|40480081|Female|Other mesenchymal|2012
0-19|~|~|~|Malignant|~|40480081|Female|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|44|40460487|Female|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|40460487|Female|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|45|40479388|Female|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|40479388|Female|Other mesenchymal|2014
0-19|0.1|0.2|0.1|Benign/Borderline|51|40552408|Female|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|40552408|Female|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|52|40654446|Female|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|40654446|Female|Other mesenchymal|2016
0-19|0.1|0.2|0.1|Benign/Borderline|51|40708069|Female|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|40708069|Female|Other mesenchymal|2017
0-19|0.1|0.2|0.1|Benign/Borderline|51|40711461|Female|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|40711461|Female|Other mesenchymal|2018
0-19|0.1|0.1|0.1|Benign/Borderline|37|40657090|Female|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|40657090|Female|Other mesenchymal|2019
0-19|0.1|0.1|0.1|Benign/Borderline|249|201507280|Female|Other mesenchymal|2019-2023
0-19|0.0|0.0|0.0|Malignant|34|201507280|Female|Other mesenchymal|2019-2023
0-19|0.1|0.2|0.1|Benign/Borderline|47|40488555|Female|Other mesenchymal|2020
0-19|~|~|~|Malignant|~|40488555|Female|Other mesenchymal|2020
0-19|0.1|0.2|0.2|Benign/Borderline|59|40157719|Female|Other mesenchymal|2021
0-19|~|~|~|Malignant|~|40157719|Female|Other mesenchymal|2021
0-19|0.1|0.1|0.1|Benign/Borderline|42|40107942|Female|Other mesenchymal|2022
0-19|~|~|~|Malignant|~|40107942|Female|Other mesenchymal|2022
0-19|0.1|0.2|0.2|Benign/Borderline|64|40095974|Female|Other mesenchymal|2023
0-19|~|~|~|Malignant|~|40095974|Female|Other mesenchymal|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004
0-19|0.7|0.9|0.8|Malignant|330|39865121|Female|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005
0-19|0.7|0.9|0.8|Malignant|328|39998876|Female|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006
0-19|0.7|0.9|0.8|Malignant|322|40165421|Female|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007
0-19|0.8|1.0|0.9|Malignant|347|40382360|Female|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008
0-19|0.8|0.9|0.8|Malignant|340|40576293|Female|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009
0-19|0.8|1.0|0.9|Malignant|360|40670476|Female|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Pilocytic astrocytoma|2010
0-19|0.9|1.1|1.0|Malignant|404|40652257|Female|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Pilocytic astrocytoma|2011
0-19|0.8|1.0|0.9|Malignant|358|40557037|Female|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Pilocytic astrocytoma|2012
0-19|0.9|1.1|1.0|Malignant|387|40480081|Female|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Pilocytic astrocytoma|2013
0-19|0.8|1.0|0.9|Malignant|366|40460487|Female|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Pilocytic astrocytoma|2014
0-19|0.9|1.1|1.0|Malignant|412|40479388|Female|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|365|40552408|Female|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Pilocytic astrocytoma|2016
0-19|0.8|0.9|0.8|Malignant|343|40654446|Female|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Pilocytic astrocytoma|2017
0-19|0.9|1.1|1.0|Malignant|411|40708069|Female|Pilocytic astrocytoma|2017
0-19|0.2|0.3|0.2|Benign/Borderline|92|40711461|Female|Pilocytic astrocytoma|2018
0-19|0.7|0.9|0.8|Malignant|334|40711461|Female|Pilocytic astrocytoma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|67|40657090|Female|Pilocytic astrocytoma|2019
0-19|0.7|0.8|0.8|Malignant|305|40657090|Female|Pilocytic astrocytoma|2019
0-19|0.3|0.4|0.3|Benign/Borderline|658|201507280|Female|Pilocytic astrocytoma|2019-2023
0-19|0.6|0.6|0.6|Malignant|1195|201507280|Female|Pilocytic astrocytoma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|73|40488555|Female|Pilocytic astrocytoma|2020
0-19|0.6|0.8|0.7|Malignant|273|40488555|Female|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|69|40157719|Female|Pilocytic astrocytoma|2021
0-19|0.6|0.8|0.7|Malignant|268|40157719|Female|Pilocytic astrocytoma|2021
0-19|0.2|0.3|0.2|Benign/Borderline|81|40107942|Female|Pilocytic astrocytoma|2022
0-19|0.6|0.8|0.7|Malignant|286|40107942|Female|Pilocytic astrocytoma|2022
0-19|0.8|1.0|0.9|Benign/Borderline|368|40095974|Female|Pilocytic astrocytoma|2023
0-19|0.1|0.2|0.2|Malignant|63|40095974|Female|Pilocytic astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|40652257|Female|Pineal parenchymal|2010
0-19|~|~|~|Malignant|~|40652257|Female|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|40557037|Female|Pineal parenchymal|2011
0-19|~|~|~|Malignant|~|40557037|Female|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|40480081|Female|Pineal parenchymal|2012
0-19|~|~|~|Malignant|~|40480081|Female|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|40460487|Female|Pineal parenchymal|2013
0-19|~|~|~|Malignant|~|40460487|Female|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|40479388|Female|Pineal parenchymal|2014
0-19|0.0|0.1|0.0|Malignant|16|40479388|Female|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|40552408|Female|Pineal parenchymal|2015
0-19|0.0|0.1|0.1|Malignant|25|40552408|Female|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|40654446|Female|Pineal parenchymal|2016
0-19|0.0|0.1|0.0|Malignant|16|40654446|Female|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|40708069|Female|Pineal parenchymal|2017
0-19|~|~|~|Malignant|~|40708069|Female|Pineal parenchymal|2017
0-19|~|~|~|Benign/Borderline|~|40711461|Female|Pineal parenchymal|2018
0-19|0.0|0.1|0.0|Malignant|18|40711461|Female|Pineal parenchymal|2018
0-19|~|~|~|Benign/Borderline|~|40657090|Female|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|19|40657090|Female|Pineal parenchymal|2019
0-19|0.0|0.0|0.0|Benign/Borderline|19|201507280|Female|Pineal parenchymal|2019-2023
0-19|0.0|0.0|0.0|Malignant|77|201507280|Female|Pineal parenchymal|2019-2023
0-19|~|~|~|Benign/Borderline|~|40488555|Female|Pineal parenchymal|2020
0-19|~|~|~|Malignant|~|40488555|Female|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|40157719|Female|Pineal parenchymal|2021
0-19|~|~|~|Malignant|~|40157719|Female|Pineal parenchymal|2021
0-19|~|~|~|Benign/Borderline|~|40107942|Female|Pineal parenchymal|2022
0-19|~|~|~|Malignant|~|40107942|Female|Pineal parenchymal|2022
0-19|~|~|~|Benign/Borderline|~|40095974|Female|Pineal parenchymal|2023
0-19|0.0|0.1|0.0|Malignant|16|40095974|Female|Pineal parenchymal|2023
0-19|0.6|0.8|0.7|Benign/Borderline|294|39865121|Female|Pituitary|2004
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004
0-19|0.7|0.9|0.8|Benign/Borderline|343|39998876|Female|Pituitary|2005
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005
0-19|0.8|1.0|0.9|Benign/Borderline|382|40165421|Female|Pituitary|2006
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006
0-19|0.8|1.0|0.9|Benign/Borderline|370|40382360|Female|Pituitary|2007
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007
0-19|0.9|1.1|1.0|Benign/Borderline|439|40576293|Female|Pituitary|2008
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008
0-19|0.9|1.1|1.0|Benign/Borderline|437|40670476|Female|Pituitary|2009
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009
0-19|1.1|1.3|1.2|Benign/Borderline|495|40652257|Female|Pituitary|2010
0-19|~|~|~|Malignant|~|40652257|Female|Pituitary|2010
0-19|1.1|1.3|1.2|Benign/Borderline|492|40557037|Female|Pituitary|2011
0-19|~|~|~|Malignant|~|40557037|Female|Pituitary|2011
0-19|1.2|1.4|1.3|Benign/Borderline|542|40480081|Female|Pituitary|2012
0-19|~|~|~|Malignant|~|40480081|Female|Pituitary|2012
0-19|1.2|1.4|1.3|Benign/Borderline|536|40460487|Female|Pituitary|2013
0-19|~|~|~|Malignant|~|40460487|Female|Pituitary|2013
0-19|1.3|1.5|1.4|Benign/Borderline|583|40479388|Female|Pituitary|2014
0-19|~|~|~|Malignant|~|40479388|Female|Pituitary|2014
0-19|1.3|1.5|1.4|Benign/Borderline|586|40552408|Female|Pituitary|2015
0-19|~|~|~|Malignant|~|40552408|Female|Pituitary|2015
0-19|1.4|1.7|1.6|Benign/Borderline|646|40654446|Female|Pituitary|2016
0-19|~|~|~|Malignant|~|40654446|Female|Pituitary|2016
0-19|1.6|1.8|1.7|Benign/Borderline|694|40708069|Female|Pituitary|2017
0-19|~|~|~|Malignant|~|40708069|Female|Pituitary|2017
0-19|1.5|1.7|1.6|Benign/Borderline|669|40711461|Female|Pituitary|2018
0-19|~|~|~|Malignant|~|40711461|Female|Pituitary|2018
0-19|1.5|1.7|1.6|Benign/Borderline|668|40657090|Female|Pituitary|2019
0-19|~|~|~|Malignant|~|40657090|Female|Pituitary|2019
0-19|1.5|1.6|1.5|Benign/Borderline|3195|201507280|Female|Pituitary|2019-2023
0-19|0.0|0.0|0.0|Malignant|38|201507280|Female|Pituitary|2019-2023
0-19|1.4|1.7|1.5|Benign/Borderline|635|40488555|Female|Pituitary|2020
0-19|~|~|~|Malignant|~|40488555|Female|Pituitary|2020
0-19|1.6|1.8|1.7|Benign/Borderline|694|40157719|Female|Pituitary|2021
0-19|~|~|~|Malignant|~|40157719|Female|Pituitary|2021
0-19|1.4|1.6|1.5|Benign/Borderline|628|40107942|Female|Pituitary|2022
0-19|~|~|~|Malignant|~|40107942|Female|Pituitary|2022
0-19|1.2|1.5|1.3|Benign/Borderline|570|40095974|Female|Pituitary|2023
0-19|0.1|0.1|0.1|Malignant|35|40095974|Female|Pituitary|2023
0-19|1.9|2.2|2.1|Benign/Borderline|831|39865121|Female|Total|2004
0-19|3.1|3.5|3.3|Malignant|1309|39865121|Female|Total|2004
0-19|2.3|2.6|2.5|Benign/Borderline|995|39998876|Female|Total|2005
0-19|2.9|3.3|3.1|Malignant|1243|39998876|Female|Total|2005
0-19|2.3|2.6|2.5|Benign/Borderline|1011|40165421|Female|Total|2006
0-19|2.9|3.3|3.1|Malignant|1245|40165421|Female|Total|2006
0-19|2.4|2.7|2.5|Benign/Borderline|1035|40382360|Female|Total|2007
0-19|3.1|3.4|3.3|Malignant|1308|40382360|Female|Total|2007
0-19|2.6|2.9|2.7|Benign/Borderline|1129|40576293|Female|Total|2008
0-19|3.0|3.4|3.2|Malignant|1298|40576293|Female|Total|2008
0-19|2.6|2.9|2.8|Benign/Borderline|1148|40670476|Female|Total|2009
0-19|3.1|3.4|3.2|Malignant|1306|40670476|Female|Total|2009
0-19|2.8|3.1|3.0|Benign/Borderline|1225|40652257|Female|Total|2010
0-19|3.1|3.4|3.2|Malignant|1311|40652257|Female|Total|2010
0-19|2.9|3.2|3.0|Benign/Borderline|1251|40557037|Female|Total|2011
0-19|3.2|3.5|3.4|Malignant|1359|40557037|Female|Total|2011
0-19|3.1|3.4|3.3|Benign/Borderline|1333|40480081|Female|Total|2012
0-19|2.9|3.3|3.1|Malignant|1252|40480081|Female|Total|2012
0-19|3.2|3.5|3.4|Benign/Borderline|1365|40460487|Female|Total|2013
0-19|3.2|3.6|3.4|Malignant|1367|40460487|Female|Total|2013
0-19|3.2|3.6|3.4|Benign/Borderline|1379|40479388|Female|Total|2014
0-19|3.3|3.6|3.5|Malignant|1398|40479388|Female|Total|2014
0-19|3.3|3.6|3.5|Benign/Borderline|1414|40552408|Female|Total|2015
0-19|3.1|3.4|3.2|Malignant|1307|40552408|Female|Total|2015
0-19|3.3|3.7|3.5|Benign/Borderline|1434|40654446|Female|Total|2016
0-19|3.1|3.4|3.2|Malignant|1308|40654446|Female|Total|2016
0-19|3.4|3.8|3.6|Benign/Borderline|1470|40708069|Female|Total|2017
0-19|3.2|3.5|3.4|Malignant|1364|40708069|Female|Total|2017
0-19|3.4|3.7|3.5|Benign/Borderline|1457|40711461|Female|Total|2018
0-19|2.7|3.1|2.9|Malignant|1174|40711461|Female|Total|2018
0-19|3.2|3.6|3.4|Benign/Borderline|1399|40657090|Female|Total|2019
0-19|2.5|2.8|2.6|Malignant|1056|40657090|Female|Total|2019
0-19|3.4|3.6|3.5|Benign/Borderline|7194|201507280|Female|Total|2019-2023
0-19|2.3|2.4|2.3|Malignant|4693|201507280|Female|Total|2019-2023
0-19|3.2|3.5|3.3|Benign/Borderline|1365|40488555|Female|Total|2020
0-19|2.4|2.7|2.5|Malignant|1010|40488555|Female|Total|2020
0-19|3.4|3.7|3.6|Benign/Borderline|1451|40157719|Female|Total|2021
0-19|2.4|2.7|2.6|Malignant|1028|40157719|Female|Total|2021
0-19|3.2|3.5|3.3|Benign/Borderline|1368|40107942|Female|Total|2022
0-19|2.2|2.5|2.4|Malignant|941|40107942|Female|Total|2022
0-19|3.8|4.1|3.9|Benign/Borderline|1611|40095974|Female|Total|2023
0-19|1.5|1.8|1.6|Malignant|658|40095974|Female|Total|2023
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005
0-19|0.3|0.5|0.4|Benign/Borderline|164|40165421|Female|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.4|0.3|Benign/Borderline|137|40382360|Female|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|150|40576293|Female|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|40652257|Female|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|40652257|Female|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.3|Benign/Borderline|139|40557037|Female|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|40557037|Female|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|147|40480081|Female|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|40480081|Female|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.5|0.4|Benign/Borderline|158|40460487|Female|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|40460487|Female|Tumors of Cranial and Spinal Nerves|2013
0-19|0.2|0.3|0.3|Benign/Borderline|112|40479388|Female|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|40479388|Female|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.5|0.4|Benign/Borderline|160|40552408|Female|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|40552408|Female|Tumors of Cranial and Spinal Nerves|2015
0-19|0.3|0.4|0.3|Benign/Borderline|132|40654446|Female|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|40654446|Female|Tumors of Cranial and Spinal Nerves|2016
0-19|0.3|0.4|0.3|Benign/Borderline|139|40708069|Female|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|40708069|Female|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.2|0.2|Benign/Borderline|82|40711461|Female|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|40711461|Female|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.2|0.2|Benign/Borderline|82|40657090|Female|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|40657090|Female|Tumors of Cranial and Spinal Nerves|2019
0-19|0.2|0.2|0.2|Benign/Borderline|403|201507280|Female|Tumors of Cranial and Spinal Nerves|2019-2023
0-19|~|~|~|Malignant|~|201507280|Female|Tumors of Cranial and Spinal Nerves|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|78|40488555|Female|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|40488555|Female|Tumors of Cranial and Spinal Nerves|2020
0-19|0.2|0.3|0.2|Benign/Borderline|86|40157719|Female|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|40157719|Female|Tumors of Cranial and Spinal Nerves|2021
0-19|0.1|0.2|0.2|Benign/Borderline|76|40107942|Female|Tumors of Cranial and Spinal Nerves|2022
0-19|~|~|~|Malignant|~|40107942|Female|Tumors of Cranial and Spinal Nerves|2022
0-19|0.2|0.2|0.2|Benign/Borderline|81|40095974|Female|Tumors of Cranial and Spinal Nerves|2023
0-19|~|~|~|Malignant|~|40095974|Female|Tumors of Cranial and Spinal Nerves|2023
0-19|0.4|0.6|0.5|Benign/Borderline|193|39865121|Female|Tumors of Neuroepthelial Tissue|2004
0-19|2.9|3.2|3.0|Malignant|1211|39865121|Female|Tumors of Neuroepthelial Tissue|2004
0-19|0.4|0.6|0.5|Benign/Borderline|202|39998876|Female|Tumors of Neuroepthelial Tissue|2005
0-19|2.7|3.1|2.9|Malignant|1153|39998876|Female|Tumors of Neuroepthelial Tissue|2005
0-19|0.4|0.6|0.5|Benign/Borderline|208|40165421|Female|Tumors of Neuroepthelial Tissue|2006
0-19|2.8|3.1|2.9|Malignant|1172|40165421|Female|Tumors of Neuroepthelial Tissue|2006
0-19|0.5|0.7|0.6|Benign/Borderline|233|40382360|Female|Tumors of Neuroepthelial Tissue|2007
0-19|2.9|3.3|3.1|Malignant|1246|40382360|Female|Tumors of Neuroepthelial Tissue|2007
0-19|0.5|0.6|0.6|Benign/Borderline|231|40576293|Female|Tumors of Neuroepthelial Tissue|2008
0-19|2.9|3.3|3.1|Malignant|1244|40576293|Female|Tumors of Neuroepthelial Tissue|2008
0-19|0.5|0.6|0.5|Benign/Borderline|219|40670476|Female|Tumors of Neuroepthelial Tissue|2009
0-19|2.9|3.2|3.0|Malignant|1226|40670476|Female|Tumors of Neuroepthelial Tissue|2009
0-19|0.5|0.7|0.6|Benign/Borderline|236|40652257|Female|Tumors of Neuroepthelial Tissue|2010
0-19|2.9|3.2|3.0|Malignant|1231|40652257|Female|Tumors of Neuroepthelial Tissue|2010
0-19|0.5|0.7|0.6|Benign/Borderline|251|40557037|Female|Tumors of Neuroepthelial Tissue|2011
0-19|3.0|3.3|3.2|Malignant|1282|40557037|Female|Tumors of Neuroepthelial Tissue|2011
0-19|0.6|0.7|0.6|Benign/Borderline|261|40480081|Female|Tumors of Neuroepthelial Tissue|2012
0-19|2.8|3.1|2.9|Malignant|1192|40480081|Female|Tumors of Neuroepthelial Tissue|2012
0-19|0.6|0.8|0.7|Benign/Borderline|276|40460487|Female|Tumors of Neuroepthelial Tissue|2013
0-19|3.0|3.3|3.2|Malignant|1277|40460487|Female|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.7|0.7|Benign/Borderline|264|40479388|Female|Tumors of Neuroepthelial Tissue|2014
0-19|3.1|3.5|3.3|Malignant|1326|40479388|Female|Tumors of Neuroepthelial Tissue|2014
0-19|0.6|0.7|0.7|Benign/Borderline|268|40552408|Female|Tumors of Neuroepthelial Tissue|2015
0-19|2.9|3.2|3.0|Malignant|1223|40552408|Female|Tumors of Neuroepthelial Tissue|2015
0-19|0.6|0.8|0.7|Benign/Borderline|291|40654446|Female|Tumors of Neuroepthelial Tissue|2016
0-19|2.8|3.1|3.0|Malignant|1205|40654446|Female|Tumors of Neuroepthelial Tissue|2016
0-19|0.6|0.8|0.7|Benign/Borderline|290|40708069|Female|Tumors of Neuroepthelial Tissue|2017
0-19|3.0|3.3|3.2|Malignant|1283|40708069|Female|Tumors of Neuroepthelial Tissue|2017
0-19|0.8|1.0|0.9|Benign/Borderline|348|40711461|Female|Tumors of Neuroepthelial Tissue|2018
0-19|2.5|2.8|2.7|Malignant|1087|40711461|Female|Tumors of Neuroepthelial Tissue|2018
0-19|0.7|0.9|0.8|Benign/Borderline|313|40657090|Female|Tumors of Neuroepthelial Tissue|2019
0-19|2.3|2.6|2.4|Malignant|978|40657090|Female|Tumors of Neuroepthelial Tissue|2019
0-19|0.9|1.0|1.0|Benign/Borderline|1908|201507280|Female|Tumors of Neuroepthelial Tissue|2019-2023
0-19|2.0|2.2|2.1|Malignant|4221|201507280|Female|Tumors of Neuroepthelial Tissue|2019-2023
0-19|0.7|0.9|0.8|Benign/Borderline|314|40488555|Female|Tumors of Neuroepthelial Tissue|2020
0-19|2.1|2.4|2.3|Malignant|918|40488555|Female|Tumors of Neuroepthelial Tissue|2020
0-19|0.7|0.8|0.7|Benign/Borderline|292|40157719|Female|Tumors of Neuroepthelial Tissue|2021
0-19|2.2|2.5|2.3|Malignant|936|40157719|Female|Tumors of Neuroepthelial Tissue|2021
0-19|0.8|1.0|0.9|Benign/Borderline|350|40107942|Female|Tumors of Neuroepthelial Tissue|2022
0-19|2.0|2.3|2.2|Malignant|861|40107942|Female|Tumors of Neuroepthelial Tissue|2022
0-19|1.5|1.7|1.6|Benign/Borderline|639|40095974|Female|Tumors of Neuroepthelial Tissue|2023
0-19|1.2|1.4|1.3|Malignant|528|40095974|Female|Tumors of Neuroepthelial Tissue|2023
0-19|0.8|1.0|0.9|Benign/Borderline|379|39865121|Female|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004
0-19|0.9|1.1|1.0|Benign/Borderline|421|39998876|Female|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005
0-19|1.0|1.2|1.1|Benign/Borderline|459|40165421|Female|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006
0-19|1.0|1.2|1.1|Benign/Borderline|466|40382360|Female|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007
0-19|1.1|1.3|1.2|Benign/Borderline|507|40576293|Female|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008
0-19|1.2|1.4|1.3|Benign/Borderline|528|40670476|Female|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009
0-19|1.3|1.5|1.4|Benign/Borderline|591|40652257|Female|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|40652257|Female|Tumors of Sellar Region|2010
0-19|1.3|1.5|1.4|Benign/Borderline|579|40557037|Female|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|40557037|Female|Tumors of Sellar Region|2011
0-19|1.4|1.6|1.5|Benign/Borderline|620|40480081|Female|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|40480081|Female|Tumors of Sellar Region|2012
0-19|1.4|1.7|1.5|Benign/Borderline|625|40460487|Female|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|40460487|Female|Tumors of Sellar Region|2013
0-19|1.5|1.8|1.7|Benign/Borderline|678|40479388|Female|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|40479388|Female|Tumors of Sellar Region|2014
0-19|1.5|1.8|1.6|Benign/Borderline|668|40552408|Female|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|40552408|Female|Tumors of Sellar Region|2015
0-19|1.6|1.9|1.7|Benign/Borderline|715|40654446|Female|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|40654446|Female|Tumors of Sellar Region|2016
0-19|1.7|2.0|1.9|Benign/Borderline|774|40708069|Female|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|40708069|Female|Tumors of Sellar Region|2017
0-19|1.6|1.9|1.7|Benign/Borderline|725|40711461|Female|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|40711461|Female|Tumors of Sellar Region|2018
0-19|1.7|2.0|1.8|Benign/Borderline|755|40657090|Female|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|40657090|Female|Tumors of Sellar Region|2019
0-19|1.7|1.8|1.7|Benign/Borderline|3573|201507280|Female|Tumors of Sellar Region|2019-2023
0-19|0.0|0.0|0.0|Malignant|38|201507280|Female|Tumors of Sellar Region|2019-2023
0-19|1.6|1.8|1.7|Benign/Borderline|707|40488555|Female|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|40488555|Female|Tumors of Sellar Region|2020
0-19|1.7|2.0|1.9|Benign/Borderline|774|40157719|Female|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|40157719|Female|Tumors of Sellar Region|2021
0-19|1.6|1.8|1.7|Benign/Borderline|697|40107942|Female|Tumors of Sellar Region|2022
0-19|~|~|~|Malignant|~|40107942|Female|Tumors of Sellar Region|2022
0-19|1.4|1.6|1.5|Benign/Borderline|640|40095974|Female|Tumors of Sellar Region|2023
0-19|0.1|0.1|0.1|Malignant|35|40095974|Female|Tumors of Sellar Region|2023
0-19|0.1|0.2|0.2|Benign/Borderline|74|39865121|Female|Tumors of the Meninges|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004
0-19|0.2|0.3|0.3|Benign/Borderline|111|39998876|Female|Tumors of the Meninges|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005
0-19|0.1|0.2|0.2|Benign/Borderline|77|40165421|Female|Tumors of the Meninges|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006
0-19|0.2|0.3|0.2|Benign/Borderline|97|40382360|Female|Tumors of the Meninges|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|94|40576293|Female|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008
0-19|0.2|0.3|0.3|Benign/Borderline|109|40670476|Female|Tumors of the Meninges|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|101|40652257|Female|Tumors of the Meninges|2010
0-19|~|~|~|Malignant|~|40652257|Female|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|117|40557037|Female|Tumors of the Meninges|2011
0-19|~|~|~|Malignant|~|40557037|Female|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|141|40480081|Female|Tumors of the Meninges|2012
0-19|~|~|~|Malignant|~|40480081|Female|Tumors of the Meninges|2012
0-19|0.3|0.4|0.3|Benign/Borderline|142|40460487|Female|Tumors of the Meninges|2013
0-19|~|~|~|Malignant|~|40460487|Female|Tumors of the Meninges|2013
0-19|0.3|0.4|0.4|Benign/Borderline|153|40479388|Female|Tumors of the Meninges|2014
0-19|~|~|~|Malignant|~|40479388|Female|Tumors of the Meninges|2014
0-19|0.3|0.4|0.3|Benign/Borderline|141|40552408|Female|Tumors of the Meninges|2015
0-19|~|~|~|Malignant|~|40552408|Female|Tumors of the Meninges|2015
0-19|0.3|0.4|0.4|Benign/Borderline|152|40654446|Female|Tumors of the Meninges|2016
0-19|~|~|~|Malignant|~|40654446|Female|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|133|40708069|Female|Tumors of the Meninges|2017
0-19|~|~|~|Malignant|~|40708069|Female|Tumors of the Meninges|2017
0-19|0.3|0.4|0.4|Benign/Borderline|145|40711461|Female|Tumors of the Meninges|2018
0-19|~|~|~|Malignant|~|40711461|Female|Tumors of the Meninges|2018
0-19|0.3|0.4|0.3|Benign/Borderline|130|40657090|Female|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|40657090|Female|Tumors of the Meninges|2019
0-19|0.3|0.4|0.3|Benign/Borderline|690|201507280|Female|Tumors of the Meninges|2019-2023
0-19|0.0|0.0|0.0|Malignant|49|201507280|Female|Tumors of the Meninges|2019-2023
0-19|0.3|0.4|0.3|Benign/Borderline|130|40488555|Female|Tumors of the Meninges|2020
0-19|~|~|~|Malignant|~|40488555|Female|Tumors of the Meninges|2020
0-19|0.4|0.5|0.4|Benign/Borderline|167|40157719|Female|Tumors of the Meninges|2021
0-19|~|~|~|Malignant|~|40157719|Female|Tumors of the Meninges|2021
0-19|0.3|0.4|0.3|Benign/Borderline|123|40107942|Female|Tumors of the Meninges|2022
0-19|~|~|~|Malignant|~|40107942|Female|Tumors of the Meninges|2022
0-19|0.3|0.4|0.3|Benign/Borderline|140|40095974|Female|Tumors of the Meninges|2023
0-19|~|~|~|Malignant|~|40095974|Female|Tumors of the Meninges|2023
0-19|0.1|0.2|0.1|Benign/Borderline|55|39865121|Female|Unclassified Tumors|2004
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004
0-19|0.2|0.2|0.2|Benign/Borderline|81|39998876|Female|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|85|40165421|Female|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|29|40165421|Female|Unclassified Tumors|2006
0-19|0.2|0.3|0.2|Benign/Borderline|87|40382360|Female|Unclassified Tumors|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Unclassified Tumors|2007
0-19|0.3|0.4|0.3|Benign/Borderline|127|40576293|Female|Unclassified Tumors|2008
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008
0-19|0.2|0.3|0.3|Benign/Borderline|116|40670476|Female|Unclassified Tumors|2009
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|40652257|Female|Unclassified Tumors|2010
0-19|~|~|~|Malignant|~|40652257|Female|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|142|40557037|Female|Unclassified Tumors|2011
0-19|0.0|0.1|0.0|Malignant|18|40557037|Female|Unclassified Tumors|2011
0-19|0.3|0.4|0.4|Benign/Borderline|147|40480081|Female|Unclassified Tumors|2012
0-19|0.0|0.1|0.1|Malignant|23|40480081|Female|Unclassified Tumors|2012
0-19|0.3|0.4|0.4|Benign/Borderline|142|40460487|Female|Unclassified Tumors|2013
0-19|0.0|0.1|0.1|Malignant|25|40460487|Female|Unclassified Tumors|2013
0-19|0.3|0.4|0.4|Benign/Borderline|149|40479388|Female|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|21|40479388|Female|Unclassified Tumors|2014
0-19|0.3|0.5|0.4|Benign/Borderline|159|40552408|Female|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|18|40552408|Female|Unclassified Tumors|2015
0-19|0.2|0.3|0.3|Benign/Borderline|116|40654446|Female|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|25|40654446|Female|Unclassified Tumors|2016
0-19|0.2|0.3|0.3|Benign/Borderline|119|40708069|Female|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|21|40708069|Female|Unclassified Tumors|2017
0-19|0.3|0.4|0.3|Benign/Borderline|133|40711461|Female|Unclassified Tumors|2018
0-19|0.0|0.1|0.1|Malignant|28|40711461|Female|Unclassified Tumors|2018
0-19|0.2|0.3|0.2|Benign/Borderline|102|40657090|Female|Unclassified Tumors|2019
0-19|~|~|~|Malignant|~|40657090|Female|Unclassified Tumors|2019
0-19|0.2|0.3|0.3|Benign/Borderline|544|201507280|Female|Unclassified Tumors|2019-2023
0-19|0.0|0.1|0.1|Malignant|119|201507280|Female|Unclassified Tumors|2019-2023
0-19|0.2|0.4|0.3|Benign/Borderline|122|40488555|Female|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|26|40488555|Female|Unclassified Tumors|2020
0-19|0.2|0.4|0.3|Benign/Borderline|120|40157719|Female|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Malignant|28|40157719|Female|Unclassified Tumors|2021
0-19|0.2|0.3|0.3|Benign/Borderline|107|40107942|Female|Unclassified Tumors|2022
0-19|0.0|0.1|0.1|Malignant|26|40107942|Female|Unclassified Tumors|2022
0-19|0.2|0.3|0.2|Benign/Borderline|93|40095974|Female|Unclassified Tumors|2023
0-19|0.0|0.1|0.1|Malignant|25|40095974|Female|Unclassified Tumors|2023
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.1|Benign/Borderline|25|39998876|Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Malignant|36|40382360|Female|Unique astrocytoma variants|2007
0-19|0.0|0.1|0.1|Benign/Borderline|27|40576293|Female|Unique astrocytoma variants|2008
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|36|40670476|Female|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|21|40670476|Female|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|33|40652257|Female|Unique astrocytoma variants|2010
0-19|~|~|~|Malignant|~|40652257|Female|Unique astrocytoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|21|40557037|Female|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|24|40557037|Female|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|35|40480081|Female|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.0|Malignant|19|40480081|Female|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|40|40460487|Female|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.0|Malignant|18|40460487|Female|Unique astrocytoma variants|2013
0-19|0.1|0.1|0.1|Benign/Borderline|45|40479388|Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.0|Malignant|16|40479388|Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|24|40552408|Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|26|40552408|Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Benign/Borderline|26|40654446|Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|21|40654446|Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Benign/Borderline|26|40708069|Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Malignant|26|40708069|Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Benign/Borderline|28|40711461|Female|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|24|40711461|Female|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|32|40657090|Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.0|Malignant|19|40657090|Female|Unique astrocytoma variants|2019
0-19|0.1|0.1|0.1|Benign/Borderline|139|201507280|Female|Unique astrocytoma variants|2019-2023
0-19|0.0|0.1|0.1|Malignant|120|201507280|Female|Unique astrocytoma variants|2019-2023
0-19|0.0|0.1|0.1|Benign/Borderline|28|40488555|Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.1|Malignant|22|40488555|Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.1|Benign/Borderline|23|40157719|Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Malignant|24|40157719|Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Benign/Borderline|28|40107942|Female|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.1|Malignant|26|40107942|Female|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.1|Benign/Borderline|28|40095974|Female|Unique astrocytoma variants|2023
0-19|0.0|0.1|0.1|Malignant|29|40095974|Female|Unique astrocytoma variants|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|All other|2010
0-19|~|~|~|Malignant|~|42572815|Male|All other|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|All other|2011
0-19|~|~|~|Malignant|~|42485770|Male|All other|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|All other|2012
0-19|~|~|~|Malignant|~|42389392|Male|All other|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|All other|2013
0-19|~|~|~|Malignant|~|42341913|Male|All other|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|All other|2014
0-19|~|~|~|Malignant|~|42354730|Male|All other|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|All other|2015
0-19|~|~|~|Malignant|~|42429306|Male|All other|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|All other|2016
0-19|~|~|~|Malignant|~|42538623|Male|All other|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|All other|2017
0-19|~|~|~|Malignant|~|42610191|Male|All other|2017
0-19|0.0|0.1|0.1|Benign/Borderline|26|42621973|Male|All other|2018
0-19|0.3|0.4|0.3|Malignant|135|42621973|Male|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|40|42569598|Male|All other|2019
0-19|0.3|0.4|0.4|Malignant|157|42569598|Male|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|227|211020485|Male|All other|2019-2023
0-19|0.5|0.5|0.5|Malignant|1082|211020485|Male|All other|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|38|42398074|Male|All other|2020
0-19|0.3|0.4|0.4|Malignant|154|42398074|Male|All other|2020
0-19|0.1|0.2|0.1|Benign/Borderline|50|42055125|Male|All other|2021
0-19|0.4|0.6|0.5|Malignant|200|42055125|Male|All other|2021
0-19|0.1|0.2|0.1|Benign/Borderline|48|42005478|Male|All other|2022
0-19|0.5|0.7|0.6|Malignant|245|42005478|Male|All other|2022
0-19|0.1|0.2|0.1|Benign/Borderline|51|41992210|Male|All other|2023
0-19|0.7|0.9|0.8|Malignant|326|41992210|Male|All other|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|36|42158997|Male|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007
0-19|0.1|0.2|0.1|Malignant|56|42367071|Male|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|41|42609915|Male|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|44|42572815|Male|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|33|42485770|Male|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Anaplastic astrocytoma|2012
0-19|0.1|0.1|0.1|Malignant|45|42389392|Male|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Anaplastic astrocytoma|2013
0-19|0.1|0.1|0.1|Malignant|45|42341913|Male|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Anaplastic astrocytoma|2014
0-19|0.1|0.2|0.1|Malignant|56|42354730|Male|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|46|42429306|Male|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|45|42538623|Male|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Anaplastic astrocytoma|2017
0-19|0.1|0.1|0.1|Malignant|34|42610191|Male|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Anaplastic astrocytoma|2018
0-19|0.1|0.1|0.1|Malignant|38|42621973|Male|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Anaplastic astrocytoma|2019
0-19|0.1|0.1|0.1|Malignant|38|42569598|Male|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Anaplastic astrocytoma|2019-2023
0-19|0.0|0.1|0.0|Malignant|102|211020485|Male|Anaplastic astrocytoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|29|42398074|Male|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Anaplastic astrocytoma|2021
0-19|0.0|0.1|0.0|Malignant|19|42055125|Male|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Anaplastic astrocytoma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Anaplastic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Anaplastic astrocytoma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Anaplastic astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|42572815|Male|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|42485770|Male|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|42389392|Male|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|42341913|Male|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|42354730|Male|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|42429306|Male|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|42538623|Male|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Anaplastic oligodendroglioma|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Anaplastic oligodendroglioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Anaplastic oligodendroglioma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Anaplastic oligodendroglioma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.3|Malignant|108|41889233|Male|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|97|42006384|Male|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.3|Malignant|108|42158997|Male|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|95|42541971|Male|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|106|42609915|Male|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.3|Malignant|122|42572815|Male|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Astrocytoma, NOS|2011
0-19|0.2|0.3|0.2|Malignant|104|42485770|Male|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Astrocytoma, NOS|2012
0-19|0.2|0.2|0.2|Malignant|82|42389392|Male|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|94|42341913|Male|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|113|42354730|Male|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Astrocytoma, NOS|2015
0-19|0.2|0.3|0.2|Malignant|96|42429306|Male|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Astrocytoma, NOS|2016
0-19|0.2|0.3|0.2|Malignant|91|42538623|Male|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Astrocytoma, NOS|2017
0-19|0.2|0.3|0.3|Malignant|107|42610191|Male|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Astrocytoma, NOS|2018
0-19|0.2|0.3|0.2|Malignant|92|42621973|Male|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Astrocytoma, NOS|2019
0-19|0.1|0.2|0.2|Malignant|76|42569598|Male|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Astrocytoma, NOS|2019-2023
0-19|0.1|0.2|0.1|Malignant|308|211020485|Male|Astrocytoma, NOS|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Astrocytoma, NOS|2020
0-19|0.1|0.2|0.1|Malignant|50|42398074|Male|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|71|42055125|Male|Astrocytoma, NOS|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Astrocytoma, NOS|2022
0-19|0.1|0.2|0.2|Malignant|68|42005478|Male|Astrocytoma, NOS|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Astrocytoma, NOS|2023
0-19|0.1|0.1|0.1|Malignant|43|41992210|Male|Astrocytoma, NOS|2023
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005
0-19|0.1|0.1|0.1|Benign/Borderline|41|42158997|Male|Choroid plexus|2006
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009
0-19|0.1|0.1|0.1|Benign/Borderline|40|42572815|Male|Choroid plexus|2010
0-19|0.0|0.1|0.0|Malignant|17|42572815|Male|Choroid plexus|2010
0-19|0.1|0.1|0.1|Benign/Borderline|34|42485770|Male|Choroid plexus|2011
0-19|~|~|~|Malignant|~|42485770|Male|Choroid plexus|2011
0-19|0.1|0.1|0.1|Benign/Borderline|36|42389392|Male|Choroid plexus|2012
0-19|~|~|~|Malignant|~|42389392|Male|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|38|42341913|Male|Choroid plexus|2013
0-19|~|~|~|Malignant|~|42341913|Male|Choroid plexus|2013
0-19|0.1|0.1|0.1|Benign/Borderline|36|42354730|Male|Choroid plexus|2014
0-19|~|~|~|Malignant|~|42354730|Male|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|35|42429306|Male|Choroid plexus|2015
0-19|0.0|0.1|0.0|Malignant|18|42429306|Male|Choroid plexus|2015
0-19|0.1|0.1|0.1|Benign/Borderline|38|42538623|Male|Choroid plexus|2016
0-19|~|~|~|Malignant|~|42538623|Male|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|32|42610191|Male|Choroid plexus|2017
0-19|~|~|~|Malignant|~|42610191|Male|Choroid plexus|2017
0-19|0.1|0.1|0.1|Benign/Borderline|42|42621973|Male|Choroid plexus|2018
0-19|~|~|~|Malignant|~|42621973|Male|Choroid plexus|2018
0-19|0.1|0.1|0.1|Benign/Borderline|34|42569598|Male|Choroid plexus|2019
0-19|0.0|0.1|0.0|Malignant|16|42569598|Male|Choroid plexus|2019
0-19|0.1|0.1|0.1|Benign/Borderline|170|211020485|Male|Choroid plexus|2019-2023
0-19|0.0|0.0|0.0|Malignant|57|211020485|Male|Choroid plexus|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|34|42398074|Male|Choroid plexus|2020
0-19|~|~|~|Malignant|~|42398074|Male|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|26|42055125|Male|Choroid plexus|2021
0-19|~|~|~|Malignant|~|42055125|Male|Choroid plexus|2021
0-19|0.1|0.1|0.1|Benign/Borderline|42|42005478|Male|Choroid plexus|2022
0-19|~|~|~|Malignant|~|42005478|Male|Choroid plexus|2022
0-19|0.1|0.1|0.1|Benign/Borderline|34|41992210|Male|Choroid plexus|2023
0-19|~|~|~|Malignant|~|41992210|Male|Choroid plexus|2023
0-19|0.2|0.3|0.2|Benign/Borderline|87|41889233|Male|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|89|42367071|Male|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007
0-19|0.2|0.3|0.2|Benign/Borderline|97|42541971|Male|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008
0-19|0.2|0.2|0.2|Benign/Borderline|83|42609915|Male|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009
0-19|0.2|0.2|0.2|Benign/Borderline|84|42572815|Male|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|42572815|Male|Craniopharyngioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|71|42485770|Male|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|42485770|Male|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|81|42389392|Male|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|42389392|Male|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|95|42341913|Male|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|42341913|Male|Craniopharyngioma|2013
0-19|0.2|0.3|0.3|Benign/Borderline|108|42354730|Male|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|42354730|Male|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|100|42429306|Male|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|42429306|Male|Craniopharyngioma|2015
0-19|0.2|0.2|0.2|Benign/Borderline|80|42538623|Male|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|42538623|Male|Craniopharyngioma|2016
0-19|0.2|0.3|0.2|Benign/Borderline|104|42610191|Male|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Craniopharyngioma|2017
0-19|0.2|0.3|0.2|Benign/Borderline|103|42621973|Male|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Craniopharyngioma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|80|42569598|Male|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Craniopharyngioma|2019
0-19|0.2|0.2|0.2|Benign/Borderline|415|211020485|Male|Craniopharyngioma|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Craniopharyngioma|2019-2023
0-19|0.1|0.2|0.1|Benign/Borderline|58|42398074|Male|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Craniopharyngioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|104|42055125|Male|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Craniopharyngioma|2021
0-19|0.2|0.3|0.2|Benign/Borderline|92|42005478|Male|Craniopharyngioma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Craniopharyngioma|2022
0-19|0.2|0.2|0.2|Benign/Borderline|81|41992210|Male|Craniopharyngioma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Craniopharyngioma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Diffuse astrocytoma|2010
0-19|~|~|~|Malignant|~|42572815|Male|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Diffuse astrocytoma|2011
0-19|0.0|0.1|0.1|Malignant|24|42485770|Male|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Diffuse astrocytoma|2012
0-19|0.0|0.1|0.0|Malignant|19|42389392|Male|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Diffuse astrocytoma|2013
0-19|~|~|~|Malignant|~|42341913|Male|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|42354730|Male|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|42429306|Male|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|42538623|Male|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Diffuse astrocytoma|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Diffuse astrocytoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Diffuse astrocytoma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Diffuse astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Diffuse astrocytoma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Diffuse astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004
0-19|0.6|0.8|0.7|Malignant|296|41889233|Male|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005
0-19|0.6|0.8|0.7|Malignant|277|42006384|Male|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006
0-19|0.6|0.8|0.7|Malignant|297|42158997|Male|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007
0-19|0.6|0.8|0.7|Malignant|296|42367071|Male|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008
0-19|0.7|0.8|0.8|Malignant|321|42541971|Male|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009
0-19|0.7|0.8|0.7|Malignant|311|42609915|Male|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Embryonal/primitive/medulloblastoma|2010
0-19|0.7|0.8|0.7|Malignant|316|42572815|Male|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Embryonal/primitive/medulloblastoma|2011
0-19|0.6|0.8|0.7|Malignant|302|42485770|Male|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Embryonal/primitive/medulloblastoma|2012
0-19|0.6|0.8|0.7|Malignant|285|42389392|Male|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Embryonal/primitive/medulloblastoma|2013
0-19|0.6|0.7|0.7|Malignant|274|42341913|Male|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Embryonal/primitive/medulloblastoma|2014
0-19|0.6|0.8|0.7|Malignant|283|42354730|Male|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Embryonal/primitive/medulloblastoma|2015
0-19|0.6|0.8|0.7|Malignant|300|42429306|Male|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Embryonal/primitive/medulloblastoma|2016
0-19|0.6|0.8|0.7|Malignant|288|42538623|Male|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Embryonal/primitive/medulloblastoma|2017
0-19|0.6|0.8|0.7|Malignant|303|42610191|Male|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Embryonal/primitive/medulloblastoma|2018
0-19|0.4|0.6|0.5|Malignant|203|42621973|Male|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Embryonal/primitive/medulloblastoma|2019
0-19|0.4|0.5|0.4|Malignant|175|42569598|Male|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Embryonal/primitive/medulloblastoma|2019-2023
0-19|0.4|0.4|0.4|Malignant|839|211020485|Male|Embryonal/primitive/medulloblastoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Embryonal/primitive/medulloblastoma|2020
0-19|0.4|0.6|0.5|Malignant|201|42398074|Male|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Embryonal/primitive/medulloblastoma|2021
0-19|0.4|0.5|0.4|Malignant|173|42055125|Male|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Embryonal/primitive/medulloblastoma|2022
0-19|0.3|0.5|0.4|Malignant|161|42005478|Male|Embryonal/primitive/medulloblastoma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Embryonal/primitive/medulloblastoma|2023
0-19|0.3|0.4|0.3|Malignant|129|41992210|Male|Embryonal/primitive/medulloblastoma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008
0-19|0.0|0.1|0.0|Benign/Borderline|21|42609915|Male|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009
0-19|0.0|0.1|0.1|Benign/Borderline|28|42572815|Male|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|42572815|Male|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|22|42485770|Male|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|42485770|Male|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|17|42389392|Male|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|42389392|Male|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|21|42341913|Male|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|42341913|Male|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|42354730|Male|Ependymoma variants|2014
0-19|0.0|0.1|0.0|Benign/Borderline|17|42429306|Male|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|42429306|Male|Ependymoma variants|2015
0-19|0.0|0.1|0.1|Benign/Borderline|23|42538623|Male|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|42538623|Male|Ependymoma variants|2016
0-19|0.0|0.1|0.1|Benign/Borderline|22|42610191|Male|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|42610191|Male|Ependymoma variants|2017
0-19|0.0|0.1|0.1|Benign/Borderline|26|42621973|Male|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|42621973|Male|Ependymoma variants|2018
0-19|0.0|0.1|0.1|Benign/Borderline|28|42569598|Male|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|42569598|Male|Ependymoma variants|2019
0-19|0.0|0.1|0.1|Benign/Borderline|122|211020485|Male|Ependymoma variants|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Ependymoma variants|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|21|42398074|Male|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|42398074|Male|Ependymoma variants|2020
0-19|0.0|0.1|0.1|Benign/Borderline|23|42055125|Male|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|42055125|Male|Ependymoma variants|2021
0-19|0.0|0.1|0.1|Benign/Borderline|27|42005478|Male|Ependymoma variants|2022
0-19|~|~|~|Malignant|~|42005478|Male|Ependymoma variants|2022
0-19|0.0|0.1|0.1|Benign/Borderline|23|41992210|Male|Ependymoma variants|2023
0-19|~|~|~|Malignant|~|41992210|Male|Ependymoma variants|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|104|41889233|Male|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|107|42006384|Male|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.3|Malignant|109|42158997|Male|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008
0-19|0.2|0.3|0.2|Malignant|96|42541971|Male|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.3|Malignant|120|42572815|Male|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.3|Malignant|113|42485770|Male|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.3|Malignant|116|42389392|Male|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.3|Malignant|115|42341913|Male|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.3|Malignant|110|42354730|Male|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.3|Malignant|114|42429306|Male|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.3|0.2|Malignant|102|42538623|Male|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.4|0.3|Malignant|126|42610191|Male|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Ependymoma/anaplastic ependymoma|2018
0-19|0.2|0.3|0.2|Malignant|101|42621973|Male|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Ependymoma/anaplastic ependymoma|2019
0-19|0.2|0.3|0.2|Malignant|103|42569598|Male|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Ependymoma/anaplastic ependymoma|2019-2023
0-19|0.2|0.2|0.2|Malignant|417|211020485|Male|Ependymoma/anaplastic ependymoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Ependymoma/anaplastic ependymoma|2020
0-19|0.2|0.3|0.2|Malignant|95|42398074|Male|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Ependymoma/anaplastic ependymoma|2021
0-19|0.2|0.2|0.2|Malignant|80|42055125|Male|Ependymoma/anaplastic ependymoma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Ependymoma/anaplastic ependymoma|2022
0-19|0.2|0.2|0.2|Malignant|81|42005478|Male|Ependymoma/anaplastic ependymoma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Ependymoma/anaplastic ependymoma|2023
0-19|0.1|0.2|0.1|Malignant|58|41992210|Male|Ependymoma/anaplastic ependymoma|2023
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004
0-19|0.0|0.1|0.1|Benign/Borderline|23|42006384|Male|Germ Cell Tumors|2005
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005
0-19|0.0|0.1|0.1|Benign/Borderline|29|42158997|Male|Germ Cell Tumors|2006
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Germ Cell Tumors|2007
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008
0-19|0.1|0.1|0.1|Benign/Borderline|33|42609915|Male|Germ Cell Tumors|2009
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|24|42572815|Male|Germ Cell Tumors|2010
0-19|0.2|0.3|0.3|Malignant|112|42572815|Male|Germ Cell Tumors|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Germ Cell Tumors|2011
0-19|0.2|0.3|0.2|Malignant|101|42485770|Male|Germ Cell Tumors|2011
0-19|0.0|0.1|0.1|Benign/Borderline|25|42389392|Male|Germ Cell Tumors|2012
0-19|0.2|0.3|0.3|Malignant|109|42389392|Male|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|27|42341913|Male|Germ Cell Tumors|2013
0-19|0.2|0.3|0.3|Malignant|111|42341913|Male|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|27|42354730|Male|Germ Cell Tumors|2014
0-19|0.2|0.3|0.2|Malignant|103|42354730|Male|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|20|42429306|Male|Germ Cell Tumors|2015
0-19|0.2|0.3|0.2|Malignant|105|42429306|Male|Germ Cell Tumors|2015
0-19|0.1|0.1|0.1|Benign/Borderline|34|42538623|Male|Germ Cell Tumors|2016
0-19|0.2|0.3|0.3|Malignant|111|42538623|Male|Germ Cell Tumors|2016
0-19|0.0|0.1|0.1|Benign/Borderline|25|42610191|Male|Germ Cell Tumors|2017
0-19|0.3|0.4|0.3|Malignant|132|42610191|Male|Germ Cell Tumors|2017
0-19|0.1|0.1|0.1|Benign/Borderline|34|42621973|Male|Germ Cell Tumors|2018
0-19|0.2|0.2|0.2|Malignant|86|42621973|Male|Germ Cell Tumors|2018
0-19|0.0|0.1|0.1|Benign/Borderline|24|42569598|Male|Germ Cell Tumors|2019
0-19|0.2|0.3|0.3|Malignant|109|42569598|Male|Germ Cell Tumors|2019
0-19|0.0|0.1|0.1|Benign/Borderline|105|211020485|Male|Germ Cell Tumors|2019-2023
0-19|0.2|0.3|0.2|Malignant|523|211020485|Male|Germ Cell Tumors|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Germ Cell Tumors|2020
0-19|0.2|0.3|0.2|Malignant|101|42398074|Male|Germ Cell Tumors|2020
0-19|0.0|0.1|0.1|Benign/Borderline|29|42055125|Male|Germ Cell Tumors|2021
0-19|0.2|0.3|0.3|Malignant|110|42055125|Male|Germ Cell Tumors|2021
0-19|0.0|0.1|0.0|Benign/Borderline|16|42005478|Male|Germ Cell Tumors|2022
0-19|0.2|0.3|0.2|Malignant|96|42005478|Male|Germ Cell Tumors|2022
0-19|0.0|0.1|0.1|Benign/Borderline|21|41992210|Male|Germ Cell Tumors|2023
0-19|0.2|0.3|0.2|Malignant|107|41992210|Male|Germ Cell Tumors|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004
0-19|0.1|0.2|0.2|Malignant|74|41889233|Male|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007
0-19|0.1|0.2|0.2|Malignant|68|42367071|Male|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|68|42541971|Male|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009
0-19|0.2|0.2|0.2|Malignant|83|42609915|Male|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Glioblastoma|2010
0-19|0.1|0.2|0.2|Malignant|68|42572815|Male|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Glioblastoma|2011
0-19|0.2|0.2|0.2|Malignant|84|42485770|Male|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Glioblastoma|2012
0-19|0.1|0.2|0.2|Malignant|79|42389392|Male|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Glioblastoma|2013
0-19|0.2|0.3|0.2|Malignant|91|42341913|Male|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|77|42354730|Male|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Glioblastoma|2015
0-19|0.2|0.2|0.2|Malignant|81|42429306|Male|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Glioblastoma|2016
0-19|0.1|0.2|0.2|Malignant|79|42538623|Male|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|73|42610191|Male|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Glioblastoma|2018
0-19|0.1|0.2|0.2|Malignant|79|42621973|Male|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Glioblastoma|2019
0-19|0.1|0.2|0.2|Malignant|71|42569598|Male|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Glioblastoma|2019-2023
0-19|0.1|0.1|0.1|Malignant|257|211020485|Male|Glioblastoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Glioblastoma|2020
0-19|0.1|0.2|0.2|Malignant|65|42398074|Male|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Glioblastoma|2021
0-19|0.1|0.2|0.1|Malignant|60|42055125|Male|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Glioblastoma|2022
0-19|0.1|0.1|0.1|Malignant|37|42005478|Male|Glioblastoma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Glioblastoma|2023
0-19|0.0|0.1|0.1|Malignant|24|41992210|Male|Glioblastoma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004
0-19|0.5|0.6|0.6|Malignant|230|41889233|Male|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005
0-19|0.5|0.6|0.5|Malignant|222|42006384|Male|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006
0-19|0.5|0.7|0.6|Malignant|244|42158997|Male|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007
0-19|0.5|0.7|0.6|Malignant|249|42367071|Male|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008
0-19|0.6|0.7|0.6|Malignant|270|42541971|Male|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009
0-19|0.6|0.7|0.7|Malignant|275|42609915|Male|Glioma malignant, NOS|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Glioma malignant, NOS|2010
0-19|0.6|0.8|0.7|Malignant|282|42572815|Male|Glioma malignant, NOS|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Glioma malignant, NOS|2011
0-19|0.6|0.8|0.7|Malignant|286|42485770|Male|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|18|42389392|Male|Glioma malignant, NOS|2012
0-19|0.6|0.8|0.7|Malignant|290|42389392|Male|Glioma malignant, NOS|2012
0-19|0.0|0.1|0.0|Benign/Borderline|20|42341913|Male|Glioma malignant, NOS|2013
0-19|0.6|0.7|0.6|Malignant|273|42341913|Male|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.1|Benign/Borderline|25|42354730|Male|Glioma malignant, NOS|2014
0-19|0.6|0.7|0.6|Malignant|269|42354730|Male|Glioma malignant, NOS|2014
0-19|0.0|0.1|0.1|Benign/Borderline|23|42429306|Male|Glioma malignant, NOS|2015
0-19|0.7|0.8|0.7|Malignant|316|42429306|Male|Glioma malignant, NOS|2015
0-19|0.1|0.1|0.1|Benign/Borderline|33|42538623|Male|Glioma malignant, NOS|2016
0-19|0.7|0.8|0.7|Malignant|309|42538623|Male|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|23|42610191|Male|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|342|42610191|Male|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.1|Benign/Borderline|28|42621973|Male|Glioma malignant, NOS|2018
0-19|0.5|0.6|0.5|Malignant|230|42621973|Male|Glioma malignant, NOS|2018
0-19|0.0|0.1|0.0|Benign/Borderline|21|42569598|Male|Glioma malignant, NOS|2019
0-19|0.5|0.6|0.5|Malignant|229|42569598|Male|Glioma malignant, NOS|2019
0-19|0.1|0.1|0.1|Benign/Borderline|127|211020485|Male|Glioma malignant, NOS|2019-2023
0-19|0.5|0.6|0.6|Malignant|1209|211020485|Male|Glioma malignant, NOS|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|21|42398074|Male|Glioma malignant, NOS|2020
0-19|0.5|0.6|0.5|Malignant|230|42398074|Male|Glioma malignant, NOS|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Glioma malignant, NOS|2021
0-19|0.6|0.7|0.6|Malignant|267|42055125|Male|Glioma malignant, NOS|2021
0-19|0.0|0.1|0.1|Benign/Borderline|25|42005478|Male|Glioma malignant, NOS|2022
0-19|0.6|0.7|0.6|Malignant|269|42005478|Male|Glioma malignant, NOS|2022
0-19|0.1|0.1|0.1|Benign/Borderline|45|41992210|Male|Glioma malignant, NOS|2023
0-19|0.4|0.6|0.5|Malignant|214|41992210|Male|Glioma malignant, NOS|2023
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005
0-19|0.0|0.1|0.0|Benign/Borderline|19|42158997|Male|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|16|42609915|Male|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|42572815|Male|Hemangioblastoma|2010
0-19|0.0|0.1|0.1|Benign/Borderline|23|42485770|Male|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|42485770|Male|Hemangioblastoma|2011
0-19|0.0|0.1|0.1|Benign/Borderline|24|42389392|Male|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|42389392|Male|Hemangioblastoma|2012
0-19|0.0|0.1|0.0|Benign/Borderline|18|42341913|Male|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|42341913|Male|Hemangioblastoma|2013
0-19|0.0|0.1|0.0|Benign/Borderline|21|42354730|Male|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|42354730|Male|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|17|42429306|Male|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|42429306|Male|Hemangioblastoma|2015
0-19|0.0|0.1|0.0|Benign/Borderline|20|42538623|Male|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|42538623|Male|Hemangioblastoma|2016
0-19|0.0|0.1|0.0|Benign/Borderline|20|42610191|Male|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Hemangioblastoma|2017
0-19|0.0|0.1|0.0|Benign/Borderline|19|42621973|Male|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Hemangioblastoma|2018
0-19|0.0|0.1|0.1|Benign/Borderline|22|42569598|Male|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Hemangioblastoma|2019
0-19|0.0|0.1|0.0|Benign/Borderline|92|211020485|Male|Hemangioblastoma|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Hemangioblastoma|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|20|42398074|Male|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Hemangioblastoma|2020
0-19|0.0|0.1|0.0|Benign/Borderline|20|42055125|Male|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Hemangioblastoma|2021
0-19|0.0|0.1|0.0|Benign/Borderline|16|42005478|Male|Hemangioblastoma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Hemangioblastoma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Hemangioblastoma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Hemangioblastoma|2023
0-19|0.1|0.1|0.1|Benign/Borderline|35|41889233|Male|Hemangioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Hemangioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Hemangioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|57|42367071|Male|Hemangioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|51|42541971|Male|Hemangioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|63|42609915|Male|Hemangioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|61|42572815|Male|Hemangioma|2010
0-19|~|~|~|Malignant|~|42572815|Male|Hemangioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|78|42485770|Male|Hemangioma|2011
0-19|~|~|~|Malignant|~|42485770|Male|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|66|42389392|Male|Hemangioma|2012
0-19|~|~|~|Malignant|~|42389392|Male|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|67|42341913|Male|Hemangioma|2013
0-19|~|~|~|Malignant|~|42341913|Male|Hemangioma|2013
0-19|0.1|0.2|0.1|Benign/Borderline|62|42354730|Male|Hemangioma|2014
0-19|~|~|~|Malignant|~|42354730|Male|Hemangioma|2014
0-19|0.1|0.2|0.1|Benign/Borderline|58|42429306|Male|Hemangioma|2015
0-19|~|~|~|Malignant|~|42429306|Male|Hemangioma|2015
0-19|0.2|0.3|0.2|Benign/Borderline|88|42538623|Male|Hemangioma|2016
0-19|~|~|~|Malignant|~|42538623|Male|Hemangioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|67|42610191|Male|Hemangioma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Hemangioma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|68|42621973|Male|Hemangioma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Hemangioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|54|42569598|Male|Hemangioma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|298|211020485|Male|Hemangioma|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Hemangioma|2019-2023
0-19|0.1|0.2|0.1|Benign/Borderline|56|42398074|Male|Hemangioma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Hemangioma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|69|42055125|Male|Hemangioma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Hemangioma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|45|42005478|Male|Hemangioma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Hemangioma|2022
0-19|0.1|0.2|0.2|Benign/Borderline|74|41992210|Male|Hemangioma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Hemangioma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|42572815|Male|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|42485770|Male|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|42389392|Male|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|42341913|Male|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|42354730|Male|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|42429306|Male|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|42538623|Male|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|42610191|Male|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|42621973|Male|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|42569598|Male|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Local Extensions from Regional Tumors|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Local Extensions from Regional Tumors|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|42398074|Male|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|42055125|Male|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Malignant|~|42005478|Male|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Local Extensions from Regional Tumors|2023
0-19|~|~|~|Malignant|~|41992210|Male|Local Extensions from Regional Tumors|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|42572815|Male|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|42485770|Male|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|42389392|Male|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|42341913|Male|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|42354730|Male|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Malignant|~|42429306|Male|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|42538623|Male|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|42610191|Male|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|42621973|Male|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|42569598|Male|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Lymphomas and Hematopoietic Neoplasms|2019-2023
0-19|0.0|0.0|0.0|Malignant|34|211020485|Male|Lymphomas and Hematopoietic Neoplasms|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|42398074|Male|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|42055125|Male|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Malignant|~|42005478|Male|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Lymphomas and Hematopoietic Neoplasms|2023
0-19|~|~|~|Malignant|~|41992210|Male|Lymphomas and Hematopoietic Neoplasms|2023
0-19|0.1|0.1|0.1|Benign/Borderline|47|41889233|Male|Meningioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004
0-19|0.1|0.2|0.1|Benign/Borderline|53|42006384|Male|Meningioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005
0-19|0.1|0.2|0.1|Benign/Borderline|51|42158997|Male|Meningioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|55|42367071|Male|Meningioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|57|42541971|Male|Meningioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|65|42609915|Male|Meningioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|55|42572815|Male|Meningioma|2010
0-19|~|~|~|Malignant|~|42572815|Male|Meningioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|65|42485770|Male|Meningioma|2011
0-19|~|~|~|Malignant|~|42485770|Male|Meningioma|2011
0-19|0.1|0.2|0.1|Benign/Borderline|63|42389392|Male|Meningioma|2012
0-19|~|~|~|Malignant|~|42389392|Male|Meningioma|2012
0-19|0.1|0.2|0.1|Benign/Borderline|57|42341913|Male|Meningioma|2013
0-19|~|~|~|Malignant|~|42341913|Male|Meningioma|2013
0-19|0.1|0.2|0.1|Benign/Borderline|64|42354730|Male|Meningioma|2014
0-19|~|~|~|Malignant|~|42354730|Male|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|71|42429306|Male|Meningioma|2015
0-19|~|~|~|Malignant|~|42429306|Male|Meningioma|2015
0-19|0.1|0.1|0.1|Benign/Borderline|48|42538623|Male|Meningioma|2016
0-19|~|~|~|Malignant|~|42538623|Male|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|65|42610191|Male|Meningioma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Meningioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|87|42621973|Male|Meningioma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Meningioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|62|42569598|Male|Meningioma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Meningioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|316|211020485|Male|Meningioma|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Meningioma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|70|42398074|Male|Meningioma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Meningioma|2020
0-19|0.1|0.1|0.1|Benign/Borderline|48|42055125|Male|Meningioma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Meningioma|2021
0-19|0.1|0.2|0.2|Benign/Borderline|68|42005478|Male|Meningioma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Meningioma|2022
0-19|0.1|0.2|0.2|Benign/Borderline|68|41992210|Male|Meningioma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Meningioma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Mixed glioma|2010
0-19|0.0|0.1|0.0|Malignant|19|42572815|Male|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Mixed glioma|2011
0-19|~|~|~|Malignant|~|42485770|Male|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Mixed glioma|2012
0-19|~|~|~|Malignant|~|42389392|Male|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Mixed glioma|2013
0-19|~|~|~|Malignant|~|42341913|Male|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Mixed glioma|2014
0-19|~|~|~|Malignant|~|42354730|Male|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Mixed glioma|2015
0-19|~|~|~|Malignant|~|42429306|Male|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Mixed glioma|2016
0-19|~|~|~|Malignant|~|42538623|Male|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Mixed glioma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Mixed glioma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Mixed glioma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Mixed glioma|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Mixed glioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Mixed glioma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Mixed glioma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Mixed glioma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Mixed glioma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Mixed glioma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Mixed glioma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Mixed glioma|2023
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|60|42006384|Male|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|55|42158997|Male|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|23|42158997|Male|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|64|42367071|Male|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|21|42367071|Male|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.1|Benign/Borderline|50|42541971|Male|Neoplasm, unspecified|2008
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Neoplasm, unspecified|2008
0-19|0.2|0.3|0.2|Benign/Borderline|90|42609915|Male|Neoplasm, unspecified|2009
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Neoplasm, unspecified|2009
0-19|0.1|0.2|0.2|Benign/Borderline|80|42572815|Male|Neoplasm, unspecified|2010
0-19|0.0|0.1|0.0|Malignant|17|42572815|Male|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|71|42485770|Male|Neoplasm, unspecified|2011
0-19|~|~|~|Malignant|~|42485770|Male|Neoplasm, unspecified|2011
0-19|0.1|0.2|0.1|Benign/Borderline|62|42389392|Male|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|27|42389392|Male|Neoplasm, unspecified|2012
0-19|0.1|0.2|0.2|Benign/Borderline|72|42341913|Male|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.0|Malignant|19|42341913|Male|Neoplasm, unspecified|2013
0-19|0.1|0.2|0.2|Benign/Borderline|72|42354730|Male|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.1|Malignant|25|42354730|Male|Neoplasm, unspecified|2014
0-19|0.1|0.2|0.2|Benign/Borderline|64|42429306|Male|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|20|42429306|Male|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.2|Benign/Borderline|72|42538623|Male|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|22|42538623|Male|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.2|Benign/Borderline|74|42610191|Male|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.1|Malignant|28|42610191|Male|Neoplasm, unspecified|2017
0-19|0.1|0.2|0.2|Benign/Borderline|67|42621973|Male|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.0|Malignant|17|42621973|Male|Neoplasm, unspecified|2018
0-19|0.1|0.2|0.1|Benign/Borderline|56|42569598|Male|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.1|Malignant|21|42569598|Male|Neoplasm, unspecified|2019
0-19|0.1|0.1|0.1|Benign/Borderline|264|211020485|Male|Neoplasm, unspecified|2019-2023
0-19|0.0|0.1|0.1|Malignant|115|211020485|Male|Neoplasm, unspecified|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|47|42398074|Male|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|28|42398074|Male|Neoplasm, unspecified|2020
0-19|0.1|0.2|0.1|Benign/Borderline|52|42055125|Male|Neoplasm, unspecified|2021
0-19|0.0|0.1|0.1|Malignant|22|42055125|Male|Neoplasm, unspecified|2021
0-19|0.1|0.2|0.1|Benign/Borderline|60|42005478|Male|Neoplasm, unspecified|2022
0-19|0.0|0.1|0.1|Malignant|29|42005478|Male|Neoplasm, unspecified|2022
0-19|0.1|0.2|0.1|Benign/Borderline|49|41992210|Male|Neoplasm, unspecified|2023
0-19|~|~|~|Malignant|~|41992210|Male|Neoplasm, unspecified|2023
0-19|0.3|0.4|0.3|Benign/Borderline|128|41889233|Male|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004
0-19|0.2|0.4|0.3|Benign/Borderline|125|42006384|Male|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005
0-19|0.4|0.5|0.4|Benign/Borderline|179|42158997|Male|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006
0-19|0.3|0.5|0.4|Benign/Borderline|166|42367071|Male|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|156|42541971|Male|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|157|42609915|Male|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|144|42572815|Male|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|42572815|Male|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.4|Benign/Borderline|161|42485770|Male|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|42485770|Male|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|161|42389392|Male|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|42389392|Male|Nerve sheath, benign and malignant|2012
0-19|0.3|0.5|0.4|Benign/Borderline|168|42341913|Male|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|42341913|Male|Nerve sheath, benign and malignant|2013
0-19|0.3|0.4|0.4|Benign/Borderline|158|42354730|Male|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|42354730|Male|Nerve sheath, benign and malignant|2014
0-19|0.3|0.4|0.4|Benign/Borderline|157|42429306|Male|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|42429306|Male|Nerve sheath, benign and malignant|2015
0-19|0.4|0.5|0.4|Benign/Borderline|186|42538623|Male|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|42538623|Male|Nerve sheath, benign and malignant|2016
0-19|0.2|0.3|0.3|Benign/Borderline|122|42610191|Male|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|42610191|Male|Nerve sheath, benign and malignant|2017
0-19|0.2|0.3|0.2|Benign/Borderline|93|42621973|Male|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|42621973|Male|Nerve sheath, benign and malignant|2018
0-19|0.2|0.3|0.2|Benign/Borderline|106|42569598|Male|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|42569598|Male|Nerve sheath, benign and malignant|2019
0-19|0.2|0.2|0.2|Benign/Borderline|395|211020485|Male|Nerve sheath, benign and malignant|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Nerve sheath, benign and malignant|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|70|42398074|Male|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|42398074|Male|Nerve sheath, benign and malignant|2020
0-19|0.1|0.2|0.2|Benign/Borderline|73|42055125|Male|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|42055125|Male|Nerve sheath, benign and malignant|2021
0-19|0.1|0.2|0.2|Benign/Borderline|76|42005478|Male|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Malignant|~|42005478|Male|Nerve sheath, benign and malignant|2022
0-19|0.1|0.2|0.2|Benign/Borderline|70|41992210|Male|Nerve sheath, benign and malignant|2023
0-19|~|~|~|Malignant|~|41992210|Male|Nerve sheath, benign and malignant|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|42572815|Male|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|42485770|Male|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|42389392|Male|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|42341913|Male|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|42354730|Male|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|42429306|Male|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|42538623|Male|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|42610191|Male|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|42621973|Male|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|42569598|Male|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Neuroepithelial|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Neuroepithelial|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|42398074|Male|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|42055125|Male|Neuroepithelial|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Neuroepithelial|2022
0-19|~|~|~|Malignant|~|42005478|Male|Neuroepithelial|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Neuroepithelial|2023
0-19|~|~|~|Malignant|~|41992210|Male|Neuroepithelial|2023
0-19|0.3|0.4|0.4|Benign/Borderline|151|41889233|Male|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|30|41889233|Male|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.4|Benign/Borderline|160|42006384|Male|Neuronal/glial, neuronal|2005
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.4|Benign/Borderline|159|42158997|Male|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006
0-19|0.4|0.5|0.4|Benign/Borderline|175|42367071|Male|Neuronal/glial, neuronal|2007
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007
0-19|0.4|0.5|0.4|Benign/Borderline|183|42541971|Male|Neuronal/glial, neuronal|2008
0-19|0.0|0.1|0.1|Malignant|29|42541971|Male|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.4|Benign/Borderline|159|42609915|Male|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009
0-19|0.4|0.5|0.4|Benign/Borderline|176|42572815|Male|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|16|42572815|Male|Neuronal/glial, neuronal|2010
0-19|0.4|0.5|0.4|Benign/Borderline|192|42485770|Male|Neuronal/glial, neuronal|2011
0-19|0.0|0.1|0.0|Malignant|21|42485770|Male|Neuronal/glial, neuronal|2011
0-19|0.4|0.6|0.5|Benign/Borderline|211|42389392|Male|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.1|Malignant|22|42389392|Male|Neuronal/glial, neuronal|2012
0-19|0.4|0.5|0.5|Benign/Borderline|194|42341913|Male|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|23|42341913|Male|Neuronal/glial, neuronal|2013
0-19|0.4|0.5|0.4|Benign/Borderline|180|42354730|Male|Neuronal/glial, neuronal|2014
0-19|0.0|0.1|0.1|Malignant|31|42354730|Male|Neuronal/glial, neuronal|2014
0-19|0.5|0.6|0.5|Benign/Borderline|225|42429306|Male|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.1|Malignant|26|42429306|Male|Neuronal/glial, neuronal|2015
0-19|0.5|0.6|0.5|Benign/Borderline|232|42538623|Male|Neuronal/glial, neuronal|2016
0-19|0.0|0.1|0.1|Malignant|27|42538623|Male|Neuronal/glial, neuronal|2016
0-19|0.5|0.6|0.6|Benign/Borderline|241|42610191|Male|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.0|Malignant|18|42610191|Male|Neuronal/glial, neuronal|2017
0-19|0.4|0.6|0.5|Benign/Borderline|219|42621973|Male|Neuronal/glial, neuronal|2018
0-19|0.0|0.1|0.0|Malignant|21|42621973|Male|Neuronal/glial, neuronal|2018
0-19|0.5|0.6|0.6|Benign/Borderline|242|42569598|Male|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|22|42569598|Male|Neuronal/glial, neuronal|2019
0-19|0.4|0.5|0.5|Benign/Borderline|988|211020485|Male|Neuronal/glial, neuronal|2019-2023
0-19|0.0|0.1|0.0|Malignant|90|211020485|Male|Neuronal/glial, neuronal|2019-2023
0-19|0.4|0.5|0.4|Benign/Borderline|180|42398074|Male|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.0|Malignant|18|42398074|Male|Neuronal/glial, neuronal|2020
0-19|0.4|0.5|0.4|Benign/Borderline|188|42055125|Male|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|17|42055125|Male|Neuronal/glial, neuronal|2021
0-19|0.4|0.6|0.5|Benign/Borderline|209|42005478|Male|Neuronal/glial, neuronal|2022
0-19|0.0|0.1|0.0|Malignant|20|42005478|Male|Neuronal/glial, neuronal|2022
0-19|0.3|0.5|0.4|Benign/Borderline|169|41992210|Male|Neuronal/glial, neuronal|2023
0-19|~|~|~|Malignant|~|41992210|Male|Neuronal/glial, neuronal|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006
0-19|0.0|0.1|0.1|Malignant|29|42158997|Male|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008
0-19|0.0|0.1|0.1|Malignant|31|42541971|Male|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009
0-19|0.0|0.1|0.1|Malignant|28|42609915|Male|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|22|42572815|Male|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|17|42485770|Male|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|26|42389392|Male|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|20|42341913|Male|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|19|42354730|Male|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|18|42429306|Male|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Oligodendroglioma|2016
0-19|0.0|0.1|0.0|Malignant|17|42538623|Male|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Oligodendroglioma|2017
0-19|~|~|~|Malignant|~|42610191|Male|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Oligodendroglioma|2018
0-19|~|~|~|Malignant|~|42621973|Male|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Oligodendroglioma|2019
0-19|~|~|~|Malignant|~|42569598|Male|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Oligodendroglioma|2019-2023
0-19|0.0|0.0|0.0|Malignant|38|211020485|Male|Oligodendroglioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Oligodendroglioma|2020
0-19|~|~|~|Malignant|~|42398074|Male|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Oligodendroglioma|2021
0-19|~|~|~|Malignant|~|42055125|Male|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Oligodendroglioma|2022
0-19|~|~|~|Malignant|~|42005478|Male|Oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Oligodendroglioma|2023
0-19|~|~|~|Malignant|~|41992210|Male|Oligodendroglioma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|21|42158997|Male|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|21|42541971|Male|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|27|42572815|Male|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|42572815|Male|Other mesenchymal|2010
0-19|0.1|0.1|0.1|Benign/Borderline|36|42485770|Male|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|42485770|Male|Other mesenchymal|2011
0-19|0.1|0.1|0.1|Benign/Borderline|46|42389392|Male|Other mesenchymal|2012
0-19|~|~|~|Malignant|~|42389392|Male|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|36|42341913|Male|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|42341913|Male|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|36|42354730|Male|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|42354730|Male|Other mesenchymal|2014
0-19|0.1|0.1|0.1|Benign/Borderline|37|42429306|Male|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|42429306|Male|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|54|42538623|Male|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|42538623|Male|Other mesenchymal|2016
0-19|0.1|0.2|0.1|Benign/Borderline|49|42610191|Male|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|42610191|Male|Other mesenchymal|2017
0-19|0.1|0.2|0.1|Benign/Borderline|52|42621973|Male|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|42621973|Male|Other mesenchymal|2018
0-19|0.0|0.1|0.1|Benign/Borderline|28|42569598|Male|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|42569598|Male|Other mesenchymal|2019
0-19|0.1|0.1|0.1|Benign/Borderline|192|211020485|Male|Other mesenchymal|2019-2023
0-19|0.0|0.0|0.0|Malignant|57|211020485|Male|Other mesenchymal|2019-2023
0-19|0.0|0.1|0.1|Benign/Borderline|25|42398074|Male|Other mesenchymal|2020
0-19|0.0|0.1|0.0|Malignant|16|42398074|Male|Other mesenchymal|2020
0-19|0.1|0.1|0.1|Benign/Borderline|45|42055125|Male|Other mesenchymal|2021
0-19|~|~|~|Malignant|~|42055125|Male|Other mesenchymal|2021
0-19|0.1|0.2|0.1|Benign/Borderline|52|42005478|Male|Other mesenchymal|2022
0-19|~|~|~|Malignant|~|42005478|Male|Other mesenchymal|2022
0-19|0.1|0.1|0.1|Benign/Borderline|42|41992210|Male|Other mesenchymal|2023
0-19|~|~|~|Malignant|~|41992210|Male|Other mesenchymal|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004
0-19|0.8|1.0|0.9|Malignant|372|41889233|Male|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005
0-19|0.8|0.9|0.9|Malignant|355|42006384|Male|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006
0-19|0.8|1.0|0.9|Malignant|360|42158997|Male|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007
0-19|0.8|0.9|0.8|Malignant|354|42367071|Male|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008
0-19|0.9|1.0|1.0|Malignant|401|42541971|Male|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009
0-19|0.8|1.0|0.9|Malignant|371|42609915|Male|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Pilocytic astrocytoma|2010
0-19|0.8|1.0|0.9|Malignant|385|42572815|Male|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Pilocytic astrocytoma|2011
0-19|0.9|1.1|1.0|Malignant|415|42485770|Male|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Pilocytic astrocytoma|2012
0-19|0.9|1.1|1.0|Malignant|435|42389392|Male|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Pilocytic astrocytoma|2013
0-19|0.9|1.1|1.0|Malignant|435|42341913|Male|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Pilocytic astrocytoma|2014
0-19|0.8|1.0|0.9|Malignant|387|42354730|Male|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|387|42429306|Male|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Pilocytic astrocytoma|2016
0-19|0.8|1.0|0.9|Malignant|389|42538623|Male|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Pilocytic astrocytoma|2017
0-19|1.0|1.2|1.1|Malignant|454|42610191|Male|Pilocytic astrocytoma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|77|42621973|Male|Pilocytic astrocytoma|2018
0-19|0.8|0.9|0.8|Malignant|359|42621973|Male|Pilocytic astrocytoma|2018
0-19|0.2|0.3|0.2|Benign/Borderline|86|42569598|Male|Pilocytic astrocytoma|2019
0-19|0.7|0.9|0.8|Malignant|353|42569598|Male|Pilocytic astrocytoma|2019
0-19|0.3|0.4|0.3|Benign/Borderline|685|211020485|Male|Pilocytic astrocytoma|2019-2023
0-19|0.7|0.7|0.7|Malignant|1468|211020485|Male|Pilocytic astrocytoma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|71|42398074|Male|Pilocytic astrocytoma|2020
0-19|0.8|1.0|0.9|Malignant|367|42398074|Male|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|74|42055125|Male|Pilocytic astrocytoma|2021
0-19|0.8|1.0|0.9|Malignant|367|42055125|Male|Pilocytic astrocytoma|2021
0-19|0.2|0.3|0.2|Benign/Borderline|87|42005478|Male|Pilocytic astrocytoma|2022
0-19|0.7|0.9|0.8|Malignant|326|42005478|Male|Pilocytic astrocytoma|2022
0-19|0.8|1.0|0.9|Benign/Borderline|367|41992210|Male|Pilocytic astrocytoma|2023
0-19|0.1|0.2|0.1|Malignant|55|41992210|Male|Pilocytic astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007
0-19|0.0|0.1|0.0|Malignant|18|42367071|Male|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008
0-19|~|~|~|Malignant|~|42541971|Male|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|42572815|Male|Pineal parenchymal|2010
0-19|~|~|~|Malignant|~|42572815|Male|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|42485770|Male|Pineal parenchymal|2011
0-19|0.0|0.1|0.0|Malignant|20|42485770|Male|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|42389392|Male|Pineal parenchymal|2012
0-19|0.0|0.1|0.0|Malignant|19|42389392|Male|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|42341913|Male|Pineal parenchymal|2013
0-19|0.0|0.1|0.0|Malignant|17|42341913|Male|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|42354730|Male|Pineal parenchymal|2014
0-19|0.0|0.1|0.1|Malignant|23|42354730|Male|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|42429306|Male|Pineal parenchymal|2015
0-19|0.0|0.1|0.0|Malignant|20|42429306|Male|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|42538623|Male|Pineal parenchymal|2016
0-19|0.0|0.1|0.1|Malignant|25|42538623|Male|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|42610191|Male|Pineal parenchymal|2017
0-19|~|~|~|Malignant|~|42610191|Male|Pineal parenchymal|2017
0-19|~|~|~|Benign/Borderline|~|42621973|Male|Pineal parenchymal|2018
0-19|~|~|~|Malignant|~|42621973|Male|Pineal parenchymal|2018
0-19|~|~|~|Benign/Borderline|~|42569598|Male|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|16|42569598|Male|Pineal parenchymal|2019
0-19|~|~|~|Benign/Borderline|~|211020485|Male|Pineal parenchymal|2019-2023
0-19|0.0|0.0|0.0|Malignant|80|211020485|Male|Pineal parenchymal|2019-2023
0-19|~|~|~|Benign/Borderline|~|42398074|Male|Pineal parenchymal|2020
0-19|0.0|0.1|0.0|Malignant|20|42398074|Male|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|42055125|Male|Pineal parenchymal|2021
0-19|~|~|~|Malignant|~|42055125|Male|Pineal parenchymal|2021
0-19|~|~|~|Benign/Borderline|~|42005478|Male|Pineal parenchymal|2022
0-19|0.0|0.1|0.0|Malignant|17|42005478|Male|Pineal parenchymal|2022
0-19|~|~|~|Benign/Borderline|~|41992210|Male|Pineal parenchymal|2023
0-19|~|~|~|Malignant|~|41992210|Male|Pineal parenchymal|2023
0-19|0.2|0.2|0.2|Benign/Borderline|86|41889233|Male|Pituitary|2004
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004
0-19|0.2|0.4|0.3|Benign/Borderline|128|42006384|Male|Pituitary|2005
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005
0-19|0.2|0.3|0.2|Benign/Borderline|103|42158997|Male|Pituitary|2006
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006
0-19|0.2|0.3|0.3|Benign/Borderline|117|42367071|Male|Pituitary|2007
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007
0-19|0.3|0.4|0.3|Benign/Borderline|140|42541971|Male|Pituitary|2008
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008
0-19|0.3|0.4|0.4|Benign/Borderline|163|42609915|Male|Pituitary|2009
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009
0-19|0.3|0.4|0.3|Benign/Borderline|145|42572815|Male|Pituitary|2010
0-19|~|~|~|Malignant|~|42572815|Male|Pituitary|2010
0-19|0.3|0.4|0.4|Benign/Borderline|156|42485770|Male|Pituitary|2011
0-19|~|~|~|Malignant|~|42485770|Male|Pituitary|2011
0-19|0.4|0.5|0.4|Benign/Borderline|184|42389392|Male|Pituitary|2012
0-19|~|~|~|Malignant|~|42389392|Male|Pituitary|2012
0-19|0.4|0.5|0.4|Benign/Borderline|186|42341913|Male|Pituitary|2013
0-19|~|~|~|Malignant|~|42341913|Male|Pituitary|2013
0-19|0.4|0.6|0.5|Benign/Borderline|208|42354730|Male|Pituitary|2014
0-19|~|~|~|Malignant|~|42354730|Male|Pituitary|2014
0-19|0.4|0.5|0.4|Benign/Borderline|180|42429306|Male|Pituitary|2015
0-19|~|~|~|Malignant|~|42429306|Male|Pituitary|2015
0-19|0.4|0.6|0.5|Benign/Borderline|213|42538623|Male|Pituitary|2016
0-19|~|~|~|Malignant|~|42538623|Male|Pituitary|2016
0-19|0.5|0.6|0.5|Benign/Borderline|237|42610191|Male|Pituitary|2017
0-19|~|~|~|Malignant|~|42610191|Male|Pituitary|2017
0-19|0.4|0.6|0.5|Benign/Borderline|220|42621973|Male|Pituitary|2018
0-19|~|~|~|Malignant|~|42621973|Male|Pituitary|2018
0-19|0.4|0.6|0.5|Benign/Borderline|224|42569598|Male|Pituitary|2019
0-19|~|~|~|Malignant|~|42569598|Male|Pituitary|2019
0-19|0.4|0.5|0.5|Benign/Borderline|1012|211020485|Male|Pituitary|2019-2023
0-19|0.0|0.0|0.0|Malignant|24|211020485|Male|Pituitary|2019-2023
0-19|0.4|0.5|0.5|Benign/Borderline|206|42398074|Male|Pituitary|2020
0-19|~|~|~|Malignant|~|42398074|Male|Pituitary|2020
0-19|0.4|0.5|0.5|Benign/Borderline|196|42055125|Male|Pituitary|2021
0-19|~|~|~|Malignant|~|42055125|Male|Pituitary|2021
0-19|0.4|0.5|0.5|Benign/Borderline|197|42005478|Male|Pituitary|2022
0-19|~|~|~|Malignant|~|42005478|Male|Pituitary|2022
0-19|0.4|0.5|0.4|Benign/Borderline|189|41992210|Male|Pituitary|2023
0-19|0.0|0.1|0.0|Malignant|19|41992210|Male|Pituitary|2023
0-19|1.5|1.8|1.7|Benign/Borderline|701|41889233|Male|Total|2004
0-19|3.4|3.8|3.6|Malignant|1510|41889233|Male|Total|2004
0-19|1.8|2.0|1.9|Benign/Borderline|803|42006384|Male|Total|2005
0-19|3.2|3.6|3.4|Malignant|1429|42006384|Male|Total|2005
0-19|1.8|2.1|2.0|Benign/Borderline|841|42158997|Male|Total|2006
0-19|3.4|3.8|3.6|Malignant|1513|42158997|Male|Total|2006
0-19|1.9|2.2|2.0|Benign/Borderline|875|42367071|Male|Total|2007
0-19|3.4|3.8|3.6|Malignant|1528|42367071|Male|Total|2007
0-19|2.0|2.2|2.1|Benign/Borderline|898|42541971|Male|Total|2008
0-19|3.6|4.0|3.8|Malignant|1607|42541971|Male|Total|2008
0-19|2.1|2.4|2.3|Benign/Borderline|970|42609915|Male|Total|2009
0-19|3.5|3.9|3.7|Malignant|1569|42609915|Male|Total|2009
0-19|2.0|2.3|2.2|Benign/Borderline|932|42572815|Male|Total|2010
0-19|3.6|4.0|3.8|Malignant|1615|42572815|Male|Total|2010
0-19|2.2|2.5|2.3|Benign/Borderline|993|42485770|Male|Total|2011
0-19|3.6|4.0|3.8|Malignant|1617|42485770|Male|Total|2011
0-19|2.3|2.6|2.5|Benign/Borderline|1043|42389392|Male|Total|2012
0-19|3.7|4.1|3.9|Malignant|1637|42389392|Male|Total|2012
0-19|2.3|2.6|2.5|Benign/Borderline|1042|42341913|Male|Total|2013
0-19|3.6|4.0|3.8|Malignant|1608|42341913|Male|Total|2013
0-19|2.4|2.7|2.5|Benign/Borderline|1064|42354730|Male|Total|2014
0-19|3.6|3.9|3.7|Malignant|1580|42354730|Male|Total|2014
0-19|2.3|2.6|2.4|Benign/Borderline|1042|42429306|Male|Total|2015
0-19|3.6|4.0|3.8|Malignant|1622|42429306|Male|Total|2015
0-19|2.6|2.9|2.7|Benign/Borderline|1170|42538623|Male|Total|2016
0-19|3.6|3.9|3.7|Malignant|1588|42538623|Male|Total|2016
0-19|2.5|2.8|2.6|Benign/Borderline|1126|42610191|Male|Total|2017
0-19|3.8|4.2|4.0|Malignant|1704|42610191|Male|Total|2017
0-19|2.6|2.9|2.8|Benign/Borderline|1182|42621973|Male|Total|2018
0-19|2.9|3.3|3.1|Malignant|1312|42621973|Male|Total|2018
0-19|2.4|2.7|2.6|Benign/Borderline|1109|42569598|Male|Total|2019
0-19|2.9|3.2|3.0|Malignant|1290|42569598|Male|Total|2019
0-19|2.5|2.6|2.5|Benign/Borderline|5375|211020485|Male|Total|2019-2023
0-19|2.7|2.8|2.8|Malignant|5779|211020485|Male|Total|2019-2023
0-19|2.0|2.3|2.2|Benign/Borderline|923|42398074|Male|Total|2020
0-19|2.8|3.2|3.0|Malignant|1268|42398074|Male|Total|2020
0-19|2.2|2.5|2.4|Benign/Borderline|1005|42055125|Male|Total|2021
0-19|2.9|3.2|3.0|Malignant|1271|42055125|Male|Total|2021
0-19|2.3|2.6|2.5|Benign/Borderline|1058|42005478|Male|Total|2022
0-19|2.7|3.0|2.8|Malignant|1180|42005478|Male|Total|2022
0-19|2.9|3.2|3.0|Benign/Borderline|1280|41992210|Male|Total|2023
0-19|1.7|2.0|1.8|Malignant|770|41992210|Male|Total|2023
0-19|0.3|0.4|0.3|Benign/Borderline|128|41889233|Male|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004
0-19|0.2|0.4|0.3|Benign/Borderline|125|42006384|Male|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005
0-19|0.4|0.5|0.4|Benign/Borderline|179|42158997|Male|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.5|0.4|Benign/Borderline|166|42367071|Male|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|156|42541971|Male|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|157|42609915|Male|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|144|42572815|Male|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|42572815|Male|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.4|Benign/Borderline|161|42485770|Male|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|42485770|Male|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|161|42389392|Male|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|42389392|Male|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.5|0.4|Benign/Borderline|169|42341913|Male|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|42341913|Male|Tumors of Cranial and Spinal Nerves|2013
0-19|0.3|0.4|0.4|Benign/Borderline|160|42354730|Male|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|42354730|Male|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.4|0.4|Benign/Borderline|157|42429306|Male|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|42429306|Male|Tumors of Cranial and Spinal Nerves|2015
0-19|0.4|0.5|0.4|Benign/Borderline|186|42538623|Male|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|42538623|Male|Tumors of Cranial and Spinal Nerves|2016
0-19|0.2|0.3|0.3|Benign/Borderline|122|42610191|Male|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|42610191|Male|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.3|0.2|Benign/Borderline|93|42621973|Male|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|42621973|Male|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.3|0.2|Benign/Borderline|106|42569598|Male|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|42569598|Male|Tumors of Cranial and Spinal Nerves|2019
0-19|0.2|0.2|0.2|Benign/Borderline|395|211020485|Male|Tumors of Cranial and Spinal Nerves|2019-2023
0-19|~|~|~|Malignant|~|211020485|Male|Tumors of Cranial and Spinal Nerves|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|70|42398074|Male|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|42398074|Male|Tumors of Cranial and Spinal Nerves|2020
0-19|0.1|0.2|0.2|Benign/Borderline|73|42055125|Male|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|42055125|Male|Tumors of Cranial and Spinal Nerves|2021
0-19|0.1|0.2|0.2|Benign/Borderline|76|42005478|Male|Tumors of Cranial and Spinal Nerves|2022
0-19|~|~|~|Malignant|~|42005478|Male|Tumors of Cranial and Spinal Nerves|2022
0-19|0.1|0.2|0.2|Benign/Borderline|70|41992210|Male|Tumors of Cranial and Spinal Nerves|2023
0-19|~|~|~|Malignant|~|41992210|Male|Tumors of Cranial and Spinal Nerves|2023
0-19|0.5|0.6|0.6|Benign/Borderline|237|41889233|Male|Tumors of Neuroepthelial Tissue|2004
0-19|3.1|3.5|3.3|Malignant|1367|41889233|Male|Tumors of Neuroepthelial Tissue|2004
0-19|0.6|0.7|0.6|Benign/Borderline|265|42006384|Male|Tumors of Neuroepthelial Tissue|2005
0-19|2.9|3.3|3.1|Malignant|1296|42006384|Male|Tumors of Neuroepthelial Tissue|2005
0-19|0.5|0.7|0.6|Benign/Borderline|263|42158997|Male|Tumors of Neuroepthelial Tissue|2006
0-19|3.1|3.4|3.3|Malignant|1366|42158997|Male|Tumors of Neuroepthelial Tissue|2006
0-19|0.6|0.7|0.6|Benign/Borderline|273|42367071|Male|Tumors of Neuroepthelial Tissue|2007
0-19|3.1|3.5|3.3|Malignant|1384|42367071|Male|Tumors of Neuroepthelial Tissue|2007
0-19|0.6|0.8|0.7|Benign/Borderline|291|42541971|Male|Tumors of Neuroepthelial Tissue|2008
0-19|3.2|3.6|3.4|Malignant|1444|42541971|Male|Tumors of Neuroepthelial Tissue|2008
0-19|0.6|0.7|0.7|Benign/Borderline|278|42609915|Male|Tumors of Neuroepthelial Tissue|2009
0-19|3.2|3.5|3.4|Malignant|1423|42609915|Male|Tumors of Neuroepthelial Tissue|2009
0-19|0.6|0.8|0.7|Benign/Borderline|297|42572815|Male|Tumors of Neuroepthelial Tissue|2010
0-19|3.3|3.6|3.4|Malignant|1459|42572815|Male|Tumors of Neuroepthelial Tissue|2010
0-19|0.7|0.8|0.7|Benign/Borderline|318|42485770|Male|Tumors of Neuroepthelial Tissue|2011
0-19|3.3|3.7|3.5|Malignant|1479|42485770|Male|Tumors of Neuroepthelial Tissue|2011
0-19|0.7|0.9|0.8|Benign/Borderline|331|42389392|Male|Tumors of Neuroepthelial Tissue|2012
0-19|3.3|3.7|3.5|Malignant|1474|42389392|Male|Tumors of Neuroepthelial Tissue|2012
0-19|0.7|0.8|0.7|Benign/Borderline|315|42341913|Male|Tumors of Neuroepthelial Tissue|2013
0-19|3.3|3.6|3.4|Malignant|1448|42341913|Male|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.8|0.7|Benign/Borderline|306|42354730|Male|Tumors of Neuroepthelial Tissue|2014
0-19|3.2|3.6|3.4|Malignant|1429|42354730|Male|Tumors of Neuroepthelial Tissue|2014
0-19|0.7|0.9|0.8|Benign/Borderline|336|42429306|Male|Tumors of Neuroepthelial Tissue|2015
0-19|3.3|3.7|3.5|Malignant|1468|42429306|Male|Tumors of Neuroepthelial Tissue|2015
0-19|0.8|1.0|0.9|Benign/Borderline|375|42538623|Male|Tumors of Neuroepthelial Tissue|2016
0-19|3.2|3.5|3.4|Malignant|1426|42538623|Male|Tumors of Neuroepthelial Tissue|2016
0-19|0.8|0.9|0.9|Benign/Borderline|363|42610191|Male|Tumors of Neuroepthelial Tissue|2017
0-19|3.4|3.8|3.6|Malignant|1523|42610191|Male|Tumors of Neuroepthelial Tissue|2017
0-19|0.9|1.1|1.0|Benign/Borderline|439|42621973|Male|Tumors of Neuroepthelial Tissue|2018
0-19|2.6|3.0|2.8|Malignant|1190|42621973|Male|Tumors of Neuroepthelial Tissue|2018
0-19|1.0|1.2|1.1|Benign/Borderline|452|42569598|Male|Tumors of Neuroepthelial Tissue|2019
0-19|2.5|2.8|2.7|Malignant|1138|42569598|Male|Tumors of Neuroepthelial Tissue|2019
0-19|1.0|1.1|1.1|Benign/Borderline|2284|211020485|Male|Tumors of Neuroepthelial Tissue|2019-2023
0-19|2.3|2.5|2.4|Malignant|4996|211020485|Male|Tumors of Neuroepthelial Tissue|2019-2023
0-19|0.8|0.9|0.8|Benign/Borderline|356|42398074|Male|Tumors of Neuroepthelial Tissue|2020
0-19|2.5|2.8|2.6|Malignant|1112|42398074|Male|Tumors of Neuroepthelial Tissue|2020
0-19|0.8|1.0|0.9|Benign/Borderline|368|42055125|Male|Tumors of Neuroepthelial Tissue|2021
0-19|2.5|2.8|2.6|Malignant|1106|42055125|Male|Tumors of Neuroepthelial Tissue|2021
0-19|0.9|1.1|1.0|Benign/Borderline|436|42005478|Male|Tumors of Neuroepthelial Tissue|2022
0-19|2.3|2.6|2.5|Malignant|1034|42005478|Male|Tumors of Neuroepthelial Tissue|2022
0-19|1.5|1.7|1.6|Benign/Borderline|672|41992210|Male|Tumors of Neuroepthelial Tissue|2023
0-19|1.3|1.6|1.5|Malignant|606|41992210|Male|Tumors of Neuroepthelial Tissue|2023
0-19|0.4|0.5|0.4|Benign/Borderline|173|41889233|Male|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004
0-19|0.5|0.6|0.5|Benign/Borderline|222|42006384|Male|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005
0-19|0.4|0.5|0.4|Benign/Borderline|184|42158997|Male|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006
0-19|0.4|0.6|0.5|Benign/Borderline|206|42367071|Male|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007
0-19|0.5|0.6|0.6|Benign/Borderline|237|42541971|Male|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008
0-19|0.5|0.6|0.6|Benign/Borderline|246|42609915|Male|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009
0-19|0.5|0.6|0.5|Benign/Borderline|229|42572815|Male|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|42572815|Male|Tumors of Sellar Region|2010
0-19|0.5|0.6|0.5|Benign/Borderline|227|42485770|Male|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|42485770|Male|Tumors of Sellar Region|2011
0-19|0.5|0.7|0.6|Benign/Borderline|265|42389392|Male|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|42389392|Male|Tumors of Sellar Region|2012
0-19|0.6|0.7|0.7|Benign/Borderline|281|42341913|Male|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|42341913|Male|Tumors of Sellar Region|2013
0-19|0.7|0.8|0.7|Benign/Borderline|316|42354730|Male|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|42354730|Male|Tumors of Sellar Region|2014
0-19|0.6|0.7|0.7|Benign/Borderline|280|42429306|Male|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|42429306|Male|Tumors of Sellar Region|2015
0-19|0.6|0.8|0.7|Benign/Borderline|293|42538623|Male|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|42538623|Male|Tumors of Sellar Region|2016
0-19|0.7|0.9|0.8|Benign/Borderline|341|42610191|Male|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|42610191|Male|Tumors of Sellar Region|2017
0-19|0.7|0.8|0.7|Benign/Borderline|323|42621973|Male|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|42621973|Male|Tumors of Sellar Region|2018
0-19|0.6|0.8|0.7|Benign/Borderline|304|42569598|Male|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|42569598|Male|Tumors of Sellar Region|2019
0-19|0.6|0.7|0.7|Benign/Borderline|1427|211020485|Male|Tumors of Sellar Region|2019-2023
0-19|0.0|0.0|0.0|Malignant|25|211020485|Male|Tumors of Sellar Region|2019-2023
0-19|0.5|0.7|0.6|Benign/Borderline|264|42398074|Male|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|42398074|Male|Tumors of Sellar Region|2020
0-19|0.6|0.8|0.7|Benign/Borderline|300|42055125|Male|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|42055125|Male|Tumors of Sellar Region|2021
0-19|0.6|0.8|0.7|Benign/Borderline|289|42005478|Male|Tumors of Sellar Region|2022
0-19|~|~|~|Malignant|~|42005478|Male|Tumors of Sellar Region|2022
0-19|0.6|0.7|0.6|Benign/Borderline|270|41992210|Male|Tumors of Sellar Region|2023
0-19|0.0|0.1|0.0|Malignant|19|41992210|Male|Tumors of Sellar Region|2023
0-19|0.1|0.2|0.2|Benign/Borderline|79|41889233|Male|Tumors of the Meninges|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004
0-19|0.2|0.2|0.2|Benign/Borderline|86|42006384|Male|Tumors of the Meninges|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005
0-19|0.2|0.3|0.2|Benign/Borderline|91|42158997|Male|Tumors of the Meninges|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006
0-19|0.2|0.3|0.2|Benign/Borderline|88|42367071|Male|Tumors of the Meninges|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|92|42541971|Male|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008
0-19|0.2|0.3|0.2|Benign/Borderline|103|42609915|Male|Tumors of the Meninges|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|96|42572815|Male|Tumors of the Meninges|2010
0-19|~|~|~|Malignant|~|42572815|Male|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|124|42485770|Male|Tumors of the Meninges|2011
0-19|~|~|~|Malignant|~|42485770|Male|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|133|42389392|Male|Tumors of the Meninges|2012
0-19|~|~|~|Malignant|~|42389392|Male|Tumors of the Meninges|2012
0-19|0.2|0.3|0.3|Benign/Borderline|111|42341913|Male|Tumors of the Meninges|2013
0-19|~|~|~|Malignant|~|42341913|Male|Tumors of the Meninges|2013
0-19|0.2|0.3|0.3|Benign/Borderline|121|42354730|Male|Tumors of the Meninges|2014
0-19|~|~|~|Malignant|~|42354730|Male|Tumors of the Meninges|2014
0-19|0.2|0.3|0.3|Benign/Borderline|125|42429306|Male|Tumors of the Meninges|2015
0-19|~|~|~|Malignant|~|42429306|Male|Tumors of the Meninges|2015
0-19|0.2|0.3|0.3|Benign/Borderline|122|42538623|Male|Tumors of the Meninges|2016
0-19|~|~|~|Malignant|~|42538623|Male|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|134|42610191|Male|Tumors of the Meninges|2017
0-19|~|~|~|Malignant|~|42610191|Male|Tumors of the Meninges|2017
0-19|0.3|0.4|0.4|Benign/Borderline|158|42621973|Male|Tumors of the Meninges|2018
0-19|~|~|~|Malignant|~|42621973|Male|Tumors of the Meninges|2018
0-19|0.2|0.3|0.3|Benign/Borderline|112|42569598|Male|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|42569598|Male|Tumors of the Meninges|2019
0-19|0.3|0.3|0.3|Benign/Borderline|600|211020485|Male|Tumors of the Meninges|2019-2023
0-19|0.0|0.0|0.0|Malignant|64|211020485|Male|Tumors of the Meninges|2019-2023
0-19|0.2|0.3|0.3|Benign/Borderline|115|42398074|Male|Tumors of the Meninges|2020
0-19|0.0|0.1|0.0|Malignant|19|42398074|Male|Tumors of the Meninges|2020
0-19|0.2|0.3|0.3|Benign/Borderline|113|42055125|Male|Tumors of the Meninges|2021
0-19|0.0|0.1|0.0|Malignant|16|42055125|Male|Tumors of the Meninges|2021
0-19|0.3|0.4|0.3|Benign/Borderline|136|42005478|Male|Tumors of the Meninges|2022
0-19|~|~|~|Malignant|~|42005478|Male|Tumors of the Meninges|2022
0-19|0.2|0.3|0.3|Benign/Borderline|124|41992210|Male|Tumors of the Meninges|2023
0-19|~|~|~|Malignant|~|41992210|Male|Tumors of the Meninges|2023
0-19|0.1|0.2|0.2|Benign/Borderline|66|41889233|Male|Unclassified Tumors|2004
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004
0-19|0.2|0.2|0.2|Benign/Borderline|82|42006384|Male|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|95|42158997|Male|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|23|42158997|Male|Unclassified Tumors|2006
0-19|0.2|0.3|0.3|Benign/Borderline|122|42367071|Male|Unclassified Tumors|2007
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Unclassified Tumors|2007
0-19|0.2|0.3|0.2|Benign/Borderline|101|42541971|Male|Unclassified Tumors|2008
0-19|0.0|0.1|0.0|Malignant|21|42541971|Male|Unclassified Tumors|2008
0-19|0.3|0.4|0.4|Benign/Borderline|153|42609915|Male|Unclassified Tumors|2009
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|142|42572815|Male|Unclassified Tumors|2010
0-19|0.0|0.1|0.0|Malignant|18|42572815|Male|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|149|42485770|Male|Unclassified Tumors|2011
0-19|~|~|~|Malignant|~|42485770|Male|Unclassified Tumors|2011
0-19|0.3|0.4|0.3|Benign/Borderline|128|42389392|Male|Unclassified Tumors|2012
0-19|0.0|0.1|0.1|Malignant|30|42389392|Male|Unclassified Tumors|2012
0-19|0.3|0.4|0.3|Benign/Borderline|139|42341913|Male|Unclassified Tumors|2013
0-19|0.0|0.1|0.0|Malignant|21|42341913|Male|Unclassified Tumors|2013
0-19|0.3|0.4|0.3|Benign/Borderline|134|42354730|Male|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|26|42354730|Male|Unclassified Tumors|2014
0-19|0.2|0.3|0.3|Benign/Borderline|124|42429306|Male|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|21|42429306|Male|Unclassified Tumors|2015
0-19|0.3|0.4|0.4|Benign/Borderline|160|42538623|Male|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|22|42538623|Male|Unclassified Tumors|2016
0-19|0.3|0.4|0.3|Benign/Borderline|141|42610191|Male|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|29|42610191|Male|Unclassified Tumors|2017
0-19|0.3|0.4|0.3|Benign/Borderline|135|42621973|Male|Unclassified Tumors|2018
0-19|0.0|0.1|0.0|Malignant|19|42621973|Male|Unclassified Tumors|2018
0-19|0.2|0.3|0.3|Benign/Borderline|110|42569598|Male|Unclassified Tumors|2019
0-19|0.0|0.1|0.1|Malignant|21|42569598|Male|Unclassified Tumors|2019
0-19|0.2|0.3|0.3|Benign/Borderline|562|211020485|Male|Unclassified Tumors|2019-2023
0-19|0.0|0.1|0.1|Malignant|119|211020485|Male|Unclassified Tumors|2019-2023
0-19|0.2|0.3|0.2|Benign/Borderline|103|42398074|Male|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|28|42398074|Male|Unclassified Tumors|2020
0-19|0.2|0.3|0.3|Benign/Borderline|121|42055125|Male|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Malignant|22|42055125|Male|Unclassified Tumors|2021
0-19|0.2|0.3|0.2|Benign/Borderline|105|42005478|Male|Unclassified Tumors|2022
0-19|0.0|0.1|0.1|Malignant|30|42005478|Male|Unclassified Tumors|2022
0-19|0.2|0.3|0.3|Benign/Borderline|123|41992210|Male|Unclassified Tumors|2023
0-19|0.0|0.1|0.0|Malignant|18|41992210|Male|Unclassified Tumors|2023
0-19|0.1|0.1|0.1|Benign/Borderline|35|41889233|Male|Unique astrocytoma variants|2004
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004
0-19|0.1|0.1|0.1|Benign/Borderline|39|42006384|Male|Unique astrocytoma variants|2005
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|32|42367071|Male|Unique astrocytoma variants|2007
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Benign/Borderline|44|42541971|Male|Unique astrocytoma variants|2008
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|46|42609915|Male|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|35|42572815|Male|Unique astrocytoma variants|2010
0-19|0.0|0.1|0.0|Malignant|16|42572815|Male|Unique astrocytoma variants|2010
0-19|0.1|0.2|0.1|Benign/Borderline|51|42485770|Male|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|29|42485770|Male|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|46|42389392|Male|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.1|Malignant|26|42389392|Male|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|40|42341913|Male|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.1|Malignant|26|42341913|Male|Unique astrocytoma variants|2013
0-19|0.1|0.2|0.1|Benign/Borderline|52|42354730|Male|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Malignant|26|42354730|Male|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|31|42429306|Male|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|28|42429306|Male|Unique astrocytoma variants|2015
0-19|0.1|0.1|0.1|Benign/Borderline|41|42538623|Male|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|29|42538623|Male|Unique astrocytoma variants|2016
0-19|0.1|0.1|0.1|Benign/Borderline|39|42610191|Male|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.0|Malignant|17|42610191|Male|Unique astrocytoma variants|2017
0-19|0.1|0.1|0.1|Benign/Borderline|41|42621973|Male|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|22|42621973|Male|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|39|42569598|Male|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Malignant|24|42569598|Male|Unique astrocytoma variants|2019
0-19|0.1|0.1|0.1|Benign/Borderline|173|211020485|Male|Unique astrocytoma variants|2019-2023
0-19|0.0|0.1|0.0|Malignant|107|211020485|Male|Unique astrocytoma variants|2019-2023
0-19|0.0|0.1|0.1|Benign/Borderline|24|42398074|Male|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Malignant|17|42398074|Male|Unique astrocytoma variants|2020
0-19|0.1|0.1|0.1|Benign/Borderline|39|42055125|Male|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.0|Malignant|21|42055125|Male|Unique astrocytoma variants|2021
0-19|0.1|0.1|0.1|Benign/Borderline|42|42005478|Male|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.0|Malignant|19|42005478|Male|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.1|Benign/Borderline|29|41992210|Male|Unique astrocytoma variants|2023
0-19|0.0|0.1|0.1|Malignant|26|41992210|Male|Unique astrocytoma variants|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|All other|2010
0-19|0.0|0.0|0.0|Malignant|24|83225072|Male and Female|All other|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|All other|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|All other|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|All other|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|All other|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|All other|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|All other|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|All other|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|All other|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|All other|2015
0-19|0.0|0.0|0.0|Malignant|19|82981714|Male and Female|All other|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|All other|2016
0-19|0.0|0.0|0.0|Malignant|18|83193069|Male and Female|All other|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|All other|2017
0-19|0.0|0.0|0.0|Malignant|16|83318260|Male and Female|All other|2017
0-19|0.0|0.1|0.1|Benign/Borderline|53|83333434|Male and Female|All other|2018
0-19|0.3|0.4|0.3|Malignant|262|83333434|Male and Female|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|80|83226688|Male and Female|All other|2019
0-19|0.4|0.4|0.4|Malignant|324|83226688|Male and Female|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|420|412527765|Male and Female|All other|2019-2023
0-19|0.5|0.5|0.5|Malignant|2078|412527765|Male and Female|All other|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|71|82886629|Male and Female|All other|2020
0-19|0.3|0.4|0.4|Malignant|312|82886629|Male and Female|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|85|82212844|Male and Female|All other|2021
0-19|0.4|0.5|0.5|Malignant|368|82212844|Male and Female|All other|2021
0-19|0.1|0.1|0.1|Benign/Borderline|84|82113420|Male and Female|All other|2022
0-19|0.5|0.6|0.6|Malignant|471|82113420|Male and Female|All other|2022
0-19|0.1|0.1|0.1|Benign/Borderline|100|82088184|Male and Female|All other|2023
0-19|0.7|0.8|0.7|Malignant|603|82088184|Male and Female|All other|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004
0-19|0.1|0.1|0.1|Malignant|71|81754354|Male and Female|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|67|82324418|Male and Female|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007
0-19|0.1|0.1|0.1|Malignant|88|82749431|Male and Female|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|71|83280391|Male and Female|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|84|83225072|Male and Female|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|72|83042807|Male and Female|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Anaplastic astrocytoma|2012
0-19|0.1|0.1|0.1|Malignant|69|82869473|Male and Female|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Anaplastic astrocytoma|2013
0-19|0.1|0.1|0.1|Malignant|96|82802400|Male and Female|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Anaplastic astrocytoma|2014
0-19|0.1|0.1|0.1|Malignant|96|82834118|Male and Female|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|81|82981714|Male and Female|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|76|83193069|Male and Female|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Anaplastic astrocytoma|2017
0-19|0.1|0.1|0.1|Malignant|61|83318260|Male and Female|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Anaplastic astrocytoma|2018
0-19|0.1|0.1|0.1|Malignant|62|83333434|Male and Female|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Anaplastic astrocytoma|2019
0-19|0.1|0.1|0.1|Malignant|66|83226688|Male and Female|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Anaplastic astrocytoma|2019-2023
0-19|0.0|0.0|0.0|Malignant|181|412527765|Male and Female|Anaplastic astrocytoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|51|82886629|Male and Female|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Anaplastic astrocytoma|2021
0-19|0.0|0.0|0.0|Malignant|28|82212844|Male and Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Anaplastic astrocytoma|2022
0-19|0.0|0.0|0.0|Malignant|16|82113420|Male and Female|Anaplastic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Anaplastic astrocytoma|2023
0-19|0.0|0.0|0.0|Malignant|20|82088184|Male and Female|Anaplastic astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Anaplastic oligodendroglioma|2019-2023
0-19|~|~|~|Malignant|~|412527765|Male and Female|Anaplastic oligodendroglioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Anaplastic oligodendroglioma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Anaplastic oligodendroglioma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|190|82005260|Male and Female|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.2|Malignant|198|82324418|Male and Female|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|183|82749431|Male and Female|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|182|83118264|Male and Female|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|203|83280391|Male and Female|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.3|Malignant|212|83225072|Male and Female|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Astrocytoma, NOS|2011
0-19|0.2|0.3|0.2|Malignant|184|83042807|Male and Female|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Astrocytoma, NOS|2012
0-19|0.2|0.2|0.2|Malignant|165|82869473|Male and Female|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|194|82802400|Male and Female|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|218|82834118|Male and Female|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Astrocytoma, NOS|2015
0-19|0.2|0.2|0.2|Malignant|172|82981714|Male and Female|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Astrocytoma, NOS|2016
0-19|0.2|0.2|0.2|Malignant|177|83193069|Male and Female|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Astrocytoma, NOS|2017
0-19|0.2|0.3|0.2|Malignant|190|83318260|Male and Female|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Astrocytoma, NOS|2018
0-19|0.2|0.2|0.2|Malignant|179|83333434|Male and Female|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Astrocytoma, NOS|2019
0-19|0.2|0.2|0.2|Malignant|154|83226688|Male and Female|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Astrocytoma, NOS|2019-2023
0-19|0.1|0.2|0.1|Malignant|595|412527765|Male and Female|Astrocytoma, NOS|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Astrocytoma, NOS|2020
0-19|0.1|0.2|0.1|Malignant|104|82886629|Male and Female|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|140|82212844|Male and Female|Astrocytoma, NOS|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Astrocytoma, NOS|2022
0-19|0.1|0.2|0.1|Malignant|120|82113420|Male and Female|Astrocytoma, NOS|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Astrocytoma, NOS|2023
0-19|0.1|0.1|0.1|Malignant|77|82088184|Male and Female|Astrocytoma, NOS|2023
0-19|0.1|0.1|0.1|Benign/Borderline|57|81754354|Male and Female|Choroid plexus|2004
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004
0-19|0.1|0.1|0.1|Benign/Borderline|56|82005260|Male and Female|Choroid plexus|2005
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|66|82749431|Male and Female|Choroid plexus|2007
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008
0-19|0.0|0.0|0.0|Malignant|21|83118264|Male and Female|Choroid plexus|2008
0-19|0.1|0.1|0.1|Benign/Borderline|62|83280391|Male and Female|Choroid plexus|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009
0-19|0.1|0.1|0.1|Benign/Borderline|69|83225072|Male and Female|Choroid plexus|2010
0-19|0.0|0.0|0.0|Malignant|23|83225072|Male and Female|Choroid plexus|2010
0-19|0.1|0.1|0.1|Benign/Borderline|61|83042807|Male and Female|Choroid plexus|2011
0-19|0.0|0.0|0.0|Malignant|21|83042807|Male and Female|Choroid plexus|2011
0-19|0.1|0.1|0.1|Benign/Borderline|63|82869473|Male and Female|Choroid plexus|2012
0-19|0.0|0.0|0.0|Malignant|19|82869473|Male and Female|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|68|82802400|Male and Female|Choroid plexus|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Choroid plexus|2013
0-19|0.1|0.1|0.1|Benign/Borderline|57|82834118|Male and Female|Choroid plexus|2014
0-19|0.0|0.0|0.0|Malignant|27|82834118|Male and Female|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|67|82981714|Male and Female|Choroid plexus|2015
0-19|0.0|0.0|0.0|Malignant|22|82981714|Male and Female|Choroid plexus|2015
0-19|0.1|0.1|0.1|Benign/Borderline|61|83193069|Male and Female|Choroid plexus|2016
0-19|0.0|0.0|0.0|Malignant|22|83193069|Male and Female|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|67|83318260|Male and Female|Choroid plexus|2017
0-19|0.0|0.0|0.0|Malignant|16|83318260|Male and Female|Choroid plexus|2017
0-19|0.1|0.1|0.1|Benign/Borderline|69|83333434|Male and Female|Choroid plexus|2018
0-19|0.0|0.0|0.0|Malignant|17|83333434|Male and Female|Choroid plexus|2018
0-19|0.1|0.1|0.1|Benign/Borderline|59|83226688|Male and Female|Choroid plexus|2019
0-19|0.0|0.0|0.0|Malignant|26|83226688|Male and Female|Choroid plexus|2019
0-19|0.1|0.1|0.1|Benign/Borderline|295|412527765|Male and Female|Choroid plexus|2019-2023
0-19|0.0|0.0|0.0|Malignant|96|412527765|Male and Female|Choroid plexus|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|62|82886629|Male and Female|Choroid plexus|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|47|82212844|Male and Female|Choroid plexus|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Choroid plexus|2021
0-19|0.1|0.1|0.1|Benign/Borderline|65|82113420|Male and Female|Choroid plexus|2022
0-19|0.0|0.1|0.0|Malignant|28|82113420|Male and Female|Choroid plexus|2022
0-19|0.1|0.1|0.1|Benign/Borderline|62|82088184|Male and Female|Choroid plexus|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Choroid plexus|2023
0-19|0.2|0.2|0.2|Benign/Borderline|172|81754354|Male and Female|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|185|82749431|Male and Female|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007
0-19|0.2|0.2|0.2|Benign/Borderline|165|83118264|Male and Female|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008
0-19|0.2|0.2|0.2|Benign/Borderline|174|83280391|Male and Female|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009
0-19|0.2|0.3|0.2|Benign/Borderline|180|83225072|Male and Female|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Craniopharyngioma|2010
0-19|0.2|0.2|0.2|Benign/Borderline|158|83042807|Male and Female|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|159|82869473|Male and Female|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|184|82802400|Male and Female|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Craniopharyngioma|2013
0-19|0.2|0.3|0.2|Benign/Borderline|203|82834118|Male and Female|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|182|82981714|Male and Female|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Craniopharyngioma|2015
0-19|0.2|0.2|0.2|Benign/Borderline|149|83193069|Male and Female|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Craniopharyngioma|2016
0-19|0.2|0.3|0.2|Benign/Borderline|184|83318260|Male and Female|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Craniopharyngioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|159|83333434|Male and Female|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Craniopharyngioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|167|83226688|Male and Female|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Craniopharyngioma|2019
0-19|0.2|0.2|0.2|Benign/Borderline|793|412527765|Male and Female|Craniopharyngioma|2019-2023
0-19|~|~|~|Malignant|~|412527765|Male and Female|Craniopharyngioma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|130|82886629|Male and Female|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Craniopharyngioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|184|82212844|Male and Female|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Craniopharyngioma|2021
0-19|0.2|0.2|0.2|Benign/Borderline|161|82113420|Male and Female|Craniopharyngioma|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Craniopharyngioma|2022
0-19|0.2|0.2|0.2|Benign/Borderline|151|82088184|Male and Female|Craniopharyngioma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Craniopharyngioma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Diffuse astrocytoma|2010
0-19|0.0|0.1|0.0|Malignant|32|83225072|Male and Female|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Diffuse astrocytoma|2011
0-19|0.0|0.1|0.0|Malignant|35|83042807|Male and Female|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Diffuse astrocytoma|2012
0-19|0.0|0.0|0.0|Malignant|28|82869473|Male and Female|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Diffuse astrocytoma|2013
0-19|0.0|0.0|0.0|Malignant|16|82802400|Male and Female|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Diffuse astrocytoma|2019-2023
0-19|~|~|~|Malignant|~|412527765|Male and Female|Diffuse astrocytoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Diffuse astrocytoma|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Diffuse astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Diffuse astrocytoma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Diffuse astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004
0-19|0.6|0.7|0.6|Malignant|510|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005
0-19|0.5|0.6|0.6|Malignant|461|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006
0-19|0.6|0.7|0.6|Malignant|501|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007
0-19|0.6|0.7|0.6|Malignant|514|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008
0-19|0.6|0.7|0.7|Malignant|550|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009
0-19|0.6|0.7|0.6|Malignant|515|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Embryonal/primitive/medulloblastoma|2010
0-19|0.5|0.6|0.6|Malignant|489|83225072|Male and Female|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Embryonal/primitive/medulloblastoma|2011
0-19|0.6|0.7|0.6|Malignant|499|83042807|Male and Female|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Embryonal/primitive/medulloblastoma|2012
0-19|0.5|0.6|0.6|Malignant|466|82869473|Male and Female|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Embryonal/primitive/medulloblastoma|2013
0-19|0.5|0.6|0.6|Malignant|462|82802400|Male and Female|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Embryonal/primitive/medulloblastoma|2014
0-19|0.6|0.7|0.6|Malignant|496|82834118|Male and Female|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Embryonal/primitive/medulloblastoma|2015
0-19|0.5|0.7|0.6|Malignant|493|82981714|Male and Female|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Embryonal/primitive/medulloblastoma|2016
0-19|0.5|0.6|0.6|Malignant|462|83193069|Male and Female|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Embryonal/primitive/medulloblastoma|2017
0-19|0.5|0.6|0.6|Malignant|472|83318260|Male and Female|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Embryonal/primitive/medulloblastoma|2018
0-19|0.4|0.5|0.4|Malignant|359|83333434|Male and Female|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Embryonal/primitive/medulloblastoma|2019
0-19|0.3|0.4|0.4|Malignant|294|83226688|Male and Female|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Embryonal/primitive/medulloblastoma|2019-2023
0-19|0.3|0.4|0.4|Malignant|1413|412527765|Male and Female|Embryonal/primitive/medulloblastoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Embryonal/primitive/medulloblastoma|2020
0-19|0.4|0.5|0.4|Malignant|337|82886629|Male and Female|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Embryonal/primitive/medulloblastoma|2021
0-19|0.3|0.4|0.4|Malignant|299|82212844|Male and Female|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Embryonal/primitive/medulloblastoma|2022
0-19|0.3|0.4|0.3|Malignant|258|82113420|Male and Female|Embryonal/primitive/medulloblastoma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Embryonal/primitive/medulloblastoma|2023
0-19|0.2|0.3|0.3|Malignant|225|82088184|Male and Female|Embryonal/primitive/medulloblastoma|2023
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004
0-19|0.0|0.0|0.0|Benign/Borderline|26|82005260|Male and Female|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009
0-19|0.0|0.1|0.0|Benign/Borderline|41|83225072|Male and Female|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|43|83042807|Male and Female|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|33|82869473|Male and Female|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|38|82802400|Male and Female|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Ependymoma variants|2014
0-19|0.0|0.1|0.0|Benign/Borderline|31|82981714|Male and Female|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Ependymoma variants|2015
0-19|0.0|0.1|0.0|Benign/Borderline|39|83193069|Male and Female|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Ependymoma variants|2016
0-19|0.0|0.1|0.0|Benign/Borderline|37|83318260|Male and Female|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Ependymoma variants|2017
0-19|0.0|0.1|0.0|Benign/Borderline|37|83333434|Male and Female|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Ependymoma variants|2018
0-19|0.0|0.1|0.0|Benign/Borderline|39|83226688|Male and Female|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Ependymoma variants|2019
0-19|0.0|0.1|0.0|Benign/Borderline|191|412527765|Male and Female|Ependymoma variants|2019-2023
0-19|~|~|~|Malignant|~|412527765|Male and Female|Ependymoma variants|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|35|82886629|Male and Female|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Ependymoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|39|82212844|Male and Female|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Ependymoma variants|2021
0-19|0.0|0.1|0.0|Benign/Borderline|42|82113420|Male and Female|Ependymoma variants|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Ependymoma variants|2022
0-19|0.0|0.1|0.0|Benign/Borderline|36|82088184|Male and Female|Ependymoma variants|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Ependymoma variants|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|201|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|219|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.3|Malignant|210|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007
0-19|0.2|0.3|0.2|Malignant|187|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008
0-19|0.2|0.2|0.2|Malignant|174|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.3|Malignant|213|83225072|Male and Female|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.3|Malignant|210|83042807|Male and Female|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.2|Malignant|205|82869473|Male and Female|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.2|Malignant|204|82802400|Male and Female|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.2|Malignant|202|82834118|Male and Female|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.2|Malignant|202|82981714|Male and Female|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.3|0.2|Malignant|184|83193069|Male and Female|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.3|0.3|Malignant|224|83318260|Male and Female|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Ependymoma/anaplastic ependymoma|2018
0-19|0.2|0.2|0.2|Malignant|171|83333434|Male and Female|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Ependymoma/anaplastic ependymoma|2019
0-19|0.2|0.2|0.2|Malignant|175|83226688|Male and Female|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Ependymoma/anaplastic ependymoma|2019-2023
0-19|0.2|0.2|0.2|Malignant|723|412527765|Male and Female|Ependymoma/anaplastic ependymoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Ependymoma/anaplastic ependymoma|2020
0-19|0.2|0.2|0.2|Malignant|166|82886629|Male and Female|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Ependymoma/anaplastic ependymoma|2021
0-19|0.2|0.2|0.2|Malignant|148|82212844|Male and Female|Ependymoma/anaplastic ependymoma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Ependymoma/anaplastic ependymoma|2022
0-19|0.1|0.2|0.2|Malignant|135|82113420|Male and Female|Ependymoma/anaplastic ependymoma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Ependymoma/anaplastic ependymoma|2023
0-19|0.1|0.1|0.1|Malignant|99|82088184|Male and Female|Ependymoma/anaplastic ependymoma|2023
0-19|0.0|0.1|0.0|Benign/Borderline|32|81754354|Male and Female|Germ Cell Tumors|2004
0-19|0.2|0.2|0.2|Malignant|149|81754354|Male and Female|Germ Cell Tumors|2004
0-19|0.0|0.1|0.0|Benign/Borderline|37|82005260|Male and Female|Germ Cell Tumors|2005
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005
0-19|0.0|0.1|0.1|Benign/Borderline|47|82324418|Male and Female|Germ Cell Tumors|2006
0-19|0.1|0.2|0.2|Malignant|126|82324418|Male and Female|Germ Cell Tumors|2006
0-19|0.0|0.1|0.0|Benign/Borderline|35|82749431|Male and Female|Germ Cell Tumors|2007
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|38|83118264|Male and Female|Germ Cell Tumors|2008
0-19|0.1|0.2|0.2|Malignant|145|83118264|Male and Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.1|Benign/Borderline|53|83280391|Male and Female|Germ Cell Tumors|2009
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|45|83225072|Male and Female|Germ Cell Tumors|2010
0-19|0.2|0.2|0.2|Malignant|165|83225072|Male and Female|Germ Cell Tumors|2010
0-19|0.0|0.1|0.0|Benign/Borderline|37|83042807|Male and Female|Germ Cell Tumors|2011
0-19|0.1|0.2|0.2|Malignant|138|83042807|Male and Female|Germ Cell Tumors|2011
0-19|0.0|0.1|0.1|Benign/Borderline|42|82869473|Male and Female|Germ Cell Tumors|2012
0-19|0.1|0.2|0.2|Malignant|130|82869473|Male and Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|48|82802400|Male and Female|Germ Cell Tumors|2013
0-19|0.2|0.2|0.2|Malignant|159|82802400|Male and Female|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|50|82834118|Male and Female|Germ Cell Tumors|2014
0-19|0.1|0.2|0.2|Malignant|137|82834118|Male and Female|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|38|82981714|Male and Female|Germ Cell Tumors|2015
0-19|0.2|0.2|0.2|Malignant|151|82981714|Male and Female|Germ Cell Tumors|2015
0-19|0.1|0.1|0.1|Benign/Borderline|61|83193069|Male and Female|Germ Cell Tumors|2016
0-19|0.2|0.2|0.2|Malignant|169|83193069|Male and Female|Germ Cell Tumors|2016
0-19|0.0|0.1|0.0|Benign/Borderline|40|83318260|Male and Female|Germ Cell Tumors|2017
0-19|0.2|0.2|0.2|Malignant|178|83318260|Male and Female|Germ Cell Tumors|2017
0-19|0.1|0.1|0.1|Benign/Borderline|58|83333434|Male and Female|Germ Cell Tumors|2018
0-19|0.1|0.2|0.2|Malignant|130|83333434|Male and Female|Germ Cell Tumors|2018
0-19|0.0|0.1|0.1|Benign/Borderline|41|83226688|Male and Female|Germ Cell Tumors|2019
0-19|0.2|0.2|0.2|Malignant|159|83226688|Male and Female|Germ Cell Tumors|2019
0-19|0.0|0.1|0.0|Benign/Borderline|180|412527765|Male and Female|Germ Cell Tumors|2019-2023
0-19|0.2|0.2|0.2|Malignant|753|412527765|Male and Female|Germ Cell Tumors|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|29|82886629|Male and Female|Germ Cell Tumors|2020
0-19|0.2|0.2|0.2|Malignant|151|82886629|Male and Female|Germ Cell Tumors|2020
0-19|0.0|0.1|0.1|Benign/Borderline|41|82212844|Male and Female|Germ Cell Tumors|2021
0-19|0.2|0.2|0.2|Malignant|154|82212844|Male and Female|Germ Cell Tumors|2021
0-19|0.0|0.1|0.0|Benign/Borderline|30|82113420|Male and Female|Germ Cell Tumors|2022
0-19|0.1|0.2|0.2|Malignant|131|82113420|Male and Female|Germ Cell Tumors|2022
0-19|0.0|0.1|0.0|Benign/Borderline|39|82088184|Male and Female|Germ Cell Tumors|2023
0-19|0.2|0.2|0.2|Malignant|158|82088184|Male and Female|Germ Cell Tumors|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004
0-19|0.1|0.2|0.2|Malignant|127|81754354|Male and Female|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006
0-19|0.1|0.2|0.1|Malignant|111|82324418|Male and Female|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007
0-19|0.1|0.2|0.2|Malignant|126|82749431|Male and Female|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|130|83118264|Male and Female|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009
0-19|0.1|0.2|0.1|Malignant|121|83280391|Male and Female|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Glioblastoma|2010
0-19|0.1|0.2|0.1|Malignant|119|83225072|Male and Female|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Glioblastoma|2011
0-19|0.2|0.2|0.2|Malignant|159|83042807|Male and Female|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Glioblastoma|2012
0-19|0.2|0.2|0.2|Malignant|155|82869473|Male and Female|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Glioblastoma|2013
0-19|0.2|0.2|0.2|Malignant|161|82802400|Male and Female|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|146|82834118|Male and Female|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Glioblastoma|2015
0-19|0.2|0.2|0.2|Malignant|149|82981714|Male and Female|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Glioblastoma|2016
0-19|0.1|0.2|0.2|Malignant|133|83193069|Male and Female|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|143|83318260|Male and Female|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Glioblastoma|2018
0-19|0.1|0.2|0.2|Malignant|139|83333434|Male and Female|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Glioblastoma|2019
0-19|0.1|0.2|0.1|Malignant|125|83226688|Male and Female|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Glioblastoma|2019-2023
0-19|0.1|0.1|0.1|Malignant|437|412527765|Male and Female|Glioblastoma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Glioblastoma|2020
0-19|0.1|0.1|0.1|Malignant|100|82886629|Male and Female|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Glioblastoma|2021
0-19|0.1|0.2|0.1|Malignant|104|82212844|Male and Female|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Glioblastoma|2022
0-19|0.1|0.1|0.1|Malignant|69|82113420|Male and Female|Glioblastoma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Glioblastoma|2023
0-19|0.0|0.1|0.0|Malignant|39|82088184|Male and Female|Glioblastoma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004
0-19|0.5|0.6|0.6|Malignant|465|81754354|Male and Female|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005
0-19|0.5|0.6|0.6|Malignant|457|82005260|Male and Female|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006
0-19|0.6|0.7|0.6|Malignant|493|82324418|Male and Female|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007
0-19|0.6|0.7|0.6|Malignant|517|82749431|Male and Female|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008
0-19|0.6|0.7|0.7|Malignant|551|83118264|Male and Female|Glioma malignant, NOS|2008
0-19|0.0|0.0|0.0|Benign/Borderline|16|83280391|Male and Female|Glioma malignant, NOS|2009
0-19|0.6|0.8|0.7|Malignant|574|83280391|Male and Female|Glioma malignant, NOS|2009
0-19|0.0|0.0|0.0|Benign/Borderline|23|83225072|Male and Female|Glioma malignant, NOS|2010
0-19|0.6|0.7|0.7|Malignant|548|83225072|Male and Female|Glioma malignant, NOS|2010
0-19|0.0|0.1|0.0|Benign/Borderline|34|83042807|Male and Female|Glioma malignant, NOS|2011
0-19|0.7|0.8|0.7|Malignant|604|83042807|Male and Female|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|36|82869473|Male and Female|Glioma malignant, NOS|2012
0-19|0.6|0.7|0.6|Malignant|524|82869473|Male and Female|Glioma malignant, NOS|2012
0-19|0.0|0.1|0.0|Benign/Borderline|36|82802400|Male and Female|Glioma malignant, NOS|2013
0-19|0.7|0.8|0.7|Malignant|583|82802400|Male and Female|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.1|Benign/Borderline|44|82834118|Male and Female|Glioma malignant, NOS|2014
0-19|0.6|0.7|0.7|Malignant|545|82834118|Male and Female|Glioma malignant, NOS|2014
0-19|0.0|0.1|0.0|Benign/Borderline|39|82981714|Male and Female|Glioma malignant, NOS|2015
0-19|0.7|0.8|0.7|Malignant|603|82981714|Male and Female|Glioma malignant, NOS|2015
0-19|0.1|0.1|0.1|Benign/Borderline|58|83193069|Male and Female|Glioma malignant, NOS|2016
0-19|0.7|0.8|0.8|Malignant|634|83193069|Male and Female|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|49|83318260|Male and Female|Glioma malignant, NOS|2017
0-19|0.8|0.9|0.8|Malignant|674|83318260|Male and Female|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.1|Benign/Borderline|51|83333434|Male and Female|Glioma malignant, NOS|2018
0-19|0.5|0.6|0.6|Malignant|488|83333434|Male and Female|Glioma malignant, NOS|2018
0-19|0.0|0.1|0.0|Benign/Borderline|40|83226688|Male and Female|Glioma malignant, NOS|2019
0-19|0.5|0.6|0.6|Malignant|467|83226688|Male and Female|Glioma malignant, NOS|2019
0-19|0.1|0.1|0.1|Benign/Borderline|242|412527765|Male and Female|Glioma malignant, NOS|2019-2023
0-19|0.6|0.6|0.6|Malignant|2380|412527765|Male and Female|Glioma malignant, NOS|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|31|82886629|Male and Female|Glioma malignant, NOS|2020
0-19|0.5|0.6|0.6|Malignant|472|82886629|Male and Female|Glioma malignant, NOS|2020
0-19|0.0|0.1|0.0|Benign/Borderline|32|82212844|Male and Female|Glioma malignant, NOS|2021
0-19|0.6|0.7|0.7|Malignant|537|82212844|Male and Female|Glioma malignant, NOS|2021
0-19|0.0|0.1|0.1|Benign/Borderline|54|82113420|Male and Female|Glioma malignant, NOS|2022
0-19|0.6|0.7|0.6|Malignant|509|82113420|Male and Female|Glioma malignant, NOS|2022
0-19|0.1|0.1|0.1|Benign/Borderline|85|82088184|Male and Female|Glioma malignant, NOS|2023
0-19|0.4|0.5|0.5|Malignant|395|82088184|Male and Female|Glioma malignant, NOS|2023
0-19|0.0|0.1|0.0|Benign/Borderline|30|81754354|Male and Female|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004
0-19|0.0|0.1|0.0|Benign/Borderline|30|82005260|Male and Female|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005
0-19|0.0|0.0|0.0|Benign/Borderline|27|82324418|Male and Female|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006
0-19|0.0|0.1|0.0|Benign/Borderline|41|82749431|Male and Female|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007
0-19|0.0|0.0|0.0|Benign/Borderline|25|83118264|Male and Female|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|33|83280391|Male and Female|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009
0-19|0.0|0.0|0.0|Benign/Borderline|28|83225072|Male and Female|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Hemangioblastoma|2010
0-19|0.0|0.1|0.0|Benign/Borderline|42|83042807|Male and Female|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Hemangioblastoma|2011
0-19|0.0|0.1|0.1|Benign/Borderline|43|82869473|Male and Female|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Hemangioblastoma|2012
0-19|0.0|0.1|0.0|Benign/Borderline|39|82802400|Male and Female|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Hemangioblastoma|2013
0-19|0.0|0.1|0.1|Benign/Borderline|54|82834118|Male and Female|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|35|82981714|Male and Female|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Hemangioblastoma|2015
0-19|0.0|0.1|0.1|Benign/Borderline|44|83193069|Male and Female|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Hemangioblastoma|2016
0-19|0.0|0.1|0.0|Benign/Borderline|35|83318260|Male and Female|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Hemangioblastoma|2017
0-19|0.0|0.1|0.0|Benign/Borderline|39|83333434|Male and Female|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Hemangioblastoma|2018
0-19|0.0|0.1|0.0|Benign/Borderline|35|83226688|Male and Female|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Hemangioblastoma|2019
0-19|0.0|0.0|0.0|Benign/Borderline|169|412527765|Male and Female|Hemangioblastoma|2019-2023
0-19|~|~|~|Malignant|~|412527765|Male and Female|Hemangioblastoma|2019-2023
0-19|0.0|0.1|0.0|Benign/Borderline|39|82886629|Male and Female|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Hemangioblastoma|2020
0-19|0.0|0.1|0.0|Benign/Borderline|35|82212844|Male and Female|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Hemangioblastoma|2021
0-19|0.0|0.1|0.0|Benign/Borderline|30|82113420|Male and Female|Hemangioblastoma|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Hemangioblastoma|2022
0-19|0.0|0.0|0.0|Benign/Borderline|30|82088184|Male and Female|Hemangioblastoma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Hemangioblastoma|2023
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Hemangioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|47|82005260|Male and Female|Hemangioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|75|82324418|Male and Female|Hemangioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006
0-19|0.1|0.1|0.1|Benign/Borderline|90|82749431|Male and Female|Hemangioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007
0-19|0.1|0.1|0.1|Benign/Borderline|101|83118264|Male and Female|Hemangioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|117|83280391|Male and Female|Hemangioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|108|83225072|Male and Female|Hemangioma|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Hemangioma|2010
0-19|0.2|0.2|0.2|Benign/Borderline|151|83042807|Male and Female|Hemangioma|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|135|82869473|Male and Female|Hemangioma|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|132|82802400|Male and Female|Hemangioma|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Hemangioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|128|82834118|Male and Female|Hemangioma|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Hemangioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|134|82981714|Male and Female|Hemangioma|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Hemangioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|146|83193069|Male and Female|Hemangioma|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Hemangioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|124|83318260|Male and Female|Hemangioma|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Hemangioma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|127|83333434|Male and Female|Hemangioma|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Hemangioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|108|83226688|Male and Female|Hemangioma|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|586|412527765|Male and Female|Hemangioma|2019-2023
0-19|~|~|~|Malignant|~|412527765|Male and Female|Hemangioma|2019-2023
0-19|0.1|0.2|0.1|Benign/Borderline|124|82886629|Male and Female|Hemangioma|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Hemangioma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|128|82212844|Male and Female|Hemangioma|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Hemangioma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|103|82113420|Male and Female|Hemangioma|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Hemangioma|2022
0-19|0.1|0.2|0.1|Benign/Borderline|123|82088184|Male and Female|Hemangioma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Hemangioma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Local Extensions from Regional Tumors|2019-2023
0-19|0.0|0.0|0.0|Malignant|19|412527765|Male and Female|Local Extensions from Regional Tumors|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Local Extensions from Regional Tumors|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Local Extensions from Regional Tumors|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|0.0|0.0|0.0|Malignant|17|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|0.0|0.0|0.0|Malignant|17|82981714|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
0-19|0.0|0.0|0.0|Malignant|50|412527765|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Lymphomas and Hematopoietic Neoplasms|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Lymphomas and Hematopoietic Neoplasms|2023
0-19|0.1|0.1|0.1|Benign/Borderline|95|81754354|Male and Female|Meningioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004
0-19|0.1|0.2|0.2|Benign/Borderline|127|82005260|Male and Female|Meningioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|101|82324418|Male and Female|Meningioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|110|82749431|Male and Female|Meningioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|120|83118264|Male and Female|Meningioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|126|83280391|Male and Female|Meningioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|115|83225072|Male and Female|Meningioma|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Meningioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|134|83042807|Male and Female|Meningioma|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Meningioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|129|82869473|Male and Female|Meningioma|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Meningioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|134|82802400|Male and Female|Meningioma|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Meningioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|139|82834118|Male and Female|Meningioma|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|143|82981714|Male and Female|Meningioma|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Meningioma|2015
0-19|0.1|0.2|0.1|Benign/Borderline|124|83193069|Male and Female|Meningioma|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|132|83318260|Male and Female|Meningioma|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Meningioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|161|83333434|Male and Female|Meningioma|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Meningioma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|142|83226688|Male and Female|Meningioma|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Meningioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|680|412527765|Male and Female|Meningioma|2019-2023
0-19|0.0|0.0|0.0|Malignant|21|412527765|Male and Female|Meningioma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|134|82886629|Male and Female|Meningioma|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Meningioma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|141|82212844|Male and Female|Meningioma|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Meningioma|2021
0-19|0.1|0.2|0.2|Benign/Borderline|135|82113420|Male and Female|Meningioma|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Meningioma|2022
0-19|0.1|0.2|0.2|Benign/Borderline|128|82088184|Male and Female|Meningioma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Meningioma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009
0-19|0.0|0.0|0.0|Malignant|27|83280391|Male and Female|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Mixed glioma|2010
0-19|0.0|0.1|0.0|Malignant|32|83225072|Male and Female|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Mixed glioma|2011
0-19|0.0|0.0|0.0|Malignant|28|83042807|Male and Female|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Mixed glioma|2012
0-19|0.0|0.0|0.0|Malignant|25|82869473|Male and Female|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Mixed glioma|2013
0-19|0.0|0.0|0.0|Malignant|19|82802400|Male and Female|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Mixed glioma|2014
0-19|0.0|0.0|0.0|Malignant|19|82834118|Male and Female|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Mixed glioma|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Mixed glioma|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Mixed glioma|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Mixed glioma|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Mixed glioma|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Mixed glioma|2019-2023
0-19|~|~|~|Malignant|~|412527765|Male and Female|Mixed glioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Mixed glioma|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Mixed glioma|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Mixed glioma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Mixed glioma|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Mixed glioma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Mixed glioma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Mixed glioma|2023
0-19|0.1|0.1|0.1|Benign/Borderline|65|81754354|Male and Female|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|116|82005260|Male and Female|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|37|82005260|Male and Female|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|105|82324418|Male and Female|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|118|82749431|Male and Female|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|37|82749431|Male and Female|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.2|Benign/Borderline|127|83118264|Male and Female|Neoplasm, unspecified|2008
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Neoplasm, unspecified|2008
0-19|0.2|0.2|0.2|Benign/Borderline|152|83280391|Male and Female|Neoplasm, unspecified|2009
0-19|0.0|0.1|0.0|Malignant|36|83280391|Male and Female|Neoplasm, unspecified|2009
0-19|0.2|0.2|0.2|Benign/Borderline|171|83225072|Male and Female|Neoplasm, unspecified|2010
0-19|0.0|0.0|0.0|Malignant|26|83225072|Male and Female|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|140|83042807|Male and Female|Neoplasm, unspecified|2011
0-19|0.0|0.1|0.0|Malignant|32|83042807|Male and Female|Neoplasm, unspecified|2011
0-19|0.1|0.2|0.2|Benign/Borderline|140|82869473|Male and Female|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|50|82869473|Male and Female|Neoplasm, unspecified|2012
0-19|0.2|0.2|0.2|Benign/Borderline|148|82802400|Male and Female|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.1|Malignant|43|82802400|Male and Female|Neoplasm, unspecified|2013
0-19|0.2|0.2|0.2|Benign/Borderline|155|82834118|Male and Female|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.1|Malignant|44|82834118|Male and Female|Neoplasm, unspecified|2014
0-19|0.1|0.2|0.2|Benign/Borderline|147|82981714|Male and Female|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|37|82981714|Male and Female|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.2|Benign/Borderline|130|83193069|Male and Female|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|46|83193069|Male and Female|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.2|Benign/Borderline|136|83318260|Male and Female|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.1|Malignant|48|83318260|Male and Female|Neoplasm, unspecified|2017
0-19|0.1|0.2|0.2|Benign/Borderline|141|83333434|Male and Female|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.1|Malignant|44|83333434|Male and Female|Neoplasm, unspecified|2018
0-19|0.1|0.2|0.1|Benign/Borderline|104|83226688|Male and Female|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.0|Malignant|35|83226688|Male and Female|Neoplasm, unspecified|2019
0-19|0.1|0.1|0.1|Benign/Borderline|520|412527765|Male and Female|Neoplasm, unspecified|2019-2023
0-19|0.0|0.1|0.1|Malignant|232|412527765|Male and Female|Neoplasm, unspecified|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|101|82886629|Male and Female|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|53|82886629|Male and Female|Neoplasm, unspecified|2020
0-19|0.1|0.2|0.1|Benign/Borderline|113|82212844|Male and Female|Neoplasm, unspecified|2021
0-19|0.0|0.1|0.1|Malignant|49|82212844|Male and Female|Neoplasm, unspecified|2021
0-19|0.1|0.2|0.1|Benign/Borderline|109|82113420|Male and Female|Neoplasm, unspecified|2022
0-19|0.1|0.1|0.1|Malignant|55|82113420|Male and Female|Neoplasm, unspecified|2022
0-19|0.1|0.1|0.1|Benign/Borderline|93|82088184|Male and Female|Neoplasm, unspecified|2023
0-19|0.0|0.1|0.0|Malignant|40|82088184|Male and Female|Neoplasm, unspecified|2023
0-19|0.3|0.3|0.3|Benign/Borderline|244|81754354|Male and Female|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004
0-19|0.3|0.4|0.4|Benign/Borderline|291|82005260|Male and Female|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005
0-19|0.4|0.5|0.4|Benign/Borderline|343|82324418|Male and Female|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006
0-19|0.3|0.4|0.4|Benign/Borderline|303|82749431|Male and Female|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|306|83118264|Male and Female|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|313|83280391|Male and Female|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|282|83225072|Male and Female|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.4|Benign/Borderline|300|83042807|Male and Female|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|308|82869473|Male and Female|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Nerve sheath, benign and malignant|2012
0-19|0.4|0.4|0.4|Benign/Borderline|326|82802400|Male and Female|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Nerve sheath, benign and malignant|2013
0-19|0.3|0.4|0.3|Benign/Borderline|270|82834118|Male and Female|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Nerve sheath, benign and malignant|2014
0-19|0.3|0.4|0.4|Benign/Borderline|317|82981714|Male and Female|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Nerve sheath, benign and malignant|2015
0-19|0.3|0.4|0.4|Benign/Borderline|318|83193069|Male and Female|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Nerve sheath, benign and malignant|2016
0-19|0.3|0.4|0.3|Benign/Borderline|260|83318260|Male and Female|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Nerve sheath, benign and malignant|2017
0-19|0.2|0.2|0.2|Benign/Borderline|175|83333434|Male and Female|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Nerve sheath, benign and malignant|2018
0-19|0.2|0.3|0.2|Benign/Borderline|188|83226688|Male and Female|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Nerve sheath, benign and malignant|2019
0-19|0.2|0.2|0.2|Benign/Borderline|798|412527765|Male and Female|Nerve sheath, benign and malignant|2019-2023
0-19|0.0|0.0|0.0|Malignant|19|412527765|Male and Female|Nerve sheath, benign and malignant|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|148|82886629|Male and Female|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Nerve sheath, benign and malignant|2020
0-19|0.2|0.2|0.2|Benign/Borderline|159|82212844|Male and Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Nerve sheath, benign and malignant|2021
0-19|0.2|0.2|0.2|Benign/Borderline|152|82113420|Male and Female|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Nerve sheath, benign and malignant|2022
0-19|0.2|0.2|0.2|Benign/Borderline|151|82088184|Male and Female|Nerve sheath, benign and malignant|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Nerve sheath, benign and malignant|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Neuroepithelial|2019-2023
0-19|0.0|0.0|0.0|Malignant|33|412527765|Male and Female|Neuroepithelial|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Neuroepithelial|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Neuroepithelial|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Neuroepithelial|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Neuroepithelial|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Neuroepithelial|2023
0-19|0.3|0.4|0.3|Benign/Borderline|266|81754354|Male and Female|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.4|Benign/Borderline|297|82005260|Male and Female|Neuronal/glial, neuronal|2005
0-19|0.1|0.1|0.1|Malignant|57|82005260|Male and Female|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.3|Benign/Borderline|286|82324418|Male and Female|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006
0-19|0.3|0.4|0.4|Benign/Borderline|315|82749431|Male and Female|Neuronal/glial, neuronal|2007
0-19|0.1|0.1|0.1|Malignant|63|82749431|Male and Female|Neuronal/glial, neuronal|2007
0-19|0.3|0.4|0.4|Benign/Borderline|318|83118264|Male and Female|Neuronal/glial, neuronal|2008
0-19|0.1|0.1|0.1|Malignant|57|83118264|Male and Female|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.4|Benign/Borderline|296|83280391|Male and Female|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009
0-19|0.3|0.4|0.4|Benign/Borderline|319|83225072|Male and Female|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|35|83225072|Male and Female|Neuronal/glial, neuronal|2010
0-19|0.4|0.5|0.4|Benign/Borderline|346|83042807|Male and Female|Neuronal/glial, neuronal|2011
0-19|0.0|0.1|0.0|Malignant|36|83042807|Male and Female|Neuronal/glial, neuronal|2011
0-19|0.4|0.5|0.4|Benign/Borderline|368|82869473|Male and Female|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.0|Malignant|41|82869473|Male and Female|Neuronal/glial, neuronal|2012
0-19|0.4|0.5|0.4|Benign/Borderline|360|82802400|Male and Female|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|45|82802400|Male and Female|Neuronal/glial, neuronal|2013
0-19|0.4|0.5|0.4|Benign/Borderline|345|82834118|Male and Female|Neuronal/glial, neuronal|2014
0-19|0.1|0.1|0.1|Malignant|57|82834118|Male and Female|Neuronal/glial, neuronal|2014
0-19|0.4|0.5|0.5|Benign/Borderline|401|82981714|Male and Female|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.1|Malignant|43|82981714|Male and Female|Neuronal/glial, neuronal|2015
0-19|0.5|0.6|0.5|Benign/Borderline|423|83193069|Male and Female|Neuronal/glial, neuronal|2016
0-19|0.1|0.1|0.1|Malignant|56|83193069|Male and Female|Neuronal/glial, neuronal|2016
0-19|0.5|0.6|0.5|Benign/Borderline|423|83318260|Male and Female|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.1|Malignant|42|83318260|Male and Female|Neuronal/glial, neuronal|2017
0-19|0.4|0.5|0.5|Benign/Borderline|379|83333434|Male and Female|Neuronal/glial, neuronal|2018
0-19|0.0|0.1|0.1|Malignant|50|83333434|Male and Female|Neuronal/glial, neuronal|2018
0-19|0.4|0.5|0.5|Benign/Borderline|396|83226688|Male and Female|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|44|83226688|Male and Female|Neuronal/glial, neuronal|2019
0-19|0.4|0.4|0.4|Benign/Borderline|1763|412527765|Male and Female|Neuronal/glial, neuronal|2019-2023
0-19|0.0|0.1|0.0|Malignant|192|412527765|Male and Female|Neuronal/glial, neuronal|2019-2023
0-19|0.4|0.4|0.4|Benign/Borderline|339|82886629|Male and Female|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.1|Malignant|46|82886629|Male and Female|Neuronal/glial, neuronal|2020
0-19|0.4|0.4|0.4|Benign/Borderline|328|82212844|Male and Female|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|33|82212844|Male and Female|Neuronal/glial, neuronal|2021
0-19|0.4|0.5|0.5|Benign/Borderline|375|82113420|Male and Female|Neuronal/glial, neuronal|2022
0-19|0.0|0.1|0.0|Malignant|37|82113420|Male and Female|Neuronal/glial, neuronal|2022
0-19|0.4|0.4|0.4|Benign/Borderline|325|82088184|Male and Female|Neuronal/glial, neuronal|2023
0-19|0.0|0.1|0.0|Malignant|32|82088184|Male and Female|Neuronal/glial, neuronal|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|53|82005260|Male and Female|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006
0-19|0.1|0.1|0.1|Malignant|56|82324418|Male and Female|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|53|82749431|Male and Female|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008
0-19|0.0|0.1|0.1|Malignant|48|83118264|Male and Female|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009
0-19|0.0|0.1|0.1|Malignant|45|83280391|Male and Female|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|46|83225072|Male and Female|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|37|83042807|Male and Female|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|48|82869473|Male and Female|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|36|82802400|Male and Female|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|38|82834118|Male and Female|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|36|82981714|Male and Female|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Oligodendroglioma|2016
0-19|0.0|0.1|0.0|Malignant|38|83193069|Male and Female|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Oligodendroglioma|2017
0-19|0.0|0.0|0.0|Malignant|27|83318260|Male and Female|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Oligodendroglioma|2018
0-19|0.0|0.0|0.0|Malignant|25|83333434|Male and Female|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Oligodendroglioma|2019
0-19|0.0|0.0|0.0|Malignant|21|83226688|Male and Female|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|412527765|Male and Female|Oligodendroglioma|2019-2023
0-19|0.0|0.0|0.0|Malignant|93|412527765|Male and Female|Oligodendroglioma|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Oligodendroglioma|2020
0-19|0.0|0.0|0.0|Malignant|19|82886629|Male and Female|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Oligodendroglioma|2021
0-19|0.0|0.0|0.0|Malignant|23|82212844|Male and Female|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Oligodendroglioma|2022
0-19|0.0|0.0|0.0|Malignant|18|82113420|Male and Female|Oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Oligodendroglioma|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Oligodendroglioma|2023
0-19|0.0|0.0|0.0|Benign/Borderline|28|81754354|Male and Female|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004
0-19|0.0|0.1|0.0|Benign/Borderline|40|82005260|Male and Female|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006
0-19|0.0|0.1|0.0|Benign/Borderline|34|82749431|Male and Female|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|41|83118264|Male and Female|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008
0-19|0.0|0.1|0.1|Benign/Borderline|53|83280391|Male and Female|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|54|83225072|Male and Female|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Other mesenchymal|2010
0-19|0.1|0.1|0.1|Benign/Borderline|65|83042807|Male and Female|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Other mesenchymal|2011
0-19|0.1|0.2|0.1|Benign/Borderline|102|82869473|Male and Female|Other mesenchymal|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|80|82802400|Male and Female|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|81|82834118|Male and Female|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Other mesenchymal|2014
0-19|0.1|0.1|0.1|Benign/Borderline|88|82981714|Male and Female|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|106|83193069|Male and Female|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Other mesenchymal|2016
0-19|0.1|0.1|0.1|Benign/Borderline|100|83318260|Male and Female|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Other mesenchymal|2017
0-19|0.1|0.2|0.1|Benign/Borderline|103|83333434|Male and Female|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Other mesenchymal|2018
0-19|0.1|0.1|0.1|Benign/Borderline|65|83226688|Male and Female|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Other mesenchymal|2019
0-19|0.1|0.1|0.1|Benign/Borderline|441|412527765|Male and Female|Other mesenchymal|2019-2023
0-19|0.0|0.0|0.0|Malignant|91|412527765|Male and Female|Other mesenchymal|2019-2023
0-19|0.1|0.1|0.1|Benign/Borderline|72|82886629|Male and Female|Other mesenchymal|2020
0-19|0.0|0.0|0.0|Malignant|23|82886629|Male and Female|Other mesenchymal|2020
0-19|0.1|0.2|0.1|Benign/Borderline|104|82212844|Male and Female|Other mesenchymal|2021
0-19|0.0|0.0|0.0|Malignant|20|82212844|Male and Female|Other mesenchymal|2021
0-19|0.1|0.1|0.1|Benign/Borderline|94|82113420|Male and Female|Other mesenchymal|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Other mesenchymal|2022
0-19|0.1|0.2|0.1|Benign/Borderline|106|82088184|Male and Female|Other mesenchymal|2023
0-19|0.0|0.0|0.0|Malignant|22|82088184|Male and Female|Other mesenchymal|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004
0-19|0.8|0.9|0.9|Malignant|702|81754354|Male and Female|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005
0-19|0.8|0.9|0.8|Malignant|683|82005260|Male and Female|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006
0-19|0.8|0.9|0.8|Malignant|682|82324418|Male and Female|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007
0-19|0.8|0.9|0.9|Malignant|701|82749431|Male and Female|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008
0-19|0.8|1.0|0.9|Malignant|741|83118264|Male and Female|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009
0-19|0.8|0.9|0.9|Malignant|731|83280391|Male and Female|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Pilocytic astrocytoma|2010
0-19|0.9|1.0|1.0|Malignant|789|83225072|Male and Female|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Pilocytic astrocytoma|2011
0-19|0.9|1.0|0.9|Malignant|773|83042807|Male and Female|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Pilocytic astrocytoma|2012
0-19|0.9|1.1|1.0|Malignant|822|82869473|Male and Female|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Pilocytic astrocytoma|2013
0-19|0.9|1.0|1.0|Malignant|801|82802400|Male and Female|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Pilocytic astrocytoma|2014
0-19|0.9|1.0|1.0|Malignant|799|82834118|Male and Female|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|752|82981714|Male and Female|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Pilocytic astrocytoma|2016
0-19|0.8|0.9|0.9|Malignant|732|83193069|Male and Female|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Pilocytic astrocytoma|2017
0-19|1.0|1.1|1.0|Malignant|865|83318260|Male and Female|Pilocytic astrocytoma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|169|83333434|Male and Female|Pilocytic astrocytoma|2018
0-19|0.8|0.9|0.8|Malignant|693|83333434|Male and Female|Pilocytic astrocytoma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|153|83226688|Male and Female|Pilocytic astrocytoma|2019
0-19|0.7|0.9|0.8|Malignant|658|83226688|Male and Female|Pilocytic astrocytoma|2019
0-19|0.3|0.3|0.3|Benign/Borderline|1343|412527765|Male and Female|Pilocytic astrocytoma|2019-2023
0-19|0.6|0.7|0.6|Malignant|2663|412527765|Male and Female|Pilocytic astrocytoma|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|144|82886629|Male and Female|Pilocytic astrocytoma|2020
0-19|0.7|0.8|0.8|Malignant|640|82886629|Male and Female|Pilocytic astrocytoma|2020
0-19|0.2|0.2|0.2|Benign/Borderline|143|82212844|Male and Female|Pilocytic astrocytoma|2021
0-19|0.7|0.8|0.8|Malignant|635|82212844|Male and Female|Pilocytic astrocytoma|2021
0-19|0.2|0.2|0.2|Benign/Borderline|168|82113420|Male and Female|Pilocytic astrocytoma|2022
0-19|0.7|0.8|0.8|Malignant|612|82113420|Male and Female|Pilocytic astrocytoma|2022
0-19|0.8|1.0|0.9|Benign/Borderline|735|82088184|Male and Female|Pilocytic astrocytoma|2023
0-19|0.1|0.2|0.1|Malignant|118|82088184|Male and Female|Pilocytic astrocytoma|2023
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|83225072|Male and Female|Pineal parenchymal|2010
0-19|0.0|0.0|0.0|Malignant|26|83225072|Male and Female|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|83042807|Male and Female|Pineal parenchymal|2011
0-19|0.0|0.1|0.0|Malignant|35|83042807|Male and Female|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|82869473|Male and Female|Pineal parenchymal|2012
0-19|0.0|0.1|0.0|Malignant|33|82869473|Male and Female|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|82802400|Male and Female|Pineal parenchymal|2013
0-19|0.0|0.1|0.0|Malignant|32|82802400|Male and Female|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|82834118|Male and Female|Pineal parenchymal|2014
0-19|0.0|0.1|0.0|Malignant|39|82834118|Male and Female|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|82981714|Male and Female|Pineal parenchymal|2015
0-19|0.0|0.1|0.1|Malignant|45|82981714|Male and Female|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|83193069|Male and Female|Pineal parenchymal|2016
0-19|0.0|0.1|0.0|Malignant|41|83193069|Male and Female|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|83318260|Male and Female|Pineal parenchymal|2017
0-19|0.0|0.0|0.0|Malignant|27|83318260|Male and Female|Pineal parenchymal|2017
0-19|~|~|~|Benign/Borderline|~|83333434|Male and Female|Pineal parenchymal|2018
0-19|0.0|0.1|0.0|Malignant|33|83333434|Male and Female|Pineal parenchymal|2018
0-19|~|~|~|Benign/Borderline|~|83226688|Male and Female|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|35|83226688|Male and Female|Pineal parenchymal|2019
0-19|0.0|0.0|0.0|Benign/Borderline|29|412527765|Male and Female|Pineal parenchymal|2019-2023
0-19|0.0|0.0|0.0|Malignant|157|412527765|Male and Female|Pineal parenchymal|2019-2023
0-19|~|~|~|Benign/Borderline|~|82886629|Male and Female|Pineal parenchymal|2020
0-19|0.0|0.1|0.0|Malignant|34|82886629|Male and Female|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|82212844|Male and Female|Pineal parenchymal|2021
0-19|0.0|0.0|0.0|Malignant|27|82212844|Male and Female|Pineal parenchymal|2021
0-19|~|~|~|Benign/Borderline|~|82113420|Male and Female|Pineal parenchymal|2022
0-19|0.0|0.1|0.0|Malignant|32|82113420|Male and Female|Pineal parenchymal|2022
0-19|~|~|~|Benign/Borderline|~|82088184|Male and Female|Pineal parenchymal|2023
0-19|0.0|0.1|0.0|Malignant|29|82088184|Male and Female|Pineal parenchymal|2023
0-19|0.4|0.5|0.5|Benign/Borderline|380|81754354|Male and Female|Pituitary|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004
0-19|0.5|0.6|0.6|Benign/Borderline|471|82005260|Male and Female|Pituitary|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005
0-19|0.5|0.6|0.6|Benign/Borderline|485|82324418|Male and Female|Pituitary|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006
0-19|0.5|0.6|0.6|Benign/Borderline|487|82749431|Male and Female|Pituitary|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007
0-19|0.6|0.7|0.7|Benign/Borderline|579|83118264|Male and Female|Pituitary|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008
0-19|0.6|0.8|0.7|Benign/Borderline|600|83280391|Male and Female|Pituitary|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009
0-19|0.7|0.8|0.7|Benign/Borderline|640|83225072|Male and Female|Pituitary|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Pituitary|2010
0-19|0.7|0.8|0.8|Benign/Borderline|648|83042807|Male and Female|Pituitary|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Pituitary|2011
0-19|0.8|0.9|0.9|Benign/Borderline|726|82869473|Male and Female|Pituitary|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Pituitary|2012
0-19|0.8|0.9|0.9|Benign/Borderline|722|82802400|Male and Female|Pituitary|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Pituitary|2013
0-19|0.9|1.0|0.9|Benign/Borderline|791|82834118|Male and Female|Pituitary|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Pituitary|2014
0-19|0.8|1.0|0.9|Benign/Borderline|766|82981714|Male and Female|Pituitary|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Pituitary|2015
0-19|0.9|1.1|1.0|Benign/Borderline|859|83193069|Male and Female|Pituitary|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Pituitary|2016
0-19|1.0|1.2|1.1|Benign/Borderline|931|83318260|Male and Female|Pituitary|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Pituitary|2017
0-19|1.0|1.1|1.0|Benign/Borderline|889|83333434|Male and Female|Pituitary|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Pituitary|2018
0-19|1.0|1.1|1.0|Benign/Borderline|892|83226688|Male and Female|Pituitary|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Pituitary|2019
0-19|1.0|1.0|1.0|Benign/Borderline|4207|412527765|Male and Female|Pituitary|2019-2023
0-19|0.0|0.0|0.0|Malignant|62|412527765|Male and Female|Pituitary|2019-2023
0-19|0.9|1.1|1.0|Benign/Borderline|841|82886629|Male and Female|Pituitary|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Pituitary|2020
0-19|1.0|1.1|1.0|Benign/Borderline|890|82212844|Male and Female|Pituitary|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Pituitary|2021
0-19|0.9|1.0|1.0|Benign/Borderline|825|82113420|Male and Female|Pituitary|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Pituitary|2022
0-19|0.8|0.9|0.9|Benign/Borderline|759|82088184|Male and Female|Pituitary|2023
0-19|0.0|0.1|0.1|Malignant|54|82088184|Male and Female|Pituitary|2023
0-19|1.8|2.0|1.9|Benign/Borderline|1532|81754354|Male and Female|Total|2004
0-19|3.3|3.6|3.5|Malignant|2819|81754354|Male and Female|Total|2004
0-19|2.1|2.3|2.2|Benign/Borderline|1798|82005260|Male and Female|Total|2005
0-19|3.1|3.4|3.3|Malignant|2672|82005260|Male and Female|Total|2005
0-19|2.1|2.3|2.2|Benign/Borderline|1852|82324418|Male and Female|Total|2006
0-19|3.2|3.5|3.4|Malignant|2758|82324418|Male and Female|Total|2006
0-19|2.2|2.4|2.3|Benign/Borderline|1910|82749431|Male and Female|Total|2007
0-19|3.3|3.6|3.4|Malignant|2836|82749431|Male and Female|Total|2007
0-19|2.3|2.5|2.4|Benign/Borderline|2027|83118264|Male and Female|Total|2008
0-19|3.4|3.6|3.5|Malignant|2905|83118264|Male and Female|Total|2008
0-19|2.4|2.6|2.5|Benign/Borderline|2118|83280391|Male and Female|Total|2009
0-19|3.3|3.6|3.5|Malignant|2875|83280391|Male and Female|Total|2009
0-19|2.5|2.7|2.6|Benign/Borderline|2157|83225072|Male and Female|Total|2010
0-19|3.4|3.7|3.5|Malignant|2926|83225072|Male and Female|Total|2010
0-19|2.6|2.8|2.7|Benign/Borderline|2244|83042807|Male and Female|Total|2011
0-19|3.5|3.7|3.6|Malignant|2976|83042807|Male and Female|Total|2011
0-19|2.7|3.0|2.8|Benign/Borderline|2376|82869473|Male and Female|Total|2012
0-19|3.4|3.6|3.5|Malignant|2889|82869473|Male and Female|Total|2012
0-19|2.8|3.0|2.9|Benign/Borderline|2407|82802400|Male and Female|Total|2013
0-19|3.5|3.7|3.6|Malignant|2975|82802400|Male and Female|Total|2013
0-19|2.8|3.1|2.9|Benign/Borderline|2443|82834118|Male and Female|Total|2014
0-19|3.5|3.7|3.6|Malignant|2978|82834118|Male and Female|Total|2014
0-19|2.8|3.1|2.9|Benign/Borderline|2456|82981714|Male and Female|Total|2015
0-19|3.4|3.7|3.5|Malignant|2929|82981714|Male and Female|Total|2015
0-19|3.0|3.2|3.1|Benign/Borderline|2604|83193069|Male and Female|Total|2016
0-19|3.4|3.6|3.5|Malignant|2896|83193069|Male and Female|Total|2016
0-19|3.0|3.2|3.1|Benign/Borderline|2596|83318260|Male and Female|Total|2017
0-19|3.6|3.8|3.7|Malignant|3068|83318260|Male and Female|Total|2017
0-19|3.0|3.3|3.1|Benign/Borderline|2639|83333434|Male and Female|Total|2018
0-19|2.9|3.1|3.0|Malignant|2486|83333434|Male and Female|Total|2018
0-19|2.9|3.1|3.0|Benign/Borderline|2508|83226688|Male and Female|Total|2019
0-19|2.7|2.9|2.8|Malignant|2346|83226688|Male and Female|Total|2019
0-19|3.0|3.1|3.0|Benign/Borderline|12569|412527765|Male and Female|Total|2019-2023
0-19|2.5|2.6|2.6|Malignant|10472|412527765|Male and Female|Total|2019-2023
0-19|2.6|2.8|2.7|Benign/Borderline|2288|82886629|Male and Female|Total|2020
0-19|2.6|2.9|2.8|Malignant|2278|82886629|Male and Female|Total|2020
0-19|2.8|3.1|3.0|Benign/Borderline|2456|82212844|Male and Female|Total|2021
0-19|2.7|2.9|2.8|Malignant|2299|82212844|Male and Female|Total|2021
0-19|2.8|3.0|2.9|Benign/Borderline|2426|82113420|Male and Female|Total|2022
0-19|2.5|2.7|2.6|Malignant|2121|82113420|Male and Female|Total|2022
0-19|3.3|3.6|3.5|Benign/Borderline|2891|82088184|Male and Female|Total|2023
0-19|1.7|1.8|1.7|Malignant|1428|82088184|Male and Female|Total|2023
0-19|0.3|0.3|0.3|Benign/Borderline|244|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004
0-19|0.3|0.4|0.4|Benign/Borderline|291|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005
0-19|0.4|0.5|0.4|Benign/Borderline|343|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.4|0.4|Benign/Borderline|303|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|306|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|313|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|282|83225072|Male and Female|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.4|Benign/Borderline|300|83042807|Male and Female|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|308|82869473|Male and Female|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Tumors of Cranial and Spinal Nerves|2012
0-19|0.4|0.4|0.4|Benign/Borderline|327|82802400|Male and Female|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Tumors of Cranial and Spinal Nerves|2013
0-19|0.3|0.4|0.3|Benign/Borderline|272|82834118|Male and Female|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.4|0.4|Benign/Borderline|317|82981714|Male and Female|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Tumors of Cranial and Spinal Nerves|2015
0-19|0.3|0.4|0.4|Benign/Borderline|318|83193069|Male and Female|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Tumors of Cranial and Spinal Nerves|2016
0-19|0.3|0.4|0.3|Benign/Borderline|261|83318260|Male and Female|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.2|0.2|Benign/Borderline|175|83333434|Male and Female|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.3|0.2|Benign/Borderline|188|83226688|Male and Female|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Tumors of Cranial and Spinal Nerves|2019
0-19|0.2|0.2|0.2|Benign/Borderline|798|412527765|Male and Female|Tumors of Cranial and Spinal Nerves|2019-2023
0-19|0.0|0.0|0.0|Malignant|19|412527765|Male and Female|Tumors of Cranial and Spinal Nerves|2019-2023
0-19|0.1|0.2|0.2|Benign/Borderline|148|82886629|Male and Female|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Tumors of Cranial and Spinal Nerves|2020
0-19|0.2|0.2|0.2|Benign/Borderline|159|82212844|Male and Female|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Tumors of Cranial and Spinal Nerves|2021
0-19|0.2|0.2|0.2|Benign/Borderline|152|82113420|Male and Female|Tumors of Cranial and Spinal Nerves|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Tumors of Cranial and Spinal Nerves|2022
0-19|0.2|0.2|0.2|Benign/Borderline|151|82088184|Male and Female|Tumors of Cranial and Spinal Nerves|2023
0-19|~|~|~|Malignant|~|82088184|Male and Female|Tumors of Cranial and Spinal Nerves|2023
0-19|0.5|0.6|0.5|Benign/Borderline|430|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004
0-19|3.0|3.3|3.2|Malignant|2578|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004
0-19|0.5|0.6|0.6|Benign/Borderline|467|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005
0-19|2.9|3.1|3.0|Malignant|2449|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005
0-19|0.5|0.6|0.6|Benign/Borderline|471|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006
0-19|3.0|3.2|3.1|Malignant|2538|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006
0-19|0.6|0.7|0.6|Benign/Borderline|506|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007
0-19|3.1|3.3|3.2|Malignant|2630|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007
0-19|0.6|0.7|0.6|Benign/Borderline|522|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008
0-19|3.1|3.4|3.2|Malignant|2688|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008
0-19|0.5|0.7|0.6|Benign/Borderline|497|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009
0-19|3.1|3.3|3.2|Malignant|2649|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009
0-19|0.6|0.7|0.6|Benign/Borderline|533|83225072|Male and Female|Tumors of Neuroepthelial Tissue|2010
0-19|3.1|3.4|3.2|Malignant|2690|83225072|Male and Female|Tumors of Neuroepthelial Tissue|2010
0-19|0.6|0.7|0.7|Benign/Borderline|569|83042807|Male and Female|Tumors of Neuroepthelial Tissue|2011
0-19|3.2|3.5|3.3|Malignant|2761|83042807|Male and Female|Tumors of Neuroepthelial Tissue|2011
0-19|0.7|0.8|0.7|Benign/Borderline|592|82869473|Male and Female|Tumors of Neuroepthelial Tissue|2012
0-19|3.1|3.3|3.2|Malignant|2666|82869473|Male and Female|Tumors of Neuroepthelial Tissue|2012
0-19|0.7|0.8|0.7|Benign/Borderline|591|82802400|Male and Female|Tumors of Neuroepthelial Tissue|2013
0-19|3.2|3.4|3.3|Malignant|2725|82802400|Male and Female|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.7|0.7|Benign/Borderline|570|82834118|Male and Female|Tumors of Neuroepthelial Tissue|2014
0-19|3.2|3.5|3.3|Malignant|2755|82834118|Male and Female|Tumors of Neuroepthelial Tissue|2014
0-19|0.7|0.8|0.7|Benign/Borderline|604|82981714|Male and Female|Tumors of Neuroepthelial Tissue|2015
0-19|3.1|3.4|3.3|Malignant|2691|82981714|Male and Female|Tumors of Neuroepthelial Tissue|2015
0-19|0.7|0.9|0.8|Benign/Borderline|666|83193069|Male and Female|Tumors of Neuroepthelial Tissue|2016
0-19|3.1|3.3|3.2|Malignant|2631|83193069|Male and Female|Tumors of Neuroepthelial Tissue|2016
0-19|0.7|0.8|0.8|Benign/Borderline|653|83318260|Male and Female|Tumors of Neuroepthelial Tissue|2017
0-19|3.3|3.5|3.4|Malignant|2806|83318260|Male and Female|Tumors of Neuroepthelial Tissue|2017
0-19|0.9|1.0|0.9|Benign/Borderline|787|83333434|Male and Female|Tumors of Neuroepthelial Tissue|2018
0-19|2.6|2.9|2.7|Malignant|2277|83333434|Male and Female|Tumors of Neuroepthelial Tissue|2018
0-19|0.9|1.0|0.9|Benign/Borderline|765|83226688|Male and Female|Tumors of Neuroepthelial Tissue|2019
0-19|2.4|2.7|2.6|Malignant|2116|83226688|Male and Female|Tumors of Neuroepthelial Tissue|2019
0-19|1.0|1.0|1.0|Benign/Borderline|4192|412527765|Male and Female|Tumors of Neuroepthelial Tissue|2019-2023
0-19|2.2|2.3|2.2|Malignant|9217|412527765|Male and Female|Tumors of Neuroepthelial Tissue|2019-2023
0-19|0.7|0.9|0.8|Benign/Borderline|670|82886629|Male and Female|Tumors of Neuroepthelial Tissue|2020
0-19|2.4|2.6|2.5|Malignant|2030|82886629|Male and Female|Tumors of Neuroepthelial Tissue|2020
0-19|0.7|0.9|0.8|Benign/Borderline|660|82212844|Male and Female|Tumors of Neuroepthelial Tissue|2021
0-19|2.4|2.6|2.5|Malignant|2042|82212844|Male and Female|Tumors of Neuroepthelial Tissue|2021
0-19|0.9|1.0|1.0|Benign/Borderline|786|82113420|Male and Female|Tumors of Neuroepthelial Tissue|2022
0-19|2.2|2.4|2.3|Malignant|1895|82113420|Male and Female|Tumors of Neuroepthelial Tissue|2022
0-19|1.5|1.7|1.6|Benign/Borderline|1311|82088184|Male and Female|Tumors of Neuroepthelial Tissue|2023
0-19|1.3|1.5|1.4|Malignant|1134|82088184|Male and Female|Tumors of Neuroepthelial Tissue|2023
0-19|0.6|0.7|0.7|Benign/Borderline|552|81754354|Male and Female|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004
0-19|0.7|0.8|0.8|Benign/Borderline|643|82005260|Male and Female|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005
0-19|0.7|0.8|0.8|Benign/Borderline|643|82324418|Male and Female|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006
0-19|0.7|0.9|0.8|Benign/Borderline|672|82749431|Male and Female|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007
0-19|0.8|0.9|0.9|Benign/Borderline|744|83118264|Male and Female|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008
0-19|0.8|1.0|0.9|Benign/Borderline|774|83280391|Male and Female|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009
0-19|0.9|1.0|1.0|Benign/Borderline|820|83225072|Male and Female|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|83225072|Male and Female|Tumors of Sellar Region|2010
0-19|0.9|1.0|1.0|Benign/Borderline|806|83042807|Male and Female|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|83042807|Male and Female|Tumors of Sellar Region|2011
0-19|1.0|1.1|1.1|Benign/Borderline|885|82869473|Male and Female|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|82869473|Male and Female|Tumors of Sellar Region|2012
0-19|1.0|1.2|1.1|Benign/Borderline|906|82802400|Male and Female|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|82802400|Male and Female|Tumors of Sellar Region|2013
0-19|1.1|1.3|1.2|Benign/Borderline|994|82834118|Male and Female|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|82834118|Male and Female|Tumors of Sellar Region|2014
0-19|1.1|1.2|1.1|Benign/Borderline|948|82981714|Male and Female|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|82981714|Male and Female|Tumors of Sellar Region|2015
0-19|1.1|1.3|1.2|Benign/Borderline|1008|83193069|Male and Female|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|83193069|Male and Female|Tumors of Sellar Region|2016
0-19|1.2|1.4|1.3|Benign/Borderline|1115|83318260|Male and Female|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|83318260|Male and Female|Tumors of Sellar Region|2017
0-19|1.2|1.3|1.2|Benign/Borderline|1048|83333434|Male and Female|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Tumors of Sellar Region|2018
0-19|1.2|1.3|1.2|Benign/Borderline|1059|83226688|Male and Female|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|83226688|Male and Female|Tumors of Sellar Region|2019
0-19|1.1|1.2|1.2|Benign/Borderline|5000|412527765|Male and Female|Tumors of Sellar Region|2019-2023
0-19|0.0|0.0|0.0|Malignant|63|412527765|Male and Female|Tumors of Sellar Region|2019-2023
0-19|1.1|1.2|1.1|Benign/Borderline|971|82886629|Male and Female|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|82886629|Male and Female|Tumors of Sellar Region|2020
0-19|1.2|1.4|1.3|Benign/Borderline|1074|82212844|Male and Female|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|82212844|Male and Female|Tumors of Sellar Region|2021
0-19|1.1|1.2|1.2|Benign/Borderline|986|82113420|Male and Female|Tumors of Sellar Region|2022
0-19|~|~|~|Malignant|~|82113420|Male and Female|Tumors of Sellar Region|2022
0-19|1.0|1.1|1.1|Benign/Borderline|910|82088184|Male and Female|Tumors of Sellar Region|2023
0-19|0.0|0.1|0.1|Malignant|54|82088184|Male and Female|Tumors of Sellar Region|2023
0-19|0.2|0.2|0.2|Benign/Borderline|153|81754354|Male and Female|Tumors of the Meninges|2004
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004
0-19|0.2|0.3|0.2|Benign/Borderline|197|82005260|Male and Female|Tumors of the Meninges|2005
0-19|0.0|0.0|0.0|Malignant|20|82005260|Male and Female|Tumors of the Meninges|2005
0-19|0.2|0.2|0.2|Benign/Borderline|168|82324418|Male and Female|Tumors of the Meninges|2006
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006
0-19|0.2|0.3|0.2|Benign/Borderline|185|82749431|Male and Female|Tumors of the Meninges|2007
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|186|83118264|Male and Female|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008
0-19|0.2|0.3|0.3|Benign/Borderline|212|83280391|Male and Female|Tumors of the Meninges|2009
0-19|0.0|0.0|0.0|Malignant|21|83280391|Male and Female|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|197|83225072|Male and Female|Tumors of the Meninges|2010
0-19|0.0|0.0|0.0|Malignant|21|83225072|Male and Female|Tumors of the Meninges|2010
0-19|0.3|0.3|0.3|Benign/Borderline|241|83042807|Male and Female|Tumors of the Meninges|2011
0-19|0.0|0.0|0.0|Malignant|16|83042807|Male and Female|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|274|82869473|Male and Female|Tumors of the Meninges|2012
0-19|0.0|0.0|0.0|Malignant|17|82869473|Male and Female|Tumors of the Meninges|2012
0-19|0.3|0.3|0.3|Benign/Borderline|253|82802400|Male and Female|Tumors of the Meninges|2013
0-19|0.0|0.0|0.0|Malignant|22|82802400|Male and Female|Tumors of the Meninges|2013
0-19|0.3|0.4|0.3|Benign/Borderline|274|82834118|Male and Female|Tumors of the Meninges|2014
0-19|0.0|0.0|0.0|Malignant|18|82834118|Male and Female|Tumors of the Meninges|2014
0-19|0.3|0.4|0.3|Benign/Borderline|266|82981714|Male and Female|Tumors of the Meninges|2015
0-19|0.0|0.0|0.0|Malignant|22|82981714|Male and Female|Tumors of the Meninges|2015
0-19|0.3|0.4|0.3|Benign/Borderline|274|83193069|Male and Female|Tumors of the Meninges|2016
0-19|0.0|0.0|0.0|Malignant|22|83193069|Male and Female|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|267|83318260|Male and Female|Tumors of the Meninges|2017
0-19|0.0|0.0|0.0|Malignant|17|83318260|Male and Female|Tumors of the Meninges|2017
0-19|0.3|0.4|0.4|Benign/Borderline|303|83333434|Male and Female|Tumors of the Meninges|2018
0-19|~|~|~|Malignant|~|83333434|Male and Female|Tumors of the Meninges|2018
0-19|0.3|0.3|0.3|Benign/Borderline|242|83226688|Male and Female|Tumors of the Meninges|2019
0-19|0.0|0.0|0.0|Malignant|16|83226688|Male and Female|Tumors of the Meninges|2019
0-19|0.3|0.3|0.3|Benign/Borderline|1290|412527765|Male and Female|Tumors of the Meninges|2019-2023
0-19|0.0|0.0|0.0|Malignant|113|412527765|Male and Female|Tumors of the Meninges|2019-2023
0-19|0.3|0.3|0.3|Benign/Borderline|245|82886629|Male and Female|Tumors of the Meninges|2020
0-19|0.0|0.1|0.0|Malignant|29|82886629|Male and Female|Tumors of the Meninges|2020
0-19|0.3|0.4|0.3|Benign/Borderline|280|82212844|Male and Female|Tumors of the Meninges|2021
0-19|0.0|0.0|0.0|Malignant|28|82212844|Male and Female|Tumors of the Meninges|2021
0-19|0.3|0.4|0.3|Benign/Borderline|259|82113420|Male and Female|Tumors of the Meninges|2022
0-19|0.0|0.0|0.0|Malignant|16|82113420|Male and Female|Tumors of the Meninges|2022
0-19|0.3|0.4|0.3|Benign/Borderline|264|82088184|Male and Female|Tumors of the Meninges|2023
0-19|0.0|0.0|0.0|Malignant|24|82088184|Male and Female|Tumors of the Meninges|2023
0-19|0.1|0.2|0.1|Benign/Borderline|121|81754354|Male and Female|Unclassified Tumors|2004
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004
0-19|0.2|0.2|0.2|Benign/Borderline|163|82005260|Male and Female|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|180|82324418|Male and Female|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Unclassified Tumors|2006
0-19|0.2|0.3|0.2|Benign/Borderline|209|82749431|Male and Female|Unclassified Tumors|2007
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Unclassified Tumors|2007
0-19|0.2|0.3|0.3|Benign/Borderline|228|83118264|Male and Female|Unclassified Tumors|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Unclassified Tumors|2008
0-19|0.3|0.4|0.3|Benign/Borderline|269|83280391|Male and Female|Unclassified Tumors|2009
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|280|83225072|Male and Female|Unclassified Tumors|2010
0-19|0.0|0.0|0.0|Malignant|27|83225072|Male and Female|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|291|83042807|Male and Female|Unclassified Tumors|2011
0-19|0.0|0.1|0.0|Malignant|33|83042807|Male and Female|Unclassified Tumors|2011
0-19|0.3|0.4|0.3|Benign/Borderline|275|82869473|Male and Female|Unclassified Tumors|2012
0-19|0.0|0.1|0.1|Malignant|53|82869473|Male and Female|Unclassified Tumors|2012
0-19|0.3|0.4|0.3|Benign/Borderline|281|82802400|Male and Female|Unclassified Tumors|2013
0-19|0.0|0.1|0.1|Malignant|46|82802400|Male and Female|Unclassified Tumors|2013
0-19|0.3|0.4|0.3|Benign/Borderline|283|82834118|Male and Female|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|47|82834118|Male and Female|Unclassified Tumors|2014
0-19|0.3|0.4|0.3|Benign/Borderline|283|82981714|Male and Female|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|39|82981714|Male and Female|Unclassified Tumors|2015
0-19|0.3|0.4|0.3|Benign/Borderline|276|83193069|Male and Female|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|47|83193069|Male and Female|Unclassified Tumors|2016
0-19|0.3|0.4|0.3|Benign/Borderline|260|83318260|Male and Female|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|50|83318260|Male and Female|Unclassified Tumors|2017
0-19|0.3|0.4|0.3|Benign/Borderline|268|83333434|Male and Female|Unclassified Tumors|2018
0-19|0.0|0.1|0.1|Malignant|47|83333434|Male and Female|Unclassified Tumors|2018
0-19|0.2|0.3|0.3|Benign/Borderline|212|83226688|Male and Female|Unclassified Tumors|2019
0-19|0.0|0.1|0.0|Malignant|35|83226688|Male and Female|Unclassified Tumors|2019
0-19|0.3|0.3|0.3|Benign/Borderline|1106|412527765|Male and Female|Unclassified Tumors|2019-2023
0-19|0.1|0.1|0.1|Malignant|238|412527765|Male and Female|Unclassified Tumors|2019-2023
0-19|0.2|0.3|0.3|Benign/Borderline|225|82886629|Male and Female|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|54|82886629|Male and Female|Unclassified Tumors|2020
0-19|0.3|0.3|0.3|Benign/Borderline|241|82212844|Male and Female|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Malignant|50|82212844|Male and Female|Unclassified Tumors|2021
0-19|0.2|0.3|0.3|Benign/Borderline|212|82113420|Male and Female|Unclassified Tumors|2022
0-19|0.1|0.1|0.1|Malignant|56|82113420|Male and Female|Unclassified Tumors|2022
0-19|0.2|0.3|0.3|Benign/Borderline|216|82088184|Male and Female|Unclassified Tumors|2023
0-19|0.0|0.1|0.1|Malignant|43|82088184|Male and Female|Unclassified Tumors|2023
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004
0-19|0.1|0.1|0.1|Benign/Borderline|64|82005260|Male and Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.0|Malignant|31|82005260|Male and Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|50|82324418|Male and Female|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|37|82324418|Male and Female|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|68|82749431|Male and Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Malignant|59|82749431|Male and Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Benign/Borderline|71|83118264|Male and Female|Unique astrocytoma variants|2008
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|82|83280391|Male and Female|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|45|83280391|Male and Female|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|68|83225072|Male and Female|Unique astrocytoma variants|2010
0-19|0.0|0.0|0.0|Malignant|27|83225072|Male and Female|Unique astrocytoma variants|2010
0-19|0.1|0.1|0.1|Benign/Borderline|72|83042807|Male and Female|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|53|83042807|Male and Female|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|81|82869473|Male and Female|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.1|Malignant|45|82869473|Male and Female|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|80|82802400|Male and Female|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.1|Malignant|44|82802400|Male and Female|Unique astrocytoma variants|2013
0-19|0.1|0.1|0.1|Benign/Borderline|97|82834118|Male and Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Malignant|42|82834118|Male and Female|Unique astrocytoma variants|2014
0-19|0.1|0.1|0.1|Benign/Borderline|55|82981714|Male and Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|54|82981714|Male and Female|Unique astrocytoma variants|2015
0-19|0.1|0.1|0.1|Benign/Borderline|67|83193069|Male and Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|50|83193069|Male and Female|Unique astrocytoma variants|2016
0-19|0.1|0.1|0.1|Benign/Borderline|65|83318260|Male and Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Malignant|43|83318260|Male and Female|Unique astrocytoma variants|2017
0-19|0.1|0.1|0.1|Benign/Borderline|69|83333434|Male and Female|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|46|83333434|Male and Female|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|71|83226688|Male and Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Malignant|43|83226688|Male and Female|Unique astrocytoma variants|2019
0-19|0.1|0.1|0.1|Benign/Borderline|312|412527765|Male and Female|Unique astrocytoma variants|2019-2023
0-19|0.0|0.1|0.1|Malignant|227|412527765|Male and Female|Unique astrocytoma variants|2019-2023
0-19|0.0|0.1|0.1|Benign/Borderline|52|82886629|Male and Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Malignant|39|82886629|Male and Female|Unique astrocytoma variants|2020
0-19|0.1|0.1|0.1|Benign/Borderline|62|82212844|Male and Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Malignant|45|82212844|Male and Female|Unique astrocytoma variants|2021
0-19|0.1|0.1|0.1|Benign/Borderline|70|82113420|Male and Female|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.1|Malignant|45|82113420|Male and Female|Unique astrocytoma variants|2022
0-19|0.1|0.1|0.1|Benign/Borderline|57|82088184|Male and Female|Unique astrocytoma variants|2023
0-19|0.0|0.1|0.1|Malignant|55|82088184|Male and Female|Unique astrocytoma variants|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004
20+|~|~|~|Malignant|~|109112165|Female|All other|2004
20+|0.0|0.0|0.0|Benign/Borderline|19|110320645|Female|All other|2005
20+|~|~|~|Malignant|~|110320645|Female|All other|2005
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006
20+|~|~|~|Malignant|~|111567226|Female|All other|2006
20+|0.0|0.0|0.0|Benign/Borderline|19|112783993|Female|All other|2007
20+|~|~|~|Malignant|~|112783993|Female|All other|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008
20+|~|~|~|Malignant|~|114027722|Female|All other|2008
20+|0.0|0.0|0.0|Benign/Borderline|19|115293599|Female|All other|2009
20+|~|~|~|Malignant|~|115293599|Female|All other|2009
20+|0.0|0.0|0.0|Benign/Borderline|23|116602141|Female|All other|2010
20+|0.0|0.0|0.0|Malignant|19|116602141|Female|All other|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|All other|2011
20+|0.0|0.0|0.0|Malignant|21|117837363|Female|All other|2011
20+|0.0|0.0|0.0|Benign/Borderline|21|119040975|Female|All other|2012
20+|~|~|~|Malignant|~|119040975|Female|All other|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|All other|2013
20+|0.0|0.0|0.0|Malignant|23|120141498|Female|All other|2013
20+|0.0|0.0|0.0|Benign/Borderline|17|121280256|Female|All other|2014
20+|0.0|0.0|0.0|Malignant|21|121280256|Female|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|22|122363537|Female|All other|2015
20+|0.0|0.0|0.0|Malignant|27|122363537|Female|All other|2015
20+|0.0|0.0|0.0|Benign/Borderline|32|123423539|Female|All other|2016
20+|0.0|0.0|0.0|Malignant|26|123423539|Female|All other|2016
20+|0.0|0.0|0.0|Benign/Borderline|33|124394893|Female|All other|2017
20+|0.0|0.0|0.0|Malignant|32|124394893|Female|All other|2017
20+|0.0|0.1|0.0|Benign/Borderline|51|125266771|Female|All other|2018
20+|0.1|0.2|0.1|Malignant|178|125266771|Female|All other|2018
20+|0.0|0.1|0.0|Benign/Borderline|48|126086679|Female|All other|2019
20+|0.2|0.2|0.2|Malignant|223|126086679|Female|All other|2019
20+|0.1|0.1|0.1|Benign/Borderline|371|639008149|Female|All other|2019-2023
20+|0.2|0.2|0.2|Malignant|1209|639008149|Female|All other|2019-2023
20+|0.0|0.1|0.0|Benign/Borderline|50|126845517|Female|All other|2020
20+|0.1|0.2|0.2|Malignant|216|126845517|Female|All other|2020
20+|0.0|0.1|0.1|Benign/Borderline|67|127498344|Female|All other|2021
20+|0.1|0.2|0.2|Malignant|199|127498344|Female|All other|2021
20+|0.1|0.1|0.1|Benign/Borderline|84|128573447|Female|All other|2022
20+|0.1|0.2|0.2|Malignant|216|128573447|Female|All other|2022
20+|0.1|0.1|0.1|Benign/Borderline|122|130004162|Female|All other|2023
20+|0.3|0.3|0.3|Malignant|355|130004162|Female|All other|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004
20+|0.5|0.6|0.5|Malignant|568|109112165|Female|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006
20+|0.4|0.5|0.4|Malignant|511|111567226|Female|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007
20+|0.4|0.5|0.5|Malignant|533|112783993|Female|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008
20+|0.4|0.5|0.4|Malignant|507|114027722|Female|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009
20+|0.4|0.5|0.4|Malignant|501|115293599|Female|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Anaplastic astrocytoma|2010
20+|0.4|0.5|0.5|Malignant|573|116602141|Female|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Anaplastic astrocytoma|2011
20+|0.4|0.5|0.5|Malignant|572|117837363|Female|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Anaplastic astrocytoma|2012
20+|0.4|0.5|0.5|Malignant|594|119040975|Female|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Anaplastic astrocytoma|2013
20+|0.5|0.6|0.5|Malignant|642|120141498|Female|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Anaplastic astrocytoma|2014
20+|0.5|0.5|0.5|Malignant|619|121280256|Female|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Anaplastic astrocytoma|2015
20+|0.5|0.6|0.6|Malignant|706|122363537|Female|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Anaplastic astrocytoma|2016
20+|0.5|0.5|0.5|Malignant|644|123423539|Female|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Anaplastic astrocytoma|2017
20+|0.5|0.6|0.5|Malignant|675|124394893|Female|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Anaplastic astrocytoma|2018
20+|0.4|0.5|0.5|Malignant|632|125266771|Female|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Anaplastic astrocytoma|2019
20+|0.4|0.5|0.4|Malignant|576|126086679|Female|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Anaplastic astrocytoma|2019-2023
20+|0.3|0.3|0.3|Malignant|1933|639008149|Female|Anaplastic astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Anaplastic astrocytoma|2020
20+|0.4|0.4|0.4|Malignant|525|126845517|Female|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Anaplastic astrocytoma|2021
20+|0.3|0.3|0.3|Malignant|361|127498344|Female|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Anaplastic astrocytoma|2022
20+|0.2|0.2|0.2|Malignant|244|128573447|Female|Anaplastic astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Anaplastic astrocytoma|2023
20+|0.2|0.2|0.2|Malignant|227|130004162|Female|Anaplastic astrocytoma|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004
20+|0.1|0.2|0.2|Malignant|186|109112165|Female|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005
20+|0.1|0.2|0.2|Malignant|168|110320645|Female|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006
20+|0.1|0.1|0.1|Malignant|140|111567226|Female|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007
20+|0.1|0.2|0.1|Malignant|162|112783993|Female|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008
20+|0.1|0.2|0.1|Malignant|171|114027722|Female|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009
20+|0.1|0.1|0.1|Malignant|149|115293599|Female|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Anaplastic oligodendroglioma|2010
20+|0.1|0.1|0.1|Malignant|136|116602141|Female|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.1|Malignant|153|117837363|Female|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.1|Malignant|170|119040975|Female|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Anaplastic oligodendroglioma|2013
20+|0.1|0.2|0.1|Malignant|154|120141498|Female|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Anaplastic oligodendroglioma|2014
20+|0.1|0.2|0.1|Malignant|155|121280256|Female|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.1|Malignant|166|122363537|Female|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Anaplastic oligodendroglioma|2016
20+|0.1|0.2|0.1|Malignant|171|123423539|Female|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Anaplastic oligodendroglioma|2017
20+|0.1|0.2|0.1|Malignant|185|124394893|Female|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Anaplastic oligodendroglioma|2018
20+|0.1|0.2|0.1|Malignant|158|125266771|Female|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Anaplastic oligodendroglioma|2019
20+|0.1|0.2|0.1|Malignant|165|126086679|Female|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Anaplastic oligodendroglioma|2019-2023
20+|0.1|0.1|0.1|Malignant|588|639008149|Female|Anaplastic oligodendroglioma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Anaplastic oligodendroglioma|2020
20+|0.1|0.1|0.1|Malignant|132|126845517|Female|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Anaplastic oligodendroglioma|2021
20+|0.1|0.1|0.1|Malignant|119|127498344|Female|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Anaplastic oligodendroglioma|2022
20+|0.0|0.1|0.1|Malignant|66|128573447|Female|Anaplastic oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Anaplastic oligodendroglioma|2023
20+|0.1|0.1|0.1|Malignant|106|130004162|Female|Anaplastic oligodendroglioma|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004
20+|0.5|0.6|0.5|Malignant|577|109112165|Female|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005
20+|0.5|0.5|0.5|Malignant|566|110320645|Female|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006
20+|0.5|0.5|0.5|Malignant|549|111567226|Female|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007
20+|0.4|0.5|0.5|Malignant|539|112783993|Female|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008
20+|0.4|0.5|0.4|Malignant|494|114027722|Female|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009
20+|0.4|0.5|0.4|Malignant|483|115293599|Female|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Astrocytoma, NOS|2010
20+|0.4|0.4|0.4|Malignant|480|116602141|Female|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Astrocytoma, NOS|2011
20+|0.4|0.4|0.4|Malignant|470|117837363|Female|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Astrocytoma, NOS|2012
20+|0.4|0.5|0.4|Malignant|493|119040975|Female|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Astrocytoma, NOS|2013
20+|0.3|0.4|0.4|Malignant|463|120141498|Female|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Astrocytoma, NOS|2014
20+|0.4|0.4|0.4|Malignant|508|121280256|Female|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Astrocytoma, NOS|2015
20+|0.4|0.5|0.4|Malignant|532|122363537|Female|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Astrocytoma, NOS|2016
20+|0.4|0.5|0.5|Malignant|570|123423539|Female|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Astrocytoma, NOS|2017
20+|0.4|0.5|0.4|Malignant|526|124394893|Female|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Astrocytoma, NOS|2018
20+|0.4|0.5|0.5|Malignant|604|125266771|Female|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Astrocytoma, NOS|2019
20+|0.4|0.5|0.4|Malignant|561|126086679|Female|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Astrocytoma, NOS|2019-2023
20+|0.5|0.5|0.5|Malignant|3021|639008149|Female|Astrocytoma, NOS|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Astrocytoma, NOS|2020
20+|0.4|0.5|0.4|Malignant|538|126845517|Female|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Astrocytoma, NOS|2021
20+|0.5|0.6|0.5|Malignant|655|127498344|Female|Astrocytoma, NOS|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Astrocytoma, NOS|2022
20+|0.6|0.6|0.6|Malignant|721|128573447|Female|Astrocytoma, NOS|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Astrocytoma, NOS|2023
20+|0.4|0.5|0.4|Malignant|546|130004162|Female|Astrocytoma, NOS|2023
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004
20+|0.0|0.0|0.0|Benign/Borderline|39|110320645|Female|Choroid plexus|2005
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005
20+|0.0|0.1|0.0|Benign/Borderline|44|111567226|Female|Choroid plexus|2006
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006
20+|0.0|0.1|0.1|Benign/Borderline|56|112783993|Female|Choroid plexus|2007
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007
20+|0.0|0.1|0.0|Benign/Borderline|50|114027722|Female|Choroid plexus|2008
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008
20+|0.0|0.1|0.0|Benign/Borderline|45|115293599|Female|Choroid plexus|2009
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009
20+|0.0|0.1|0.0|Benign/Borderline|50|116602141|Female|Choroid plexus|2010
20+|~|~|~|Malignant|~|116602141|Female|Choroid plexus|2010
20+|0.0|0.1|0.0|Benign/Borderline|54|117837363|Female|Choroid plexus|2011
20+|~|~|~|Malignant|~|117837363|Female|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|43|119040975|Female|Choroid plexus|2012
20+|~|~|~|Malignant|~|119040975|Female|Choroid plexus|2012
20+|0.0|0.1|0.0|Benign/Borderline|51|120141498|Female|Choroid plexus|2013
20+|~|~|~|Malignant|~|120141498|Female|Choroid plexus|2013
20+|0.0|0.1|0.0|Benign/Borderline|50|121280256|Female|Choroid plexus|2014
20+|~|~|~|Malignant|~|121280256|Female|Choroid plexus|2014
20+|0.0|0.1|0.0|Benign/Borderline|47|122363537|Female|Choroid plexus|2015
20+|~|~|~|Malignant|~|122363537|Female|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|43|123423539|Female|Choroid plexus|2016
20+|~|~|~|Malignant|~|123423539|Female|Choroid plexus|2016
20+|0.0|0.0|0.0|Benign/Borderline|43|124394893|Female|Choroid plexus|2017
20+|~|~|~|Malignant|~|124394893|Female|Choroid plexus|2017
20+|0.0|0.1|0.0|Benign/Borderline|60|125266771|Female|Choroid plexus|2018
20+|~|~|~|Malignant|~|125266771|Female|Choroid plexus|2018
20+|0.0|0.1|0.0|Benign/Borderline|55|126086679|Female|Choroid plexus|2019
20+|~|~|~|Malignant|~|126086679|Female|Choroid plexus|2019
20+|0.0|0.0|0.0|Benign/Borderline|240|639008149|Female|Choroid plexus|2019-2023
20+|~|~|~|Malignant|~|639008149|Female|Choroid plexus|2019-2023
20+|0.0|0.1|0.0|Benign/Borderline|46|126845517|Female|Choroid plexus|2020
20+|~|~|~|Malignant|~|126845517|Female|Choroid plexus|2020
20+|0.0|0.1|0.0|Benign/Borderline|45|127498344|Female|Choroid plexus|2021
20+|~|~|~|Malignant|~|127498344|Female|Choroid plexus|2021
20+|0.0|0.1|0.0|Benign/Borderline|51|128573447|Female|Choroid plexus|2022
20+|~|~|~|Malignant|~|128573447|Female|Choroid plexus|2022
20+|0.0|0.0|0.0|Benign/Borderline|43|130004162|Female|Choroid plexus|2023
20+|~|~|~|Malignant|~|130004162|Female|Choroid plexus|2023
20+|0.2|0.2|0.2|Benign/Borderline|208|109112165|Female|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|208|111567226|Female|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|223|112783993|Female|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|228|114027722|Female|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|234|115293599|Female|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|245|116602141|Female|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|116602141|Female|Craniopharyngioma|2010
20+|0.2|0.2|0.2|Benign/Borderline|222|117837363|Female|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|117837363|Female|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|229|119040975|Female|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|119040975|Female|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|249|120141498|Female|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|120141498|Female|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|230|121280256|Female|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|121280256|Female|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|244|122363537|Female|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|122363537|Female|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|234|123423539|Female|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|123423539|Female|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|254|124394893|Female|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|124394893|Female|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|250|125266771|Female|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|125266771|Female|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|245|126086679|Female|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|126086679|Female|Craniopharyngioma|2019
20+|0.2|0.2|0.2|Benign/Borderline|1191|639008149|Female|Craniopharyngioma|2019-2023
20+|~|~|~|Malignant|~|639008149|Female|Craniopharyngioma|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|227|126845517|Female|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|126845517|Female|Craniopharyngioma|2020
20+|0.2|0.2|0.2|Benign/Borderline|226|127498344|Female|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|127498344|Female|Craniopharyngioma|2021
20+|0.2|0.2|0.2|Benign/Borderline|247|128573447|Female|Craniopharyngioma|2022
20+|~|~|~|Malignant|~|128573447|Female|Craniopharyngioma|2022
20+|0.2|0.2|0.2|Benign/Borderline|246|130004162|Female|Craniopharyngioma|2023
20+|~|~|~|Malignant|~|130004162|Female|Craniopharyngioma|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|114|109112165|Female|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005
20+|0.1|0.1|0.1|Malignant|132|110320645|Female|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006
20+|0.1|0.1|0.1|Malignant|94|111567226|Female|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007
20+|0.1|0.1|0.1|Malignant|133|112783993|Female|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008
20+|0.1|0.1|0.1|Malignant|130|114027722|Female|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Diffuse astrocytoma|2010
20+|0.1|0.2|0.1|Malignant|163|116602141|Female|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|114|117837363|Female|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|95|119040975|Female|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Diffuse astrocytoma|2013
20+|0.0|0.1|0.1|Malignant|71|120141498|Female|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Diffuse astrocytoma|2014
20+|0.0|0.1|0.0|Malignant|63|121280256|Female|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Diffuse astrocytoma|2015
20+|0.0|0.0|0.0|Malignant|35|122363537|Female|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Diffuse astrocytoma|2016
20+|~|~|~|Malignant|~|123423539|Female|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Diffuse astrocytoma|2017
20+|~|~|~|Malignant|~|124394893|Female|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Diffuse astrocytoma|2018
20+|~|~|~|Malignant|~|125266771|Female|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|126086679|Female|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Diffuse astrocytoma|2019-2023
20+|0.0|0.0|0.0|Malignant|16|639008149|Female|Diffuse astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|126845517|Female|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|127498344|Female|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Diffuse astrocytoma|2022
20+|~|~|~|Malignant|~|128573447|Female|Diffuse astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Diffuse astrocytoma|2023
20+|~|~|~|Malignant|~|130004162|Female|Diffuse astrocytoma|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|70|109112165|Female|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|83|110320645|Female|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|93|112783993|Female|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|88|114027722|Female|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|102|115293599|Female|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|73|116602141|Female|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Embryonal/primitive/medulloblastoma|2011
20+|0.0|0.1|0.1|Malignant|70|117837363|Female|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|80|119040975|Female|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|91|120141498|Female|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|75|121280256|Female|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Embryonal/primitive/medulloblastoma|2015
20+|0.0|0.1|0.1|Malignant|68|122363537|Female|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Embryonal/primitive/medulloblastoma|2016
20+|0.0|0.1|0.1|Malignant|64|123423539|Female|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Embryonal/primitive/medulloblastoma|2017
20+|0.0|0.1|0.1|Malignant|62|124394893|Female|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Embryonal/primitive/medulloblastoma|2018
20+|0.0|0.1|0.0|Malignant|56|125266771|Female|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Embryonal/primitive/medulloblastoma|2019
20+|0.0|0.1|0.1|Malignant|61|126086679|Female|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Embryonal/primitive/medulloblastoma|2019-2023
20+|0.0|0.1|0.1|Malignant|295|639008149|Female|Embryonal/primitive/medulloblastoma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|60|126845517|Female|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Embryonal/primitive/medulloblastoma|2021
20+|0.0|0.1|0.1|Malignant|64|127498344|Female|Embryonal/primitive/medulloblastoma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Embryonal/primitive/medulloblastoma|2022
20+|0.0|0.1|0.0|Malignant|53|128573447|Female|Embryonal/primitive/medulloblastoma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Embryonal/primitive/medulloblastoma|2023
20+|0.0|0.1|0.1|Malignant|57|130004162|Female|Embryonal/primitive/medulloblastoma|2023
20+|0.1|0.1|0.1|Benign/Borderline|107|109112165|Female|Ependymoma variants|2004
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|117|110320645|Female|Ependymoma variants|2005
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|149|111567226|Female|Ependymoma variants|2006
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|114|112783993|Female|Ependymoma variants|2007
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|110|114027722|Female|Ependymoma variants|2008
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|113|115293599|Female|Ependymoma variants|2009
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|124|116602141|Female|Ependymoma variants|2010
20+|~|~|~|Malignant|~|116602141|Female|Ependymoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|122|117837363|Female|Ependymoma variants|2011
20+|~|~|~|Malignant|~|117837363|Female|Ependymoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|130|119040975|Female|Ependymoma variants|2012
20+|~|~|~|Malignant|~|119040975|Female|Ependymoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|117|120141498|Female|Ependymoma variants|2013
20+|~|~|~|Malignant|~|120141498|Female|Ependymoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|132|121280256|Female|Ependymoma variants|2014
20+|~|~|~|Malignant|~|121280256|Female|Ependymoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|136|122363537|Female|Ependymoma variants|2015
20+|~|~|~|Malignant|~|122363537|Female|Ependymoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|128|123423539|Female|Ependymoma variants|2016
20+|~|~|~|Malignant|~|123423539|Female|Ependymoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|119|124394893|Female|Ependymoma variants|2017
20+|~|~|~|Malignant|~|124394893|Female|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|117|125266771|Female|Ependymoma variants|2018
20+|~|~|~|Malignant|~|125266771|Female|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|109|126086679|Female|Ependymoma variants|2019
20+|~|~|~|Malignant|~|126086679|Female|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|609|639008149|Female|Ependymoma variants|2019-2023
20+|~|~|~|Malignant|~|639008149|Female|Ependymoma variants|2019-2023
20+|0.1|0.1|0.1|Benign/Borderline|124|126845517|Female|Ependymoma variants|2020
20+|~|~|~|Malignant|~|126845517|Female|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|138|127498344|Female|Ependymoma variants|2021
20+|~|~|~|Malignant|~|127498344|Female|Ependymoma variants|2021
20+|0.1|0.1|0.1|Benign/Borderline|113|128573447|Female|Ependymoma variants|2022
20+|~|~|~|Malignant|~|128573447|Female|Ependymoma variants|2022
20+|0.1|0.1|0.1|Benign/Borderline|125|130004162|Female|Ependymoma variants|2023
20+|~|~|~|Malignant|~|130004162|Female|Ependymoma variants|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004
20+|0.2|0.3|0.3|Malignant|294|109112165|Female|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005
20+|0.2|0.3|0.3|Malignant|305|110320645|Female|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|296|111567226|Female|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|300|112783993|Female|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008
20+|0.2|0.3|0.3|Malignant|318|114027722|Female|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|348|115293599|Female|Ependymoma/anaplastic ependymoma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Ependymoma/anaplastic ependymoma|2010
20+|0.2|0.3|0.3|Malignant|297|116602141|Female|Ependymoma/anaplastic ependymoma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|303|117837363|Female|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Ependymoma/anaplastic ependymoma|2012
20+|0.2|0.3|0.3|Malignant|305|119040975|Female|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.2|Malignant|281|120141498|Female|Ependymoma/anaplastic ependymoma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.2|0.2|Malignant|249|121280256|Female|Ependymoma/anaplastic ependymoma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.2|Malignant|277|122363537|Female|Ependymoma/anaplastic ependymoma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.2|Malignant|280|123423539|Female|Ependymoma/anaplastic ependymoma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|295|124394893|Female|Ependymoma/anaplastic ependymoma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.2|0.2|Malignant|242|125266771|Female|Ependymoma/anaplastic ependymoma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.2|0.2|Malignant|255|126086679|Female|Ependymoma/anaplastic ependymoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|60|639008149|Female|Ependymoma/anaplastic ependymoma|2019-2023
20+|0.2|0.2|0.2|Malignant|1195|639008149|Female|Ependymoma/anaplastic ependymoma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|257|126845517|Female|Ependymoma/anaplastic ependymoma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|263|127498344|Female|Ependymoma/anaplastic ependymoma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Ependymoma/anaplastic ependymoma|2022
20+|0.1|0.2|0.2|Malignant|211|128573447|Female|Ependymoma/anaplastic ependymoma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Ependymoma/anaplastic ependymoma|2023
20+|0.1|0.2|0.2|Malignant|209|130004162|Female|Ependymoma/anaplastic ependymoma|2023
20+|0.0|0.0|0.0|Benign/Borderline|18|109112165|Female|Germ Cell Tumors|2004
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|38|111567226|Female|Germ Cell Tumors|2006
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|37|112783993|Female|Germ Cell Tumors|2007
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|33|114027722|Female|Germ Cell Tumors|2008
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008
20+|0.0|0.1|0.0|Benign/Borderline|43|115293599|Female|Germ Cell Tumors|2009
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|32|116602141|Female|Germ Cell Tumors|2010
20+|~|~|~|Malignant|~|116602141|Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|40|117837363|Female|Germ Cell Tumors|2011
20+|~|~|~|Malignant|~|117837363|Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|32|119040975|Female|Germ Cell Tumors|2012
20+|~|~|~|Malignant|~|119040975|Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|27|120141498|Female|Germ Cell Tumors|2013
20+|~|~|~|Malignant|~|120141498|Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|32|121280256|Female|Germ Cell Tumors|2014
20+|~|~|~|Malignant|~|121280256|Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|34|122363537|Female|Germ Cell Tumors|2015
20+|~|~|~|Malignant|~|122363537|Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|34|123423539|Female|Germ Cell Tumors|2016
20+|~|~|~|Malignant|~|123423539|Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|25|124394893|Female|Germ Cell Tumors|2017
20+|~|~|~|Malignant|~|124394893|Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|20|125266771|Female|Germ Cell Tumors|2018
20+|~|~|~|Malignant|~|125266771|Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|45|126086679|Female|Germ Cell Tumors|2019
20+|~|~|~|Malignant|~|126086679|Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|145|639008149|Female|Germ Cell Tumors|2019-2023
20+|0.0|0.0|0.0|Malignant|35|639008149|Female|Germ Cell Tumors|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|24|126845517|Female|Germ Cell Tumors|2020
20+|~|~|~|Malignant|~|126845517|Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|29|127498344|Female|Germ Cell Tumors|2021
20+|~|~|~|Malignant|~|127498344|Female|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Benign/Borderline|22|128573447|Female|Germ Cell Tumors|2022
20+|~|~|~|Malignant|~|128573447|Female|Germ Cell Tumors|2022
20+|0.0|0.0|0.0|Benign/Borderline|25|130004162|Female|Germ Cell Tumors|2023
20+|~|~|~|Malignant|~|130004162|Female|Germ Cell Tumors|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004
20+|3.4|3.6|3.5|Malignant|4106|109112165|Female|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005
20+|3.4|3.6|3.5|Malignant|4162|110320645|Female|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006
20+|3.5|3.7|3.6|Malignant|4290|111567226|Female|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007
20+|3.5|3.7|3.6|Malignant|4379|112783993|Female|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008
20+|3.4|3.6|3.5|Malignant|4403|114027722|Female|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009
20+|3.4|3.6|3.5|Malignant|4492|115293599|Female|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Glioblastoma|2010
20+|3.4|3.6|3.5|Malignant|4612|116602141|Female|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Glioblastoma|2011
20+|3.4|3.6|3.5|Malignant|4582|117837363|Female|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Glioblastoma|2012
20+|3.5|3.7|3.6|Malignant|4861|119040975|Female|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Glioblastoma|2013
20+|3.4|3.7|3.6|Malignant|4905|120141498|Female|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Glioblastoma|2014
20+|3.3|3.5|3.4|Malignant|4807|121280256|Female|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Glioblastoma|2015
20+|3.5|3.7|3.6|Malignant|5135|122363537|Female|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Glioblastoma|2016
20+|3.5|3.7|3.6|Malignant|5220|123423539|Female|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Glioblastoma|2017
20+|3.5|3.7|3.6|Malignant|5259|124394893|Female|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Glioblastoma|2018
20+|3.4|3.6|3.5|Malignant|5294|125266771|Female|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Glioblastoma|2019
20+|3.4|3.6|3.5|Malignant|5351|126086679|Female|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Glioblastoma|2019-2023
20+|3.5|3.6|3.5|Malignant|28151|639008149|Female|Glioblastoma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Glioblastoma|2020
20+|3.5|3.7|3.6|Malignant|5627|126845517|Female|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Glioblastoma|2021
20+|3.4|3.6|3.5|Malignant|5586|127498344|Female|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Glioblastoma|2022
20+|3.5|3.7|3.6|Malignant|5842|128573447|Female|Glioblastoma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Glioblastoma|2023
20+|3.4|3.5|3.4|Malignant|5745|130004162|Female|Glioblastoma|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004
20+|0.3|0.4|0.4|Malignant|429|109112165|Female|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005
20+|0.3|0.4|0.3|Malignant|404|110320645|Female|Glioma malignant, NOS|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006
20+|0.3|0.4|0.3|Malignant|400|111567226|Female|Glioma malignant, NOS|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007
20+|0.3|0.4|0.3|Malignant|414|112783993|Female|Glioma malignant, NOS|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008
20+|0.3|0.4|0.4|Malignant|450|114027722|Female|Glioma malignant, NOS|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|522|115293599|Female|Glioma malignant, NOS|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Glioma malignant, NOS|2010
20+|0.3|0.4|0.3|Malignant|414|116602141|Female|Glioma malignant, NOS|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Glioma malignant, NOS|2011
20+|0.3|0.4|0.4|Malignant|449|117837363|Female|Glioma malignant, NOS|2011
20+|0.0|0.0|0.0|Benign/Borderline|17|119040975|Female|Glioma malignant, NOS|2012
20+|0.3|0.4|0.3|Malignant|442|119040975|Female|Glioma malignant, NOS|2012
20+|0.0|0.0|0.0|Benign/Borderline|18|120141498|Female|Glioma malignant, NOS|2013
20+|0.3|0.4|0.4|Malignant|478|120141498|Female|Glioma malignant, NOS|2013
20+|0.0|0.0|0.0|Benign/Borderline|27|121280256|Female|Glioma malignant, NOS|2014
20+|0.3|0.4|0.4|Malignant|456|121280256|Female|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|30|122363537|Female|Glioma malignant, NOS|2015
20+|0.4|0.4|0.4|Malignant|530|122363537|Female|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|25|123423539|Female|Glioma malignant, NOS|2016
20+|0.4|0.4|0.4|Malignant|538|123423539|Female|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|34|124394893|Female|Glioma malignant, NOS|2017
20+|0.4|0.5|0.4|Malignant|560|124394893|Female|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|18|125266771|Female|Glioma malignant, NOS|2018
20+|0.3|0.4|0.4|Malignant|512|125266771|Female|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|26|126086679|Female|Glioma malignant, NOS|2019
20+|0.3|0.4|0.4|Malignant|503|126086679|Female|Glioma malignant, NOS|2019
20+|0.0|0.0|0.0|Benign/Borderline|150|639008149|Female|Glioma malignant, NOS|2019-2023
20+|0.4|0.4|0.4|Malignant|2719|639008149|Female|Glioma malignant, NOS|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|18|126845517|Female|Glioma malignant, NOS|2020
20+|0.3|0.4|0.4|Malignant|503|126845517|Female|Glioma malignant, NOS|2020
20+|0.0|0.0|0.0|Benign/Borderline|23|127498344|Female|Glioma malignant, NOS|2021
20+|0.3|0.4|0.4|Malignant|505|127498344|Female|Glioma malignant, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|29|128573447|Female|Glioma malignant, NOS|2022
20+|0.4|0.5|0.4|Malignant|585|128573447|Female|Glioma malignant, NOS|2022
20+|0.0|0.1|0.0|Benign/Borderline|54|130004162|Female|Glioma malignant, NOS|2023
20+|0.4|0.5|0.4|Malignant|623|130004162|Female|Glioma malignant, NOS|2023
20+|0.2|0.2|0.2|Benign/Borderline|210|109112165|Female|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004
20+|0.2|0.2|0.2|Benign/Borderline|235|110320645|Female|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005
20+|0.2|0.2|0.2|Benign/Borderline|225|111567226|Female|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006
20+|0.2|0.2|0.2|Benign/Borderline|219|112783993|Female|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007
20+|0.2|0.2|0.2|Benign/Borderline|243|114027722|Female|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008
20+|0.2|0.2|0.2|Benign/Borderline|240|115293599|Female|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009
20+|0.2|0.2|0.2|Benign/Borderline|241|116602141|Female|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|116602141|Female|Hemangioblastoma|2010
20+|0.2|0.2|0.2|Benign/Borderline|252|117837363|Female|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|117837363|Female|Hemangioblastoma|2011
20+|0.2|0.3|0.2|Benign/Borderline|267|119040975|Female|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|119040975|Female|Hemangioblastoma|2012
20+|0.2|0.2|0.2|Benign/Borderline|236|120141498|Female|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|120141498|Female|Hemangioblastoma|2013
20+|0.2|0.2|0.2|Benign/Borderline|222|121280256|Female|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|121280256|Female|Hemangioblastoma|2014
20+|0.2|0.2|0.2|Benign/Borderline|252|122363537|Female|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|122363537|Female|Hemangioblastoma|2015
20+|0.2|0.2|0.2|Benign/Borderline|279|123423539|Female|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|123423539|Female|Hemangioblastoma|2016
20+|0.2|0.2|0.2|Benign/Borderline|238|124394893|Female|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|124394893|Female|Hemangioblastoma|2017
20+|0.2|0.2|0.2|Benign/Borderline|230|125266771|Female|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|125266771|Female|Hemangioblastoma|2018
20+|0.2|0.3|0.2|Benign/Borderline|290|126086679|Female|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|126086679|Female|Hemangioblastoma|2019
20+|0.2|0.2|0.2|Benign/Borderline|1275|639008149|Female|Hemangioblastoma|2019-2023
20+|~|~|~|Malignant|~|639008149|Female|Hemangioblastoma|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|246|126845517|Female|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|126845517|Female|Hemangioblastoma|2020
20+|0.2|0.2|0.2|Benign/Borderline|255|127498344|Female|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|127498344|Female|Hemangioblastoma|2021
20+|0.2|0.2|0.2|Benign/Borderline|250|128573447|Female|Hemangioblastoma|2022
20+|~|~|~|Malignant|~|128573447|Female|Hemangioblastoma|2022
20+|0.2|0.2|0.2|Benign/Borderline|234|130004162|Female|Hemangioblastoma|2023
20+|~|~|~|Malignant|~|130004162|Female|Hemangioblastoma|2023
20+|0.2|0.3|0.2|Benign/Borderline|249|109112165|Female|Hemangioma|2004
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004
20+|0.2|0.3|0.3|Benign/Borderline|293|110320645|Female|Hemangioma|2005
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005
20+|0.3|0.3|0.3|Benign/Borderline|325|111567226|Female|Hemangioma|2006
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006
20+|0.3|0.4|0.3|Benign/Borderline|385|112783993|Female|Hemangioma|2007
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007
20+|0.4|0.5|0.4|Benign/Borderline|494|114027722|Female|Hemangioma|2008
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008
20+|0.4|0.5|0.5|Benign/Borderline|547|115293599|Female|Hemangioma|2009
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009
20+|0.5|0.6|0.6|Benign/Borderline|685|116602141|Female|Hemangioma|2010
20+|~|~|~|Malignant|~|116602141|Female|Hemangioma|2010
20+|0.6|0.7|0.6|Benign/Borderline|733|117837363|Female|Hemangioma|2011
20+|~|~|~|Malignant|~|117837363|Female|Hemangioma|2011
20+|0.6|0.7|0.6|Benign/Borderline|748|119040975|Female|Hemangioma|2012
20+|~|~|~|Malignant|~|119040975|Female|Hemangioma|2012
20+|0.6|0.7|0.6|Benign/Borderline|764|120141498|Female|Hemangioma|2013
20+|~|~|~|Malignant|~|120141498|Female|Hemangioma|2013
20+|0.5|0.6|0.6|Benign/Borderline|711|121280256|Female|Hemangioma|2014
20+|~|~|~|Malignant|~|121280256|Female|Hemangioma|2014
20+|0.5|0.5|0.5|Benign/Borderline|621|122363537|Female|Hemangioma|2015
20+|~|~|~|Malignant|~|122363537|Female|Hemangioma|2015
20+|0.4|0.5|0.5|Benign/Borderline|616|123423539|Female|Hemangioma|2016
20+|~|~|~|Malignant|~|123423539|Female|Hemangioma|2016
20+|0.4|0.5|0.5|Benign/Borderline|582|124394893|Female|Hemangioma|2017
20+|~|~|~|Malignant|~|124394893|Female|Hemangioma|2017
20+|0.4|0.5|0.5|Benign/Borderline|612|125266771|Female|Hemangioma|2018
20+|~|~|~|Malignant|~|125266771|Female|Hemangioma|2018
20+|0.4|0.5|0.5|Benign/Borderline|598|126086679|Female|Hemangioma|2019
20+|~|~|~|Malignant|~|126086679|Female|Hemangioma|2019
20+|0.4|0.5|0.5|Benign/Borderline|3083|639008149|Female|Hemangioma|2019-2023
20+|~|~|~|Malignant|~|639008149|Female|Hemangioma|2019-2023
20+|0.5|0.5|0.5|Benign/Borderline|656|126845517|Female|Hemangioma|2020
20+|~|~|~|Malignant|~|126845517|Female|Hemangioma|2020
20+|0.4|0.5|0.4|Benign/Borderline|572|127498344|Female|Hemangioma|2021
20+|~|~|~|Malignant|~|127498344|Female|Hemangioma|2021
20+|0.4|0.5|0.4|Benign/Borderline|582|128573447|Female|Hemangioma|2022
20+|~|~|~|Malignant|~|128573447|Female|Hemangioma|2022
20+|0.4|0.5|0.5|Benign/Borderline|675|130004162|Female|Hemangioma|2023
20+|~|~|~|Malignant|~|130004162|Female|Hemangioma|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|24|112783993|Female|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|22|116602141|Female|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|23|117837363|Female|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|20|119040975|Female|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|16|120141498|Female|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|26|121280256|Female|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|17|122363537|Female|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Malignant|~|123423539|Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Malignant|~|124394893|Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Malignant|~|125266771|Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Malignant|~|126086679|Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Local Extensions from Regional Tumors|2019-2023
20+|0.0|0.0|0.0|Malignant|60|639008149|Female|Local Extensions from Regional Tumors|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Malignant|~|126845517|Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Malignant|~|127498344|Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Local Extensions from Regional Tumors|2022
20+|~|~|~|Malignant|~|128573447|Female|Local Extensions from Regional Tumors|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Local Extensions from Regional Tumors|2023
20+|~|~|~|Malignant|~|130004162|Female|Local Extensions from Regional Tumors|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.5|0.6|0.5|Malignant|591|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.5|0.6|0.6|Malignant|666|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.5|0.6|0.6|Malignant|675|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.5|0.6|0.5|Malignant|639|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.5|0.6|0.6|Malignant|703|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.5|0.6|0.5|Malignant|666|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.5|0.6|0.6|Malignant|740|116602141|Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.5|0.6|0.6|Malignant|716|117837363|Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.5|0.6|0.5|Malignant|703|119040975|Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.5|0.6|0.6|Malignant|743|120141498|Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.6|0.6|Malignant|814|121280256|Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.5|0.6|0.5|Malignant|764|122363537|Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.5|0.6|0.6|Malignant|841|123423539|Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.5|0.6|0.6|Malignant|837|124394893|Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.5|0.6|0.6|Malignant|823|125266771|Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.5|0.6|0.5|Malignant|803|126086679|Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
20+|0.5|0.5|0.5|Malignant|4112|639008149|Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.5|0.6|0.5|Malignant|855|126845517|Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.5|0.6|0.5|Malignant|819|127498344|Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|0.4|0.5|0.5|Malignant|761|128573447|Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Lymphomas and Hematopoietic Neoplasms|2023
20+|0.5|0.6|0.5|Malignant|874|130004162|Female|Lymphomas and Hematopoietic Neoplasms|2023
20+|12.3|12.7|12.5|Benign/Borderline|14525|109112165|Female|Meningioma|2004
20+|0.2|0.3|0.2|Malignant|274|109112165|Female|Meningioma|2004
20+|13.8|14.2|14.0|Benign/Borderline|16575|110320645|Female|Meningioma|2005
20+|0.2|0.3|0.2|Malignant|281|110320645|Female|Meningioma|2005
20+|14.5|14.9|14.7|Benign/Borderline|17690|111567226|Female|Meningioma|2006
20+|0.2|0.2|0.2|Malignant|252|111567226|Female|Meningioma|2006
20+|15.1|15.6|15.3|Benign/Borderline|18724|112783993|Female|Meningioma|2007
20+|0.2|0.2|0.2|Malignant|267|112783993|Female|Meningioma|2007
20+|15.9|16.4|16.2|Benign/Borderline|20079|114027722|Female|Meningioma|2008
20+|0.2|0.2|0.2|Malignant|218|114027722|Female|Meningioma|2008
20+|17.0|17.5|17.3|Benign/Borderline|21828|115293599|Female|Meningioma|2009
20+|0.1|0.2|0.2|Malignant|208|115293599|Female|Meningioma|2009
20+|16.5|17.0|16.8|Benign/Borderline|21549|116602141|Female|Meningioma|2010
20+|0.1|0.2|0.2|Malignant|210|116602141|Female|Meningioma|2010
20+|16.8|17.2|17.0|Benign/Borderline|22075|117837363|Female|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|188|117837363|Female|Meningioma|2011
20+|17.2|17.7|17.4|Benign/Borderline|23024|119040975|Female|Meningioma|2012
20+|0.1|0.2|0.2|Malignant|209|119040975|Female|Meningioma|2012
20+|17.5|17.9|17.7|Benign/Borderline|23692|120141498|Female|Meningioma|2013
20+|0.1|0.2|0.2|Malignant|229|120141498|Female|Meningioma|2013
20+|18.0|18.5|18.2|Benign/Borderline|24830|121280256|Female|Meningioma|2014
20+|0.1|0.2|0.2|Malignant|220|121280256|Female|Meningioma|2014
20+|18.7|19.2|19.0|Benign/Borderline|26220|122363537|Female|Meningioma|2015
20+|0.1|0.2|0.1|Malignant|202|122363537|Female|Meningioma|2015
20+|19.3|19.8|19.5|Benign/Borderline|27313|123423539|Female|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|175|123423539|Female|Meningioma|2016
20+|19.9|20.4|20.2|Benign/Borderline|28712|124394893|Female|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|186|124394893|Female|Meningioma|2017
20+|20.3|20.8|20.5|Benign/Borderline|29635|125266771|Female|Meningioma|2018
20+|0.1|0.2|0.1|Malignant|182|125266771|Female|Meningioma|2018
20+|21.3|21.8|21.6|Benign/Borderline|31627|126086679|Female|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|168|126086679|Female|Meningioma|2019
20+|21.3|21.5|21.4|Benign/Borderline|161336|639008149|Female|Meningioma|2019-2023
20+|0.1|0.1|0.1|Malignant|960|639008149|Female|Meningioma|2019-2023
20+|19.3|19.8|19.5|Benign/Borderline|28959|126845517|Female|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|173|126845517|Female|Meningioma|2020
20+|21.4|21.9|21.7|Benign/Borderline|32610|127498344|Female|Meningioma|2021
20+|0.1|0.2|0.1|Malignant|204|127498344|Female|Meningioma|2021
20+|21.8|22.3|22.0|Benign/Borderline|33730|128573447|Female|Meningioma|2022
20+|0.1|0.2|0.1|Malignant|221|128573447|Female|Meningioma|2022
20+|21.8|22.3|22.1|Benign/Borderline|34410|130004162|Female|Meningioma|2023
20+|0.1|0.1|0.1|Malignant|194|130004162|Female|Meningioma|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004
20+|0.2|0.2|0.2|Malignant|198|109112165|Female|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005
20+|0.2|0.2|0.2|Malignant|236|110320645|Female|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006
20+|0.2|0.3|0.2|Malignant|273|111567226|Female|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007
20+|0.2|0.3|0.2|Malignant|241|112783993|Female|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008
20+|0.2|0.3|0.2|Malignant|263|114027722|Female|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009
20+|0.2|0.3|0.3|Malignant|288|115293599|Female|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Mixed glioma|2010
20+|0.2|0.3|0.2|Malignant|274|116602141|Female|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Mixed glioma|2011
20+|0.2|0.3|0.2|Malignant|275|117837363|Female|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Mixed glioma|2012
20+|0.2|0.2|0.2|Malignant|243|119040975|Female|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Mixed glioma|2013
20+|0.2|0.2|0.2|Malignant|248|120141498|Female|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Mixed glioma|2014
20+|0.1|0.2|0.2|Malignant|201|121280256|Female|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Mixed glioma|2015
20+|0.1|0.1|0.1|Malignant|131|122363537|Female|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Mixed glioma|2016
20+|0.0|0.0|0.0|Malignant|43|123423539|Female|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|31|124394893|Female|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Mixed glioma|2018
20+|~|~|~|Malignant|~|125266771|Female|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Mixed glioma|2019
20+|~|~|~|Malignant|~|126086679|Female|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Mixed glioma|2019-2023
20+|0.0|0.0|0.0|Malignant|24|639008149|Female|Mixed glioma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Mixed glioma|2020
20+|~|~|~|Malignant|~|126845517|Female|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Mixed glioma|2021
20+|~|~|~|Malignant|~|127498344|Female|Mixed glioma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Mixed glioma|2022
20+|~|~|~|Malignant|~|128573447|Female|Mixed glioma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Mixed glioma|2023
20+|~|~|~|Malignant|~|130004162|Female|Mixed glioma|2023
20+|0.6|0.6|0.6|Benign/Borderline|696|109112165|Female|Neoplasm, unspecified|2004
20+|0.5|0.6|0.5|Malignant|681|109112165|Female|Neoplasm, unspecified|2004
20+|0.7|0.8|0.7|Benign/Borderline|869|110320645|Female|Neoplasm, unspecified|2005
20+|0.5|0.6|0.6|Malignant|716|110320645|Female|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Benign/Borderline|805|111567226|Female|Neoplasm, unspecified|2006
20+|0.5|0.6|0.6|Malignant|723|111567226|Female|Neoplasm, unspecified|2006
20+|0.7|0.7|0.7|Benign/Borderline|856|112783993|Female|Neoplasm, unspecified|2007
20+|0.5|0.5|0.5|Malignant|649|112783993|Female|Neoplasm, unspecified|2007
20+|0.6|0.7|0.7|Benign/Borderline|838|114027722|Female|Neoplasm, unspecified|2008
20+|0.5|0.6|0.6|Malignant|753|114027722|Female|Neoplasm, unspecified|2008
20+|0.7|0.8|0.7|Benign/Borderline|924|115293599|Female|Neoplasm, unspecified|2009
20+|0.5|0.6|0.6|Malignant|784|115293599|Female|Neoplasm, unspecified|2009
20+|0.6|0.7|0.7|Benign/Borderline|833|116602141|Female|Neoplasm, unspecified|2010
20+|0.4|0.5|0.5|Malignant|642|116602141|Female|Neoplasm, unspecified|2010
20+|0.6|0.7|0.7|Benign/Borderline|856|117837363|Female|Neoplasm, unspecified|2011
20+|0.4|0.5|0.5|Malignant|650|117837363|Female|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|892|119040975|Female|Neoplasm, unspecified|2012
20+|0.4|0.5|0.5|Malignant|653|119040975|Female|Neoplasm, unspecified|2012
20+|0.6|0.7|0.6|Benign/Borderline|806|120141498|Female|Neoplasm, unspecified|2013
20+|0.4|0.5|0.5|Malignant|667|120141498|Female|Neoplasm, unspecified|2013
20+|0.6|0.7|0.7|Benign/Borderline|911|121280256|Female|Neoplasm, unspecified|2014
20+|0.5|0.5|0.5|Malignant|745|121280256|Female|Neoplasm, unspecified|2014
20+|0.6|0.7|0.7|Benign/Borderline|884|122363537|Female|Neoplasm, unspecified|2015
20+|0.5|0.5|0.5|Malignant|741|122363537|Female|Neoplasm, unspecified|2015
20+|0.6|0.7|0.6|Benign/Borderline|833|123423539|Female|Neoplasm, unspecified|2016
20+|0.4|0.5|0.4|Malignant|626|123423539|Female|Neoplasm, unspecified|2016
20+|0.5|0.6|0.6|Benign/Borderline|792|124394893|Female|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Malignant|688|124394893|Female|Neoplasm, unspecified|2017
20+|0.5|0.6|0.5|Benign/Borderline|767|125266771|Female|Neoplasm, unspecified|2018
20+|0.4|0.5|0.5|Malignant|688|125266771|Female|Neoplasm, unspecified|2018
20+|0.4|0.5|0.5|Benign/Borderline|652|126086679|Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.5|Malignant|713|126086679|Female|Neoplasm, unspecified|2019
20+|0.5|0.5|0.5|Benign/Borderline|3394|639008149|Female|Neoplasm, unspecified|2019-2023
20+|0.4|0.5|0.5|Malignant|3647|639008149|Female|Neoplasm, unspecified|2019-2023
20+|0.5|0.5|0.5|Benign/Borderline|682|126845517|Female|Neoplasm, unspecified|2020
20+|0.5|0.5|0.5|Malignant|789|126845517|Female|Neoplasm, unspecified|2020
20+|0.4|0.5|0.5|Benign/Borderline|650|127498344|Female|Neoplasm, unspecified|2021
20+|0.4|0.5|0.5|Malignant|733|127498344|Female|Neoplasm, unspecified|2021
20+|0.5|0.6|0.5|Benign/Borderline|777|128573447|Female|Neoplasm, unspecified|2022
20+|0.4|0.5|0.4|Malignant|722|128573447|Female|Neoplasm, unspecified|2022
20+|0.4|0.5|0.4|Benign/Borderline|633|130004162|Female|Neoplasm, unspecified|2023
20+|0.4|0.4|0.4|Malignant|690|130004162|Female|Neoplasm, unspecified|2023
20+|2.3|2.4|2.3|Benign/Borderline|2628|109112165|Female|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004
20+|2.5|2.6|2.5|Benign/Borderline|2889|110320645|Female|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005
20+|2.5|2.7|2.6|Benign/Borderline|3021|111567226|Female|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006
20+|2.5|2.7|2.6|Benign/Borderline|3059|112783993|Female|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007
20+|2.6|2.8|2.7|Benign/Borderline|3202|114027722|Female|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008
20+|2.6|2.8|2.7|Benign/Borderline|3320|115293599|Female|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009
20+|2.5|2.6|2.6|Benign/Borderline|3152|116602141|Female|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|23|116602141|Female|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|3410|117837363|Female|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|21|117837363|Female|Nerve sheath, benign and malignant|2011
20+|2.8|2.9|2.9|Benign/Borderline|3642|119040975|Female|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|28|119040975|Female|Nerve sheath, benign and malignant|2012
20+|2.9|3.1|3.0|Benign/Borderline|3832|120141498|Female|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|25|120141498|Female|Nerve sheath, benign and malignant|2013
20+|3.0|3.2|3.1|Benign/Borderline|3978|121280256|Female|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|16|121280256|Female|Nerve sheath, benign and malignant|2014
20+|3.1|3.3|3.2|Benign/Borderline|4166|122363537|Female|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|24|122363537|Female|Nerve sheath, benign and malignant|2015
20+|3.0|3.2|3.1|Benign/Borderline|4149|123423539|Female|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|29|123423539|Female|Nerve sheath, benign and malignant|2016
20+|3.0|3.2|3.1|Benign/Borderline|4124|124394893|Female|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|19|124394893|Female|Nerve sheath, benign and malignant|2017
20+|3.0|3.2|3.1|Benign/Borderline|4206|125266771|Female|Nerve sheath, benign and malignant|2018
20+|0.0|0.0|0.0|Malignant|16|125266771|Female|Nerve sheath, benign and malignant|2018
20+|3.0|3.2|3.1|Benign/Borderline|4319|126086679|Female|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|19|126086679|Female|Nerve sheath, benign and malignant|2019
20+|3.0|3.1|3.0|Benign/Borderline|21254|639008149|Female|Nerve sheath, benign and malignant|2019-2023
20+|0.0|0.0|0.0|Malignant|115|639008149|Female|Nerve sheath, benign and malignant|2019-2023
20+|2.6|2.8|2.7|Benign/Borderline|3716|126845517|Female|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|16|126845517|Female|Nerve sheath, benign and malignant|2020
20+|3.1|3.3|3.2|Benign/Borderline|4549|127498344|Female|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|29|127498344|Female|Nerve sheath, benign and malignant|2021
20+|2.9|3.1|3.0|Benign/Borderline|4325|128573447|Female|Nerve sheath, benign and malignant|2022
20+|0.0|0.0|0.0|Malignant|25|128573447|Female|Nerve sheath, benign and malignant|2022
20+|2.9|3.1|3.0|Benign/Borderline|4345|130004162|Female|Nerve sheath, benign and malignant|2023
20+|0.0|0.0|0.0|Malignant|26|130004162|Female|Nerve sheath, benign and malignant|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|20|109112165|Female|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|27|116602141|Female|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|23|117837363|Female|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|28|119040975|Female|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|21|120141498|Female|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|22|121280256|Female|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|39|122363537|Female|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|22|123423539|Female|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|16|124394893|Female|Neuroepithelial|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Neuroepithelial|2018
20+|~|~|~|Malignant|~|125266771|Female|Neuroepithelial|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Malignant|17|126086679|Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Benign/Borderline|28|639008149|Female|Neuroepithelial|2019-2023
20+|0.0|0.0|0.0|Malignant|50|639008149|Female|Neuroepithelial|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Neuroepithelial|2020
20+|~|~|~|Malignant|~|126845517|Female|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Neuroepithelial|2021
20+|~|~|~|Malignant|~|127498344|Female|Neuroepithelial|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Neuroepithelial|2022
20+|~|~|~|Malignant|~|128573447|Female|Neuroepithelial|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Neuroepithelial|2023
20+|~|~|~|Malignant|~|130004162|Female|Neuroepithelial|2023
20+|0.1|0.2|0.1|Benign/Borderline|154|109112165|Female|Neuronal/glial, neuronal|2004
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004
20+|0.1|0.2|0.2|Benign/Borderline|187|110320645|Female|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|188|111567226|Female|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006
20+|0.2|0.2|0.2|Benign/Borderline|208|112783993|Female|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|205|114027722|Female|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|226|115293599|Female|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009
20+|0.2|0.3|0.2|Benign/Borderline|250|116602141|Female|Neuronal/glial, neuronal|2010
20+|0.0|0.0|0.0|Malignant|18|116602141|Female|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|250|117837363|Female|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|18|117837363|Female|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|217|119040975|Female|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|22|119040975|Female|Neuronal/glial, neuronal|2012
20+|0.1|0.2|0.2|Benign/Borderline|185|120141498|Female|Neuronal/glial, neuronal|2013
20+|~|~|~|Malignant|~|120141498|Female|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|245|121280256|Female|Neuronal/glial, neuronal|2014
20+|~|~|~|Malignant|~|121280256|Female|Neuronal/glial, neuronal|2014
20+|0.2|0.2|0.2|Benign/Borderline|242|122363537|Female|Neuronal/glial, neuronal|2015
20+|0.0|0.0|0.0|Malignant|16|122363537|Female|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|249|123423539|Female|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|28|123423539|Female|Neuronal/glial, neuronal|2016
20+|0.2|0.3|0.2|Benign/Borderline|278|124394893|Female|Neuronal/glial, neuronal|2017
20+|0.0|0.0|0.0|Malignant|22|124394893|Female|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|220|125266771|Female|Neuronal/glial, neuronal|2018
20+|~|~|~|Malignant|~|125266771|Female|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|254|126086679|Female|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|17|126086679|Female|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|1212|639008149|Female|Neuronal/glial, neuronal|2019-2023
20+|0.0|0.0|0.0|Malignant|96|639008149|Female|Neuronal/glial, neuronal|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|239|126845517|Female|Neuronal/glial, neuronal|2020
20+|~|~|~|Malignant|~|126845517|Female|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|244|127498344|Female|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|16|127498344|Female|Neuronal/glial, neuronal|2021
20+|0.2|0.2|0.2|Benign/Borderline|252|128573447|Female|Neuronal/glial, neuronal|2022
20+|0.0|0.0|0.0|Malignant|26|128573447|Female|Neuronal/glial, neuronal|2022
20+|0.2|0.2|0.2|Benign/Borderline|223|130004162|Female|Neuronal/glial, neuronal|2023
20+|0.0|0.0|0.0|Malignant|25|130004162|Female|Neuronal/glial, neuronal|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004
20+|0.3|0.4|0.3|Malignant|356|109112165|Female|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005
20+|0.3|0.4|0.3|Malignant|367|110320645|Female|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006
20+|0.3|0.4|0.4|Malignant|389|111567226|Female|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007
20+|0.3|0.4|0.3|Malignant|374|112783993|Female|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008
20+|0.3|0.4|0.3|Malignant|375|114027722|Female|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009
20+|0.3|0.4|0.3|Malignant|372|115293599|Female|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Oligodendroglioma|2010
20+|0.3|0.3|0.3|Malignant|343|116602141|Female|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Oligodendroglioma|2011
20+|0.3|0.3|0.3|Malignant|324|117837363|Female|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Oligodendroglioma|2012
20+|0.2|0.3|0.3|Malignant|305|119040975|Female|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Oligodendroglioma|2013
20+|0.3|0.3|0.3|Malignant|358|120141498|Female|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Oligodendroglioma|2014
20+|0.2|0.3|0.3|Malignant|314|121280256|Female|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Oligodendroglioma|2015
20+|0.2|0.3|0.3|Malignant|319|122363537|Female|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Oligodendroglioma|2016
20+|0.3|0.3|0.3|Malignant|350|123423539|Female|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Oligodendroglioma|2017
20+|0.3|0.3|0.3|Malignant|329|124394893|Female|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Oligodendroglioma|2018
20+|0.2|0.3|0.3|Malignant|315|125266771|Female|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|126086679|Female|Oligodendroglioma|2019
20+|0.2|0.3|0.3|Malignant|325|126086679|Female|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|639008149|Female|Oligodendroglioma|2019-2023
20+|0.3|0.3|0.3|Malignant|1714|639008149|Female|Oligodendroglioma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Oligodendroglioma|2020
20+|0.2|0.3|0.2|Malignant|265|126845517|Female|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|127498344|Female|Oligodendroglioma|2021
20+|0.3|0.3|0.3|Malignant|337|127498344|Female|Oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Oligodendroglioma|2022
20+|0.3|0.4|0.3|Malignant|403|128573447|Female|Oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|130004162|Female|Oligodendroglioma|2023
20+|0.3|0.4|0.3|Malignant|384|130004162|Female|Oligodendroglioma|2023
20+|0.0|0.1|0.1|Benign/Borderline|70|109112165|Female|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|83|110320645|Female|Other mesenchymal|2005
20+|0.0|0.0|0.0|Malignant|28|110320645|Female|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|91|111567226|Female|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|84|112783993|Female|Other mesenchymal|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|106|114027722|Female|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|53|114027722|Female|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|97|115293599|Female|Other mesenchymal|2009
20+|0.0|0.0|0.0|Malignant|31|115293599|Female|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|99|116602141|Female|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|37|116602141|Female|Other mesenchymal|2010
20+|0.1|0.1|0.1|Benign/Borderline|97|117837363|Female|Other mesenchymal|2011
20+|0.0|0.0|0.0|Malignant|32|117837363|Female|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|112|119040975|Female|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|40|119040975|Female|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|113|120141498|Female|Other mesenchymal|2013
20+|0.0|0.0|0.0|Malignant|40|120141498|Female|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|99|121280256|Female|Other mesenchymal|2014
20+|0.0|0.0|0.0|Malignant|39|121280256|Female|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|97|122363537|Female|Other mesenchymal|2015
20+|0.0|0.0|0.0|Malignant|44|122363537|Female|Other mesenchymal|2015
20+|0.1|0.1|0.1|Benign/Borderline|86|123423539|Female|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|42|123423539|Female|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|117|124394893|Female|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|68|124394893|Female|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|100|125266771|Female|Other mesenchymal|2018
20+|0.0|0.0|0.0|Malignant|51|125266771|Female|Other mesenchymal|2018
20+|0.1|0.1|0.1|Benign/Borderline|89|126086679|Female|Other mesenchymal|2019
20+|0.0|0.1|0.0|Malignant|54|126086679|Female|Other mesenchymal|2019
20+|0.1|0.1|0.1|Benign/Borderline|494|639008149|Female|Other mesenchymal|2019-2023
20+|0.0|0.0|0.0|Malignant|244|639008149|Female|Other mesenchymal|2019-2023
20+|0.0|0.1|0.1|Benign/Borderline|70|126845517|Female|Other mesenchymal|2020
20+|0.0|0.1|0.1|Malignant|65|126845517|Female|Other mesenchymal|2020
20+|0.0|0.1|0.1|Benign/Borderline|89|127498344|Female|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|60|127498344|Female|Other mesenchymal|2021
20+|0.1|0.1|0.1|Benign/Borderline|114|128573447|Female|Other mesenchymal|2022
20+|0.0|0.0|0.0|Malignant|30|128573447|Female|Other mesenchymal|2022
20+|0.1|0.1|0.1|Benign/Borderline|132|130004162|Female|Other mesenchymal|2023
20+|0.0|0.0|0.0|Malignant|35|130004162|Female|Other mesenchymal|2023
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|128|109112165|Female|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|153|110320645|Female|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|150|111567226|Female|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.2|Malignant|167|112783993|Female|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|147|114027722|Female|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009
20+|0.1|0.1|0.1|Malignant|136|115293599|Female|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116602141|Female|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|170|116602141|Female|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117837363|Female|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.1|Malignant|163|117837363|Female|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119040975|Female|Pilocytic astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|128|119040975|Female|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120141498|Female|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|162|120141498|Female|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121280256|Female|Pilocytic astrocytoma|2014
20+|0.1|0.2|0.1|Malignant|149|121280256|Female|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122363537|Female|Pilocytic astrocytoma|2015
20+|0.1|0.2|0.1|Malignant|153|122363537|Female|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123423539|Female|Pilocytic astrocytoma|2016
20+|0.1|0.1|0.1|Malignant|138|123423539|Female|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124394893|Female|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|135|124394893|Female|Pilocytic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|125266771|Female|Pilocytic astrocytoma|2018
20+|0.1|0.1|0.1|Malignant|128|125266771|Female|Pilocytic astrocytoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|16|126086679|Female|Pilocytic astrocytoma|2019
20+|0.1|0.1|0.1|Malignant|130|126086679|Female|Pilocytic astrocytoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|188|639008149|Female|Pilocytic astrocytoma|2019-2023
20+|0.1|0.1|0.1|Malignant|572|639008149|Female|Pilocytic astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|126845517|Female|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|128|126845517|Female|Pilocytic astrocytoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|16|127498344|Female|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|132|127498344|Female|Pilocytic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|128573447|Female|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Malignant|121|128573447|Female|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Benign/Borderline|128|130004162|Female|Pilocytic astrocytoma|2023
20+|0.0|0.1|0.0|Malignant|61|130004162|Female|Pilocytic astrocytoma|2023
20+|0.0|0.0|0.0|Benign/Borderline|20|109112165|Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Benign/Borderline|35|110320645|Female|Pineal parenchymal|2005
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|30|111567226|Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|29|112783993|Female|Pineal parenchymal|2007
20+|0.0|0.1|0.0|Benign/Borderline|46|114027722|Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Benign/Borderline|32|115293599|Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|30|115293599|Female|Pineal parenchymal|2009
20+|0.0|0.1|0.0|Benign/Borderline|43|116602141|Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|23|116602141|Female|Pineal parenchymal|2010
20+|0.0|0.1|0.0|Benign/Borderline|48|117837363|Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|26|117837363|Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|37|119040975|Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|21|119040975|Female|Pineal parenchymal|2012
20+|0.0|0.1|0.0|Benign/Borderline|54|120141498|Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|35|120141498|Female|Pineal parenchymal|2013
20+|0.0|0.1|0.0|Benign/Borderline|44|121280256|Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Malignant|19|121280256|Female|Pineal parenchymal|2014
20+|0.0|0.1|0.0|Benign/Borderline|53|122363537|Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|31|122363537|Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|40|123423539|Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|30|123423539|Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|39|124394893|Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|26|124394893|Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|37|125266771|Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|22|125266771|Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|31|126086679|Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|31|126086679|Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|144|639008149|Female|Pineal parenchymal|2019-2023
20+|0.0|0.0|0.0|Malignant|112|639008149|Female|Pineal parenchymal|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|28|126845517|Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|22|126845517|Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Benign/Borderline|27|127498344|Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|25|127498344|Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Benign/Borderline|31|128573447|Female|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Malignant|17|128573447|Female|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Benign/Borderline|27|130004162|Female|Pineal parenchymal|2023
20+|0.0|0.0|0.0|Malignant|17|130004162|Female|Pineal parenchymal|2023
20+|3.9|4.1|4.0|Benign/Borderline|4323|109112165|Female|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Pituitary|2004
20+|4.5|4.7|4.6|Benign/Borderline|5027|110320645|Female|Pituitary|2005
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Pituitary|2005
20+|4.9|5.2|5.0|Benign/Borderline|5544|111567226|Female|Pituitary|2006
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006
20+|5.0|5.3|5.2|Benign/Borderline|5751|112783993|Female|Pituitary|2007
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007
20+|5.4|5.7|5.6|Benign/Borderline|6237|114027722|Female|Pituitary|2008
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008
20+|5.9|6.2|6.1|Benign/Borderline|6887|115293599|Female|Pituitary|2009
20+|0.0|0.0|0.0|Malignant|18|115293599|Female|Pituitary|2009
20+|5.9|6.2|6.1|Benign/Borderline|6953|116602141|Female|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|18|116602141|Female|Pituitary|2010
20+|6.1|6.4|6.2|Benign/Borderline|7184|117837363|Female|Pituitary|2011
20+|~|~|~|Malignant|~|117837363|Female|Pituitary|2011
20+|6.5|6.8|6.7|Benign/Borderline|7763|119040975|Female|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|16|119040975|Female|Pituitary|2012
20+|6.4|6.7|6.5|Benign/Borderline|7723|120141498|Female|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|17|120141498|Female|Pituitary|2013
20+|6.7|7.0|6.8|Benign/Borderline|8021|121280256|Female|Pituitary|2014
20+|~|~|~|Malignant|~|121280256|Female|Pituitary|2014
20+|7.0|7.3|7.2|Benign/Borderline|8505|122363537|Female|Pituitary|2015
20+|~|~|~|Malignant|~|122363537|Female|Pituitary|2015
20+|7.1|7.4|7.3|Benign/Borderline|8751|123423539|Female|Pituitary|2016
20+|0.0|0.0|0.0|Malignant|17|123423539|Female|Pituitary|2016
20+|7.5|7.8|7.7|Benign/Borderline|9319|124394893|Female|Pituitary|2017
20+|~|~|~|Malignant|~|124394893|Female|Pituitary|2017
20+|7.6|7.9|7.8|Benign/Borderline|9491|125266771|Female|Pituitary|2018
20+|0.0|0.0|0.0|Malignant|16|125266771|Female|Pituitary|2018
20+|7.7|8.0|7.9|Benign/Borderline|9723|126086679|Female|Pituitary|2019
20+|0.0|0.0|0.0|Malignant|19|126086679|Female|Pituitary|2019
20+|7.4|7.6|7.5|Benign/Borderline|46783|639008149|Female|Pituitary|2019-2023
20+|0.2|0.2|0.2|Malignant|1384|639008149|Female|Pituitary|2019-2023
20+|6.8|7.1|6.9|Benign/Borderline|8577|126845517|Female|Pituitary|2020
20+|0.0|0.0|0.0|Malignant|33|126845517|Female|Pituitary|2020
20+|7.7|8.0|7.9|Benign/Borderline|9766|127498344|Female|Pituitary|2021
20+|0.0|0.1|0.0|Malignant|53|127498344|Female|Pituitary|2021
20+|7.5|7.8|7.7|Benign/Borderline|9654|128573447|Female|Pituitary|2022
20+|0.1|0.2|0.2|Malignant|201|128573447|Female|Pituitary|2022
20+|7.0|7.3|7.1|Benign/Borderline|9063|130004162|Female|Pituitary|2023
20+|0.8|0.9|0.8|Malignant|1078|130004162|Female|Pituitary|2023
20+|20.2|20.8|20.5|Benign/Borderline|23319|109112165|Female|Total|2004
20+|7.5|7.8|7.6|Malignant|8758|109112165|Female|Total|2004
20+|22.8|23.3|23.1|Benign/Borderline|26645|110320645|Female|Total|2005
20+|7.5|7.9|7.7|Malignant|8953|110320645|Female|Total|2005
20+|24.0|24.6|24.3|Benign/Borderline|28450|111567226|Female|Total|2006
20+|7.5|7.8|7.6|Malignant|9014|111567226|Female|Total|2006
20+|24.8|25.4|25.1|Benign/Borderline|29835|112783993|Female|Total|2007
20+|7.5|7.8|7.6|Malignant|9104|112783993|Female|Total|2007
20+|26.2|26.8|26.5|Benign/Borderline|31964|114027722|Female|Total|2008
20+|7.5|7.8|7.6|Malignant|9263|114027722|Female|Total|2008
20+|28.0|28.6|28.3|Benign/Borderline|34646|115293599|Female|Total|2009
20+|7.4|7.8|7.6|Malignant|9429|115293599|Female|Total|2009
20+|27.4|28.0|27.7|Benign/Borderline|34354|116602141|Female|Total|2010
20+|7.2|7.6|7.4|Malignant|9337|116602141|Female|Total|2010
20+|28.0|28.6|28.3|Benign/Borderline|35460|117837363|Female|Total|2011
20+|7.1|7.4|7.2|Malignant|9236|117837363|Female|Total|2011
20+|29.0|29.6|29.3|Benign/Borderline|37270|119040975|Female|Total|2012
20+|7.2|7.5|7.3|Malignant|9510|119040975|Female|Total|2012
20+|29.2|29.8|29.5|Benign/Borderline|37981|120141498|Female|Total|2013
20+|7.2|7.5|7.4|Malignant|9708|120141498|Female|Total|2013
20+|30.0|30.6|30.3|Benign/Borderline|39658|121280256|Female|Total|2014
20+|7.0|7.3|7.1|Malignant|9593|121280256|Female|Total|2014
20+|31.2|31.8|31.5|Benign/Borderline|41669|122363537|Female|Total|2015
20+|7.2|7.5|7.4|Malignant|9991|122363537|Female|Total|2015
20+|31.7|32.4|32.0|Benign/Borderline|42930|123423539|Female|Total|2016
20+|7.0|7.3|7.2|Malignant|9916|123423539|Female|Total|2016
20+|32.6|33.3|33.0|Benign/Borderline|44807|124394893|Female|Total|2017
20+|7.0|7.3|7.1|Malignant|10011|124394893|Female|Total|2017
20+|33.0|33.7|33.3|Benign/Borderline|45920|125266771|Female|Total|2018
20+|6.8|7.0|6.9|Malignant|9855|125266771|Female|Total|2018
20+|34.2|34.9|34.5|Benign/Borderline|48242|126086679|Female|Total|2019
20+|6.7|7.0|6.8|Malignant|9849|126086679|Female|Total|2019
20+|33.7|34.0|33.8|Benign/Borderline|242293|639008149|Female|Total|2019-2023
20+|6.8|7.0|6.9|Malignant|51248|639008149|Female|Total|2019-2023
20+|30.7|31.3|31.0|Benign/Borderline|43766|126845517|Female|Total|2020
20+|6.7|7.0|6.8|Malignant|10075|126845517|Female|Total|2020
20+|34.3|35.0|34.6|Benign/Borderline|49402|127498344|Female|Total|2021
20+|6.6|6.9|6.8|Malignant|10034|127498344|Female|Total|2021
20+|34.4|35.0|34.7|Benign/Borderline|50340|128573447|Female|Total|2022
20+|6.7|7.0|6.9|Malignant|10320|128573447|Female|Total|2022
20+|33.9|34.5|34.2|Benign/Borderline|50543|130004162|Female|Total|2023
20+|7.1|7.4|7.2|Malignant|10970|130004162|Female|Total|2023
20+|2.3|2.4|2.3|Benign/Borderline|2628|109112165|Female|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004
20+|2.5|2.6|2.5|Benign/Borderline|2892|110320645|Female|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005
20+|2.5|2.7|2.6|Benign/Borderline|3022|111567226|Female|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.7|2.6|Benign/Borderline|3060|112783993|Female|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007
20+|2.6|2.8|2.7|Benign/Borderline|3204|114027722|Female|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|3323|115293599|Female|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009
20+|2.5|2.6|2.6|Benign/Borderline|3155|116602141|Female|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|23|116602141|Female|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|3413|117837363|Female|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|21|117837363|Female|Tumors of Cranial and Spinal Nerves|2011
20+|2.8|2.9|2.9|Benign/Borderline|3642|119040975|Female|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|28|119040975|Female|Tumors of Cranial and Spinal Nerves|2012
20+|2.9|3.1|3.0|Benign/Borderline|3833|120141498|Female|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|25|120141498|Female|Tumors of Cranial and Spinal Nerves|2013
20+|3.0|3.2|3.1|Benign/Borderline|3985|121280256|Female|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|16|121280256|Female|Tumors of Cranial and Spinal Nerves|2014
20+|3.1|3.3|3.2|Benign/Borderline|4169|122363537|Female|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|24|122363537|Female|Tumors of Cranial and Spinal Nerves|2015
20+|3.0|3.2|3.1|Benign/Borderline|4156|123423539|Female|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|29|123423539|Female|Tumors of Cranial and Spinal Nerves|2016
20+|3.0|3.2|3.1|Benign/Borderline|4125|124394893|Female|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|19|124394893|Female|Tumors of Cranial and Spinal Nerves|2017
20+|3.0|3.2|3.1|Benign/Borderline|4209|125266771|Female|Tumors of Cranial and Spinal Nerves|2018
20+|0.0|0.0|0.0|Malignant|16|125266771|Female|Tumors of Cranial and Spinal Nerves|2018
20+|3.0|3.2|3.1|Benign/Borderline|4319|126086679|Female|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|19|126086679|Female|Tumors of Cranial and Spinal Nerves|2019
20+|3.0|3.1|3.0|Benign/Borderline|21262|639008149|Female|Tumors of Cranial and Spinal Nerves|2019-2023
20+|0.0|0.0|0.0|Malignant|115|639008149|Female|Tumors of Cranial and Spinal Nerves|2019-2023
20+|2.6|2.8|2.7|Benign/Borderline|3718|126845517|Female|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|16|126845517|Female|Tumors of Cranial and Spinal Nerves|2020
20+|3.1|3.3|3.2|Benign/Borderline|4550|127498344|Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|29|127498344|Female|Tumors of Cranial and Spinal Nerves|2021
20+|2.9|3.1|3.0|Benign/Borderline|4327|128573447|Female|Tumors of Cranial and Spinal Nerves|2022
20+|0.0|0.0|0.0|Malignant|25|128573447|Female|Tumors of Cranial and Spinal Nerves|2022
20+|2.9|3.1|3.0|Benign/Borderline|4348|130004162|Female|Tumors of Cranial and Spinal Nerves|2023
20+|0.0|0.0|0.0|Malignant|26|130004162|Female|Tumors of Cranial and Spinal Nerves|2023
20+|0.3|0.4|0.4|Benign/Borderline|387|109112165|Female|Tumors of Neuroepthelial Tissue|2004
20+|6.1|6.4|6.2|Malignant|7097|109112165|Female|Tumors of Neuroepthelial Tissue|2004
20+|0.4|0.4|0.4|Benign/Borderline|443|110320645|Female|Tumors of Neuroepthelial Tissue|2005
20+|6.1|6.4|6.2|Malignant|7176|110320645|Female|Tumors of Neuroepthelial Tissue|2005
20+|0.4|0.5|0.5|Benign/Borderline|494|111567226|Female|Tumors of Neuroepthelial Tissue|2006
20+|6.1|6.4|6.2|Malignant|7258|111567226|Female|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.4|Benign/Borderline|491|112783993|Female|Tumors of Neuroepthelial Tissue|2007
20+|6.1|6.4|6.3|Malignant|7429|112783993|Female|Tumors of Neuroepthelial Tissue|2007
20+|0.4|0.5|0.4|Benign/Borderline|496|114027722|Female|Tumors of Neuroepthelial Tissue|2008
20+|6.0|6.3|6.2|Malignant|7449|114027722|Female|Tumors of Neuroepthelial Tissue|2008
20+|0.4|0.5|0.5|Benign/Borderline|519|115293599|Female|Tumors of Neuroepthelial Tissue|2009
20+|6.1|6.4|6.2|Malignant|7663|115293599|Female|Tumors of Neuroepthelial Tissue|2009
20+|0.5|0.5|0.5|Benign/Borderline|558|116602141|Female|Tumors of Neuroepthelial Tissue|2010
20+|6.0|6.2|6.1|Malignant|7629|116602141|Female|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.5|0.5|Benign/Borderline|584|117837363|Female|Tumors of Neuroepthelial Tissue|2011
20+|5.8|6.1|6.0|Malignant|7577|117837363|Female|Tumors of Neuroepthelial Tissue|2011
20+|0.4|0.5|0.5|Benign/Borderline|556|119040975|Female|Tumors of Neuroepthelial Tissue|2012
20+|5.9|6.2|6.1|Malignant|7826|119040975|Female|Tumors of Neuroepthelial Tissue|2012
20+|0.4|0.5|0.5|Benign/Borderline|534|120141498|Female|Tumors of Neuroepthelial Tissue|2013
20+|5.9|6.2|6.1|Malignant|7956|120141498|Female|Tumors of Neuroepthelial Tissue|2013
20+|0.5|0.6|0.5|Benign/Borderline|616|121280256|Female|Tumors of Neuroepthelial Tissue|2014
20+|5.7|5.9|5.8|Malignant|7697|121280256|Female|Tumors of Neuroepthelial Tissue|2014
20+|0.5|0.6|0.5|Benign/Borderline|639|122363537|Female|Tumors of Neuroepthelial Tissue|2015
20+|6.0|6.2|6.1|Malignant|8165|122363537|Female|Tumors of Neuroepthelial Tissue|2015
20+|0.5|0.6|0.5|Benign/Borderline|625|123423539|Female|Tumors of Neuroepthelial Tissue|2016
20+|5.8|6.1|5.9|Malignant|8151|123423539|Female|Tumors of Neuroepthelial Tissue|2016
20+|0.5|0.6|0.5|Benign/Borderline|639|124394893|Female|Tumors of Neuroepthelial Tissue|2017
20+|5.8|6.0|5.9|Malignant|8171|124394893|Female|Tumors of Neuroepthelial Tissue|2017
20+|0.4|0.5|0.5|Benign/Borderline|599|125266771|Female|Tumors of Neuroepthelial Tissue|2018
20+|5.5|5.8|5.7|Malignant|8045|125266771|Female|Tumors of Neuroepthelial Tissue|2018
20+|0.5|0.6|0.5|Benign/Borderline|652|126086679|Female|Tumors of Neuroepthelial Tissue|2019
20+|5.5|5.8|5.6|Malignant|8038|126086679|Female|Tumors of Neuroepthelial Tissue|2019
20+|0.5|0.6|0.5|Benign/Borderline|3318|639008149|Female|Tumors of Neuroepthelial Tissue|2019-2023
20+|5.5|5.6|5.5|Malignant|40651|639008149|Female|Tumors of Neuroepthelial Tissue|2019-2023
20+|0.4|0.5|0.5|Benign/Borderline|606|126845517|Female|Tumors of Neuroepthelial Tissue|2020
20+|5.4|5.7|5.6|Malignant|8122|126845517|Female|Tumors of Neuroepthelial Tissue|2020
20+|0.5|0.6|0.5|Benign/Borderline|649|127498344|Female|Tumors of Neuroepthelial Tissue|2021
20+|5.4|5.6|5.5|Malignant|8107|127498344|Female|Tumors of Neuroepthelial Tissue|2021
20+|0.5|0.6|0.5|Benign/Borderline|635|128573447|Female|Tumors of Neuroepthelial Tissue|2022
20+|5.5|5.7|5.6|Malignant|8336|128573447|Female|Tumors of Neuroepthelial Tissue|2022
20+|0.6|0.7|0.6|Benign/Borderline|776|130004162|Female|Tumors of Neuroepthelial Tissue|2023
20+|5.1|5.4|5.3|Malignant|8048|130004162|Female|Tumors of Neuroepthelial Tissue|2023
20+|4.1|4.3|4.2|Benign/Borderline|4531|109112165|Female|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Tumors of Sellar Region|2004
20+|4.6|4.9|4.8|Benign/Borderline|5213|110320645|Female|Tumors of Sellar Region|2005
20+|0.0|0.0|0.0|Malignant|26|110320645|Female|Tumors of Sellar Region|2005
20+|5.1|5.3|5.2|Benign/Borderline|5752|111567226|Female|Tumors of Sellar Region|2006
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006
20+|5.2|5.5|5.4|Benign/Borderline|5974|112783993|Female|Tumors of Sellar Region|2007
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007
20+|5.6|5.9|5.7|Benign/Borderline|6465|114027722|Female|Tumors of Sellar Region|2008
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008
20+|6.1|6.4|6.3|Benign/Borderline|7121|115293599|Female|Tumors of Sellar Region|2009
20+|0.0|0.0|0.0|Malignant|19|115293599|Female|Tumors of Sellar Region|2009
20+|6.1|6.4|6.3|Benign/Borderline|7198|116602141|Female|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|18|116602141|Female|Tumors of Sellar Region|2010
20+|6.3|6.6|6.4|Benign/Borderline|7406|117837363|Female|Tumors of Sellar Region|2011
20+|~|~|~|Malignant|~|117837363|Female|Tumors of Sellar Region|2011
20+|6.7|7.0|6.9|Benign/Borderline|7992|119040975|Female|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|16|119040975|Female|Tumors of Sellar Region|2012
20+|6.6|6.9|6.7|Benign/Borderline|7972|120141498|Female|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|18|120141498|Female|Tumors of Sellar Region|2013
20+|6.8|7.1|7.0|Benign/Borderline|8251|121280256|Female|Tumors of Sellar Region|2014
20+|0.0|0.0|0.0|Malignant|16|121280256|Female|Tumors of Sellar Region|2014
20+|7.2|7.5|7.3|Benign/Borderline|8749|122363537|Female|Tumors of Sellar Region|2015
20+|0.0|0.0|0.0|Malignant|16|122363537|Female|Tumors of Sellar Region|2015
20+|7.3|7.6|7.5|Benign/Borderline|8985|123423539|Female|Tumors of Sellar Region|2016
20+|0.0|0.0|0.0|Malignant|17|123423539|Female|Tumors of Sellar Region|2016
20+|7.7|8.0|7.9|Benign/Borderline|9573|124394893|Female|Tumors of Sellar Region|2017
20+|~|~|~|Malignant|~|124394893|Female|Tumors of Sellar Region|2017
20+|7.8|8.1|8.0|Benign/Borderline|9741|125266771|Female|Tumors of Sellar Region|2018
20+|0.0|0.0|0.0|Malignant|16|125266771|Female|Tumors of Sellar Region|2018
20+|7.9|8.2|8.1|Benign/Borderline|9968|126086679|Female|Tumors of Sellar Region|2019
20+|0.0|0.0|0.0|Malignant|19|126086679|Female|Tumors of Sellar Region|2019
20+|7.6|7.7|7.7|Benign/Borderline|47974|639008149|Female|Tumors of Sellar Region|2019-2023
20+|0.2|0.2|0.2|Malignant|1385|639008149|Female|Tumors of Sellar Region|2019-2023
20+|7.0|7.3|7.1|Benign/Borderline|8804|126845517|Female|Tumors of Sellar Region|2020
20+|0.0|0.0|0.0|Malignant|33|126845517|Female|Tumors of Sellar Region|2020
20+|7.9|8.2|8.0|Benign/Borderline|9992|127498344|Female|Tumors of Sellar Region|2021
20+|0.0|0.1|0.0|Malignant|54|127498344|Female|Tumors of Sellar Region|2021
20+|7.7|8.0|7.9|Benign/Borderline|9901|128573447|Female|Tumors of Sellar Region|2022
20+|0.1|0.2|0.2|Malignant|201|128573447|Female|Tumors of Sellar Region|2022
20+|7.1|7.4|7.3|Benign/Borderline|9309|130004162|Female|Tumors of Sellar Region|2023
20+|0.8|0.9|0.8|Malignant|1078|130004162|Female|Tumors of Sellar Region|2023
20+|12.6|13.0|12.8|Benign/Borderline|14805|109112165|Female|Tumors of the Meninges|2004
20+|0.2|0.3|0.3|Malignant|300|109112165|Female|Tumors of the Meninges|2004
20+|14.1|14.5|14.3|Benign/Borderline|16893|110320645|Female|Tumors of the Meninges|2005
20+|0.2|0.3|0.3|Malignant|309|110320645|Female|Tumors of the Meninges|2005
20+|14.8|15.2|15.0|Benign/Borderline|18006|111567226|Female|Tumors of the Meninges|2006
20+|0.2|0.3|0.2|Malignant|283|111567226|Female|Tumors of the Meninges|2006
20+|15.4|15.8|15.6|Benign/Borderline|19027|112783993|Female|Tumors of the Meninges|2007
20+|0.2|0.3|0.3|Malignant|308|112783993|Female|Tumors of the Meninges|2007
20+|16.2|16.7|16.5|Benign/Borderline|20428|114027722|Female|Tumors of the Meninges|2008
20+|0.2|0.3|0.2|Malignant|272|114027722|Female|Tumors of the Meninges|2008
20+|17.3|17.8|17.6|Benign/Borderline|22165|115293599|Female|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|241|115293599|Female|Tumors of the Meninges|2009
20+|16.8|17.3|17.1|Benign/Borderline|21889|116602141|Female|Tumors of the Meninges|2010
20+|0.2|0.2|0.2|Malignant|247|116602141|Female|Tumors of the Meninges|2010
20+|17.1|17.5|17.3|Benign/Borderline|22424|117837363|Female|Tumors of the Meninges|2011
20+|0.2|0.2|0.2|Malignant|220|117837363|Female|Tumors of the Meninges|2011
20+|17.5|18.0|17.8|Benign/Borderline|23403|119040975|Female|Tumors of the Meninges|2012
20+|0.2|0.2|0.2|Malignant|249|119040975|Female|Tumors of the Meninges|2012
20+|17.8|18.2|18.0|Benign/Borderline|24041|120141498|Female|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|273|120141498|Female|Tumors of the Meninges|2013
20+|18.2|18.7|18.5|Benign/Borderline|25151|121280256|Female|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|264|121280256|Female|Tumors of the Meninges|2014
20+|19.0|19.5|19.3|Benign/Borderline|26569|122363537|Female|Tumors of the Meninges|2015
20+|0.2|0.2|0.2|Malignant|250|122363537|Female|Tumors of the Meninges|2015
20+|19.6|20.1|19.8|Benign/Borderline|27678|123423539|Female|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|220|123423539|Female|Tumors of the Meninges|2016
20+|20.2|20.7|20.5|Benign/Borderline|29067|124394893|Female|Tumors of the Meninges|2017
20+|0.2|0.2|0.2|Malignant|256|124394893|Female|Tumors of the Meninges|2017
20+|20.5|21.0|20.8|Benign/Borderline|29965|125266771|Female|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|236|125266771|Female|Tumors of the Meninges|2018
20+|21.6|22.1|21.9|Benign/Borderline|32006|126086679|Female|Tumors of the Meninges|2019
20+|0.1|0.2|0.2|Malignant|224|126086679|Female|Tumors of the Meninges|2019
20+|21.5|21.8|21.7|Benign/Borderline|163105|639008149|Female|Tumors of the Meninges|2019-2023
20+|0.2|0.2|0.2|Malignant|1211|639008149|Female|Tumors of the Meninges|2019-2023
20+|19.5|20.0|19.8|Benign/Borderline|29275|126845517|Female|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|238|126845517|Female|Tumors of the Meninges|2020
20+|21.7|22.2|21.9|Benign/Borderline|32954|127498344|Female|Tumors of the Meninges|2021
20+|0.2|0.2|0.2|Malignant|265|127498344|Female|Tumors of the Meninges|2021
20+|22.1|22.5|22.3|Benign/Borderline|34094|128573447|Female|Tumors of the Meninges|2022
20+|0.1|0.2|0.2|Malignant|251|128573447|Female|Tumors of the Meninges|2022
20+|22.1|22.6|22.3|Benign/Borderline|34776|130004162|Female|Tumors of the Meninges|2023
20+|0.1|0.2|0.2|Malignant|233|130004162|Female|Tumors of the Meninges|2023
20+|0.8|0.9|0.8|Benign/Borderline|949|109112165|Female|Unclassified Tumors|2004
20+|0.5|0.6|0.6|Malignant|687|109112165|Female|Unclassified Tumors|2004
20+|0.9|1.1|1.0|Benign/Borderline|1166|110320645|Female|Unclassified Tumors|2005
20+|0.5|0.6|0.6|Malignant|720|110320645|Female|Unclassified Tumors|2005
20+|0.9|1.0|1.0|Benign/Borderline|1138|111567226|Female|Unclassified Tumors|2006
20+|0.5|0.6|0.6|Malignant|728|111567226|Female|Unclassified Tumors|2006
20+|1.0|1.1|1.0|Benign/Borderline|1245|112783993|Female|Unclassified Tumors|2007
20+|0.5|0.5|0.5|Malignant|651|112783993|Female|Unclassified Tumors|2007
20+|1.0|1.2|1.1|Benign/Borderline|1337|114027722|Female|Unclassified Tumors|2008
20+|0.5|0.6|0.6|Malignant|768|114027722|Female|Unclassified Tumors|2008
20+|1.1|1.3|1.2|Benign/Borderline|1472|115293599|Female|Unclassified Tumors|2009
20+|0.5|0.6|0.6|Malignant|791|115293599|Female|Unclassified Tumors|2009
20+|1.2|1.3|1.2|Benign/Borderline|1521|116602141|Female|Unclassified Tumors|2010
20+|0.4|0.5|0.5|Malignant|650|116602141|Female|Unclassified Tumors|2010
20+|1.2|1.4|1.3|Benign/Borderline|1593|117837363|Female|Unclassified Tumors|2011
20+|0.4|0.5|0.5|Malignant|656|117837363|Female|Unclassified Tumors|2011
20+|1.2|1.4|1.3|Benign/Borderline|1641|119040975|Female|Unclassified Tumors|2012
20+|0.4|0.5|0.5|Malignant|658|119040975|Female|Unclassified Tumors|2012
20+|1.2|1.3|1.2|Benign/Borderline|1574|120141498|Female|Unclassified Tumors|2013
20+|0.4|0.5|0.5|Malignant|671|120141498|Female|Unclassified Tumors|2013
20+|1.2|1.3|1.3|Benign/Borderline|1623|121280256|Female|Unclassified Tumors|2014
20+|0.5|0.6|0.5|Malignant|753|121280256|Female|Unclassified Tumors|2014
20+|1.1|1.2|1.2|Benign/Borderline|1508|122363537|Female|Unclassified Tumors|2015
20+|0.5|0.5|0.5|Malignant|750|122363537|Female|Unclassified Tumors|2015
20+|1.0|1.2|1.1|Benign/Borderline|1451|123423539|Female|Unclassified Tumors|2016
20+|0.4|0.5|0.4|Malignant|632|123423539|Female|Unclassified Tumors|2016
20+|1.0|1.1|1.0|Benign/Borderline|1376|124394893|Female|Unclassified Tumors|2017
20+|0.4|0.5|0.5|Malignant|696|124394893|Female|Unclassified Tumors|2017
20+|1.0|1.1|1.0|Benign/Borderline|1384|125266771|Female|Unclassified Tumors|2018
20+|0.4|0.5|0.5|Malignant|699|125266771|Female|Unclassified Tumors|2018
20+|0.9|1.0|0.9|Benign/Borderline|1252|126086679|Female|Unclassified Tumors|2019
20+|0.4|0.5|0.5|Malignant|720|126086679|Female|Unclassified Tumors|2019
20+|0.9|1.0|0.9|Benign/Borderline|6482|639008149|Female|Unclassified Tumors|2019-2023
20+|0.4|0.5|0.5|Malignant|3679|639008149|Female|Unclassified Tumors|2019-2023
20+|0.9|1.0|1.0|Benign/Borderline|1338|126845517|Female|Unclassified Tumors|2020
20+|0.5|0.5|0.5|Malignant|793|126845517|Female|Unclassified Tumors|2020
20+|0.8|0.9|0.9|Benign/Borderline|1224|127498344|Female|Unclassified Tumors|2021
20+|0.4|0.5|0.5|Malignant|739|127498344|Female|Unclassified Tumors|2021
20+|0.9|1.0|1.0|Benign/Borderline|1359|128573447|Female|Unclassified Tumors|2022
20+|0.4|0.5|0.4|Malignant|732|128573447|Female|Unclassified Tumors|2022
20+|0.9|1.0|0.9|Benign/Borderline|1309|130004162|Female|Unclassified Tumors|2023
20+|0.4|0.5|0.4|Malignant|695|130004162|Female|Unclassified Tumors|2023
20+|0.0|0.1|0.0|Benign/Borderline|55|109112165|Female|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Unique astrocytoma variants|2005
20+|0.0|0.1|0.0|Benign/Borderline|53|111567226|Female|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|25|111567226|Female|Unique astrocytoma variants|2006
20+|0.0|0.1|0.1|Benign/Borderline|63|112783993|Female|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Unique astrocytoma variants|2007
20+|0.0|0.1|0.1|Benign/Borderline|62|114027722|Female|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Unique astrocytoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|78|115293599|Female|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|75|116602141|Female|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|21|116602141|Female|Unique astrocytoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|82|117837363|Female|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|31|117837363|Female|Unique astrocytoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|104|119040975|Female|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|32|119040975|Female|Unique astrocytoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|100|120141498|Female|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|30|120141498|Female|Unique astrocytoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|104|121280256|Female|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|39|121280256|Female|Unique astrocytoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|114|122363537|Female|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|24|122363537|Female|Unique astrocytoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|126|123423539|Female|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|37|123423539|Female|Unique astrocytoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|106|124394893|Female|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|31|124394893|Female|Unique astrocytoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|114|125266771|Female|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|34|125266771|Female|Unique astrocytoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|139|126086679|Female|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|29|126086679|Female|Unique astrocytoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|671|639008149|Female|Unique astrocytoma variants|2019-2023
20+|0.0|0.0|0.0|Malignant|149|639008149|Female|Unique astrocytoma variants|2019-2023
20+|0.1|0.1|0.1|Benign/Borderline|111|126845517|Female|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|26|126845517|Female|Unique astrocytoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|137|127498344|Female|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|21|127498344|Female|Unique astrocytoma variants|2021
20+|0.1|0.1|0.1|Benign/Borderline|125|128573447|Female|Unique astrocytoma variants|2022
20+|0.0|0.0|0.0|Malignant|34|128573447|Female|Unique astrocytoma variants|2022
20+|0.1|0.1|0.1|Benign/Borderline|159|130004162|Female|Unique astrocytoma variants|2023
20+|0.0|0.0|0.0|Malignant|39|130004162|Female|Unique astrocytoma variants|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004
20+|~|~|~|Malignant|~|101938779|Male|All other|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005
20+|~|~|~|Malignant|~|103190694|Male|All other|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|All other|2006
20+|~|~|~|Malignant|~|104488268|Male|All other|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007
20+|~|~|~|Malignant|~|105697783|Male|All other|2007
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|All other|2008
20+|~|~|~|Malignant|~|106947980|Male|All other|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009
20+|~|~|~|Malignant|~|108197539|Male|All other|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|All other|2010
20+|0.0|0.0|0.0|Malignant|16|109553360|Male|All other|2010
20+|0.0|0.0|0.0|Benign/Borderline|18|110972854|Male|All other|2011
20+|0.0|0.0|0.0|Malignant|24|110972854|Male|All other|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|All other|2012
20+|0.0|0.0|0.0|Malignant|20|112450239|Male|All other|2012
20+|0.0|0.0|0.0|Benign/Borderline|19|113812534|Male|All other|2013
20+|0.0|0.0|0.0|Malignant|29|113812534|Male|All other|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|All other|2014
20+|0.0|0.0|0.0|Malignant|27|115179072|Male|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|26|116516672|Male|All other|2015
20+|0.0|0.0|0.0|Malignant|26|116516672|Male|All other|2015
20+|0.0|0.1|0.0|Benign/Borderline|49|117786951|Male|All other|2016
20+|0.0|0.0|0.0|Malignant|28|117786951|Male|All other|2016
20+|0.0|0.1|0.0|Benign/Borderline|42|118938116|Male|All other|2017
20+|0.0|0.0|0.0|Malignant|25|118938116|Male|All other|2017
20+|0.0|0.1|0.0|Benign/Borderline|46|119976528|Male|All other|2018
20+|0.2|0.2|0.2|Malignant|224|119976528|Male|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|42|120965571|Male|All other|2019
20+|0.2|0.3|0.3|Malignant|302|120965571|Male|All other|2019
20+|0.0|0.1|0.1|Benign/Borderline|309|613244056|Male|All other|2019-2023
20+|0.3|0.3|0.3|Malignant|1650|613244056|Male|All other|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|41|121845574|Male|All other|2020
20+|0.2|0.3|0.3|Malignant|314|121845574|Male|All other|2020
20+|0.0|0.1|0.1|Benign/Borderline|61|122388572|Male|All other|2021
20+|0.2|0.3|0.2|Malignant|273|122388572|Male|All other|2021
20+|0.0|0.1|0.0|Benign/Borderline|59|123330454|Male|All other|2022
20+|0.2|0.3|0.2|Malignant|298|123330454|Male|All other|2022
20+|0.1|0.1|0.1|Benign/Borderline|106|124713885|Male|All other|2023
20+|0.3|0.4|0.4|Malignant|463|124713885|Male|All other|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004
20+|0.6|0.7|0.7|Malignant|677|101938779|Male|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005
20+|0.6|0.7|0.7|Malignant|699|103190694|Male|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006
20+|0.6|0.7|0.7|Malignant|703|104488268|Male|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007
20+|0.6|0.7|0.6|Malignant|673|105697783|Male|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008
20+|0.6|0.7|0.7|Malignant|709|106947980|Male|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009
20+|0.6|0.7|0.7|Malignant|717|108197539|Male|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Anaplastic astrocytoma|2010
20+|0.6|0.7|0.7|Malignant|713|109553360|Male|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Anaplastic astrocytoma|2011
20+|0.6|0.7|0.6|Malignant|712|110972854|Male|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Anaplastic astrocytoma|2012
20+|0.6|0.7|0.7|Malignant|747|112450239|Male|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Anaplastic astrocytoma|2013
20+|0.7|0.8|0.7|Malignant|805|113812534|Male|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Anaplastic astrocytoma|2014
20+|0.6|0.7|0.7|Malignant|800|115179072|Male|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Anaplastic astrocytoma|2015
20+|0.6|0.7|0.7|Malignant|784|116516672|Male|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Anaplastic astrocytoma|2016
20+|0.7|0.7|0.7|Malignant|844|117786951|Male|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Anaplastic astrocytoma|2017
20+|0.6|0.7|0.7|Malignant|796|118938116|Male|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Anaplastic astrocytoma|2018
20+|0.6|0.7|0.7|Malignant|819|119976528|Male|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Anaplastic astrocytoma|2019
20+|0.5|0.6|0.6|Malignant|731|120965571|Male|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Anaplastic astrocytoma|2019-2023
20+|0.4|0.4|0.4|Malignant|2490|613244056|Male|Anaplastic astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Anaplastic astrocytoma|2020
20+|0.5|0.6|0.5|Malignant|663|121845574|Male|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Anaplastic astrocytoma|2021
20+|0.4|0.4|0.4|Malignant|473|122388572|Male|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Anaplastic astrocytoma|2022
20+|0.2|0.3|0.3|Malignant|307|123330454|Male|Anaplastic astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Anaplastic astrocytoma|2023
20+|0.2|0.3|0.3|Malignant|316|124713885|Male|Anaplastic astrocytoma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004
20+|0.2|0.2|0.2|Malignant|215|101938779|Male|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005
20+|0.2|0.2|0.2|Malignant|215|103190694|Male|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006
20+|0.2|0.2|0.2|Malignant|217|104488268|Male|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007
20+|0.2|0.2|0.2|Malignant|190|105697783|Male|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008
20+|0.2|0.2|0.2|Malignant|194|106947980|Male|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009
20+|0.2|0.2|0.2|Malignant|192|108197539|Male|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Anaplastic oligodendroglioma|2010
20+|0.2|0.2|0.2|Malignant|194|109553360|Male|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.2|Malignant|191|110972854|Male|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.2|Malignant|192|112450239|Male|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Anaplastic oligodendroglioma|2013
20+|0.2|0.2|0.2|Malignant|225|113812534|Male|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Anaplastic oligodendroglioma|2014
20+|0.2|0.2|0.2|Malignant|209|115179072|Male|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.2|Malignant|194|116516672|Male|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Anaplastic oligodendroglioma|2016
20+|0.2|0.2|0.2|Malignant|203|117786951|Male|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Anaplastic oligodendroglioma|2017
20+|0.2|0.2|0.2|Malignant|239|118938116|Male|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Anaplastic oligodendroglioma|2018
20+|0.1|0.2|0.2|Malignant|187|119976528|Male|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Anaplastic oligodendroglioma|2019
20+|0.2|0.2|0.2|Malignant|224|120965571|Male|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Anaplastic oligodendroglioma|2019-2023
20+|0.1|0.1|0.1|Malignant|831|613244056|Male|Anaplastic oligodendroglioma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Anaplastic oligodendroglioma|2020
20+|0.1|0.2|0.2|Malignant|199|121845574|Male|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Anaplastic oligodendroglioma|2021
20+|0.1|0.2|0.1|Malignant|164|122388572|Male|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Anaplastic oligodendroglioma|2022
20+|0.1|0.1|0.1|Malignant|97|123330454|Male|Anaplastic oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Anaplastic oligodendroglioma|2023
20+|0.1|0.1|0.1|Malignant|147|124713885|Male|Anaplastic oligodendroglioma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004
20+|0.6|0.7|0.6|Malignant|635|101938779|Male|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005
20+|0.6|0.7|0.6|Malignant|636|103190694|Male|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006
20+|0.6|0.7|0.6|Malignant|645|104488268|Male|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007
20+|0.6|0.7|0.6|Malignant|628|105697783|Male|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008
20+|0.6|0.6|0.6|Malignant|633|106947980|Male|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009
20+|0.5|0.6|0.5|Malignant|579|108197539|Male|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Astrocytoma, NOS|2010
20+|0.5|0.6|0.6|Malignant|626|109553360|Male|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Astrocytoma, NOS|2011
20+|0.5|0.6|0.5|Malignant|592|110972854|Male|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Astrocytoma, NOS|2012
20+|0.5|0.5|0.5|Malignant|564|112450239|Male|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Astrocytoma, NOS|2013
20+|0.5|0.6|0.5|Malignant|575|113812534|Male|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Astrocytoma, NOS|2014
20+|0.5|0.6|0.5|Malignant|610|115179072|Male|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Astrocytoma, NOS|2015
20+|0.6|0.7|0.6|Malignant|706|116516672|Male|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Astrocytoma, NOS|2016
20+|0.6|0.6|0.6|Malignant|715|117786951|Male|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Astrocytoma, NOS|2017
20+|0.6|0.6|0.6|Malignant|711|118938116|Male|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Astrocytoma, NOS|2018
20+|0.6|0.7|0.6|Malignant|725|119976528|Male|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Astrocytoma, NOS|2019
20+|0.6|0.6|0.6|Malignant|723|120965571|Male|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Astrocytoma, NOS|2019-2023
20+|0.6|0.7|0.7|Malignant|3949|613244056|Male|Astrocytoma, NOS|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Astrocytoma, NOS|2020
20+|0.5|0.6|0.6|Malignant|723|121845574|Male|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Astrocytoma, NOS|2021
20+|0.7|0.8|0.7|Malignant|876|122388572|Male|Astrocytoma, NOS|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Astrocytoma, NOS|2022
20+|0.7|0.8|0.7|Malignant|888|123330454|Male|Astrocytoma, NOS|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Astrocytoma, NOS|2023
20+|0.6|0.7|0.6|Malignant|739|124713885|Male|Astrocytoma, NOS|2023
20+|0.0|0.0|0.0|Benign/Borderline|26|101938779|Male|Choroid plexus|2004
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006
20+|0.0|0.0|0.0|Benign/Borderline|36|105697783|Male|Choroid plexus|2007
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007
20+|0.0|0.0|0.0|Benign/Borderline|29|106947980|Male|Choroid plexus|2008
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008
20+|0.0|0.0|0.0|Benign/Borderline|30|108197539|Male|Choroid plexus|2009
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009
20+|0.0|0.0|0.0|Benign/Borderline|36|109553360|Male|Choroid plexus|2010
20+|~|~|~|Malignant|~|109553360|Male|Choroid plexus|2010
20+|0.0|0.0|0.0|Benign/Borderline|32|110972854|Male|Choroid plexus|2011
20+|~|~|~|Malignant|~|110972854|Male|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|36|112450239|Male|Choroid plexus|2012
20+|~|~|~|Malignant|~|112450239|Male|Choroid plexus|2012
20+|0.0|0.0|0.0|Benign/Borderline|31|113812534|Male|Choroid plexus|2013
20+|~|~|~|Malignant|~|113812534|Male|Choroid plexus|2013
20+|0.0|0.0|0.0|Benign/Borderline|42|115179072|Male|Choroid plexus|2014
20+|~|~|~|Malignant|~|115179072|Male|Choroid plexus|2014
20+|0.0|0.0|0.0|Benign/Borderline|38|116516672|Male|Choroid plexus|2015
20+|~|~|~|Malignant|~|116516672|Male|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|31|117786951|Male|Choroid plexus|2016
20+|~|~|~|Malignant|~|117786951|Male|Choroid plexus|2016
20+|0.0|0.1|0.0|Benign/Borderline|55|118938116|Male|Choroid plexus|2017
20+|~|~|~|Malignant|~|118938116|Male|Choroid plexus|2017
20+|0.0|0.0|0.0|Benign/Borderline|25|119976528|Male|Choroid plexus|2018
20+|~|~|~|Malignant|~|119976528|Male|Choroid plexus|2018
20+|0.0|0.0|0.0|Benign/Borderline|33|120965571|Male|Choroid plexus|2019
20+|~|~|~|Malignant|~|120965571|Male|Choroid plexus|2019
20+|0.0|0.0|0.0|Benign/Borderline|163|613244056|Male|Choroid plexus|2019-2023
20+|0.0|0.0|0.0|Malignant|21|613244056|Male|Choroid plexus|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|27|121845574|Male|Choroid plexus|2020
20+|~|~|~|Malignant|~|121845574|Male|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|38|122388572|Male|Choroid plexus|2021
20+|~|~|~|Malignant|~|122388572|Male|Choroid plexus|2021
20+|0.0|0.0|0.0|Benign/Borderline|30|123330454|Male|Choroid plexus|2022
20+|~|~|~|Malignant|~|123330454|Male|Choroid plexus|2022
20+|0.0|0.0|0.0|Benign/Borderline|35|124713885|Male|Choroid plexus|2023
20+|~|~|~|Malignant|~|124713885|Male|Choroid plexus|2023
20+|0.2|0.2|0.2|Benign/Borderline|188|101938779|Male|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004
20+|0.2|0.3|0.2|Benign/Borderline|237|103190694|Male|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|195|104488268|Male|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|202|105697783|Male|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|202|106947980|Male|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|202|108197539|Male|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|203|109553360|Male|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|109553360|Male|Craniopharyngioma|2010
20+|0.2|0.2|0.2|Benign/Borderline|201|110972854|Male|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|110972854|Male|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|220|112450239|Male|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|112450239|Male|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|237|113812534|Male|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|113812534|Male|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|217|115179072|Male|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|115179072|Male|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|230|116516672|Male|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|116516672|Male|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|249|117786951|Male|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|117786951|Male|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|252|118938116|Male|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|118938116|Male|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|232|119976528|Male|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|119976528|Male|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|256|120965571|Male|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|120965571|Male|Craniopharyngioma|2019
20+|0.2|0.2|0.2|Benign/Borderline|1241|613244056|Male|Craniopharyngioma|2019-2023
20+|~|~|~|Malignant|~|613244056|Male|Craniopharyngioma|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|245|121845574|Male|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|121845574|Male|Craniopharyngioma|2020
20+|0.2|0.2|0.2|Benign/Borderline|237|122388572|Male|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|122388572|Male|Craniopharyngioma|2021
20+|0.2|0.2|0.2|Benign/Borderline|260|123330454|Male|Craniopharyngioma|2022
20+|~|~|~|Malignant|~|123330454|Male|Craniopharyngioma|2022
20+|0.2|0.2|0.2|Benign/Borderline|243|124713885|Male|Craniopharyngioma|2023
20+|~|~|~|Malignant|~|124713885|Male|Craniopharyngioma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004
20+|0.1|0.2|0.1|Malignant|146|101938779|Male|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|148|103190694|Male|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008
20+|0.2|0.2|0.2|Malignant|210|106947980|Male|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Diffuse astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|187|109553360|Male|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|136|110972854|Male|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|113|112450239|Male|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Diffuse astrocytoma|2013
20+|0.1|0.1|0.1|Malignant|104|113812534|Male|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Diffuse astrocytoma|2014
20+|0.0|0.1|0.1|Malignant|69|115179072|Male|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Diffuse astrocytoma|2015
20+|0.0|0.1|0.0|Malignant|49|116516672|Male|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Diffuse astrocytoma|2016
20+|0.0|0.0|0.0|Malignant|23|117786951|Male|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Diffuse astrocytoma|2017
20+|~|~|~|Malignant|~|118938116|Male|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Diffuse astrocytoma|2018
20+|~|~|~|Malignant|~|119976528|Male|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|120965571|Male|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Diffuse astrocytoma|2019-2023
20+|0.0|0.0|0.0|Malignant|16|613244056|Male|Diffuse astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|121845574|Male|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|122388572|Male|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Diffuse astrocytoma|2022
20+|~|~|~|Malignant|~|123330454|Male|Diffuse astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Diffuse astrocytoma|2023
20+|~|~|~|Malignant|~|124713885|Male|Diffuse astrocytoma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|96|101938779|Male|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|106|103190694|Male|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|124|106947980|Male|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|132|108197539|Male|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|126|109553360|Male|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Embryonal/primitive/medulloblastoma|2011
20+|0.1|0.1|0.1|Malignant|115|110972854|Male|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|93|112450239|Male|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|98|113812534|Male|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|108|115179072|Male|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Embryonal/primitive/medulloblastoma|2015
20+|0.1|0.1|0.1|Malignant|102|116516672|Male|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Embryonal/primitive/medulloblastoma|2016
20+|0.1|0.1|0.1|Malignant|119|117786951|Male|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Embryonal/primitive/medulloblastoma|2017
20+|0.1|0.1|0.1|Malignant|98|118938116|Male|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Embryonal/primitive/medulloblastoma|2018
20+|0.1|0.1|0.1|Malignant|87|119976528|Male|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Embryonal/primitive/medulloblastoma|2019
20+|0.1|0.1|0.1|Malignant|81|120965571|Male|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Embryonal/primitive/medulloblastoma|2019-2023
20+|0.1|0.1|0.1|Malignant|383|613244056|Male|Embryonal/primitive/medulloblastoma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|67|121845574|Male|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.1|0.1|Malignant|79|122388572|Male|Embryonal/primitive/medulloblastoma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Embryonal/primitive/medulloblastoma|2022
20+|0.1|0.1|0.1|Malignant|80|123330454|Male|Embryonal/primitive/medulloblastoma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Embryonal/primitive/medulloblastoma|2023
20+|0.1|0.1|0.1|Malignant|76|124713885|Male|Embryonal/primitive/medulloblastoma|2023
20+|0.1|0.2|0.1|Benign/Borderline|142|101938779|Male|Ependymoma variants|2004
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004
20+|0.1|0.2|0.1|Benign/Borderline|151|103190694|Male|Ependymoma variants|2005
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005
20+|0.1|0.2|0.2|Benign/Borderline|163|104488268|Male|Ependymoma variants|2006
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|137|105697783|Male|Ependymoma variants|2007
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007
20+|0.1|0.2|0.1|Benign/Borderline|146|106947980|Male|Ependymoma variants|2008
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008
20+|0.1|0.2|0.1|Benign/Borderline|150|108197539|Male|Ependymoma variants|2009
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009
20+|0.1|0.2|0.1|Benign/Borderline|156|109553360|Male|Ependymoma variants|2010
20+|~|~|~|Malignant|~|109553360|Male|Ependymoma variants|2010
20+|0.1|0.2|0.1|Benign/Borderline|151|110972854|Male|Ependymoma variants|2011
20+|~|~|~|Malignant|~|110972854|Male|Ependymoma variants|2011
20+|0.1|0.2|0.1|Benign/Borderline|166|112450239|Male|Ependymoma variants|2012
20+|~|~|~|Malignant|~|112450239|Male|Ependymoma variants|2012
20+|0.1|0.2|0.1|Benign/Borderline|162|113812534|Male|Ependymoma variants|2013
20+|~|~|~|Malignant|~|113812534|Male|Ependymoma variants|2013
20+|0.1|0.2|0.2|Benign/Borderline|171|115179072|Male|Ependymoma variants|2014
20+|~|~|~|Malignant|~|115179072|Male|Ependymoma variants|2014
20+|0.1|0.2|0.1|Benign/Borderline|161|116516672|Male|Ependymoma variants|2015
20+|~|~|~|Malignant|~|116516672|Male|Ependymoma variants|2015
20+|0.1|0.2|0.2|Benign/Borderline|175|117786951|Male|Ependymoma variants|2016
20+|~|~|~|Malignant|~|117786951|Male|Ependymoma variants|2016
20+|0.1|0.2|0.1|Benign/Borderline|165|118938116|Male|Ependymoma variants|2017
20+|~|~|~|Malignant|~|118938116|Male|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|144|119976528|Male|Ependymoma variants|2018
20+|~|~|~|Malignant|~|119976528|Male|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|143|120965571|Male|Ependymoma variants|2019
20+|~|~|~|Malignant|~|120965571|Male|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|796|613244056|Male|Ependymoma variants|2019-2023
20+|~|~|~|Malignant|~|613244056|Male|Ependymoma variants|2019-2023
20+|0.1|0.1|0.1|Benign/Borderline|144|121845574|Male|Ependymoma variants|2020
20+|~|~|~|Malignant|~|121845574|Male|Ependymoma variants|2020
20+|0.1|0.2|0.1|Benign/Borderline|154|122388572|Male|Ependymoma variants|2021
20+|~|~|~|Malignant|~|122388572|Male|Ependymoma variants|2021
20+|0.1|0.2|0.2|Benign/Borderline|184|123330454|Male|Ependymoma variants|2022
20+|~|~|~|Malignant|~|123330454|Male|Ependymoma variants|2022
20+|0.1|0.2|0.1|Benign/Borderline|171|124713885|Male|Ependymoma variants|2023
20+|~|~|~|Malignant|~|124713885|Male|Ependymoma variants|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004
20+|0.3|0.3|0.3|Malignant|306|101938779|Male|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005
20+|0.3|0.3|0.3|Malignant|302|103190694|Male|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|292|104488268|Male|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|289|105697783|Male|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008
20+|0.3|0.3|0.3|Malignant|324|106947980|Male|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|339|108197539|Male|Ependymoma/anaplastic ependymoma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Ependymoma/anaplastic ependymoma|2010
20+|0.3|0.3|0.3|Malignant|333|109553360|Male|Ependymoma/anaplastic ependymoma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|298|110972854|Male|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Ependymoma/anaplastic ependymoma|2012
20+|0.3|0.3|0.3|Malignant|329|112450239|Male|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.3|Malignant|310|113812534|Male|Ependymoma/anaplastic ependymoma|2013
20+|0.0|0.0|0.0|Benign/Borderline|22|115179072|Male|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.3|0.3|Malignant|323|115179072|Male|Ependymoma/anaplastic ependymoma|2014
20+|0.0|0.0|0.0|Benign/Borderline|16|116516672|Male|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.3|Malignant|309|116516672|Male|Ependymoma/anaplastic ependymoma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.3|Malignant|331|117786951|Male|Ependymoma/anaplastic ependymoma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.3|Malignant|312|118938116|Male|Ependymoma/anaplastic ependymoma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.3|0.3|Malignant|318|119976528|Male|Ependymoma/anaplastic ependymoma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.3|0.2|Malignant|284|120965571|Male|Ependymoma/anaplastic ependymoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|53|613244056|Male|Ependymoma/anaplastic ependymoma|2019-2023
20+|0.2|0.2|0.2|Malignant|1355|613244056|Male|Ependymoma/anaplastic ependymoma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.3|0.2|Malignant|281|121845574|Male|Ependymoma/anaplastic ependymoma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|272|122388572|Male|Ependymoma/anaplastic ependymoma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Ependymoma/anaplastic ependymoma|2022
20+|0.2|0.2|0.2|Malignant|263|123330454|Male|Ependymoma/anaplastic ependymoma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Ependymoma/anaplastic ependymoma|2023
20+|0.2|0.2|0.2|Malignant|255|124713885|Male|Ependymoma/anaplastic ependymoma|2023
20+|0.0|0.0|0.0|Benign/Borderline|22|101938779|Male|Germ Cell Tumors|2004
20+|0.0|0.1|0.0|Malignant|41|101938779|Male|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|33|103190694|Male|Germ Cell Tumors|2005
20+|0.0|0.1|0.0|Malignant|54|103190694|Male|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006
20+|0.0|0.1|0.0|Malignant|47|104488268|Male|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Germ Cell Tumors|2007
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|34|106947980|Male|Germ Cell Tumors|2008
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008
20+|0.0|0.1|0.0|Benign/Borderline|39|108197539|Male|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|30|109553360|Male|Germ Cell Tumors|2010
20+|0.0|0.1|0.1|Malignant|57|109553360|Male|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|24|110972854|Male|Germ Cell Tumors|2011
20+|0.0|0.1|0.1|Malignant|60|110972854|Male|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|33|112450239|Male|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Malignant|42|112450239|Male|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|27|113812534|Male|Germ Cell Tumors|2013
20+|0.0|0.1|0.0|Malignant|46|113812534|Male|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|30|115179072|Male|Germ Cell Tumors|2014
20+|0.0|0.1|0.1|Malignant|63|115179072|Male|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|30|116516672|Male|Germ Cell Tumors|2015
20+|0.0|0.1|0.0|Malignant|55|116516672|Male|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|34|117786951|Male|Germ Cell Tumors|2016
20+|0.0|0.1|0.1|Malignant|69|117786951|Male|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|33|118938116|Male|Germ Cell Tumors|2017
20+|0.0|0.1|0.1|Malignant|62|118938116|Male|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|24|119976528|Male|Germ Cell Tumors|2018
20+|0.0|0.1|0.1|Malignant|60|119976528|Male|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|33|120965571|Male|Germ Cell Tumors|2019
20+|0.0|0.1|0.1|Malignant|64|120965571|Male|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|129|613244056|Male|Germ Cell Tumors|2019-2023
20+|0.0|0.1|0.0|Malignant|290|613244056|Male|Germ Cell Tumors|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|26|121845574|Male|Germ Cell Tumors|2020
20+|0.0|0.1|0.0|Malignant|46|121845574|Male|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|20|122388572|Male|Germ Cell Tumors|2021
20+|0.0|0.1|0.1|Malignant|68|122388572|Male|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Benign/Borderline|24|123330454|Male|Germ Cell Tumors|2022
20+|0.0|0.1|0.0|Malignant|53|123330454|Male|Germ Cell Tumors|2022
20+|0.0|0.0|0.0|Benign/Borderline|26|124713885|Male|Germ Cell Tumors|2023
20+|0.0|0.1|0.0|Malignant|59|124713885|Male|Germ Cell Tumors|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004
20+|5.5|5.8|5.6|Malignant|5485|101938779|Male|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005
20+|5.5|5.8|5.6|Malignant|5552|103190694|Male|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006
20+|5.3|5.6|5.4|Malignant|5506|104488268|Male|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007
20+|5.5|5.7|5.6|Malignant|5825|105697783|Male|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008
20+|5.5|5.8|5.7|Malignant|6025|106947980|Male|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009
20+|5.4|5.7|5.6|Malignant|6016|108197539|Male|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Glioblastoma|2010
20+|5.4|5.7|5.5|Malignant|6131|109553360|Male|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Glioblastoma|2011
20+|5.4|5.7|5.5|Malignant|6310|110972854|Male|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Glioblastoma|2012
20+|5.4|5.7|5.6|Malignant|6515|112450239|Male|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Glioblastoma|2013
20+|5.4|5.7|5.6|Malignant|6643|113812534|Male|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Glioblastoma|2014
20+|5.5|5.7|5.6|Malignant|6815|115179072|Male|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Glioblastoma|2015
20+|5.4|5.7|5.6|Malignant|6923|116516672|Male|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Glioblastoma|2016
20+|5.5|5.8|5.7|Malignant|7225|117786951|Male|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Glioblastoma|2017
20+|5.6|5.8|5.7|Malignant|7384|118938116|Male|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Glioblastoma|2018
20+|5.5|5.8|5.6|Malignant|7474|119976528|Male|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Glioblastoma|2019
20+|5.5|5.8|5.6|Malignant|7595|120965571|Male|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Glioblastoma|2019-2023
20+|5.4|5.5|5.5|Malignant|38395|613244056|Male|Glioblastoma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Glioblastoma|2020
20+|5.4|5.7|5.6|Malignant|7677|121845574|Male|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Glioblastoma|2021
20+|5.4|5.6|5.5|Malignant|7674|122388572|Male|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Glioblastoma|2022
20+|5.3|5.5|5.4|Malignant|7735|123330454|Male|Glioblastoma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Glioblastoma|2023
20+|5.2|5.4|5.3|Malignant|7714|124713885|Male|Glioblastoma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004
20+|0.4|0.5|0.4|Malignant|427|101938779|Male|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005
20+|0.4|0.5|0.5|Malignant|445|103190694|Male|Glioma malignant, NOS|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006
20+|0.4|0.5|0.4|Malignant|443|104488268|Male|Glioma malignant, NOS|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007
20+|0.4|0.5|0.5|Malignant|461|105697783|Male|Glioma malignant, NOS|2007
20+|0.0|0.0|0.0|Benign/Borderline|18|106947980|Male|Glioma malignant, NOS|2008
20+|0.4|0.5|0.5|Malignant|483|106947980|Male|Glioma malignant, NOS|2008
20+|0.0|0.0|0.0|Benign/Borderline|16|108197539|Male|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|465|108197539|Male|Glioma malignant, NOS|2009
20+|0.0|0.0|0.0|Benign/Borderline|16|109553360|Male|Glioma malignant, NOS|2010
20+|0.4|0.4|0.4|Malignant|407|109553360|Male|Glioma malignant, NOS|2010
20+|0.0|0.0|0.0|Benign/Borderline|17|110972854|Male|Glioma malignant, NOS|2011
20+|0.4|0.5|0.5|Malignant|502|110972854|Male|Glioma malignant, NOS|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Glioma malignant, NOS|2012
20+|0.4|0.5|0.4|Malignant|485|112450239|Male|Glioma malignant, NOS|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Glioma malignant, NOS|2013
20+|0.4|0.5|0.4|Malignant|472|113812534|Male|Glioma malignant, NOS|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Glioma malignant, NOS|2014
20+|0.4|0.5|0.5|Malignant|507|115179072|Male|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|22|116516672|Male|Glioma malignant, NOS|2015
20+|0.4|0.5|0.4|Malignant|483|116516672|Male|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|30|117786951|Male|Glioma malignant, NOS|2016
20+|0.4|0.5|0.5|Malignant|545|117786951|Male|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|19|118938116|Male|Glioma malignant, NOS|2017
20+|0.5|0.6|0.5|Malignant|613|118938116|Male|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|25|119976528|Male|Glioma malignant, NOS|2018
20+|0.4|0.5|0.5|Malignant|579|119976528|Male|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|24|120965571|Male|Glioma malignant, NOS|2019
20+|0.4|0.5|0.5|Malignant|558|120965571|Male|Glioma malignant, NOS|2019
20+|0.0|0.0|0.0|Benign/Borderline|124|613244056|Male|Glioma malignant, NOS|2019-2023
20+|0.5|0.5|0.5|Malignant|3124|613244056|Male|Glioma malignant, NOS|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Glioma malignant, NOS|2020
20+|0.4|0.5|0.5|Malignant|572|121845574|Male|Glioma malignant, NOS|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Glioma malignant, NOS|2021
20+|0.4|0.5|0.5|Malignant|592|122388572|Male|Glioma malignant, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|38|123330454|Male|Glioma malignant, NOS|2022
20+|0.5|0.6|0.6|Malignant|710|123330454|Male|Glioma malignant, NOS|2022
20+|0.0|0.0|0.0|Benign/Borderline|34|124713885|Male|Glioma malignant, NOS|2023
20+|0.5|0.6|0.5|Malignant|692|124713885|Male|Glioma malignant, NOS|2023
20+|0.2|0.3|0.2|Benign/Borderline|252|101938779|Male|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004
20+|0.2|0.3|0.3|Benign/Borderline|287|103190694|Male|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005
20+|0.2|0.3|0.3|Benign/Borderline|280|104488268|Male|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006
20+|0.2|0.3|0.2|Benign/Borderline|258|105697783|Male|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007
20+|0.2|0.3|0.3|Benign/Borderline|295|106947980|Male|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008
20+|0.2|0.3|0.3|Benign/Borderline|279|108197539|Male|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009
20+|0.2|0.3|0.3|Benign/Borderline|307|109553360|Male|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|109553360|Male|Hemangioblastoma|2010
20+|0.2|0.3|0.3|Benign/Borderline|283|110972854|Male|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|110972854|Male|Hemangioblastoma|2011
20+|0.2|0.3|0.3|Benign/Borderline|289|112450239|Male|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|112450239|Male|Hemangioblastoma|2012
20+|0.2|0.3|0.2|Benign/Borderline|279|113812534|Male|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|113812534|Male|Hemangioblastoma|2013
20+|0.2|0.3|0.3|Benign/Borderline|284|115179072|Male|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|115179072|Male|Hemangioblastoma|2014
20+|0.2|0.3|0.3|Benign/Borderline|303|116516672|Male|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|116516672|Male|Hemangioblastoma|2015
20+|0.2|0.3|0.2|Benign/Borderline|295|117786951|Male|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|117786951|Male|Hemangioblastoma|2016
20+|0.3|0.3|0.3|Benign/Borderline|342|118938116|Male|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|118938116|Male|Hemangioblastoma|2017
20+|0.2|0.3|0.2|Benign/Borderline|314|119976528|Male|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|119976528|Male|Hemangioblastoma|2018
20+|0.2|0.3|0.2|Benign/Borderline|289|120965571|Male|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|120965571|Male|Hemangioblastoma|2019
20+|0.2|0.3|0.2|Benign/Borderline|1549|613244056|Male|Hemangioblastoma|2019-2023
20+|~|~|~|Malignant|~|613244056|Male|Hemangioblastoma|2019-2023
20+|0.2|0.3|0.3|Benign/Borderline|320|121845574|Male|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|121845574|Male|Hemangioblastoma|2020
20+|0.2|0.3|0.2|Benign/Borderline|304|122388572|Male|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|122388572|Male|Hemangioblastoma|2021
20+|0.2|0.3|0.3|Benign/Borderline|324|123330454|Male|Hemangioblastoma|2022
20+|~|~|~|Malignant|~|123330454|Male|Hemangioblastoma|2022
20+|0.2|0.3|0.2|Benign/Borderline|312|124713885|Male|Hemangioblastoma|2023
20+|~|~|~|Malignant|~|124713885|Male|Hemangioblastoma|2023
20+|0.1|0.2|0.1|Benign/Borderline|145|101938779|Male|Hemangioma|2004
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004
20+|0.2|0.2|0.2|Benign/Borderline|208|103190694|Male|Hemangioma|2005
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005
20+|0.2|0.3|0.2|Benign/Borderline|242|104488268|Male|Hemangioma|2006
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006
20+|0.2|0.3|0.3|Benign/Borderline|275|105697783|Male|Hemangioma|2007
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007
20+|0.3|0.4|0.3|Benign/Borderline|333|106947980|Male|Hemangioma|2008
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008
20+|0.4|0.5|0.4|Benign/Borderline|449|108197539|Male|Hemangioma|2009
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009
20+|0.4|0.5|0.4|Benign/Borderline|459|109553360|Male|Hemangioma|2010
20+|~|~|~|Malignant|~|109553360|Male|Hemangioma|2010
20+|0.4|0.5|0.5|Benign/Borderline|526|110972854|Male|Hemangioma|2011
20+|~|~|~|Malignant|~|110972854|Male|Hemangioma|2011
20+|0.4|0.5|0.5|Benign/Borderline|516|112450239|Male|Hemangioma|2012
20+|~|~|~|Malignant|~|112450239|Male|Hemangioma|2012
20+|0.4|0.5|0.4|Benign/Borderline|523|113812534|Male|Hemangioma|2013
20+|~|~|~|Malignant|~|113812534|Male|Hemangioma|2013
20+|0.4|0.5|0.5|Benign/Borderline|526|115179072|Male|Hemangioma|2014
20+|~|~|~|Malignant|~|115179072|Male|Hemangioma|2014
20+|0.4|0.5|0.4|Benign/Borderline|484|116516672|Male|Hemangioma|2015
20+|~|~|~|Malignant|~|116516672|Male|Hemangioma|2015
20+|0.3|0.4|0.4|Benign/Borderline|440|117786951|Male|Hemangioma|2016
20+|~|~|~|Malignant|~|117786951|Male|Hemangioma|2016
20+|0.4|0.4|0.4|Benign/Borderline|468|118938116|Male|Hemangioma|2017
20+|~|~|~|Malignant|~|118938116|Male|Hemangioma|2017
20+|0.4|0.4|0.4|Benign/Borderline|490|119976528|Male|Hemangioma|2018
20+|~|~|~|Malignant|~|119976528|Male|Hemangioma|2018
20+|0.4|0.4|0.4|Benign/Borderline|512|120965571|Male|Hemangioma|2019
20+|~|~|~|Malignant|~|120965571|Male|Hemangioma|2019
20+|0.4|0.4|0.4|Benign/Borderline|2515|613244056|Male|Hemangioma|2019-2023
20+|~|~|~|Malignant|~|613244056|Male|Hemangioma|2019-2023
20+|0.3|0.4|0.4|Benign/Borderline|481|121845574|Male|Hemangioma|2020
20+|~|~|~|Malignant|~|121845574|Male|Hemangioma|2020
20+|0.4|0.4|0.4|Benign/Borderline|502|122388572|Male|Hemangioma|2021
20+|~|~|~|Malignant|~|122388572|Male|Hemangioma|2021
20+|0.3|0.4|0.4|Benign/Borderline|462|123330454|Male|Hemangioma|2022
20+|~|~|~|Malignant|~|123330454|Male|Hemangioma|2022
20+|0.4|0.5|0.4|Benign/Borderline|558|124713885|Male|Hemangioma|2023
20+|~|~|~|Malignant|~|124713885|Male|Hemangioma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|25|101938779|Male|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|23|103190694|Male|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|36|104488268|Male|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|31|106947980|Male|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|30|108197539|Male|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|31|109553360|Male|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|23|110972854|Male|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|27|112450239|Male|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|29|113812534|Male|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|24|115179072|Male|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|23|116516672|Male|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Local Extensions from Regional Tumors|2016
20+|0.0|0.0|0.0|Malignant|26|117786951|Male|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Local Extensions from Regional Tumors|2017
20+|0.0|0.0|0.0|Malignant|25|118938116|Male|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Local Extensions from Regional Tumors|2018
20+|0.0|0.0|0.0|Malignant|18|119976528|Male|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Local Extensions from Regional Tumors|2019
20+|0.0|0.0|0.0|Malignant|20|120965571|Male|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Local Extensions from Regional Tumors|2019-2023
20+|0.0|0.0|0.0|Malignant|86|613244056|Male|Local Extensions from Regional Tumors|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Local Extensions from Regional Tumors|2020
20+|0.0|0.0|0.0|Malignant|16|121845574|Male|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Local Extensions from Regional Tumors|2021
20+|0.0|0.0|0.0|Malignant|19|122388572|Male|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Local Extensions from Regional Tumors|2022
20+|~|~|~|Malignant|~|123330454|Male|Local Extensions from Regional Tumors|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Local Extensions from Regional Tumors|2023
20+|0.0|0.0|0.0|Malignant|20|124713885|Male|Local Extensions from Regional Tumors|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.7|0.8|0.8|Malignant|749|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.7|0.8|0.8|Malignant|775|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.7|0.8|0.8|Malignant|761|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.7|0.8|0.7|Malignant|733|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.7|0.8|0.8|Malignant|772|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.7|0.8|0.7|Malignant|751|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.6|0.7|0.7|Malignant|757|109553360|Male|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.7|0.8|0.7|Malignant|806|110972854|Male|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.6|0.7|0.7|Malignant|752|112450239|Male|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.6|0.7|0.6|Malignant|728|113812534|Male|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.7|0.7|Malignant|822|115179072|Male|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.6|0.7|0.7|Malignant|828|116516672|Male|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.6|0.7|0.7|Malignant|831|117786951|Male|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.7|0.8|0.7|Malignant|887|118938116|Male|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.6|0.7|0.7|Malignant|861|119976528|Male|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.6|0.7|0.6|Malignant|853|120965571|Male|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Lymphomas and Hematopoietic Neoplasms|2019-2023
20+|0.6|0.6|0.6|Malignant|4224|613244056|Male|Lymphomas and Hematopoietic Neoplasms|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.6|0.7|0.6|Malignant|849|121845574|Male|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.6|0.7|0.6|Malignant|850|122388572|Male|Lymphomas and Hematopoietic Neoplasms|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Lymphomas and Hematopoietic Neoplasms|2022
20+|0.6|0.7|0.6|Malignant|855|123330454|Male|Lymphomas and Hematopoietic Neoplasms|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Lymphomas and Hematopoietic Neoplasms|2023
20+|0.5|0.6|0.6|Malignant|817|124713885|Male|Lymphomas and Hematopoietic Neoplasms|2023
20+|5.1|5.4|5.3|Benign/Borderline|4979|101938779|Male|Meningioma|2004
20+|0.2|0.2|0.2|Malignant|175|101938779|Male|Meningioma|2004
20+|5.7|6.0|5.8|Benign/Borderline|5553|103190694|Male|Meningioma|2005
20+|0.1|0.2|0.2|Malignant|153|103190694|Male|Meningioma|2005
20+|6.0|6.3|6.1|Benign/Borderline|5958|104488268|Male|Meningioma|2006
20+|0.1|0.2|0.2|Malignant|156|104488268|Male|Meningioma|2006
20+|6.1|6.4|6.3|Benign/Borderline|6236|105697783|Male|Meningioma|2007
20+|0.1|0.2|0.2|Malignant|176|105697783|Male|Meningioma|2007
20+|6.6|6.9|6.8|Benign/Borderline|6879|106947980|Male|Meningioma|2008
20+|0.1|0.2|0.1|Malignant|150|106947980|Male|Meningioma|2008
20+|7.0|7.4|7.2|Benign/Borderline|7394|108197539|Male|Meningioma|2009
20+|0.1|0.2|0.1|Malignant|151|108197539|Male|Meningioma|2009
20+|6.9|7.3|7.1|Benign/Borderline|7459|109553360|Male|Meningioma|2010
20+|0.1|0.1|0.1|Malignant|124|109553360|Male|Meningioma|2010
20+|7.0|7.3|7.2|Benign/Borderline|7717|110972854|Male|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|144|110972854|Male|Meningioma|2011
20+|7.1|7.4|7.2|Benign/Borderline|7980|112450239|Male|Meningioma|2012
20+|0.1|0.2|0.1|Malignant|155|112450239|Male|Meningioma|2012
20+|7.4|7.8|7.6|Benign/Borderline|8531|113812534|Male|Meningioma|2013
20+|0.1|0.2|0.1|Malignant|159|113812534|Male|Meningioma|2013
20+|7.4|7.8|7.6|Benign/Borderline|8739|115179072|Male|Meningioma|2014
20+|0.1|0.2|0.1|Malignant|170|115179072|Male|Meningioma|2014
20+|7.8|8.1|8.0|Benign/Borderline|9371|116516672|Male|Meningioma|2015
20+|0.1|0.1|0.1|Malignant|151|116516672|Male|Meningioma|2015
20+|8.0|8.3|8.1|Benign/Borderline|9711|117786951|Male|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|162|117786951|Male|Meningioma|2016
20+|8.3|8.7|8.5|Benign/Borderline|10392|118938116|Male|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|153|118938116|Male|Meningioma|2017
20+|8.5|8.8|8.6|Benign/Borderline|10762|119976528|Male|Meningioma|2018
20+|0.1|0.1|0.1|Malignant|144|119976528|Male|Meningioma|2018
20+|9.0|9.4|9.2|Benign/Borderline|11627|120965571|Male|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|153|120965571|Male|Meningioma|2019
20+|9.0|9.2|9.1|Benign/Borderline|59716|613244056|Male|Meningioma|2019-2023
20+|0.1|0.1|0.1|Malignant|750|613244056|Male|Meningioma|2019-2023
20+|8.4|8.7|8.5|Benign/Borderline|10993|121845574|Male|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|147|121845574|Male|Meningioma|2020
20+|8.9|9.2|9.1|Benign/Borderline|11878|122388572|Male|Meningioma|2021
20+|0.1|0.1|0.1|Malignant|160|122388572|Male|Meningioma|2021
20+|9.3|9.6|9.4|Benign/Borderline|12611|123330454|Male|Meningioma|2022
20+|0.1|0.1|0.1|Malignant|160|123330454|Male|Meningioma|2022
20+|9.0|9.4|9.2|Benign/Borderline|12607|124713885|Male|Meningioma|2023
20+|0.1|0.1|0.1|Malignant|130|124713885|Male|Meningioma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004
20+|0.3|0.3|0.3|Malignant|294|101938779|Male|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006
20+|0.3|0.4|0.4|Malignant|368|104488268|Male|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007
20+|0.3|0.4|0.3|Malignant|353|105697783|Male|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008
20+|0.3|0.4|0.3|Malignant|341|106947980|Male|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009
20+|0.3|0.4|0.4|Malignant|390|108197539|Male|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Mixed glioma|2010
20+|0.3|0.4|0.3|Malignant|342|109553360|Male|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Mixed glioma|2011
20+|0.3|0.4|0.3|Malignant|367|110972854|Male|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Mixed glioma|2012
20+|0.3|0.3|0.3|Malignant|332|112450239|Male|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Mixed glioma|2013
20+|0.3|0.4|0.3|Malignant|374|113812534|Male|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Mixed glioma|2014
20+|0.2|0.3|0.2|Malignant|269|115179072|Male|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Mixed glioma|2015
20+|0.1|0.2|0.1|Malignant|148|116516672|Male|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Mixed glioma|2016
20+|0.0|0.1|0.1|Malignant|63|117786951|Male|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|30|118938116|Male|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Mixed glioma|2018
20+|~|~|~|Malignant|~|119976528|Male|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Mixed glioma|2019
20+|~|~|~|Malignant|~|120965571|Male|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Mixed glioma|2019-2023
20+|0.0|0.0|0.0|Malignant|43|613244056|Male|Mixed glioma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Mixed glioma|2020
20+|~|~|~|Malignant|~|121845574|Male|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Mixed glioma|2021
20+|~|~|~|Malignant|~|122388572|Male|Mixed glioma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Mixed glioma|2022
20+|~|~|~|Malignant|~|123330454|Male|Mixed glioma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Mixed glioma|2023
20+|~|~|~|Malignant|~|124713885|Male|Mixed glioma|2023
20+|0.5|0.6|0.6|Benign/Borderline|507|101938779|Male|Neoplasm, unspecified|2004
20+|0.6|0.7|0.7|Malignant|587|101938779|Male|Neoplasm, unspecified|2004
20+|0.6|0.7|0.7|Benign/Borderline|636|103190694|Male|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Malignant|601|103190694|Male|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Benign/Borderline|631|104488268|Male|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Malignant|563|104488268|Male|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Benign/Borderline|588|105697783|Male|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Malignant|566|105697783|Male|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Benign/Borderline|625|106947980|Male|Neoplasm, unspecified|2008
20+|0.6|0.7|0.6|Malignant|613|106947980|Male|Neoplasm, unspecified|2008
20+|0.6|0.7|0.6|Benign/Borderline|619|108197539|Male|Neoplasm, unspecified|2009
20+|0.6|0.7|0.6|Malignant|632|108197539|Male|Neoplasm, unspecified|2009
20+|0.6|0.7|0.7|Benign/Borderline|681|109553360|Male|Neoplasm, unspecified|2010
20+|0.6|0.6|0.6|Malignant|600|109553360|Male|Neoplasm, unspecified|2010
20+|0.6|0.7|0.6|Benign/Borderline|642|110972854|Male|Neoplasm, unspecified|2011
20+|0.6|0.6|0.6|Malignant|612|110972854|Male|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|715|112450239|Male|Neoplasm, unspecified|2012
20+|0.5|0.6|0.6|Malignant|617|112450239|Male|Neoplasm, unspecified|2012
20+|0.6|0.7|0.6|Benign/Borderline|698|113812534|Male|Neoplasm, unspecified|2013
20+|0.5|0.6|0.6|Malignant|607|113812534|Male|Neoplasm, unspecified|2013
20+|0.5|0.6|0.6|Benign/Borderline|650|115179072|Male|Neoplasm, unspecified|2014
20+|0.6|0.7|0.6|Malignant|670|115179072|Male|Neoplasm, unspecified|2014
20+|0.5|0.6|0.6|Benign/Borderline|658|116516672|Male|Neoplasm, unspecified|2015
20+|0.5|0.6|0.6|Malignant|631|116516672|Male|Neoplasm, unspecified|2015
20+|0.5|0.6|0.5|Benign/Borderline|606|117786951|Male|Neoplasm, unspecified|2016
20+|0.5|0.6|0.6|Malignant|638|117786951|Male|Neoplasm, unspecified|2016
20+|0.5|0.5|0.5|Benign/Borderline|584|118938116|Male|Neoplasm, unspecified|2017
20+|0.5|0.5|0.5|Malignant|583|118938116|Male|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Benign/Borderline|565|119976528|Male|Neoplasm, unspecified|2018
20+|0.5|0.6|0.6|Malignant|668|119976528|Male|Neoplasm, unspecified|2018
20+|0.4|0.5|0.4|Benign/Borderline|515|120965571|Male|Neoplasm, unspecified|2019
20+|0.5|0.6|0.6|Malignant|714|120965571|Male|Neoplasm, unspecified|2019
20+|0.4|0.4|0.4|Benign/Borderline|2730|613244056|Male|Neoplasm, unspecified|2019-2023
20+|0.5|0.6|0.6|Malignant|3522|613244056|Male|Neoplasm, unspecified|2019-2023
20+|0.4|0.5|0.4|Benign/Borderline|560|121845574|Male|Neoplasm, unspecified|2020
20+|0.6|0.7|0.6|Malignant|752|121845574|Male|Neoplasm, unspecified|2020
20+|0.4|0.5|0.5|Benign/Borderline|575|122388572|Male|Neoplasm, unspecified|2021
20+|0.5|0.6|0.6|Malignant|736|122388572|Male|Neoplasm, unspecified|2021
20+|0.4|0.5|0.5|Benign/Borderline|580|123330454|Male|Neoplasm, unspecified|2022
20+|0.5|0.6|0.6|Malignant|704|123330454|Male|Neoplasm, unspecified|2022
20+|0.3|0.4|0.4|Benign/Borderline|500|124713885|Male|Neoplasm, unspecified|2023
20+|0.4|0.5|0.5|Malignant|616|124713885|Male|Neoplasm, unspecified|2023
20+|2.2|2.4|2.3|Benign/Borderline|2384|101938779|Male|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004
20+|2.5|2.7|2.6|Benign/Borderline|2732|103190694|Male|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Nerve sheath, benign and malignant|2005
20+|2.5|2.7|2.6|Benign/Borderline|2708|104488268|Male|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006
20+|2.5|2.7|2.6|Benign/Borderline|2801|105697783|Male|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007
20+|2.5|2.7|2.6|Benign/Borderline|2786|106947980|Male|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008
20+|2.6|2.8|2.7|Benign/Borderline|2967|108197539|Male|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Nerve sheath, benign and malignant|2009
20+|2.6|2.8|2.7|Benign/Borderline|3024|109553360|Male|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|23|109553360|Male|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|3119|110972854|Male|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|17|110972854|Male|Nerve sheath, benign and malignant|2011
20+|2.7|2.9|2.8|Benign/Borderline|3333|112450239|Male|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|25|112450239|Male|Nerve sheath, benign and malignant|2012
20+|2.8|3.0|2.9|Benign/Borderline|3460|113812534|Male|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|22|113812534|Male|Nerve sheath, benign and malignant|2013
20+|3.0|3.2|3.1|Benign/Borderline|3734|115179072|Male|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|21|115179072|Male|Nerve sheath, benign and malignant|2014
20+|2.9|3.1|3.0|Benign/Borderline|3739|116516672|Male|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|17|116516672|Male|Nerve sheath, benign and malignant|2015
20+|2.9|3.1|3.0|Benign/Borderline|3731|117786951|Male|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|25|117786951|Male|Nerve sheath, benign and malignant|2016
20+|2.9|3.1|3.0|Benign/Borderline|3853|118938116|Male|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|27|118938116|Male|Nerve sheath, benign and malignant|2017
20+|2.9|3.1|3.0|Benign/Borderline|3911|119976528|Male|Nerve sheath, benign and malignant|2018
20+|~|~|~|Malignant|~|119976528|Male|Nerve sheath, benign and malignant|2018
20+|3.0|3.2|3.1|Benign/Borderline|3981|120965571|Male|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|20|120965571|Male|Nerve sheath, benign and malignant|2019
20+|2.9|3.0|3.0|Benign/Borderline|19752|613244056|Male|Nerve sheath, benign and malignant|2019-2023
20+|0.0|0.0|0.0|Malignant|111|613244056|Male|Nerve sheath, benign and malignant|2019-2023
20+|2.5|2.7|2.6|Benign/Borderline|3450|121845574|Male|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|23|121845574|Male|Nerve sheath, benign and malignant|2020
20+|2.9|3.1|3.0|Benign/Borderline|3982|122388572|Male|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|18|122388572|Male|Nerve sheath, benign and malignant|2021
20+|3.1|3.3|3.2|Benign/Borderline|4259|123330454|Male|Nerve sheath, benign and malignant|2022
20+|0.0|0.0|0.0|Malignant|32|123330454|Male|Nerve sheath, benign and malignant|2022
20+|2.9|3.1|3.0|Benign/Borderline|4080|124713885|Male|Nerve sheath, benign and malignant|2023
20+|0.0|0.0|0.0|Malignant|18|124713885|Male|Nerve sheath, benign and malignant|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|31|105697783|Male|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|25|109553360|Male|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|27|110972854|Male|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|27|112450239|Male|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|27|113812534|Male|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|35|115179072|Male|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|34|116516672|Male|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|25|117786951|Male|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|19|118938116|Male|Neuroepithelial|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Neuroepithelial|2018
20+|~|~|~|Malignant|~|119976528|Male|Neuroepithelial|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Neuroepithelial|2019
20+|~|~|~|Malignant|~|120965571|Male|Neuroepithelial|2019
20+|0.0|0.0|0.0|Benign/Borderline|30|613244056|Male|Neuroepithelial|2019-2023
20+|0.0|0.0|0.0|Malignant|49|613244056|Male|Neuroepithelial|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Neuroepithelial|2020
20+|~|~|~|Malignant|~|121845574|Male|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Neuroepithelial|2021
20+|~|~|~|Malignant|~|122388572|Male|Neuroepithelial|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Neuroepithelial|2022
20+|~|~|~|Malignant|~|123330454|Male|Neuroepithelial|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Neuroepithelial|2023
20+|~|~|~|Malignant|~|124713885|Male|Neuroepithelial|2023
20+|0.1|0.2|0.2|Benign/Borderline|163|101938779|Male|Neuronal/glial, neuronal|2004
20+|0.0|0.0|0.0|Malignant|22|101938779|Male|Neuronal/glial, neuronal|2004
20+|0.2|0.2|0.2|Benign/Borderline|192|103190694|Male|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|202|104488268|Male|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|26|104488268|Male|Neuronal/glial, neuronal|2006
20+|0.2|0.2|0.2|Benign/Borderline|187|105697783|Male|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|218|106947980|Male|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|218|108197539|Male|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Neuronal/glial, neuronal|2009
20+|0.2|0.2|0.2|Benign/Borderline|236|109553360|Male|Neuronal/glial, neuronal|2010
20+|~|~|~|Malignant|~|109553360|Male|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|196|110972854|Male|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|22|110972854|Male|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|212|112450239|Male|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|22|112450239|Male|Neuronal/glial, neuronal|2012
20+|0.2|0.2|0.2|Benign/Borderline|218|113812534|Male|Neuronal/glial, neuronal|2013
20+|0.0|0.0|0.0|Malignant|18|113812534|Male|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|227|115179072|Male|Neuronal/glial, neuronal|2014
20+|0.0|0.0|0.0|Malignant|20|115179072|Male|Neuronal/glial, neuronal|2014
20+|0.2|0.3|0.2|Benign/Borderline|269|116516672|Male|Neuronal/glial, neuronal|2015
20+|0.0|0.0|0.0|Malignant|17|116516672|Male|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|250|117786951|Male|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|19|117786951|Male|Neuronal/glial, neuronal|2016
20+|0.2|0.3|0.2|Benign/Borderline|258|118938116|Male|Neuronal/glial, neuronal|2017
20+|~|~|~|Malignant|~|118938116|Male|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|258|119976528|Male|Neuronal/glial, neuronal|2018
20+|~|~|~|Malignant|~|119976528|Male|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|264|120965571|Male|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|18|120965571|Male|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|1193|613244056|Male|Neuronal/glial, neuronal|2019-2023
20+|0.0|0.0|0.0|Malignant|122|613244056|Male|Neuronal/glial, neuronal|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|227|121845574|Male|Neuronal/glial, neuronal|2020
20+|0.0|0.0|0.0|Malignant|19|121845574|Male|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|256|122388572|Male|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|29|122388572|Male|Neuronal/glial, neuronal|2021
20+|0.2|0.2|0.2|Benign/Borderline|218|123330454|Male|Neuronal/glial, neuronal|2022
20+|0.0|0.0|0.0|Malignant|27|123330454|Male|Neuronal/glial, neuronal|2022
20+|0.2|0.2|0.2|Benign/Borderline|228|124713885|Male|Neuronal/glial, neuronal|2023
20+|0.0|0.0|0.0|Malignant|29|124713885|Male|Neuronal/glial, neuronal|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004
20+|0.4|0.5|0.5|Malignant|476|101938779|Male|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005
20+|0.4|0.5|0.4|Malignant|445|103190694|Male|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006
20+|0.4|0.5|0.5|Malignant|484|104488268|Male|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007
20+|0.4|0.5|0.4|Malignant|445|105697783|Male|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008
20+|0.4|0.4|0.4|Malignant|420|106947980|Male|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009
20+|0.4|0.5|0.5|Malignant|482|108197539|Male|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Oligodendroglioma|2010
20+|0.4|0.5|0.4|Malignant|479|109553360|Male|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Oligodendroglioma|2011
20+|0.4|0.5|0.4|Malignant|454|110972854|Male|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Oligodendroglioma|2012
20+|0.3|0.4|0.4|Malignant|386|112450239|Male|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Oligodendroglioma|2013
20+|0.3|0.4|0.3|Malignant|369|113812534|Male|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Oligodendroglioma|2014
20+|0.3|0.4|0.4|Malignant|429|115179072|Male|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Oligodendroglioma|2015
20+|0.3|0.4|0.4|Malignant|412|116516672|Male|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Oligodendroglioma|2016
20+|0.3|0.4|0.4|Malignant|410|117786951|Male|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Oligodendroglioma|2017
20+|0.3|0.4|0.4|Malignant|412|118938116|Male|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Oligodendroglioma|2018
20+|0.3|0.4|0.3|Malignant|364|119976528|Male|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Oligodendroglioma|2019
20+|0.3|0.4|0.4|Malignant|430|120965571|Male|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|613244056|Male|Oligodendroglioma|2019-2023
20+|0.3|0.4|0.4|Malignant|2122|613244056|Male|Oligodendroglioma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Oligodendroglioma|2020
20+|0.3|0.4|0.3|Malignant|387|121845574|Male|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Oligodendroglioma|2021
20+|0.3|0.4|0.4|Malignant|417|122388572|Male|Oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Oligodendroglioma|2022
20+|0.4|0.4|0.4|Malignant|469|123330454|Male|Oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Oligodendroglioma|2023
20+|0.3|0.4|0.4|Malignant|419|124713885|Male|Oligodendroglioma|2023
20+|0.1|0.1|0.1|Benign/Borderline|84|101938779|Male|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|34|101938779|Male|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|75|103190694|Male|Other mesenchymal|2005
20+|0.0|0.1|0.0|Malignant|37|103190694|Male|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|70|104488268|Male|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|30|104488268|Male|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|84|105697783|Male|Other mesenchymal|2007
20+|0.0|0.1|0.0|Malignant|41|105697783|Male|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|105|106947980|Male|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|48|106947980|Male|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|105|108197539|Male|Other mesenchymal|2009
20+|0.0|0.1|0.0|Malignant|50|108197539|Male|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|83|109553360|Male|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|35|109553360|Male|Other mesenchymal|2010
20+|0.1|0.1|0.1|Benign/Borderline|72|110972854|Male|Other mesenchymal|2011
20+|0.0|0.1|0.0|Malignant|46|110972854|Male|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|94|112450239|Male|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|33|112450239|Male|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|73|113812534|Male|Other mesenchymal|2013
20+|0.0|0.1|0.0|Malignant|46|113812534|Male|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|91|115179072|Male|Other mesenchymal|2014
20+|0.0|0.1|0.0|Malignant|48|115179072|Male|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|107|116516672|Male|Other mesenchymal|2015
20+|0.0|0.1|0.0|Malignant|51|116516672|Male|Other mesenchymal|2015
20+|0.1|0.1|0.1|Benign/Borderline|85|117786951|Male|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|45|117786951|Male|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|89|118938116|Male|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|53|118938116|Male|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|91|119976528|Male|Other mesenchymal|2018
20+|0.0|0.1|0.0|Malignant|62|119976528|Male|Other mesenchymal|2018
20+|0.0|0.1|0.1|Benign/Borderline|75|120965571|Male|Other mesenchymal|2019
20+|0.0|0.1|0.0|Malignant|47|120965571|Male|Other mesenchymal|2019
20+|0.1|0.1|0.1|Benign/Borderline|431|613244056|Male|Other mesenchymal|2019-2023
20+|0.0|0.0|0.0|Malignant|227|613244056|Male|Other mesenchymal|2019-2023
20+|0.0|0.1|0.0|Benign/Borderline|63|121845574|Male|Other mesenchymal|2020
20+|0.0|0.1|0.0|Malignant|56|121845574|Male|Other mesenchymal|2020
20+|0.1|0.1|0.1|Benign/Borderline|90|122388572|Male|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|54|122388572|Male|Other mesenchymal|2021
20+|0.1|0.1|0.1|Benign/Borderline|111|123330454|Male|Other mesenchymal|2022
20+|0.0|0.0|0.0|Malignant|47|123330454|Male|Other mesenchymal|2022
20+|0.1|0.1|0.1|Benign/Borderline|92|124713885|Male|Other mesenchymal|2023
20+|0.0|0.0|0.0|Malignant|23|124713885|Male|Other mesenchymal|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004
20+|0.1|0.2|0.1|Malignant|152|101938779|Male|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.2|Malignant|158|103190694|Male|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|144|105697783|Male|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|146|106947980|Male|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009
20+|0.1|0.2|0.1|Malignant|139|108197539|Male|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.1|Malignant|165|109553360|Male|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.2|Malignant|176|110972854|Male|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112450239|Male|Pilocytic astrocytoma|2012
20+|0.1|0.2|0.1|Malignant|148|112450239|Male|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|148|113812534|Male|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115179072|Male|Pilocytic astrocytoma|2014
20+|0.1|0.2|0.1|Malignant|154|115179072|Male|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Pilocytic astrocytoma|2015
20+|0.1|0.2|0.1|Malignant|149|116516672|Male|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|117786951|Male|Pilocytic astrocytoma|2016
20+|0.1|0.2|0.1|Malignant|166|117786951|Male|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|118938116|Male|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|145|118938116|Male|Pilocytic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|119976528|Male|Pilocytic astrocytoma|2018
20+|0.1|0.2|0.1|Malignant|156|119976528|Male|Pilocytic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|120965571|Male|Pilocytic astrocytoma|2019
20+|0.1|0.2|0.1|Malignant|164|120965571|Male|Pilocytic astrocytoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|167|613244056|Male|Pilocytic astrocytoma|2019-2023
20+|0.1|0.1|0.1|Malignant|640|613244056|Male|Pilocytic astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|121845574|Male|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|145|121845574|Male|Pilocytic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|133|122388572|Male|Pilocytic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|123330454|Male|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Malignant|144|123330454|Male|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Benign/Borderline|138|124713885|Male|Pilocytic astrocytoma|2023
20+|0.0|0.1|0.0|Malignant|54|124713885|Male|Pilocytic astrocytoma|2023
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|18|104488268|Male|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|16|105697783|Male|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Benign/Borderline|24|106947980|Male|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|22|106947980|Male|Pineal parenchymal|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009
20+|~|~|~|Benign/Borderline|~|109553360|Male|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|18|109553360|Male|Pineal parenchymal|2010
20+|~|~|~|Benign/Borderline|~|110972854|Male|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|18|110972854|Male|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|25|112450239|Male|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|20|112450239|Male|Pineal parenchymal|2012
20+|~|~|~|Benign/Borderline|~|113812534|Male|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|36|113812534|Male|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Benign/Borderline|22|115179072|Male|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Malignant|16|115179072|Male|Pineal parenchymal|2014
20+|~|~|~|Benign/Borderline|~|116516672|Male|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|28|116516672|Male|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|26|117786951|Male|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|36|117786951|Male|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|19|118938116|Male|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|27|118938116|Male|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|24|119976528|Male|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|21|119976528|Male|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|16|120965571|Male|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|18|120965571|Male|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|85|613244056|Male|Pineal parenchymal|2019-2023
20+|0.0|0.0|0.0|Malignant|112|613244056|Male|Pineal parenchymal|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|19|121845574|Male|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|24|121845574|Male|Pineal parenchymal|2020
20+|~|~|~|Benign/Borderline|~|122388572|Male|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|32|122388572|Male|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Benign/Borderline|24|123330454|Male|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Malignant|21|123330454|Male|Pineal parenchymal|2022
20+|~|~|~|Benign/Borderline|~|124713885|Male|Pineal parenchymal|2023
20+|0.0|0.0|0.0|Malignant|17|124713885|Male|Pineal parenchymal|2023
20+|3.5|3.7|3.6|Benign/Borderline|3556|101938779|Male|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004
20+|3.8|4.0|3.9|Benign/Borderline|3917|103190694|Male|Pituitary|2005
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005
20+|3.9|4.2|4.1|Benign/Borderline|4185|104488268|Male|Pituitary|2006
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006
20+|4.3|4.5|4.4|Benign/Borderline|4629|105697783|Male|Pituitary|2007
20+|0.0|0.0|0.0|Malignant|25|105697783|Male|Pituitary|2007
20+|4.6|4.9|4.7|Benign/Borderline|5028|106947980|Male|Pituitary|2008
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008
20+|4.9|5.1|5.0|Benign/Borderline|5411|108197539|Male|Pituitary|2009
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009
20+|5.0|5.3|5.1|Benign/Borderline|5666|109553360|Male|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|16|109553360|Male|Pituitary|2010
20+|5.1|5.3|5.2|Benign/Borderline|5815|110972854|Male|Pituitary|2011
20+|0.0|0.0|0.0|Malignant|24|110972854|Male|Pituitary|2011
20+|5.4|5.7|5.6|Benign/Borderline|6346|112450239|Male|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|19|112450239|Male|Pituitary|2012
20+|5.5|5.7|5.6|Benign/Borderline|6458|113812534|Male|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|30|113812534|Male|Pituitary|2013
20+|5.5|5.7|5.6|Benign/Borderline|6591|115179072|Male|Pituitary|2014
20+|0.0|0.0|0.0|Malignant|23|115179072|Male|Pituitary|2014
20+|5.7|5.9|5.8|Benign/Borderline|6938|116516672|Male|Pituitary|2015
20+|0.0|0.0|0.0|Malignant|19|116516672|Male|Pituitary|2015
20+|5.7|6.0|5.8|Benign/Borderline|7097|117786951|Male|Pituitary|2016
20+|0.0|0.0|0.0|Malignant|26|117786951|Male|Pituitary|2016
20+|5.9|6.1|6.0|Benign/Borderline|7404|118938116|Male|Pituitary|2017
20+|0.0|0.0|0.0|Malignant|22|118938116|Male|Pituitary|2017
20+|5.9|6.2|6.0|Benign/Borderline|7543|119976528|Male|Pituitary|2018
20+|0.0|0.0|0.0|Malignant|27|119976528|Male|Pituitary|2018
20+|5.9|6.2|6.1|Benign/Borderline|7730|120965571|Male|Pituitary|2019
20+|~|~|~|Malignant|~|120965571|Male|Pituitary|2019
20+|5.6|5.7|5.7|Benign/Borderline|36746|613244056|Male|Pituitary|2019-2023
20+|0.2|0.2|0.2|Malignant|1408|613244056|Male|Pituitary|2019-2023
20+|5.1|5.4|5.3|Benign/Borderline|6759|121845574|Male|Pituitary|2020
20+|0.0|0.0|0.0|Malignant|29|121845574|Male|Pituitary|2020
20+|5.8|6.1|5.9|Benign/Borderline|7652|122388572|Male|Pituitary|2021
20+|0.0|0.0|0.0|Malignant|33|122388572|Male|Pituitary|2021
20+|5.7|6.0|5.9|Benign/Borderline|7690|123330454|Male|Pituitary|2022
20+|0.1|0.2|0.2|Malignant|214|123330454|Male|Pituitary|2022
20+|5.1|5.3|5.2|Benign/Borderline|6915|124713885|Male|Pituitary|2023
20+|0.8|0.9|0.8|Malignant|1118|124713885|Male|Pituitary|2023
20+|12.7|13.1|12.9|Benign/Borderline|12576|101938779|Male|Total|2004
20+|10.7|11.1|10.9|Malignant|10667|101938779|Male|Total|2004
20+|14.1|14.6|14.3|Benign/Borderline|14210|103190694|Male|Total|2005
20+|10.7|11.1|10.9|Malignant|10829|103190694|Male|Total|2005
20+|14.5|15.0|14.7|Benign/Borderline|14868|104488268|Male|Total|2006
20+|10.5|10.9|10.7|Malignant|10856|104488268|Male|Total|2006
20+|15.0|15.4|15.2|Benign/Borderline|15642|105697783|Male|Total|2007
20+|10.5|10.9|10.7|Malignant|11095|105697783|Male|Total|2007
20+|15.9|16.4|16.1|Benign/Borderline|16890|106947980|Male|Total|2008
20+|10.7|11.1|10.9|Malignant|11424|106947980|Male|Total|2008
20+|16.8|17.3|17.0|Benign/Borderline|18077|108197539|Male|Total|2009
20+|10.5|10.9|10.7|Malignant|11454|108197539|Male|Total|2009
20+|16.9|17.4|17.1|Benign/Borderline|18574|109553360|Male|Total|2010
20+|10.3|10.6|10.5|Malignant|11449|109553360|Male|Total|2010
20+|17.0|17.5|17.2|Benign/Borderline|19023|110972854|Male|Total|2011
20+|10.3|10.7|10.5|Malignant|11708|110972854|Male|Total|2011
20+|17.7|18.2|17.9|Benign/Borderline|20178|112450239|Male|Total|2012
20+|10.1|10.4|10.2|Malignant|11690|112450239|Male|Total|2012
20+|18.0|18.5|18.2|Benign/Borderline|20921|113812534|Male|Total|2013
20+|10.1|10.4|10.2|Malignant|11929|113812534|Male|Total|2013
20+|18.2|18.7|18.5|Benign/Borderline|21559|115179072|Male|Total|2014
20+|10.2|10.6|10.4|Malignant|12268|115179072|Male|Total|2014
20+|18.7|19.2|19.0|Benign/Borderline|22583|116516672|Male|Total|2015
20+|9.9|10.2|10.1|Malignant|12159|116516672|Male|Total|2015
20+|18.8|19.3|19.1|Benign/Borderline|22997|117786951|Male|Total|2016
20+|10.0|10.4|10.2|Malignant|12597|117786951|Male|Total|2016
20+|19.4|19.9|19.7|Benign/Borderline|24181|118938116|Male|Total|2017
20+|9.9|10.3|10.1|Malignant|12684|118938116|Male|Total|2017
20+|19.5|20.0|19.7|Benign/Borderline|24681|119976528|Male|Total|2018
20+|9.8|10.1|10.0|Malignant|12691|119976528|Male|Total|2018
20+|20.0|20.6|20.3|Benign/Borderline|25776|120965571|Male|Total|2019
20+|9.7|10.1|9.9|Malignant|12785|120965571|Male|Total|2019
20+|19.6|19.8|19.7|Benign/Borderline|128789|613244056|Male|Total|2019-2023
20+|9.6|9.7|9.7|Malignant|64513|613244056|Male|Total|2019-2023
20+|18.1|18.6|18.3|Benign/Borderline|23613|121845574|Male|Total|2020
20+|9.5|9.8|9.7|Malignant|12770|121845574|Male|Total|2020
20+|19.7|20.2|20.0|Benign/Borderline|26008|122388572|Male|Total|2021
20+|9.4|9.7|9.6|Malignant|12749|122388572|Male|Total|2021
20+|20.3|20.8|20.5|Benign/Borderline|27131|123330454|Male|Total|2022
20+|9.3|9.7|9.5|Malignant|12891|123330454|Male|Total|2022
20+|19.3|19.8|19.5|Benign/Borderline|26261|124713885|Male|Total|2023
20+|9.5|9.8|9.7|Malignant|13318|124713885|Male|Total|2023
20+|2.2|2.4|2.3|Benign/Borderline|2384|101938779|Male|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004
20+|2.5|2.7|2.6|Benign/Borderline|2732|103190694|Male|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Tumors of Cranial and Spinal Nerves|2005
20+|2.5|2.7|2.6|Benign/Borderline|2709|104488268|Male|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.7|2.6|Benign/Borderline|2802|105697783|Male|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007
20+|2.5|2.7|2.6|Benign/Borderline|2788|106947980|Male|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|2971|108197539|Male|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Tumors of Cranial and Spinal Nerves|2009
20+|2.6|2.8|2.7|Benign/Borderline|3025|109553360|Male|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|23|109553360|Male|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|3122|110972854|Male|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|17|110972854|Male|Tumors of Cranial and Spinal Nerves|2011
20+|2.7|2.9|2.8|Benign/Borderline|3335|112450239|Male|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|25|112450239|Male|Tumors of Cranial and Spinal Nerves|2012
20+|2.8|3.0|2.9|Benign/Borderline|3464|113812534|Male|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|22|113812534|Male|Tumors of Cranial and Spinal Nerves|2013
20+|3.0|3.2|3.1|Benign/Borderline|3737|115179072|Male|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|21|115179072|Male|Tumors of Cranial and Spinal Nerves|2014
20+|2.9|3.1|3.0|Benign/Borderline|3746|116516672|Male|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|17|116516672|Male|Tumors of Cranial and Spinal Nerves|2015
20+|2.9|3.1|3.0|Benign/Borderline|3735|117786951|Male|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|25|117786951|Male|Tumors of Cranial and Spinal Nerves|2016
20+|2.9|3.1|3.0|Benign/Borderline|3857|118938116|Male|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|27|118938116|Male|Tumors of Cranial and Spinal Nerves|2017
20+|2.9|3.1|3.0|Benign/Borderline|3914|119976528|Male|Tumors of Cranial and Spinal Nerves|2018
20+|~|~|~|Malignant|~|119976528|Male|Tumors of Cranial and Spinal Nerves|2018
20+|3.0|3.2|3.1|Benign/Borderline|3986|120965571|Male|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|20|120965571|Male|Tumors of Cranial and Spinal Nerves|2019
20+|2.9|3.0|3.0|Benign/Borderline|19765|613244056|Male|Tumors of Cranial and Spinal Nerves|2019-2023
20+|0.0|0.0|0.0|Malignant|111|613244056|Male|Tumors of Cranial and Spinal Nerves|2019-2023
20+|2.5|2.7|2.6|Benign/Borderline|3452|121845574|Male|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|23|121845574|Male|Tumors of Cranial and Spinal Nerves|2020
20+|2.9|3.1|3.0|Benign/Borderline|3986|122388572|Male|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|18|122388572|Male|Tumors of Cranial and Spinal Nerves|2021
20+|3.1|3.3|3.2|Benign/Borderline|4260|123330454|Male|Tumors of Cranial and Spinal Nerves|2022
20+|0.0|0.0|0.0|Malignant|32|123330454|Male|Tumors of Cranial and Spinal Nerves|2022
20+|2.9|3.1|3.0|Benign/Borderline|4081|124713885|Male|Tumors of Cranial and Spinal Nerves|2023
20+|0.0|0.0|0.0|Malignant|18|124713885|Male|Tumors of Cranial and Spinal Nerves|2023
20+|0.4|0.5|0.4|Benign/Borderline|455|101938779|Male|Tumors of Neuroepthelial Tissue|2004
20+|8.9|9.3|9.1|Malignant|9002|101938779|Male|Tumors of Neuroepthelial Tissue|2004
20+|0.5|0.6|0.5|Benign/Borderline|531|103190694|Male|Tumors of Neuroepthelial Tissue|2005
20+|8.9|9.3|9.1|Malignant|9129|103190694|Male|Tumors of Neuroepthelial Tissue|2005
20+|0.5|0.6|0.5|Benign/Borderline|565|104488268|Male|Tumors of Neuroepthelial Tissue|2006
20+|8.8|9.2|9.0|Malignant|9213|104488268|Male|Tumors of Neuroepthelial Tissue|2006
20+|0.5|0.5|0.5|Benign/Borderline|529|105697783|Male|Tumors of Neuroepthelial Tissue|2007
20+|8.9|9.2|9.0|Malignant|9421|105697783|Male|Tumors of Neuroepthelial Tissue|2007
20+|0.5|0.6|0.6|Benign/Borderline|596|106947980|Male|Tumors of Neuroepthelial Tissue|2008
20+|9.0|9.3|9.2|Malignant|9712|106947980|Male|Tumors of Neuroepthelial Tissue|2008
20+|0.5|0.6|0.6|Benign/Borderline|605|108197539|Male|Tumors of Neuroepthelial Tissue|2009
20+|8.9|9.2|9.1|Malignant|9763|108197539|Male|Tumors of Neuroepthelial Tissue|2009
20+|0.6|0.7|0.6|Benign/Borderline|658|109553360|Male|Tumors of Neuroepthelial Tissue|2010
20+|8.7|9.1|8.9|Malignant|9792|109553360|Male|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.6|0.6|Benign/Borderline|619|110972854|Male|Tumors of Neuroepthelial Tissue|2011
20+|8.7|9.0|8.8|Malignant|9959|110972854|Male|Tumors of Neuroepthelial Tissue|2011
20+|0.5|0.6|0.6|Benign/Borderline|650|112450239|Male|Tumors of Neuroepthelial Tissue|2012
20+|8.5|8.9|8.7|Malignant|10008|112450239|Male|Tumors of Neuroepthelial Tissue|2012
20+|0.5|0.6|0.5|Benign/Borderline|627|113812534|Male|Tumors of Neuroepthelial Tissue|2013
20+|8.6|8.9|8.8|Malignant|10252|113812534|Male|Tumors of Neuroepthelial Tissue|2013
20+|0.6|0.6|0.6|Benign/Borderline|691|115179072|Male|Tumors of Neuroepthelial Tissue|2014
20+|8.6|8.9|8.7|Malignant|10410|115179072|Male|Tumors of Neuroepthelial Tissue|2014
20+|0.6|0.7|0.6|Benign/Borderline|713|116516672|Male|Tumors of Neuroepthelial Tissue|2015
20+|8.4|8.7|8.5|Malignant|10374|116516672|Male|Tumors of Neuroepthelial Tissue|2015
20+|0.6|0.7|0.6|Benign/Borderline|743|117786951|Male|Tumors of Neuroepthelial Tissue|2016
20+|8.5|8.8|8.7|Malignant|10758|117786951|Male|Tumors of Neuroepthelial Tissue|2016
20+|0.6|0.7|0.6|Benign/Borderline|751|118938116|Male|Tumors of Neuroepthelial Tissue|2017
20+|8.5|8.8|8.6|Malignant|10859|118938116|Male|Tumors of Neuroepthelial Tissue|2017
20+|0.6|0.7|0.6|Benign/Borderline|739|119976528|Male|Tumors of Neuroepthelial Tissue|2018
20+|8.3|8.6|8.4|Malignant|10813|119976528|Male|Tumors of Neuroepthelial Tissue|2018
20+|0.6|0.7|0.6|Benign/Borderline|752|120965571|Male|Tumors of Neuroepthelial Tissue|2019
20+|8.2|8.5|8.4|Malignant|10886|120965571|Male|Tumors of Neuroepthelial Tissue|2019
20+|0.6|0.7|0.6|Benign/Borderline|3951|613244056|Male|Tumors of Neuroepthelial Tissue|2019-2023
20+|8.0|8.1|8.0|Malignant|53829|613244056|Male|Tumors of Neuroepthelial Tissue|2019-2023
20+|0.5|0.6|0.6|Benign/Borderline|710|121845574|Male|Tumors of Neuroepthelial Tissue|2020
20+|8.0|8.3|8.1|Malignant|10835|121845574|Male|Tumors of Neuroepthelial Tissue|2020
20+|0.6|0.7|0.6|Benign/Borderline|762|122388572|Male|Tumors of Neuroepthelial Tissue|2021
20+|7.9|8.2|8.1|Malignant|10797|122388572|Male|Tumors of Neuroepthelial Tissue|2021
20+|0.6|0.7|0.6|Benign/Borderline|803|123330454|Male|Tumors of Neuroepthelial Tissue|2022
20+|7.8|8.1|7.9|Malignant|10804|123330454|Male|Tumors of Neuroepthelial Tissue|2022
20+|0.7|0.8|0.7|Benign/Borderline|924|124713885|Male|Tumors of Neuroepthelial Tissue|2023
20+|7.4|7.7|7.6|Malignant|10507|124713885|Male|Tumors of Neuroepthelial Tissue|2023
20+|3.6|3.9|3.8|Benign/Borderline|3744|101938779|Male|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004
20+|4.0|4.2|4.1|Benign/Borderline|4154|103190694|Male|Tumors of Sellar Region|2005
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005
20+|4.1|4.4|4.3|Benign/Borderline|4380|104488268|Male|Tumors of Sellar Region|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006
20+|4.5|4.7|4.6|Benign/Borderline|4831|105697783|Male|Tumors of Sellar Region|2007
20+|0.0|0.0|0.0|Malignant|25|105697783|Male|Tumors of Sellar Region|2007
20+|4.8|5.1|4.9|Benign/Borderline|5230|106947980|Male|Tumors of Sellar Region|2008
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008
20+|5.0|5.3|5.2|Benign/Borderline|5613|108197539|Male|Tumors of Sellar Region|2009
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009
20+|5.2|5.5|5.3|Benign/Borderline|5869|109553360|Male|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|16|109553360|Male|Tumors of Sellar Region|2010
20+|5.2|5.5|5.4|Benign/Borderline|6016|110972854|Male|Tumors of Sellar Region|2011
20+|0.0|0.0|0.0|Malignant|25|110972854|Male|Tumors of Sellar Region|2011
20+|5.6|5.9|5.8|Benign/Borderline|6566|112450239|Male|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|19|112450239|Male|Tumors of Sellar Region|2012
20+|5.6|5.9|5.8|Benign/Borderline|6695|113812534|Male|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|30|113812534|Male|Tumors of Sellar Region|2013
20+|5.6|5.9|5.8|Benign/Borderline|6808|115179072|Male|Tumors of Sellar Region|2014
20+|0.0|0.0|0.0|Malignant|26|115179072|Male|Tumors of Sellar Region|2014
20+|5.8|6.1|6.0|Benign/Borderline|7168|116516672|Male|Tumors of Sellar Region|2015
20+|0.0|0.0|0.0|Malignant|19|116516672|Male|Tumors of Sellar Region|2015
20+|5.9|6.2|6.0|Benign/Borderline|7346|117786951|Male|Tumors of Sellar Region|2016
20+|0.0|0.0|0.0|Malignant|27|117786951|Male|Tumors of Sellar Region|2016
20+|6.1|6.3|6.2|Benign/Borderline|7656|118938116|Male|Tumors of Sellar Region|2017
20+|0.0|0.0|0.0|Malignant|22|118938116|Male|Tumors of Sellar Region|2017
20+|6.1|6.3|6.2|Benign/Borderline|7775|119976528|Male|Tumors of Sellar Region|2018
20+|0.0|0.0|0.0|Malignant|27|119976528|Male|Tumors of Sellar Region|2018
20+|6.1|6.4|6.3|Benign/Borderline|7986|120965571|Male|Tumors of Sellar Region|2019
20+|~|~|~|Malignant|~|120965571|Male|Tumors of Sellar Region|2019
20+|5.8|5.9|5.9|Benign/Borderline|37987|613244056|Male|Tumors of Sellar Region|2019-2023
20+|0.2|0.2|0.2|Malignant|1409|613244056|Male|Tumors of Sellar Region|2019-2023
20+|5.3|5.6|5.5|Benign/Borderline|7004|121845574|Male|Tumors of Sellar Region|2020
20+|0.0|0.0|0.0|Malignant|30|121845574|Male|Tumors of Sellar Region|2020
20+|6.0|6.2|6.1|Benign/Borderline|7889|122388572|Male|Tumors of Sellar Region|2021
20+|0.0|0.0|0.0|Malignant|33|122388572|Male|Tumors of Sellar Region|2021
20+|5.9|6.2|6.1|Benign/Borderline|7950|123330454|Male|Tumors of Sellar Region|2022
20+|0.1|0.2|0.2|Malignant|214|123330454|Male|Tumors of Sellar Region|2022
20+|5.3|5.5|5.4|Benign/Borderline|7158|124713885|Male|Tumors of Sellar Region|2023
20+|0.8|0.9|0.8|Malignant|1118|124713885|Male|Tumors of Sellar Region|2023
20+|5.5|5.8|5.6|Benign/Borderline|5315|101938779|Male|Tumors of the Meninges|2004
20+|0.2|0.2|0.2|Malignant|210|101938779|Male|Tumors of the Meninges|2004
20+|6.0|6.3|6.2|Benign/Borderline|5915|103190694|Male|Tumors of the Meninges|2005
20+|0.2|0.2|0.2|Malignant|193|103190694|Male|Tumors of the Meninges|2005
20+|6.3|6.6|6.5|Benign/Borderline|6308|104488268|Male|Tumors of the Meninges|2006
20+|0.2|0.2|0.2|Malignant|189|104488268|Male|Tumors of the Meninges|2006
20+|6.4|6.8|6.6|Benign/Borderline|6578|105697783|Male|Tumors of the Meninges|2007
20+|0.2|0.2|0.2|Malignant|222|105697783|Male|Tumors of the Meninges|2007
20+|7.0|7.3|7.1|Benign/Borderline|7279|106947980|Male|Tumors of the Meninges|2008
20+|0.2|0.2|0.2|Malignant|203|106947980|Male|Tumors of the Meninges|2008
20+|7.4|7.7|7.5|Benign/Borderline|7778|108197539|Male|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|202|108197539|Male|Tumors of the Meninges|2009
20+|7.3|7.6|7.4|Benign/Borderline|7849|109553360|Male|Tumors of the Meninges|2010
20+|0.1|0.2|0.1|Malignant|161|109553360|Male|Tumors of the Meninges|2010
20+|7.3|7.6|7.5|Benign/Borderline|8072|110972854|Male|Tumors of the Meninges|2011
20+|0.2|0.2|0.2|Malignant|191|110972854|Male|Tumors of the Meninges|2011
20+|7.4|7.7|7.6|Benign/Borderline|8363|112450239|Male|Tumors of the Meninges|2012
20+|0.1|0.2|0.2|Malignant|188|112450239|Male|Tumors of the Meninges|2012
20+|7.7|8.1|7.9|Benign/Borderline|8883|113812534|Male|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|205|113812534|Male|Tumors of the Meninges|2013
20+|7.8|8.1|7.9|Benign/Borderline|9114|115179072|Male|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|220|115179072|Male|Tumors of the Meninges|2014
20+|8.1|8.5|8.3|Benign/Borderline|9781|116516672|Male|Tumors of the Meninges|2015
20+|0.1|0.2|0.2|Malignant|204|116516672|Male|Tumors of the Meninges|2015
20+|8.3|8.6|8.4|Benign/Borderline|10091|117786951|Male|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|212|117786951|Male|Tumors of the Meninges|2016
20+|8.7|9.0|8.9|Benign/Borderline|10823|118938116|Male|Tumors of the Meninges|2017
20+|0.1|0.2|0.2|Malignant|210|118938116|Male|Tumors of the Meninges|2017
20+|8.8|9.1|9.0|Benign/Borderline|11167|119976528|Male|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|211|119976528|Male|Tumors of the Meninges|2018
20+|9.3|9.7|9.5|Benign/Borderline|11991|120965571|Male|Tumors of the Meninges|2019
20+|0.1|0.2|0.2|Malignant|201|120965571|Male|Tumors of the Meninges|2019
20+|9.3|9.5|9.4|Benign/Borderline|61696|613244056|Male|Tumors of the Meninges|2019-2023
20+|0.1|0.2|0.1|Malignant|983|613244056|Male|Tumors of the Meninges|2019-2023
20+|8.7|9.0|8.8|Benign/Borderline|11376|121845574|Male|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|205|121845574|Male|Tumors of the Meninges|2020
20+|9.2|9.5|9.4|Benign/Borderline|12272|122388572|Male|Tumors of the Meninges|2021
20+|0.1|0.2|0.2|Malignant|215|122388572|Male|Tumors of the Meninges|2021
20+|9.6|10.0|9.8|Benign/Borderline|13046|123330454|Male|Tumors of the Meninges|2022
20+|0.1|0.2|0.2|Malignant|209|123330454|Male|Tumors of the Meninges|2022
20+|9.4|9.7|9.5|Benign/Borderline|13011|124713885|Male|Tumors of the Meninges|2023
20+|0.1|0.1|0.1|Malignant|153|124713885|Male|Tumors of the Meninges|2023
20+|0.6|0.8|0.7|Benign/Borderline|654|101938779|Male|Unclassified Tumors|2004
20+|0.6|0.7|0.7|Malignant|595|101938779|Male|Unclassified Tumors|2004
20+|0.8|0.9|0.9|Benign/Borderline|845|103190694|Male|Unclassified Tumors|2005
20+|0.6|0.7|0.7|Malignant|610|103190694|Male|Unclassified Tumors|2005
20+|0.8|0.9|0.9|Benign/Borderline|875|104488268|Male|Unclassified Tumors|2006
20+|0.6|0.7|0.6|Malignant|574|104488268|Male|Unclassified Tumors|2006
20+|0.8|0.9|0.9|Benign/Borderline|865|105697783|Male|Unclassified Tumors|2007
20+|0.6|0.7|0.6|Malignant|575|105697783|Male|Unclassified Tumors|2007
20+|0.9|1.0|0.9|Benign/Borderline|962|106947980|Male|Unclassified Tumors|2008
20+|0.6|0.7|0.7|Malignant|623|106947980|Male|Unclassified Tumors|2008
20+|1.0|1.1|1.0|Benign/Borderline|1070|108197539|Male|Unclassified Tumors|2009
20+|0.6|0.7|0.7|Malignant|641|108197539|Male|Unclassified Tumors|2009
20+|1.0|1.1|1.1|Benign/Borderline|1142|109553360|Male|Unclassified Tumors|2010
20+|0.6|0.7|0.6|Malignant|612|109553360|Male|Unclassified Tumors|2010
20+|1.0|1.1|1.1|Benign/Borderline|1169|110972854|Male|Unclassified Tumors|2011
20+|0.6|0.7|0.6|Malignant|627|110972854|Male|Unclassified Tumors|2011
20+|1.1|1.2|1.1|Benign/Borderline|1231|112450239|Male|Unclassified Tumors|2012
20+|0.6|0.7|0.6|Malignant|629|112450239|Male|Unclassified Tumors|2012
20+|1.0|1.2|1.1|Benign/Borderline|1224|113812534|Male|Unclassified Tumors|2013
20+|0.5|0.6|0.6|Malignant|617|113812534|Male|Unclassified Tumors|2013
20+|1.0|1.1|1.0|Benign/Borderline|1178|115179072|Male|Unclassified Tumors|2014
20+|0.6|0.7|0.6|Malignant|682|115179072|Male|Unclassified Tumors|2014
20+|0.9|1.1|1.0|Benign/Borderline|1144|116516672|Male|Unclassified Tumors|2015
20+|0.5|0.6|0.6|Malignant|639|116516672|Male|Unclassified Tumors|2015
20+|0.9|1.0|0.9|Benign/Borderline|1047|117786951|Male|Unclassified Tumors|2016
20+|0.5|0.6|0.6|Malignant|649|117786951|Male|Unclassified Tumors|2016
20+|0.8|0.9|0.9|Benign/Borderline|1057|118938116|Male|Unclassified Tumors|2017
20+|0.5|0.5|0.5|Malignant|592|118938116|Male|Unclassified Tumors|2017
20+|0.8|0.9|0.9|Benign/Borderline|1058|119976528|Male|Unclassified Tumors|2018
20+|0.5|0.6|0.6|Malignant|686|119976528|Male|Unclassified Tumors|2018
20+|0.8|0.9|0.8|Benign/Borderline|1028|120965571|Male|Unclassified Tumors|2019
20+|0.6|0.6|0.6|Malignant|727|120965571|Male|Unclassified Tumors|2019
20+|0.8|0.9|0.8|Benign/Borderline|5255|613244056|Male|Unclassified Tumors|2019-2023
20+|0.6|0.6|0.6|Malignant|3581|613244056|Male|Unclassified Tumors|2019-2023
20+|0.8|0.9|0.8|Benign/Borderline|1043|121845574|Male|Unclassified Tumors|2020
20+|0.6|0.7|0.6|Malignant|766|121845574|Male|Unclassified Tumors|2020
20+|0.8|0.9|0.9|Benign/Borderline|1079|122388572|Male|Unclassified Tumors|2021
20+|0.6|0.6|0.6|Malignant|749|122388572|Male|Unclassified Tumors|2021
20+|0.8|0.9|0.8|Benign/Borderline|1045|123330454|Male|Unclassified Tumors|2022
20+|0.5|0.6|0.6|Malignant|713|123330454|Male|Unclassified Tumors|2022
20+|0.8|0.9|0.8|Benign/Borderline|1060|124713885|Male|Unclassified Tumors|2023
20+|0.4|0.5|0.5|Malignant|626|124713885|Male|Unclassified Tumors|2023
20+|0.1|0.1|0.1|Benign/Borderline|101|101938779|Male|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Unique astrocytoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|116|103190694|Male|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|140|104488268|Male|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Unique astrocytoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|125|105697783|Male|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|30|105697783|Male|Unique astrocytoma variants|2007
20+|0.1|0.2|0.1|Benign/Borderline|153|106947980|Male|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008
20+|0.1|0.2|0.2|Benign/Borderline|166|108197539|Male|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|38|108197539|Male|Unique astrocytoma variants|2009
20+|0.1|0.2|0.2|Benign/Borderline|189|109553360|Male|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|26|109553360|Male|Unique astrocytoma variants|2010
20+|0.1|0.2|0.2|Benign/Borderline|192|110972854|Male|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|31|110972854|Male|Unique astrocytoma variants|2011
20+|0.1|0.2|0.2|Benign/Borderline|184|112450239|Male|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|27|112450239|Male|Unique astrocytoma variants|2012
20+|0.1|0.2|0.2|Benign/Borderline|177|113812534|Male|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|39|113812534|Male|Unique astrocytoma variants|2013
20+|0.1|0.2|0.2|Benign/Borderline|183|115179072|Male|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|40|115179072|Male|Unique astrocytoma variants|2014
20+|0.1|0.2|0.2|Benign/Borderline|186|116516672|Male|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|28|116516672|Male|Unique astrocytoma variants|2015
20+|0.1|0.2|0.2|Benign/Borderline|210|117786951|Male|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|31|117786951|Male|Unique astrocytoma variants|2016
20+|0.1|0.2|0.2|Benign/Borderline|217|118938116|Male|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|43|118938116|Male|Unique astrocytoma variants|2017
20+|0.2|0.2|0.2|Benign/Borderline|243|119976528|Male|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|32|119976528|Male|Unique astrocytoma variants|2018
20+|0.2|0.2|0.2|Benign/Borderline|247|120965571|Male|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|29|120965571|Male|Unique astrocytoma variants|2019
20+|0.2|0.2|0.2|Benign/Borderline|1330|613244056|Male|Unique astrocytoma variants|2019-2023
20+|0.0|0.0|0.0|Malignant|167|613244056|Male|Unique astrocytoma variants|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|250|121845574|Male|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|38|121845574|Male|Unique astrocytoma variants|2020
20+|0.2|0.2|0.2|Benign/Borderline|259|122388572|Male|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|31|122388572|Male|Unique astrocytoma variants|2021
20+|0.2|0.2|0.2|Benign/Borderline|287|123330454|Male|Unique astrocytoma variants|2022
20+|0.0|0.0|0.0|Malignant|38|123330454|Male|Unique astrocytoma variants|2022
20+|0.2|0.2|0.2|Benign/Borderline|287|124713885|Male|Unique astrocytoma variants|2023
20+|0.0|0.0|0.0|Malignant|31|124713885|Male|Unique astrocytoma variants|2023
20+|0.0|0.0|0.0|Benign/Borderline|26|211050944|Male and Female|All other|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004
20+|0.0|0.0|0.0|Benign/Borderline|32|213511339|Male and Female|All other|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006
20+|0.0|0.0|0.0|Benign/Borderline|32|218481776|Male and Female|All other|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007
20+|0.0|0.0|0.0|Benign/Borderline|36|220975702|Male and Female|All other|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008
20+|0.0|0.0|0.0|Benign/Borderline|30|223491138|Male and Female|All other|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009
20+|0.0|0.0|0.0|Benign/Borderline|34|226155501|Male and Female|All other|2010
20+|0.0|0.0|0.0|Malignant|35|226155501|Male and Female|All other|2010
20+|0.0|0.0|0.0|Benign/Borderline|32|228810217|Male and Female|All other|2011
20+|0.0|0.0|0.0|Malignant|45|228810217|Male and Female|All other|2011
20+|0.0|0.0|0.0|Benign/Borderline|34|231491214|Male and Female|All other|2012
20+|0.0|0.0|0.0|Malignant|35|231491214|Male and Female|All other|2012
20+|0.0|0.0|0.0|Benign/Borderline|34|233954032|Male and Female|All other|2013
20+|0.0|0.0|0.0|Malignant|52|233954032|Male and Female|All other|2013
20+|0.0|0.0|0.0|Benign/Borderline|30|236459328|Male and Female|All other|2014
20+|0.0|0.0|0.0|Malignant|48|236459328|Male and Female|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|48|238880209|Male and Female|All other|2015
20+|0.0|0.0|0.0|Malignant|53|238880209|Male and Female|All other|2015
20+|0.0|0.0|0.0|Benign/Borderline|81|241210490|Male and Female|All other|2016
20+|0.0|0.0|0.0|Malignant|54|241210490|Male and Female|All other|2016
20+|0.0|0.0|0.0|Benign/Borderline|75|243333009|Male and Female|All other|2017
20+|0.0|0.0|0.0|Malignant|57|243333009|Male and Female|All other|2017
20+|0.0|0.0|0.0|Benign/Borderline|97|245243299|Male and Female|All other|2018
20+|0.1|0.2|0.2|Malignant|402|245243299|Male and Female|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|90|247052250|Male and Female|All other|2019
20+|0.2|0.2|0.2|Malignant|525|247052250|Male and Female|All other|2019
20+|0.1|0.1|0.1|Benign/Borderline|680|1252252205|Male and Female|All other|2019-2023
20+|0.2|0.2|0.2|Malignant|2859|1252252205|Male and Female|All other|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|91|248691091|Male and Female|All other|2020
20+|0.2|0.2|0.2|Malignant|530|248691091|Male and Female|All other|2020
20+|0.0|0.1|0.1|Benign/Borderline|128|249886916|Male and Female|All other|2021
20+|0.2|0.2|0.2|Malignant|472|249886916|Male and Female|All other|2021
20+|0.0|0.1|0.1|Benign/Borderline|143|251903901|Male and Female|All other|2022
20+|0.2|0.2|0.2|Malignant|514|251903901|Male and Female|All other|2022
20+|0.1|0.1|0.1|Benign/Borderline|228|254718047|Male and Female|All other|2023
20+|0.3|0.4|0.3|Malignant|818|254718047|Male and Female|All other|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004
20+|0.6|0.6|0.6|Malignant|1245|211050944|Male and Female|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005
20+|0.5|0.6|0.6|Malignant|1213|213511339|Male and Female|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006
20+|0.5|0.6|0.6|Malignant|1214|216055494|Male and Female|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007
20+|0.5|0.6|0.5|Malignant|1206|218481776|Male and Female|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008
20+|0.5|0.6|0.5|Malignant|1216|220975702|Male and Female|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009
20+|0.5|0.6|0.5|Malignant|1218|223491138|Male and Female|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Anaplastic astrocytoma|2010
20+|0.5|0.6|0.6|Malignant|1286|226155501|Male and Female|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Anaplastic astrocytoma|2011
20+|0.5|0.6|0.5|Malignant|1284|228810217|Male and Female|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Anaplastic astrocytoma|2012
20+|0.5|0.6|0.6|Malignant|1341|231491214|Male and Female|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Anaplastic astrocytoma|2013
20+|0.6|0.6|0.6|Malignant|1447|233954032|Male and Female|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Anaplastic astrocytoma|2014
20+|0.6|0.6|0.6|Malignant|1419|236459328|Male and Female|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Anaplastic astrocytoma|2015
20+|0.6|0.6|0.6|Malignant|1490|238880209|Male and Female|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Anaplastic astrocytoma|2016
20+|0.6|0.6|0.6|Malignant|1488|241210490|Male and Female|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Anaplastic astrocytoma|2017
20+|0.6|0.6|0.6|Malignant|1471|243333009|Male and Female|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Anaplastic astrocytoma|2018
20+|0.5|0.6|0.6|Malignant|1451|245243299|Male and Female|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Anaplastic astrocytoma|2019
20+|0.5|0.5|0.5|Malignant|1307|247052250|Male and Female|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Anaplastic astrocytoma|2019-2023
20+|0.3|0.4|0.4|Malignant|4423|1252252205|Male and Female|Anaplastic astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Anaplastic astrocytoma|2020
20+|0.4|0.5|0.5|Malignant|1188|248691091|Male and Female|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Anaplastic astrocytoma|2021
20+|0.3|0.4|0.3|Malignant|834|249886916|Male and Female|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Anaplastic astrocytoma|2022
20+|0.2|0.3|0.2|Malignant|551|251903901|Male and Female|Anaplastic astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Anaplastic astrocytoma|2023
20+|0.2|0.3|0.2|Malignant|543|254718047|Male and Female|Anaplastic astrocytoma|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004
20+|0.2|0.2|0.2|Malignant|401|211050944|Male and Female|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005
20+|0.2|0.2|0.2|Malignant|383|213511339|Male and Female|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006
20+|0.1|0.2|0.2|Malignant|357|216055494|Male and Female|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007
20+|0.1|0.2|0.2|Malignant|352|218481776|Male and Female|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008
20+|0.1|0.2|0.2|Malignant|365|220975702|Male and Female|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009
20+|0.1|0.2|0.2|Malignant|341|223491138|Male and Female|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Anaplastic oligodendroglioma|2010
20+|0.1|0.2|0.1|Malignant|330|226155501|Male and Female|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.1|Malignant|344|228810217|Male and Female|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.2|Malignant|362|231491214|Male and Female|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Anaplastic oligodendroglioma|2013
20+|0.1|0.2|0.2|Malignant|379|233954032|Male and Female|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Anaplastic oligodendroglioma|2014
20+|0.1|0.2|0.2|Malignant|364|236459328|Male and Female|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.2|Malignant|360|238880209|Male and Female|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Anaplastic oligodendroglioma|2016
20+|0.1|0.2|0.2|Malignant|374|241210490|Male and Female|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Anaplastic oligodendroglioma|2017
20+|0.2|0.2|0.2|Malignant|424|243333009|Male and Female|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Anaplastic oligodendroglioma|2018
20+|0.1|0.2|0.1|Malignant|345|245243299|Male and Female|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Anaplastic oligodendroglioma|2019
20+|0.1|0.2|0.2|Malignant|389|247052250|Male and Female|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Anaplastic oligodendroglioma|2019-2023
20+|0.1|0.1|0.1|Malignant|1419|1252252205|Male and Female|Anaplastic oligodendroglioma|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Anaplastic oligodendroglioma|2020
20+|0.1|0.1|0.1|Malignant|331|248691091|Male and Female|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Anaplastic oligodendroglioma|2021
20+|0.1|0.1|0.1|Malignant|283|249886916|Male and Female|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Anaplastic oligodendroglioma|2022
20+|0.1|0.1|0.1|Malignant|163|251903901|Male and Female|Anaplastic oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Anaplastic oligodendroglioma|2023
20+|0.1|0.1|0.1|Malignant|253|254718047|Male and Female|Anaplastic oligodendroglioma|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004
20+|0.5|0.6|0.6|Malignant|1212|211050944|Male and Female|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005
20+|0.5|0.6|0.6|Malignant|1202|213511339|Male and Female|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006
20+|0.5|0.6|0.6|Malignant|1194|216055494|Male and Female|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007
20+|0.5|0.6|0.5|Malignant|1167|218481776|Male and Female|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008
20+|0.5|0.5|0.5|Malignant|1127|220975702|Male and Female|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009
20+|0.4|0.5|0.5|Malignant|1062|223491138|Male and Female|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Astrocytoma, NOS|2010
20+|0.5|0.5|0.5|Malignant|1106|226155501|Male and Female|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Astrocytoma, NOS|2011
20+|0.4|0.5|0.5|Malignant|1062|228810217|Male and Female|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Astrocytoma, NOS|2012
20+|0.4|0.5|0.5|Malignant|1057|231491214|Male and Female|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Astrocytoma, NOS|2013
20+|0.4|0.5|0.4|Malignant|1038|233954032|Male and Female|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Astrocytoma, NOS|2014
20+|0.4|0.5|0.5|Malignant|1118|236459328|Male and Female|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Astrocytoma, NOS|2015
20+|0.5|0.5|0.5|Malignant|1238|238880209|Male and Female|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Astrocytoma, NOS|2016
20+|0.5|0.6|0.5|Malignant|1285|241210490|Male and Female|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Astrocytoma, NOS|2017
20+|0.5|0.5|0.5|Malignant|1237|243333009|Male and Female|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Astrocytoma, NOS|2018
20+|0.5|0.6|0.5|Malignant|1329|245243299|Male and Female|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Astrocytoma, NOS|2019
20+|0.5|0.5|0.5|Malignant|1284|247052250|Male and Female|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Astrocytoma, NOS|2019-2023
20+|0.6|0.6|0.6|Malignant|6970|1252252205|Male and Female|Astrocytoma, NOS|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Astrocytoma, NOS|2020
20+|0.5|0.5|0.5|Malignant|1261|248691091|Male and Female|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Astrocytoma, NOS|2021
20+|0.6|0.7|0.6|Malignant|1531|249886916|Male and Female|Astrocytoma, NOS|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Astrocytoma, NOS|2022
20+|0.6|0.7|0.7|Malignant|1609|251903901|Male and Female|Astrocytoma, NOS|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Astrocytoma, NOS|2023
20+|0.5|0.6|0.5|Malignant|1285|254718047|Male and Female|Astrocytoma, NOS|2023
20+|0.0|0.0|0.0|Benign/Borderline|65|211050944|Male and Female|Choroid plexus|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004
20+|0.0|0.0|0.0|Benign/Borderline|76|213511339|Male and Female|Choroid plexus|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005
20+|0.0|0.0|0.0|Benign/Borderline|70|216055494|Male and Female|Choroid plexus|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006
20+|0.0|0.1|0.0|Benign/Borderline|92|218481776|Male and Female|Choroid plexus|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007
20+|0.0|0.0|0.0|Benign/Borderline|79|220975702|Male and Female|Choroid plexus|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008
20+|0.0|0.0|0.0|Benign/Borderline|75|223491138|Male and Female|Choroid plexus|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009
20+|0.0|0.0|0.0|Benign/Borderline|86|226155501|Male and Female|Choroid plexus|2010
20+|~|~|~|Malignant|~|226155501|Male and Female|Choroid plexus|2010
20+|0.0|0.0|0.0|Benign/Borderline|86|228810217|Male and Female|Choroid plexus|2011
20+|~|~|~|Malignant|~|228810217|Male and Female|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|79|231491214|Male and Female|Choroid plexus|2012
20+|~|~|~|Malignant|~|231491214|Male and Female|Choroid plexus|2012
20+|0.0|0.0|0.0|Benign/Borderline|82|233954032|Male and Female|Choroid plexus|2013
20+|~|~|~|Malignant|~|233954032|Male and Female|Choroid plexus|2013
20+|0.0|0.0|0.0|Benign/Borderline|92|236459328|Male and Female|Choroid plexus|2014
20+|~|~|~|Malignant|~|236459328|Male and Female|Choroid plexus|2014
20+|0.0|0.0|0.0|Benign/Borderline|85|238880209|Male and Female|Choroid plexus|2015
20+|~|~|~|Malignant|~|238880209|Male and Female|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|74|241210490|Male and Female|Choroid plexus|2016
20+|~|~|~|Malignant|~|241210490|Male and Female|Choroid plexus|2016
20+|0.0|0.0|0.0|Benign/Borderline|98|243333009|Male and Female|Choroid plexus|2017
20+|~|~|~|Malignant|~|243333009|Male and Female|Choroid plexus|2017
20+|0.0|0.0|0.0|Benign/Borderline|85|245243299|Male and Female|Choroid plexus|2018
20+|~|~|~|Malignant|~|245243299|Male and Female|Choroid plexus|2018
20+|0.0|0.0|0.0|Benign/Borderline|88|247052250|Male and Female|Choroid plexus|2019
20+|~|~|~|Malignant|~|247052250|Male and Female|Choroid plexus|2019
20+|0.0|0.0|0.0|Benign/Borderline|403|1252252205|Male and Female|Choroid plexus|2019-2023
20+|0.0|0.0|0.0|Malignant|31|1252252205|Male and Female|Choroid plexus|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|73|248691091|Male and Female|Choroid plexus|2020
20+|~|~|~|Malignant|~|248691091|Male and Female|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|83|249886916|Male and Female|Choroid plexus|2021
20+|~|~|~|Malignant|~|249886916|Male and Female|Choroid plexus|2021
20+|0.0|0.0|0.0|Benign/Borderline|81|251903901|Male and Female|Choroid plexus|2022
20+|~|~|~|Malignant|~|251903901|Male and Female|Choroid plexus|2022
20+|0.0|0.0|0.0|Benign/Borderline|78|254718047|Male and Female|Choroid plexus|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Choroid plexus|2023
20+|0.2|0.2|0.2|Benign/Borderline|396|211050944|Male and Female|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004
20+|0.2|0.2|0.2|Benign/Borderline|423|213511339|Male and Female|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|403|216055494|Male and Female|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|425|218481776|Male and Female|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|430|220975702|Male and Female|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|436|223491138|Male and Female|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|448|226155501|Male and Female|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|226155501|Male and Female|Craniopharyngioma|2010
20+|0.2|0.2|0.2|Benign/Borderline|423|228810217|Male and Female|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|228810217|Male and Female|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|449|231491214|Male and Female|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|231491214|Male and Female|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|486|233954032|Male and Female|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|233954032|Male and Female|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|447|236459328|Male and Female|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|236459328|Male and Female|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|474|238880209|Male and Female|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|238880209|Male and Female|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|483|241210490|Male and Female|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|241210490|Male and Female|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|506|243333009|Male and Female|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|243333009|Male and Female|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|482|245243299|Male and Female|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|245243299|Male and Female|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|501|247052250|Male and Female|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|247052250|Male and Female|Craniopharyngioma|2019
20+|0.2|0.2|0.2|Benign/Borderline|2432|1252252205|Male and Female|Craniopharyngioma|2019-2023
20+|~|~|~|Malignant|~|1252252205|Male and Female|Craniopharyngioma|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|472|248691091|Male and Female|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|248691091|Male and Female|Craniopharyngioma|2020
20+|0.2|0.2|0.2|Benign/Borderline|463|249886916|Male and Female|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|249886916|Male and Female|Craniopharyngioma|2021
20+|0.2|0.2|0.2|Benign/Borderline|507|251903901|Male and Female|Craniopharyngioma|2022
20+|~|~|~|Malignant|~|251903901|Male and Female|Craniopharyngioma|2022
20+|0.2|0.2|0.2|Benign/Borderline|489|254718047|Male and Female|Craniopharyngioma|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Craniopharyngioma|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|260|211050944|Male and Female|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|294|216055494|Male and Female|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|318|218481776|Male and Female|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008
20+|0.1|0.2|0.2|Malignant|340|220975702|Male and Female|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009
20+|0.1|0.2|0.2|Malignant|368|223491138|Male and Female|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Diffuse astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|350|226155501|Male and Female|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|250|228810217|Male and Female|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|208|231491214|Male and Female|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Diffuse astrocytoma|2013
20+|0.1|0.1|0.1|Malignant|175|233954032|Male and Female|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Diffuse astrocytoma|2014
20+|0.0|0.1|0.1|Malignant|132|236459328|Male and Female|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Diffuse astrocytoma|2015
20+|0.0|0.0|0.0|Malignant|84|238880209|Male and Female|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Diffuse astrocytoma|2016
20+|0.0|0.0|0.0|Malignant|35|241210490|Male and Female|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Diffuse astrocytoma|2017
20+|0.0|0.0|0.0|Malignant|24|243333009|Male and Female|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Diffuse astrocytoma|2018
20+|0.0|0.0|0.0|Malignant|23|245243299|Male and Female|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|247052250|Male and Female|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Diffuse astrocytoma|2019-2023
20+|0.0|0.0|0.0|Malignant|32|1252252205|Male and Female|Diffuse astrocytoma|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|248691091|Male and Female|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|249886916|Male and Female|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Diffuse astrocytoma|2022
20+|~|~|~|Malignant|~|251903901|Male and Female|Diffuse astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Diffuse astrocytoma|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Diffuse astrocytoma|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|166|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|189|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|217|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|212|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|234|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|199|226155501|Male and Female|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Embryonal/primitive/medulloblastoma|2011
20+|0.1|0.1|0.1|Malignant|185|228810217|Male and Female|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|173|231491214|Male and Female|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|189|233954032|Male and Female|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|183|236459328|Male and Female|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Embryonal/primitive/medulloblastoma|2015
20+|0.1|0.1|0.1|Malignant|170|238880209|Male and Female|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Embryonal/primitive/medulloblastoma|2016
20+|0.1|0.1|0.1|Malignant|183|241210490|Male and Female|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Embryonal/primitive/medulloblastoma|2017
20+|0.1|0.1|0.1|Malignant|160|243333009|Male and Female|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Embryonal/primitive/medulloblastoma|2018
20+|0.1|0.1|0.1|Malignant|143|245243299|Male and Female|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Embryonal/primitive/medulloblastoma|2019
20+|0.1|0.1|0.1|Malignant|142|247052250|Male and Female|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Embryonal/primitive/medulloblastoma|2019-2023
20+|0.1|0.1|0.1|Malignant|678|1252252205|Male and Female|Embryonal/primitive/medulloblastoma|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|127|248691091|Male and Female|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.1|0.1|Malignant|143|249886916|Male and Female|Embryonal/primitive/medulloblastoma|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Embryonal/primitive/medulloblastoma|2022
20+|0.0|0.1|0.1|Malignant|133|251903901|Male and Female|Embryonal/primitive/medulloblastoma|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Embryonal/primitive/medulloblastoma|2023
20+|0.0|0.1|0.1|Malignant|133|254718047|Male and Female|Embryonal/primitive/medulloblastoma|2023
20+|0.1|0.1|0.1|Benign/Borderline|249|211050944|Male and Female|Ependymoma variants|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|268|213511339|Male and Female|Ependymoma variants|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|312|216055494|Male and Female|Ependymoma variants|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|251|218481776|Male and Female|Ependymoma variants|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|263|223491138|Male and Female|Ependymoma variants|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|280|226155501|Male and Female|Ependymoma variants|2010
20+|~|~|~|Malignant|~|226155501|Male and Female|Ependymoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|273|228810217|Male and Female|Ependymoma variants|2011
20+|~|~|~|Malignant|~|228810217|Male and Female|Ependymoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|296|231491214|Male and Female|Ependymoma variants|2012
20+|~|~|~|Malignant|~|231491214|Male and Female|Ependymoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|279|233954032|Male and Female|Ependymoma variants|2013
20+|~|~|~|Malignant|~|233954032|Male and Female|Ependymoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|303|236459328|Male and Female|Ependymoma variants|2014
20+|~|~|~|Malignant|~|236459328|Male and Female|Ependymoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|297|238880209|Male and Female|Ependymoma variants|2015
20+|~|~|~|Malignant|~|238880209|Male and Female|Ependymoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|303|241210490|Male and Female|Ependymoma variants|2016
20+|~|~|~|Malignant|~|241210490|Male and Female|Ependymoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|284|243333009|Male and Female|Ependymoma variants|2017
20+|~|~|~|Malignant|~|243333009|Male and Female|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|261|245243299|Male and Female|Ependymoma variants|2018
20+|~|~|~|Malignant|~|245243299|Male and Female|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|252|247052250|Male and Female|Ependymoma variants|2019
20+|~|~|~|Malignant|~|247052250|Male and Female|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|1405|1252252205|Male and Female|Ependymoma variants|2019-2023
20+|0.0|0.0|0.0|Malignant|16|1252252205|Male and Female|Ependymoma variants|2019-2023
20+|0.1|0.1|0.1|Benign/Borderline|268|248691091|Male and Female|Ependymoma variants|2020
20+|~|~|~|Malignant|~|248691091|Male and Female|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|292|249886916|Male and Female|Ependymoma variants|2021
20+|~|~|~|Malignant|~|249886916|Male and Female|Ependymoma variants|2021
20+|0.1|0.1|0.1|Benign/Borderline|297|251903901|Male and Female|Ependymoma variants|2022
20+|~|~|~|Malignant|~|251903901|Male and Female|Ependymoma variants|2022
20+|0.1|0.1|0.1|Benign/Borderline|296|254718047|Male and Female|Ependymoma variants|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Ependymoma variants|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004
20+|0.3|0.3|0.3|Malignant|600|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005
20+|0.3|0.3|0.3|Malignant|607|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|588|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|589|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008
20+|0.3|0.3|0.3|Malignant|642|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|687|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009
20+|0.0|0.0|0.0|Benign/Borderline|17|226155501|Male and Female|Ependymoma/anaplastic ependymoma|2010
20+|0.3|0.3|0.3|Malignant|630|226155501|Male and Female|Ependymoma/anaplastic ependymoma|2010
20+|0.0|0.0|0.0|Benign/Borderline|17|228810217|Male and Female|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|601|228810217|Male and Female|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Ependymoma/anaplastic ependymoma|2012
20+|0.2|0.3|0.3|Malignant|634|231491214|Male and Female|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.2|Malignant|591|233954032|Male and Female|Ependymoma/anaplastic ependymoma|2013
20+|0.0|0.0|0.0|Benign/Borderline|29|236459328|Male and Female|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.3|0.2|Malignant|572|236459328|Male and Female|Ependymoma/anaplastic ependymoma|2014
20+|0.0|0.0|0.0|Benign/Borderline|28|238880209|Male and Female|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.2|Malignant|586|238880209|Male and Female|Ependymoma/anaplastic ependymoma|2015
20+|0.0|0.0|0.0|Benign/Borderline|21|241210490|Male and Female|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.3|Malignant|611|241210490|Male and Female|Ependymoma/anaplastic ependymoma|2016
20+|0.0|0.0|0.0|Benign/Borderline|26|243333009|Male and Female|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|607|243333009|Male and Female|Ependymoma/anaplastic ependymoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|19|245243299|Male and Female|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.2|0.2|Malignant|560|245243299|Male and Female|Ependymoma/anaplastic ependymoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|19|247052250|Male and Female|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.2|0.2|Malignant|539|247052250|Male and Female|Ependymoma/anaplastic ependymoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|113|1252252205|Male and Female|Ependymoma/anaplastic ependymoma|2019-2023
20+|0.2|0.2|0.2|Malignant|2550|1252252205|Male and Female|Ependymoma/anaplastic ependymoma|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|29|248691091|Male and Female|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|538|248691091|Male and Female|Ependymoma/anaplastic ependymoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|21|249886916|Male and Female|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|535|249886916|Male and Female|Ependymoma/anaplastic ependymoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|25|251903901|Male and Female|Ependymoma/anaplastic ependymoma|2022
20+|0.2|0.2|0.2|Malignant|474|251903901|Male and Female|Ependymoma/anaplastic ependymoma|2022
20+|0.0|0.0|0.0|Benign/Borderline|19|254718047|Male and Female|Ependymoma/anaplastic ependymoma|2023
20+|0.2|0.2|0.2|Malignant|464|254718047|Male and Female|Ependymoma/anaplastic ependymoma|2023
20+|0.0|0.0|0.0|Benign/Borderline|40|211050944|Male and Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Malignant|55|211050944|Male and Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|69|213511339|Male and Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|67|216055494|Male and Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Malignant|62|216055494|Male and Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|72|218481776|Male and Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|67|220975702|Male and Female|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Benign/Borderline|82|223491138|Male and Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|62|226155501|Male and Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Malignant|65|226155501|Male and Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|64|228810217|Male and Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Malignant|69|228810217|Male and Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|65|231491214|Male and Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Malignant|52|231491214|Male and Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|54|233954032|Male and Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Malignant|52|233954032|Male and Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|62|236459328|Male and Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Malignant|70|236459328|Male and Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|64|238880209|Male and Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Malignant|60|238880209|Male and Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|68|241210490|Male and Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Malignant|80|241210490|Male and Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|58|243333009|Male and Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Malignant|67|243333009|Male and Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|44|245243299|Male and Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Malignant|67|245243299|Male and Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|78|247052250|Male and Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Malignant|76|247052250|Male and Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|274|1252252205|Male and Female|Germ Cell Tumors|2019-2023
20+|0.0|0.0|0.0|Malignant|325|1252252205|Male and Female|Germ Cell Tumors|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|50|248691091|Male and Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Malignant|54|248691091|Male and Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|49|249886916|Male and Female|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Malignant|76|249886916|Male and Female|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Benign/Borderline|46|251903901|Male and Female|Germ Cell Tumors|2022
20+|0.0|0.0|0.0|Malignant|55|251903901|Male and Female|Germ Cell Tumors|2022
20+|0.0|0.0|0.0|Benign/Borderline|51|254718047|Male and Female|Germ Cell Tumors|2023
20+|0.0|0.0|0.0|Malignant|64|254718047|Male and Female|Germ Cell Tumors|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004
20+|4.4|4.6|4.5|Malignant|9591|211050944|Male and Female|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005
20+|4.4|4.5|4.5|Malignant|9714|213511339|Male and Female|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006
20+|4.3|4.5|4.4|Malignant|9796|216055494|Male and Female|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007
20+|4.4|4.6|4.5|Malignant|10204|218481776|Male and Female|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008
20+|4.4|4.6|4.5|Malignant|10428|220975702|Male and Female|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009
20+|4.4|4.5|4.4|Malignant|10508|223491138|Male and Female|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Glioblastoma|2010
20+|4.4|4.5|4.4|Malignant|10743|226155501|Male and Female|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Glioblastoma|2011
20+|4.3|4.5|4.4|Malignant|10892|228810217|Male and Female|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Glioblastoma|2012
20+|4.4|4.6|4.5|Malignant|11376|231491214|Male and Female|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Glioblastoma|2013
20+|4.4|4.6|4.5|Malignant|11548|233954032|Male and Female|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Glioblastoma|2014
20+|4.4|4.5|4.4|Malignant|11622|236459328|Male and Female|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Glioblastoma|2015
20+|4.4|4.6|4.5|Malignant|12058|238880209|Male and Female|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Glioblastoma|2016
20+|4.5|4.6|4.6|Malignant|12445|241210490|Male and Female|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Glioblastoma|2017
20+|4.5|4.6|4.5|Malignant|12643|243333009|Male and Female|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Glioblastoma|2018
20+|4.4|4.6|4.5|Malignant|12768|245243299|Male and Female|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Glioblastoma|2019
20+|4.4|4.6|4.5|Malignant|12946|247052250|Male and Female|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Glioblastoma|2019-2023
20+|4.4|4.5|4.4|Malignant|66546|1252252205|Male and Female|Glioblastoma|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Glioblastoma|2020
20+|4.4|4.6|4.5|Malignant|13304|248691091|Male and Female|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Glioblastoma|2021
20+|4.4|4.5|4.4|Malignant|13260|249886916|Male and Female|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Glioblastoma|2022
20+|4.4|4.5|4.4|Malignant|13577|251903901|Male and Female|Glioblastoma|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Glioblastoma|2023
20+|4.2|4.4|4.3|Malignant|13459|254718047|Male and Female|Glioblastoma|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004
20+|0.4|0.4|0.4|Malignant|856|211050944|Male and Female|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005
20+|0.4|0.4|0.4|Malignant|849|213511339|Male and Female|Glioma malignant, NOS|2005
20+|0.0|0.0|0.0|Benign/Borderline|19|216055494|Male and Female|Glioma malignant, NOS|2006
20+|0.4|0.4|0.4|Malignant|843|216055494|Male and Female|Glioma malignant, NOS|2006
20+|0.0|0.0|0.0|Benign/Borderline|16|218481776|Male and Female|Glioma malignant, NOS|2007
20+|0.4|0.4|0.4|Malignant|875|218481776|Male and Female|Glioma malignant, NOS|2007
20+|0.0|0.0|0.0|Benign/Borderline|26|220975702|Male and Female|Glioma malignant, NOS|2008
20+|0.4|0.4|0.4|Malignant|933|220975702|Male and Female|Glioma malignant, NOS|2008
20+|0.0|0.0|0.0|Benign/Borderline|29|223491138|Male and Female|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|987|223491138|Male and Female|Glioma malignant, NOS|2009
20+|0.0|0.0|0.0|Benign/Borderline|22|226155501|Male and Female|Glioma malignant, NOS|2010
20+|0.3|0.4|0.4|Malignant|821|226155501|Male and Female|Glioma malignant, NOS|2010
20+|0.0|0.0|0.0|Benign/Borderline|31|228810217|Male and Female|Glioma malignant, NOS|2011
20+|0.4|0.4|0.4|Malignant|951|228810217|Male and Female|Glioma malignant, NOS|2011
20+|0.0|0.0|0.0|Benign/Borderline|32|231491214|Male and Female|Glioma malignant, NOS|2012
20+|0.4|0.4|0.4|Malignant|927|231491214|Male and Female|Glioma malignant, NOS|2012
20+|0.0|0.0|0.0|Benign/Borderline|32|233954032|Male and Female|Glioma malignant, NOS|2013
20+|0.4|0.4|0.4|Malignant|950|233954032|Male and Female|Glioma malignant, NOS|2013
20+|0.0|0.0|0.0|Benign/Borderline|42|236459328|Male and Female|Glioma malignant, NOS|2014
20+|0.4|0.4|0.4|Malignant|963|236459328|Male and Female|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|52|238880209|Male and Female|Glioma malignant, NOS|2015
20+|0.4|0.4|0.4|Malignant|1013|238880209|Male and Female|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|55|241210490|Male and Female|Glioma malignant, NOS|2016
20+|0.4|0.5|0.4|Malignant|1083|241210490|Male and Female|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|53|243333009|Male and Female|Glioma malignant, NOS|2017
20+|0.4|0.5|0.5|Malignant|1173|243333009|Male and Female|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|43|245243299|Male and Female|Glioma malignant, NOS|2018
20+|0.4|0.5|0.4|Malignant|1091|245243299|Male and Female|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|50|247052250|Male and Female|Glioma malignant, NOS|2019
20+|0.4|0.4|0.4|Malignant|1061|247052250|Male and Female|Glioma malignant, NOS|2019
20+|0.0|0.0|0.0|Benign/Borderline|274|1252252205|Male and Female|Glioma malignant, NOS|2019-2023
20+|0.4|0.5|0.4|Malignant|5843|1252252205|Male and Female|Glioma malignant, NOS|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|32|248691091|Male and Female|Glioma malignant, NOS|2020
20+|0.4|0.4|0.4|Malignant|1075|248691091|Male and Female|Glioma malignant, NOS|2020
20+|0.0|0.0|0.0|Benign/Borderline|37|249886916|Male and Female|Glioma malignant, NOS|2021
20+|0.4|0.4|0.4|Malignant|1097|249886916|Male and Female|Glioma malignant, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|67|251903901|Male and Female|Glioma malignant, NOS|2022
20+|0.5|0.5|0.5|Malignant|1295|251903901|Male and Female|Glioma malignant, NOS|2022
20+|0.0|0.0|0.0|Benign/Borderline|88|254718047|Male and Female|Glioma malignant, NOS|2023
20+|0.5|0.5|0.5|Malignant|1315|254718047|Male and Female|Glioma malignant, NOS|2023
20+|0.2|0.2|0.2|Benign/Borderline|462|211050944|Male and Female|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004
20+|0.2|0.3|0.2|Benign/Borderline|522|213511339|Male and Female|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005
20+|0.2|0.3|0.2|Benign/Borderline|505|216055494|Male and Female|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006
20+|0.2|0.2|0.2|Benign/Borderline|477|218481776|Male and Female|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007
20+|0.2|0.3|0.2|Benign/Borderline|538|220975702|Male and Female|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008
20+|0.2|0.3|0.2|Benign/Borderline|519|223491138|Male and Female|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009
20+|0.2|0.3|0.2|Benign/Borderline|548|226155501|Male and Female|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|226155501|Male and Female|Hemangioblastoma|2010
20+|0.2|0.3|0.2|Benign/Borderline|535|228810217|Male and Female|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|228810217|Male and Female|Hemangioblastoma|2011
20+|0.2|0.3|0.2|Benign/Borderline|556|231491214|Male and Female|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|231491214|Male and Female|Hemangioblastoma|2012
20+|0.2|0.2|0.2|Benign/Borderline|515|233954032|Male and Female|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|233954032|Male and Female|Hemangioblastoma|2013
20+|0.2|0.2|0.2|Benign/Borderline|506|236459328|Male and Female|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|236459328|Male and Female|Hemangioblastoma|2014
20+|0.2|0.2|0.2|Benign/Borderline|555|238880209|Male and Female|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|238880209|Male and Female|Hemangioblastoma|2015
20+|0.2|0.2|0.2|Benign/Borderline|574|241210490|Male and Female|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|241210490|Male and Female|Hemangioblastoma|2016
20+|0.2|0.3|0.2|Benign/Borderline|580|243333009|Male and Female|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|243333009|Male and Female|Hemangioblastoma|2017
20+|0.2|0.2|0.2|Benign/Borderline|544|245243299|Male and Female|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|245243299|Male and Female|Hemangioblastoma|2018
20+|0.2|0.2|0.2|Benign/Borderline|579|247052250|Male and Female|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|247052250|Male and Female|Hemangioblastoma|2019
20+|0.2|0.2|0.2|Benign/Borderline|2824|1252252205|Male and Female|Hemangioblastoma|2019-2023
20+|~|~|~|Malignant|~|1252252205|Male and Female|Hemangioblastoma|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|566|248691091|Male and Female|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|248691091|Male and Female|Hemangioblastoma|2020
20+|0.2|0.2|0.2|Benign/Borderline|559|249886916|Male and Female|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|249886916|Male and Female|Hemangioblastoma|2021
20+|0.2|0.2|0.2|Benign/Borderline|574|251903901|Male and Female|Hemangioblastoma|2022
20+|~|~|~|Malignant|~|251903901|Male and Female|Hemangioblastoma|2022
20+|0.2|0.2|0.2|Benign/Borderline|546|254718047|Male and Female|Hemangioblastoma|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Hemangioblastoma|2023
20+|0.2|0.2|0.2|Benign/Borderline|394|211050944|Male and Female|Hemangioma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004
20+|0.2|0.3|0.2|Benign/Borderline|501|213511339|Male and Female|Hemangioma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005
20+|0.2|0.3|0.3|Benign/Borderline|567|216055494|Male and Female|Hemangioma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006
20+|0.3|0.3|0.3|Benign/Borderline|660|218481776|Male and Female|Hemangioma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007
20+|0.3|0.4|0.4|Benign/Borderline|827|220975702|Male and Female|Hemangioma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008
20+|0.4|0.5|0.4|Benign/Borderline|996|223491138|Male and Female|Hemangioma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009
20+|0.5|0.5|0.5|Benign/Borderline|1144|226155501|Male and Female|Hemangioma|2010
20+|~|~|~|Malignant|~|226155501|Male and Female|Hemangioma|2010
20+|0.5|0.6|0.5|Benign/Borderline|1259|228810217|Male and Female|Hemangioma|2011
20+|~|~|~|Malignant|~|228810217|Male and Female|Hemangioma|2011
20+|0.5|0.6|0.5|Benign/Borderline|1264|231491214|Male and Female|Hemangioma|2012
20+|~|~|~|Malignant|~|231491214|Male and Female|Hemangioma|2012
20+|0.5|0.6|0.5|Benign/Borderline|1287|233954032|Male and Female|Hemangioma|2013
20+|~|~|~|Malignant|~|233954032|Male and Female|Hemangioma|2013
20+|0.5|0.5|0.5|Benign/Borderline|1237|236459328|Male and Female|Hemangioma|2014
20+|~|~|~|Malignant|~|236459328|Male and Female|Hemangioma|2014
20+|0.4|0.5|0.5|Benign/Borderline|1105|238880209|Male and Female|Hemangioma|2015
20+|~|~|~|Malignant|~|238880209|Male and Female|Hemangioma|2015
20+|0.4|0.5|0.4|Benign/Borderline|1056|241210490|Male and Female|Hemangioma|2016
20+|~|~|~|Malignant|~|241210490|Male and Female|Hemangioma|2016
20+|0.4|0.4|0.4|Benign/Borderline|1050|243333009|Male and Female|Hemangioma|2017
20+|~|~|~|Malignant|~|243333009|Male and Female|Hemangioma|2017
20+|0.4|0.5|0.4|Benign/Borderline|1102|245243299|Male and Female|Hemangioma|2018
20+|~|~|~|Malignant|~|245243299|Male and Female|Hemangioma|2018
20+|0.4|0.5|0.4|Benign/Borderline|1110|247052250|Male and Female|Hemangioma|2019
20+|~|~|~|Malignant|~|247052250|Male and Female|Hemangioma|2019
20+|0.4|0.4|0.4|Benign/Borderline|5598|1252252205|Male and Female|Hemangioma|2019-2023
20+|~|~|~|Malignant|~|1252252205|Male and Female|Hemangioma|2019-2023
20+|0.4|0.5|0.4|Benign/Borderline|1137|248691091|Male and Female|Hemangioma|2020
20+|~|~|~|Malignant|~|248691091|Male and Female|Hemangioma|2020
20+|0.4|0.4|0.4|Benign/Borderline|1074|249886916|Male and Female|Hemangioma|2021
20+|~|~|~|Malignant|~|249886916|Male and Female|Hemangioma|2021
20+|0.4|0.4|0.4|Benign/Borderline|1044|251903901|Male and Female|Hemangioma|2022
20+|~|~|~|Malignant|~|251903901|Male and Female|Hemangioma|2022
20+|0.4|0.5|0.5|Benign/Borderline|1233|254718047|Male and Female|Hemangioma|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Hemangioma|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|49|211050944|Male and Female|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|54|216055494|Male and Female|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|47|218481776|Male and Female|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|52|220975702|Male and Female|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|55|223491138|Male and Female|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|53|226155501|Male and Female|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|46|228810217|Male and Female|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|47|231491214|Male and Female|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|45|233954032|Male and Female|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|50|236459328|Male and Female|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|40|238880209|Male and Female|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Local Extensions from Regional Tumors|2016
20+|0.0|0.0|0.0|Malignant|41|241210490|Male and Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Local Extensions from Regional Tumors|2017
20+|0.0|0.0|0.0|Malignant|40|243333009|Male and Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Local Extensions from Regional Tumors|2018
20+|0.0|0.0|0.0|Malignant|31|245243299|Male and Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Local Extensions from Regional Tumors|2019
20+|0.0|0.0|0.0|Malignant|34|247052250|Male and Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Local Extensions from Regional Tumors|2019-2023
20+|0.0|0.0|0.0|Malignant|146|1252252205|Male and Female|Local Extensions from Regional Tumors|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Local Extensions from Regional Tumors|2020
20+|0.0|0.0|0.0|Malignant|26|248691091|Male and Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Local Extensions from Regional Tumors|2021
20+|0.0|0.0|0.0|Malignant|32|249886916|Male and Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Local Extensions from Regional Tumors|2022
20+|0.0|0.0|0.0|Malignant|23|251903901|Male and Female|Local Extensions from Regional Tumors|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Local Extensions from Regional Tumors|2023
20+|0.0|0.0|0.0|Malignant|31|254718047|Male and Female|Local Extensions from Regional Tumors|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.6|0.7|0.6|Malignant|1340|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.6|0.7|0.7|Malignant|1441|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.6|0.7|0.7|Malignant|1436|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.6|0.7|0.6|Malignant|1372|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.6|0.7|0.7|Malignant|1475|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.6|0.6|0.6|Malignant|1417|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.6|0.7|0.6|Malignant|1497|226155501|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.6|0.7|0.6|Malignant|1522|228810217|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.6|0.6|0.6|Malignant|1455|231491214|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.6|0.6|0.6|Malignant|1471|233954032|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.7|0.6|Malignant|1636|236459328|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.6|0.6|0.6|Malignant|1592|238880209|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.6|0.7|0.6|Malignant|1672|241210490|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.6|0.7|0.6|Malignant|1724|243333009|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.6|0.6|0.6|Malignant|1684|245243299|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.6|0.6|0.6|Malignant|1656|247052250|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
20+|0.6|0.6|0.6|Malignant|8336|1252252205|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.6|0.6|0.6|Malignant|1704|248691091|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.5|0.6|0.6|Malignant|1669|249886916|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|0.5|0.6|0.5|Malignant|1616|251903901|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Lymphomas and Hematopoietic Neoplasms|2023
20+|0.5|0.6|0.6|Malignant|1691|254718047|Male and Female|Lymphomas and Hematopoietic Neoplasms|2023
20+|9.0|9.3|9.2|Benign/Borderline|19504|211050944|Male and Female|Meningioma|2004
20+|0.2|0.2|0.2|Malignant|449|211050944|Male and Female|Meningioma|2004
20+|10.1|10.4|10.2|Benign/Borderline|22128|213511339|Male and Female|Meningioma|2005
20+|0.2|0.2|0.2|Malignant|434|213511339|Male and Female|Meningioma|2005
20+|10.6|10.9|10.8|Benign/Borderline|23648|216055494|Male and Female|Meningioma|2006
20+|0.2|0.2|0.2|Malignant|408|216055494|Male and Female|Meningioma|2006
20+|11.0|11.3|11.2|Benign/Borderline|24960|218481776|Male and Female|Meningioma|2007
20+|0.2|0.2|0.2|Malignant|443|218481776|Male and Female|Meningioma|2007
20+|11.7|11.9|11.8|Benign/Borderline|26958|220975702|Male and Female|Meningioma|2008
20+|0.1|0.2|0.2|Malignant|368|220975702|Male and Female|Meningioma|2008
20+|12.4|12.7|12.6|Benign/Borderline|29222|223491138|Male and Female|Meningioma|2009
20+|0.1|0.2|0.2|Malignant|359|223491138|Male and Female|Meningioma|2009
20+|12.1|12.4|12.3|Benign/Borderline|29008|226155501|Male and Female|Meningioma|2010
20+|0.1|0.2|0.1|Malignant|334|226155501|Male and Female|Meningioma|2010
20+|12.3|12.5|12.4|Benign/Borderline|29792|228810217|Male and Female|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|332|228810217|Male and Female|Meningioma|2011
20+|12.5|12.8|12.7|Benign/Borderline|31004|231491214|Male and Female|Meningioma|2012
20+|0.1|0.2|0.1|Malignant|364|231491214|Male and Female|Meningioma|2012
20+|12.8|13.1|13.0|Benign/Borderline|32223|233954032|Male and Female|Meningioma|2013
20+|0.1|0.2|0.2|Malignant|388|233954032|Male and Female|Meningioma|2013
20+|13.1|13.4|13.2|Benign/Borderline|33569|236459328|Male and Female|Meningioma|2014
20+|0.1|0.2|0.2|Malignant|390|236459328|Male and Female|Meningioma|2014
20+|13.6|13.9|13.8|Benign/Borderline|35591|238880209|Male and Female|Meningioma|2015
20+|0.1|0.2|0.1|Malignant|353|238880209|Male and Female|Meningioma|2015
20+|14.0|14.3|14.1|Benign/Borderline|37024|241210490|Male and Female|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|337|241210490|Male and Female|Meningioma|2016
20+|14.5|14.8|14.7|Benign/Borderline|39104|243333009|Male and Female|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|339|243333009|Male and Female|Meningioma|2017
20+|14.7|15.0|14.9|Benign/Borderline|40397|245243299|Male and Female|Meningioma|2018
20+|0.1|0.1|0.1|Malignant|326|245243299|Male and Female|Meningioma|2018
20+|15.5|15.8|15.7|Benign/Borderline|43254|247052250|Male and Female|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|321|247052250|Male and Female|Meningioma|2019
20+|15.5|15.6|15.5|Benign/Borderline|221052|1252252205|Male and Female|Meningioma|2019-2023
20+|0.1|0.1|0.1|Malignant|1710|1252252205|Male and Female|Meningioma|2019-2023
20+|14.1|14.4|14.3|Benign/Borderline|39952|248691091|Male and Female|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|320|248691091|Male and Female|Meningioma|2020
20+|15.5|15.8|15.7|Benign/Borderline|44488|249886916|Male and Female|Meningioma|2021
20+|0.1|0.1|0.1|Malignant|364|249886916|Male and Female|Meningioma|2021
20+|15.9|16.2|16.0|Benign/Borderline|46341|251903901|Male and Female|Meningioma|2022
20+|0.1|0.1|0.1|Malignant|381|251903901|Male and Female|Meningioma|2022
20+|15.8|16.1|15.9|Benign/Borderline|47017|254718047|Male and Female|Meningioma|2023
20+|0.1|0.1|0.1|Malignant|324|254718047|Male and Female|Meningioma|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004
20+|0.2|0.3|0.2|Malignant|492|211050944|Male and Female|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005
20+|0.2|0.3|0.3|Malignant|565|213511339|Male and Female|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006
20+|0.3|0.3|0.3|Malignant|641|216055494|Male and Female|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007
20+|0.3|0.3|0.3|Malignant|594|218481776|Male and Female|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008
20+|0.3|0.3|0.3|Malignant|604|220975702|Male and Female|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009
20+|0.3|0.3|0.3|Malignant|678|223491138|Male and Female|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Mixed glioma|2010
20+|0.3|0.3|0.3|Malignant|616|226155501|Male and Female|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Mixed glioma|2011
20+|0.3|0.3|0.3|Malignant|642|228810217|Male and Female|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Mixed glioma|2012
20+|0.2|0.3|0.3|Malignant|575|231491214|Male and Female|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Mixed glioma|2013
20+|0.3|0.3|0.3|Malignant|622|233954032|Male and Female|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Mixed glioma|2014
20+|0.2|0.2|0.2|Malignant|470|236459328|Male and Female|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Mixed glioma|2015
20+|0.1|0.1|0.1|Malignant|279|238880209|Male and Female|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Mixed glioma|2016
20+|0.0|0.1|0.0|Malignant|106|241210490|Male and Female|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|61|243333009|Male and Female|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Mixed glioma|2018
20+|0.0|0.0|0.0|Malignant|20|245243299|Male and Female|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Mixed glioma|2019
20+|0.0|0.0|0.0|Malignant|20|247052250|Male and Female|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Mixed glioma|2019-2023
20+|0.0|0.0|0.0|Malignant|67|1252252205|Male and Female|Mixed glioma|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Mixed glioma|2020
20+|0.0|0.0|0.0|Malignant|18|248691091|Male and Female|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Mixed glioma|2021
20+|~|~|~|Malignant|~|249886916|Male and Female|Mixed glioma|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Mixed glioma|2022
20+|~|~|~|Malignant|~|251903901|Male and Female|Mixed glioma|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Mixed glioma|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Mixed glioma|2023
20+|0.5|0.6|0.6|Benign/Borderline|1203|211050944|Male and Female|Neoplasm, unspecified|2004
20+|0.6|0.6|0.6|Malignant|1268|211050944|Male and Female|Neoplasm, unspecified|2004
20+|0.7|0.7|0.7|Benign/Borderline|1505|213511339|Male and Female|Neoplasm, unspecified|2005
20+|0.6|0.6|0.6|Malignant|1317|213511339|Male and Female|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Benign/Borderline|1436|216055494|Male and Female|Neoplasm, unspecified|2006
20+|0.6|0.6|0.6|Malignant|1286|216055494|Male and Female|Neoplasm, unspecified|2006
20+|0.6|0.7|0.7|Benign/Borderline|1444|218481776|Male and Female|Neoplasm, unspecified|2007
20+|0.5|0.6|0.5|Malignant|1215|218481776|Male and Female|Neoplasm, unspecified|2007
20+|0.6|0.7|0.7|Benign/Borderline|1463|220975702|Male and Female|Neoplasm, unspecified|2008
20+|0.6|0.6|0.6|Malignant|1366|220975702|Male and Female|Neoplasm, unspecified|2008
20+|0.6|0.7|0.7|Benign/Borderline|1543|223491138|Male and Female|Neoplasm, unspecified|2009
20+|0.6|0.6|0.6|Malignant|1416|223491138|Male and Female|Neoplasm, unspecified|2009
20+|0.6|0.7|0.7|Benign/Borderline|1514|226155501|Male and Female|Neoplasm, unspecified|2010
20+|0.5|0.6|0.5|Malignant|1242|226155501|Male and Female|Neoplasm, unspecified|2010
20+|0.6|0.7|0.6|Benign/Borderline|1498|228810217|Male and Female|Neoplasm, unspecified|2011
20+|0.5|0.6|0.5|Malignant|1262|228810217|Male and Female|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|1607|231491214|Male and Female|Neoplasm, unspecified|2012
20+|0.5|0.6|0.5|Malignant|1270|231491214|Male and Female|Neoplasm, unspecified|2012
20+|0.6|0.6|0.6|Benign/Borderline|1504|233954032|Male and Female|Neoplasm, unspecified|2013
20+|0.5|0.5|0.5|Malignant|1274|233954032|Male and Female|Neoplasm, unspecified|2013
20+|0.6|0.7|0.6|Benign/Borderline|1561|236459328|Male and Female|Neoplasm, unspecified|2014
20+|0.5|0.6|0.6|Malignant|1415|236459328|Male and Female|Neoplasm, unspecified|2014
20+|0.6|0.7|0.6|Benign/Borderline|1542|238880209|Male and Female|Neoplasm, unspecified|2015
20+|0.5|0.6|0.5|Malignant|1372|238880209|Male and Female|Neoplasm, unspecified|2015
20+|0.5|0.6|0.6|Benign/Borderline|1439|241210490|Male and Female|Neoplasm, unspecified|2016
20+|0.5|0.5|0.5|Malignant|1264|241210490|Male and Female|Neoplasm, unspecified|2016
20+|0.5|0.6|0.5|Benign/Borderline|1376|243333009|Male and Female|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Malignant|1271|243333009|Male and Female|Neoplasm, unspecified|2017
20+|0.5|0.5|0.5|Benign/Borderline|1332|245243299|Male and Female|Neoplasm, unspecified|2018
20+|0.5|0.5|0.5|Malignant|1356|245243299|Male and Female|Neoplasm, unspecified|2018
20+|0.4|0.5|0.4|Benign/Borderline|1167|247052250|Male and Female|Neoplasm, unspecified|2019
20+|0.5|0.5|0.5|Malignant|1427|247052250|Male and Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.5|Benign/Borderline|6124|1252252205|Male and Female|Neoplasm, unspecified|2019-2023
20+|0.5|0.5|0.5|Malignant|7169|1252252205|Male and Female|Neoplasm, unspecified|2019-2023
20+|0.4|0.5|0.5|Benign/Borderline|1242|248691091|Male and Female|Neoplasm, unspecified|2020
20+|0.5|0.6|0.6|Malignant|1541|248691091|Male and Female|Neoplasm, unspecified|2020
20+|0.4|0.5|0.5|Benign/Borderline|1225|249886916|Male and Female|Neoplasm, unspecified|2021
20+|0.5|0.5|0.5|Malignant|1469|249886916|Male and Female|Neoplasm, unspecified|2021
20+|0.5|0.5|0.5|Benign/Borderline|1357|251903901|Male and Female|Neoplasm, unspecified|2022
20+|0.5|0.5|0.5|Malignant|1426|251903901|Male and Female|Neoplasm, unspecified|2022
20+|0.4|0.4|0.4|Benign/Borderline|1133|254718047|Male and Female|Neoplasm, unspecified|2023
20+|0.4|0.5|0.4|Malignant|1306|254718047|Male and Female|Neoplasm, unspecified|2023
20+|2.3|2.4|2.3|Benign/Borderline|5012|211050944|Male and Female|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004
20+|2.5|2.7|2.6|Benign/Borderline|5621|213511339|Male and Female|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Nerve sheath, benign and malignant|2005
20+|2.5|2.7|2.6|Benign/Borderline|5729|216055494|Male and Female|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006
20+|2.5|2.7|2.6|Benign/Borderline|5860|218481776|Male and Female|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007
20+|2.5|2.7|2.6|Benign/Borderline|5988|220975702|Male and Female|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008
20+|2.6|2.8|2.7|Benign/Borderline|6287|223491138|Male and Female|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Nerve sheath, benign and malignant|2009
20+|2.5|2.7|2.6|Benign/Borderline|6176|226155501|Male and Female|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|46|226155501|Male and Female|Nerve sheath, benign and malignant|2010
20+|2.7|2.8|2.7|Benign/Borderline|6529|228810217|Male and Female|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|38|228810217|Male and Female|Nerve sheath, benign and malignant|2011
20+|2.8|2.9|2.8|Benign/Borderline|6975|231491214|Male and Female|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|53|231491214|Male and Female|Nerve sheath, benign and malignant|2012
20+|2.9|3.0|2.9|Benign/Borderline|7292|233954032|Male and Female|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|47|233954032|Male and Female|Nerve sheath, benign and malignant|2013
20+|3.0|3.1|3.1|Benign/Borderline|7712|236459328|Male and Female|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|37|236459328|Male and Female|Nerve sheath, benign and malignant|2014
20+|3.0|3.2|3.1|Benign/Borderline|7905|238880209|Male and Female|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|41|238880209|Male and Female|Nerve sheath, benign and malignant|2015
20+|3.0|3.1|3.1|Benign/Borderline|7880|241210490|Male and Female|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|54|241210490|Male and Female|Nerve sheath, benign and malignant|2016
20+|3.0|3.1|3.0|Benign/Borderline|7977|243333009|Male and Female|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|46|243333009|Male and Female|Nerve sheath, benign and malignant|2017
20+|3.0|3.1|3.0|Benign/Borderline|8117|245243299|Male and Female|Nerve sheath, benign and malignant|2018
20+|0.0|0.0|0.0|Malignant|31|245243299|Male and Female|Nerve sheath, benign and malignant|2018
20+|3.0|3.1|3.1|Benign/Borderline|8300|247052250|Male and Female|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|39|247052250|Male and Female|Nerve sheath, benign and malignant|2019
20+|3.0|3.0|3.0|Benign/Borderline|41006|1252252205|Male and Female|Nerve sheath, benign and malignant|2019-2023
20+|0.0|0.0|0.0|Malignant|226|1252252205|Male and Female|Nerve sheath, benign and malignant|2019-2023
20+|2.6|2.7|2.6|Benign/Borderline|7166|248691091|Male and Female|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|39|248691091|Male and Female|Nerve sheath, benign and malignant|2020
20+|3.1|3.2|3.1|Benign/Borderline|8531|249886916|Male and Female|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|47|249886916|Male and Female|Nerve sheath, benign and malignant|2021
20+|3.0|3.2|3.1|Benign/Borderline|8584|251903901|Male and Female|Nerve sheath, benign and malignant|2022
20+|0.0|0.0|0.0|Malignant|57|251903901|Male and Female|Nerve sheath, benign and malignant|2022
20+|2.9|3.1|3.0|Benign/Borderline|8425|254718047|Male and Female|Nerve sheath, benign and malignant|2023
20+|0.0|0.0|0.0|Malignant|44|254718047|Male and Female|Nerve sheath, benign and malignant|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|49|211050944|Male and Female|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|42|216055494|Male and Female|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|51|218481776|Male and Female|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|52|226155501|Male and Female|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|50|228810217|Male and Female|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|55|231491214|Male and Female|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|48|233954032|Male and Female|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|57|236459328|Male and Female|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|73|238880209|Male and Female|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|47|241210490|Male and Female|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|35|243333009|Male and Female|Neuroepithelial|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Neuroepithelial|2018
20+|0.0|0.0|0.0|Malignant|24|245243299|Male and Female|Neuroepithelial|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Malignant|28|247052250|Male and Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Benign/Borderline|58|1252252205|Male and Female|Neuroepithelial|2019-2023
20+|0.0|0.0|0.0|Malignant|99|1252252205|Male and Female|Neuroepithelial|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Neuroepithelial|2020
20+|0.0|0.0|0.0|Malignant|24|248691091|Male and Female|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Neuroepithelial|2021
20+|0.0|0.0|0.0|Malignant|25|249886916|Male and Female|Neuroepithelial|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Neuroepithelial|2022
20+|0.0|0.0|0.0|Malignant|16|251903901|Male and Female|Neuroepithelial|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Neuroepithelial|2023
20+|~|~|~|Malignant|~|254718047|Male and Female|Neuroepithelial|2023
20+|0.1|0.2|0.1|Benign/Borderline|317|211050944|Male and Female|Neuronal/glial, neuronal|2004
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004
20+|0.2|0.2|0.2|Benign/Borderline|379|213511339|Male and Female|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|54|213511339|Male and Female|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|390|216055494|Male and Female|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|44|216055494|Male and Female|Neuronal/glial, neuronal|2006
20+|0.2|0.2|0.2|Benign/Borderline|395|218481776|Male and Female|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|45|218481776|Male and Female|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|423|220975702|Male and Female|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|50|220975702|Male and Female|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|444|223491138|Male and Female|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|42|223491138|Male and Female|Neuronal/glial, neuronal|2009
20+|0.2|0.2|0.2|Benign/Borderline|486|226155501|Male and Female|Neuronal/glial, neuronal|2010
20+|0.0|0.0|0.0|Malignant|32|226155501|Male and Female|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|446|228810217|Male and Female|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|40|228810217|Male and Female|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|429|231491214|Male and Female|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|44|231491214|Male and Female|Neuronal/glial, neuronal|2012
20+|0.2|0.2|0.2|Benign/Borderline|403|233954032|Male and Female|Neuronal/glial, neuronal|2013
20+|0.0|0.0|0.0|Malignant|33|233954032|Male and Female|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|472|236459328|Male and Female|Neuronal/glial, neuronal|2014
20+|0.0|0.0|0.0|Malignant|35|236459328|Male and Female|Neuronal/glial, neuronal|2014
20+|0.2|0.2|0.2|Benign/Borderline|511|238880209|Male and Female|Neuronal/glial, neuronal|2015
20+|0.0|0.0|0.0|Malignant|33|238880209|Male and Female|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|499|241210490|Male and Female|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|47|241210490|Male and Female|Neuronal/glial, neuronal|2016
20+|0.2|0.3|0.2|Benign/Borderline|536|243333009|Male and Female|Neuronal/glial, neuronal|2017
20+|0.0|0.0|0.0|Malignant|35|243333009|Male and Female|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|478|245243299|Male and Female|Neuronal/glial, neuronal|2018
20+|0.0|0.0|0.0|Malignant|25|245243299|Male and Female|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|518|247052250|Male and Female|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|35|247052250|Male and Female|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|2405|1252252205|Male and Female|Neuronal/glial, neuronal|2019-2023
20+|0.0|0.0|0.0|Malignant|218|1252252205|Male and Female|Neuronal/glial, neuronal|2019-2023
20+|0.2|0.2|0.2|Benign/Borderline|466|248691091|Male and Female|Neuronal/glial, neuronal|2020
20+|0.0|0.0|0.0|Malignant|31|248691091|Male and Female|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|500|249886916|Male and Female|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|45|249886916|Male and Female|Neuronal/glial, neuronal|2021
20+|0.2|0.2|0.2|Benign/Borderline|470|251903901|Male and Female|Neuronal/glial, neuronal|2022
20+|0.0|0.0|0.0|Malignant|53|251903901|Male and Female|Neuronal/glial, neuronal|2022
20+|0.2|0.2|0.2|Benign/Borderline|451|254718047|Male and Female|Neuronal/glial, neuronal|2023
20+|0.0|0.0|0.0|Malignant|54|254718047|Male and Female|Neuronal/glial, neuronal|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004
20+|0.4|0.4|0.4|Malignant|832|211050944|Male and Female|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005
20+|0.4|0.4|0.4|Malignant|812|213511339|Male and Female|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006
20+|0.4|0.4|0.4|Malignant|873|216055494|Male and Female|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007
20+|0.4|0.4|0.4|Malignant|819|218481776|Male and Female|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008
20+|0.3|0.4|0.4|Malignant|795|220975702|Male and Female|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009
20+|0.4|0.4|0.4|Malignant|854|223491138|Male and Female|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Oligodendroglioma|2010
20+|0.3|0.4|0.4|Malignant|822|226155501|Male and Female|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Oligodendroglioma|2011
20+|0.3|0.4|0.3|Malignant|778|228810217|Male and Female|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Oligodendroglioma|2012
20+|0.3|0.3|0.3|Malignant|691|231491214|Male and Female|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Oligodendroglioma|2013
20+|0.3|0.3|0.3|Malignant|727|233954032|Male and Female|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Oligodendroglioma|2014
20+|0.3|0.4|0.3|Malignant|743|236459328|Male and Female|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Oligodendroglioma|2015
20+|0.3|0.3|0.3|Malignant|731|238880209|Male and Female|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Oligodendroglioma|2016
20+|0.3|0.4|0.3|Malignant|760|241210490|Male and Female|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Oligodendroglioma|2017
20+|0.3|0.3|0.3|Malignant|741|243333009|Male and Female|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|245243299|Male and Female|Oligodendroglioma|2018
20+|0.3|0.3|0.3|Malignant|679|245243299|Male and Female|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|247052250|Male and Female|Oligodendroglioma|2019
20+|0.3|0.3|0.3|Malignant|755|247052250|Male and Female|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|1252252205|Male and Female|Oligodendroglioma|2019-2023
20+|0.3|0.3|0.3|Malignant|3836|1252252205|Male and Female|Oligodendroglioma|2019-2023
20+|~|~|~|Benign/Borderline|~|248691091|Male and Female|Oligodendroglioma|2020
20+|0.3|0.3|0.3|Malignant|652|248691091|Male and Female|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|249886916|Male and Female|Oligodendroglioma|2021
20+|0.3|0.3|0.3|Malignant|754|249886916|Male and Female|Oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|251903901|Male and Female|Oligodendroglioma|2022
20+|0.3|0.4|0.4|Malignant|872|251903901|Male and Female|Oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|254718047|Male and Female|Oligodendroglioma|2023
20+|0.3|0.4|0.3|Malignant|803|254718047|Male and Female|Oligodendroglioma|2023
20+|0.1|0.1|0.1|Benign/Borderline|154|211050944|Male and Female|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|60|211050944|Male and Female|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|158|213511339|Male and Female|Other mesenchymal|2005
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|161|216055494|Male and Female|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|58|216055494|Male and Female|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|168|218481776|Male and Female|Other mesenchymal|2007
20+|0.0|0.0|0.0|Malignant|80|218481776|Male and Female|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|211|220975702|Male and Female|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|101|220975702|Male and Female|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|202|223491138|Male and Female|Other mesenchymal|2009
20+|0.0|0.0|0.0|Malignant|81|223491138|Male and Female|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|182|226155501|Male and Female|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|72|226155501|Male and Female|Other mesenchymal|2010
20+|0.1|0.1|0.1|Benign/Borderline|169|228810217|Male and Female|Other mesenchymal|2011
20+|0.0|0.0|0.0|Malignant|78|228810217|Male and Female|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|206|231491214|Male and Female|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|73|231491214|Male and Female|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|186|233954032|Male and Female|Other mesenchymal|2013
20+|0.0|0.0|0.0|Malignant|86|233954032|Male and Female|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|190|236459328|Male and Female|Other mesenchymal|2014
20+|0.0|0.0|0.0|Malignant|87|236459328|Male and Female|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|204|238880209|Male and Female|Other mesenchymal|2015
20+|0.0|0.0|0.0|Malignant|95|238880209|Male and Female|Other mesenchymal|2015
20+|0.1|0.1|0.1|Benign/Borderline|171|241210490|Male and Female|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|87|241210490|Male and Female|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|206|243333009|Male and Female|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|121|243333009|Male and Female|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|191|245243299|Male and Female|Other mesenchymal|2018
20+|0.0|0.1|0.0|Malignant|113|245243299|Male and Female|Other mesenchymal|2018
20+|0.1|0.1|0.1|Benign/Borderline|164|247052250|Male and Female|Other mesenchymal|2019
20+|0.0|0.0|0.0|Malignant|101|247052250|Male and Female|Other mesenchymal|2019
20+|0.1|0.1|0.1|Benign/Borderline|925|1252252205|Male and Female|Other mesenchymal|2019-2023
20+|0.0|0.0|0.0|Malignant|471|1252252205|Male and Female|Other mesenchymal|2019-2023
20+|0.0|0.1|0.1|Benign/Borderline|133|248691091|Male and Female|Other mesenchymal|2020
20+|0.0|0.1|0.0|Malignant|121|248691091|Male and Female|Other mesenchymal|2020
20+|0.1|0.1|0.1|Benign/Borderline|179|249886916|Male and Female|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|114|249886916|Male and Female|Other mesenchymal|2021
20+|0.1|0.1|0.1|Benign/Borderline|225|251903901|Male and Female|Other mesenchymal|2022
20+|0.0|0.0|0.0|Malignant|77|251903901|Male and Female|Other mesenchymal|2022
20+|0.1|0.1|0.1|Benign/Borderline|224|254718047|Male and Female|Other mesenchymal|2023
20+|0.0|0.0|0.0|Malignant|58|254718047|Male and Female|Other mesenchymal|2023
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004
20+|0.1|0.2|0.1|Malignant|280|211050944|Male and Female|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|311|213511339|Male and Female|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|308|216055494|Male and Female|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|311|218481776|Male and Female|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|293|220975702|Male and Female|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009
20+|0.1|0.1|0.1|Malignant|275|223491138|Male and Female|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226155501|Male and Female|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|335|226155501|Male and Female|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228810217|Male and Female|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.2|Malignant|339|228810217|Male and Female|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231491214|Male and Female|Pilocytic astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|276|231491214|Male and Female|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|233954032|Male and Female|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|310|233954032|Male and Female|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236459328|Male and Female|Pilocytic astrocytoma|2014
20+|0.1|0.1|0.1|Malignant|303|236459328|Male and Female|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|238880209|Male and Female|Pilocytic astrocytoma|2015
20+|0.1|0.1|0.1|Malignant|302|238880209|Male and Female|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241210490|Male and Female|Pilocytic astrocytoma|2016
20+|0.1|0.1|0.1|Malignant|304|241210490|Male and Female|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243333009|Male and Female|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|280|243333009|Male and Female|Pilocytic astrocytoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|18|245243299|Male and Female|Pilocytic astrocytoma|2018
20+|0.1|0.1|0.1|Malignant|284|245243299|Male and Female|Pilocytic astrocytoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|26|247052250|Male and Female|Pilocytic astrocytoma|2019
20+|0.1|0.1|0.1|Malignant|294|247052250|Male and Female|Pilocytic astrocytoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|355|1252252205|Male and Female|Pilocytic astrocytoma|2019-2023
20+|0.1|0.1|0.1|Malignant|1212|1252252205|Male and Female|Pilocytic astrocytoma|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|20|248691091|Male and Female|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|273|248691091|Male and Female|Pilocytic astrocytoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|23|249886916|Male and Female|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|265|249886916|Male and Female|Pilocytic astrocytoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|20|251903901|Male and Female|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Malignant|265|251903901|Male and Female|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Benign/Borderline|266|254718047|Male and Female|Pilocytic astrocytoma|2023
20+|0.0|0.1|0.0|Malignant|115|254718047|Male and Female|Pilocytic astrocytoma|2023
20+|0.0|0.0|0.0|Benign/Borderline|27|211050944|Male and Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Benign/Borderline|50|213511339|Male and Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|48|216055494|Male and Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Benign/Borderline|47|218481776|Male and Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|45|218481776|Male and Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Benign/Borderline|70|220975702|Male and Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Benign/Borderline|44|223491138|Male and Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|48|223491138|Male and Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Benign/Borderline|56|226155501|Male and Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|41|226155501|Male and Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Benign/Borderline|63|228810217|Male and Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|44|228810217|Male and Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|62|231491214|Male and Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|41|231491214|Male and Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Benign/Borderline|68|233954032|Male and Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|71|233954032|Male and Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Benign/Borderline|66|236459328|Male and Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Malignant|35|236459328|Male and Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Benign/Borderline|65|238880209|Male and Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|59|238880209|Male and Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|66|241210490|Male and Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|66|241210490|Male and Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|58|243333009|Male and Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|53|243333009|Male and Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|61|245243299|Male and Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|43|245243299|Male and Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|47|247052250|Male and Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|49|247052250|Male and Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|229|1252252205|Male and Female|Pineal parenchymal|2019-2023
20+|0.0|0.0|0.0|Malignant|224|1252252205|Male and Female|Pineal parenchymal|2019-2023
20+|0.0|0.0|0.0|Benign/Borderline|47|248691091|Male and Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|46|248691091|Male and Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Benign/Borderline|40|249886916|Male and Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|57|249886916|Male and Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Benign/Borderline|55|251903901|Male and Female|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Malignant|38|251903901|Male and Female|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Benign/Borderline|40|254718047|Male and Female|Pineal parenchymal|2023
20+|0.0|0.0|0.0|Malignant|34|254718047|Male and Female|Pineal parenchymal|2023
20+|3.6|3.8|3.7|Benign/Borderline|7879|211050944|Male and Female|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|44|211050944|Male and Female|Pituitary|2004
20+|4.1|4.3|4.2|Benign/Borderline|8944|213511339|Male and Female|Pituitary|2005
20+|0.0|0.0|0.0|Malignant|39|213511339|Male and Female|Pituitary|2005
20+|4.4|4.6|4.5|Benign/Borderline|9729|216055494|Male and Female|Pituitary|2006
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Pituitary|2006
20+|4.6|4.8|4.7|Benign/Borderline|10380|218481776|Male and Female|Pituitary|2007
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Pituitary|2007
20+|5.0|5.2|5.1|Benign/Borderline|11265|220975702|Male and Female|Pituitary|2008
20+|0.0|0.0|0.0|Malignant|16|220975702|Male and Female|Pituitary|2008
20+|5.4|5.6|5.5|Benign/Borderline|12298|223491138|Male and Female|Pituitary|2009
20+|0.0|0.0|0.0|Malignant|28|223491138|Male and Female|Pituitary|2009
20+|5.4|5.6|5.5|Benign/Borderline|12619|226155501|Male and Female|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|34|226155501|Male and Female|Pituitary|2010
20+|5.6|5.8|5.7|Benign/Borderline|12999|228810217|Male and Female|Pituitary|2011
20+|0.0|0.0|0.0|Malignant|37|228810217|Male and Female|Pituitary|2011
20+|6.0|6.2|6.1|Benign/Borderline|14109|231491214|Male and Female|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|35|231491214|Male and Female|Pituitary|2012
20+|5.9|6.1|6.0|Benign/Borderline|14181|233954032|Male and Female|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|47|233954032|Male and Female|Pituitary|2013
20+|6.0|6.2|6.1|Benign/Borderline|14612|236459328|Male and Female|Pituitary|2014
20+|0.0|0.0|0.0|Malignant|38|236459328|Male and Female|Pituitary|2014
20+|6.3|6.5|6.4|Benign/Borderline|15443|238880209|Male and Female|Pituitary|2015
20+|0.0|0.0|0.0|Malignant|34|238880209|Male and Female|Pituitary|2015
20+|6.4|6.6|6.5|Benign/Borderline|15848|241210490|Male and Female|Pituitary|2016
20+|0.0|0.0|0.0|Malignant|43|241210490|Male and Female|Pituitary|2016
20+|6.7|6.9|6.8|Benign/Borderline|16723|243333009|Male and Female|Pituitary|2017
20+|0.0|0.0|0.0|Malignant|33|243333009|Male and Female|Pituitary|2017
20+|6.7|6.9|6.8|Benign/Borderline|17034|245243299|Male and Female|Pituitary|2018
20+|0.0|0.0|0.0|Malignant|43|245243299|Male and Female|Pituitary|2018
20+|6.8|7.0|6.9|Benign/Borderline|17453|247052250|Male and Female|Pituitary|2019
20+|0.0|0.0|0.0|Malignant|33|247052250|Male and Female|Pituitary|2019
20+|6.5|6.6|6.5|Benign/Borderline|83529|1252252205|Male and Female|Pituitary|2019-2023
20+|0.2|0.2|0.2|Malignant|2792|1252252205|Male and Female|Pituitary|2019-2023
20+|5.9|6.1|6.0|Benign/Borderline|15336|248691091|Male and Female|Pituitary|2020
20+|0.0|0.0|0.0|Malignant|62|248691091|Male and Female|Pituitary|2020
20+|6.7|6.9|6.8|Benign/Borderline|17418|249886916|Male and Female|Pituitary|2021
20+|0.0|0.0|0.0|Malignant|86|249886916|Male and Female|Pituitary|2021
20+|6.6|6.8|6.7|Benign/Borderline|17344|251903901|Male and Female|Pituitary|2022
20+|0.1|0.2|0.2|Malignant|415|251903901|Male and Female|Pituitary|2022
20+|6.0|6.2|6.1|Benign/Borderline|15978|254718047|Male and Female|Pituitary|2023
20+|0.8|0.9|0.8|Malignant|2196|254718047|Male and Female|Pituitary|2023
20+|16.7|17.1|16.9|Benign/Borderline|35895|211050944|Male and Female|Total|2004
20+|9.0|9.3|9.1|Malignant|19425|211050944|Male and Female|Total|2004
20+|18.8|19.1|18.9|Benign/Borderline|40855|213511339|Male and Female|Total|2005
20+|9.0|9.3|9.2|Malignant|19782|213511339|Male and Female|Total|2005
20+|19.6|20.0|19.8|Benign/Borderline|43318|216055494|Male and Female|Total|2006
20+|8.9|9.2|9.1|Malignant|19870|216055494|Male and Female|Total|2006
20+|20.2|20.6|20.4|Benign/Borderline|45477|218481776|Male and Female|Total|2007
20+|8.9|9.2|9.1|Malignant|20199|218481776|Male and Female|Total|2007
20+|21.4|21.8|21.6|Benign/Borderline|48854|220975702|Male and Female|Total|2008
20+|9.0|9.2|9.1|Malignant|20687|220975702|Male and Female|Total|2008
20+|22.7|23.1|22.9|Benign/Borderline|52723|223491138|Male and Female|Total|2009
20+|8.9|9.1|9.0|Malignant|20883|223491138|Male and Female|Total|2009
20+|22.5|22.8|22.7|Benign/Borderline|52928|226155501|Male and Female|Total|2010
20+|8.7|8.9|8.8|Malignant|20786|226155501|Male and Female|Total|2010
20+|22.8|23.2|23.0|Benign/Borderline|54483|228810217|Male and Female|Total|2011
20+|8.6|8.9|8.7|Malignant|20944|228810217|Male and Female|Total|2011
20+|23.7|24.1|23.9|Benign/Borderline|57448|231491214|Male and Female|Total|2012
20+|8.6|8.8|8.7|Malignant|21200|231491214|Male and Female|Total|2012
20+|23.9|24.3|24.1|Benign/Borderline|58902|233954032|Male and Female|Total|2013
20+|8.6|8.8|8.7|Malignant|21637|233954032|Male and Female|Total|2013
20+|24.5|24.9|24.7|Benign/Borderline|61217|236459328|Male and Female|Total|2014
20+|8.5|8.8|8.7|Malignant|21861|236459328|Male and Female|Total|2014
20+|25.3|25.7|25.5|Benign/Borderline|64252|238880209|Male and Female|Total|2015
20+|8.5|8.7|8.6|Malignant|22150|238880209|Male and Female|Total|2015
20+|25.6|26.0|25.8|Benign/Borderline|65927|241210490|Male and Female|Total|2016
20+|8.5|8.7|8.6|Malignant|22513|241210490|Male and Female|Total|2016
20+|26.3|26.7|26.5|Benign/Borderline|68988|243333009|Male and Female|Total|2017
20+|8.4|8.6|8.5|Malignant|22695|243333009|Male and Female|Total|2017
20+|26.6|27.0|26.8|Benign/Borderline|70601|245243299|Male and Female|Total|2018
20+|8.2|8.4|8.3|Malignant|22546|245243299|Male and Female|Total|2018
20+|27.4|27.8|27.6|Benign/Borderline|74018|247052250|Male and Female|Total|2019
20+|8.1|8.4|8.3|Malignant|22634|247052250|Male and Female|Total|2019
20+|26.9|27.1|27.0|Benign/Borderline|371082|1252252205|Male and Female|Total|2019-2023
20+|8.1|8.2|8.2|Malignant|115761|1252252205|Male and Female|Total|2019-2023
20+|24.7|25.1|24.9|Benign/Borderline|67379|248691091|Male and Female|Total|2020
20+|8.1|8.3|8.2|Malignant|22845|248691091|Male and Female|Total|2020
20+|27.4|27.8|27.6|Benign/Borderline|75410|249886916|Male and Female|Total|2021
20+|8.0|8.2|8.1|Malignant|22783|249886916|Male and Female|Total|2021
20+|27.6|28.0|27.8|Benign/Borderline|77471|251903901|Male and Female|Total|2022
20+|8.0|8.2|8.1|Malignant|23211|251903901|Male and Female|Total|2022
20+|26.9|27.3|27.1|Benign/Borderline|76804|254718047|Male and Female|Total|2023
20+|8.2|8.5|8.4|Malignant|24288|254718047|Male and Female|Total|2023
20+|2.3|2.4|2.3|Benign/Borderline|5012|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004
20+|2.5|2.7|2.6|Benign/Borderline|5624|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005
20+|2.5|2.7|2.6|Benign/Borderline|5731|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.7|2.6|Benign/Borderline|5862|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007
20+|2.5|2.7|2.6|Benign/Borderline|5992|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|6294|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009
20+|2.5|2.7|2.6|Benign/Borderline|6180|226155501|Male and Female|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|46|226155501|Male and Female|Tumors of Cranial and Spinal Nerves|2010
20+|2.7|2.8|2.7|Benign/Borderline|6535|228810217|Male and Female|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|38|228810217|Male and Female|Tumors of Cranial and Spinal Nerves|2011
20+|2.8|2.9|2.8|Benign/Borderline|6977|231491214|Male and Female|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|53|231491214|Male and Female|Tumors of Cranial and Spinal Nerves|2012
20+|2.9|3.0|2.9|Benign/Borderline|7297|233954032|Male and Female|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|47|233954032|Male and Female|Tumors of Cranial and Spinal Nerves|2013
20+|3.0|3.1|3.1|Benign/Borderline|7722|236459328|Male and Female|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|37|236459328|Male and Female|Tumors of Cranial and Spinal Nerves|2014
20+|3.0|3.2|3.1|Benign/Borderline|7915|238880209|Male and Female|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|41|238880209|Male and Female|Tumors of Cranial and Spinal Nerves|2015
20+|3.0|3.1|3.1|Benign/Borderline|7891|241210490|Male and Female|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|54|241210490|Male and Female|Tumors of Cranial and Spinal Nerves|2016
20+|3.0|3.1|3.0|Benign/Borderline|7982|243333009|Male and Female|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|46|243333009|Male and Female|Tumors of Cranial and Spinal Nerves|2017
20+|3.0|3.1|3.0|Benign/Borderline|8123|245243299|Male and Female|Tumors of Cranial and Spinal Nerves|2018
20+|0.0|0.0|0.0|Malignant|31|245243299|Male and Female|Tumors of Cranial and Spinal Nerves|2018
20+|3.0|3.1|3.1|Benign/Borderline|8305|247052250|Male and Female|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|39|247052250|Male and Female|Tumors of Cranial and Spinal Nerves|2019
20+|3.0|3.0|3.0|Benign/Borderline|41027|1252252205|Male and Female|Tumors of Cranial and Spinal Nerves|2019-2023
20+|0.0|0.0|0.0|Malignant|226|1252252205|Male and Female|Tumors of Cranial and Spinal Nerves|2019-2023
20+|2.6|2.7|2.6|Benign/Borderline|7170|248691091|Male and Female|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|39|248691091|Male and Female|Tumors of Cranial and Spinal Nerves|2020
20+|3.1|3.2|3.1|Benign/Borderline|8536|249886916|Male and Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|47|249886916|Male and Female|Tumors of Cranial and Spinal Nerves|2021
20+|3.0|3.2|3.1|Benign/Borderline|8587|251903901|Male and Female|Tumors of Cranial and Spinal Nerves|2022
20+|0.0|0.0|0.0|Malignant|57|251903901|Male and Female|Tumors of Cranial and Spinal Nerves|2022
20+|2.9|3.1|3.0|Benign/Borderline|8429|254718047|Male and Female|Tumors of Cranial and Spinal Nerves|2023
20+|0.0|0.0|0.0|Malignant|44|254718047|Male and Female|Tumors of Cranial and Spinal Nerves|2023
20+|0.4|0.4|0.4|Benign/Borderline|842|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004
20+|7.5|7.7|7.6|Malignant|16099|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004
20+|0.4|0.5|0.5|Benign/Borderline|974|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005
20+|7.4|7.7|7.5|Malignant|16305|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005
20+|0.5|0.5|0.5|Benign/Borderline|1059|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006
20+|7.4|7.6|7.5|Malignant|16471|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.5|Benign/Borderline|1020|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007
20+|7.4|7.7|7.5|Malignant|16850|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007
20+|0.5|0.5|0.5|Benign/Borderline|1092|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008
20+|7.4|7.7|7.5|Malignant|17161|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008
20+|0.5|0.5|0.5|Benign/Borderline|1124|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009
20+|7.4|7.6|7.5|Malignant|17426|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009
20+|0.5|0.6|0.5|Benign/Borderline|1216|226155501|Male and Female|Tumors of Neuroepthelial Tissue|2010
20+|7.3|7.5|7.4|Malignant|17421|226155501|Male and Female|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.6|0.5|Benign/Borderline|1203|228810217|Male and Female|Tumors of Neuroepthelial Tissue|2011
20+|7.2|7.4|7.3|Malignant|17536|228810217|Male and Female|Tumors of Neuroepthelial Tissue|2011
20+|0.5|0.6|0.5|Benign/Borderline|1206|231491214|Male and Female|Tumors of Neuroepthelial Tissue|2012
20+|7.2|7.4|7.3|Malignant|17834|231491214|Male and Female|Tumors of Neuroepthelial Tissue|2012
20+|0.5|0.5|0.5|Benign/Borderline|1161|233954032|Male and Female|Tumors of Neuroepthelial Tissue|2013
20+|7.2|7.4|7.3|Malignant|18208|233954032|Male and Female|Tumors of Neuroepthelial Tissue|2013
20+|0.5|0.6|0.6|Benign/Borderline|1307|236459328|Male and Female|Tumors of Neuroepthelial Tissue|2014
20+|7.1|7.3|7.2|Malignant|18107|236459328|Male and Female|Tumors of Neuroepthelial Tissue|2014
20+|0.5|0.6|0.6|Benign/Borderline|1352|238880209|Male and Female|Tumors of Neuroepthelial Tissue|2015
20+|7.1|7.3|7.2|Malignant|18539|238880209|Male and Female|Tumors of Neuroepthelial Tissue|2015
20+|0.5|0.6|0.6|Benign/Borderline|1368|241210490|Male and Female|Tumors of Neuroepthelial Tissue|2016
20+|7.1|7.3|7.2|Malignant|18909|241210490|Male and Female|Tumors of Neuroepthelial Tissue|2016
20+|0.5|0.6|0.6|Benign/Borderline|1390|243333009|Male and Female|Tumors of Neuroepthelial Tissue|2017
20+|7.1|7.3|7.2|Malignant|19030|243333009|Male and Female|Tumors of Neuroepthelial Tissue|2017
20+|0.5|0.6|0.5|Benign/Borderline|1338|245243299|Male and Female|Tumors of Neuroepthelial Tissue|2018
20+|6.9|7.1|7.0|Malignant|18858|245243299|Male and Female|Tumors of Neuroepthelial Tissue|2018
20+|0.5|0.6|0.6|Benign/Borderline|1404|247052250|Male and Female|Tumors of Neuroepthelial Tissue|2019
20+|6.8|7.0|6.9|Malignant|18924|247052250|Male and Female|Tumors of Neuroepthelial Tissue|2019
20+|0.6|0.6|0.6|Benign/Borderline|7269|1252252205|Male and Female|Tumors of Neuroepthelial Tissue|2019-2023
20+|6.7|6.7|6.7|Malignant|94480|1252252205|Male and Female|Tumors of Neuroepthelial Tissue|2019-2023
20+|0.5|0.6|0.5|Benign/Borderline|1316|248691091|Male and Female|Tumors of Neuroepthelial Tissue|2020
20+|6.7|6.9|6.8|Malignant|18957|248691091|Male and Female|Tumors of Neuroepthelial Tissue|2020
20+|0.6|0.6|0.6|Benign/Borderline|1411|249886916|Male and Female|Tumors of Neuroepthelial Tissue|2021
20+|6.6|6.8|6.7|Malignant|18904|249886916|Male and Female|Tumors of Neuroepthelial Tissue|2021
20+|0.5|0.6|0.6|Benign/Borderline|1438|251903901|Male and Female|Tumors of Neuroepthelial Tissue|2022
20+|6.6|6.8|6.7|Malignant|19140|251903901|Male and Female|Tumors of Neuroepthelial Tissue|2022
20+|0.6|0.7|0.7|Benign/Borderline|1700|254718047|Male and Female|Tumors of Neuroepthelial Tissue|2023
20+|6.3|6.4|6.4|Malignant|18555|254718047|Male and Female|Tumors of Neuroepthelial Tissue|2023
20+|3.8|4.0|3.9|Benign/Borderline|8275|211050944|Male and Female|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|44|211050944|Male and Female|Tumors of Sellar Region|2004
20+|4.3|4.5|4.4|Benign/Borderline|9367|213511339|Male and Female|Tumors of Sellar Region|2005
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Tumors of Sellar Region|2005
20+|4.6|4.8|4.7|Benign/Borderline|10132|216055494|Male and Female|Tumors of Sellar Region|2006
20+|0.0|0.0|0.0|Malignant|33|216055494|Male and Female|Tumors of Sellar Region|2006
20+|4.8|5.0|4.9|Benign/Borderline|10805|218481776|Male and Female|Tumors of Sellar Region|2007
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Tumors of Sellar Region|2007
20+|5.2|5.4|5.3|Benign/Borderline|11695|220975702|Male and Female|Tumors of Sellar Region|2008
20+|0.0|0.0|0.0|Malignant|18|220975702|Male and Female|Tumors of Sellar Region|2008
20+|5.6|5.8|5.7|Benign/Borderline|12734|223491138|Male and Female|Tumors of Sellar Region|2009
20+|0.0|0.0|0.0|Malignant|29|223491138|Male and Female|Tumors of Sellar Region|2009
20+|5.6|5.8|5.7|Benign/Borderline|13067|226155501|Male and Female|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|34|226155501|Male and Female|Tumors of Sellar Region|2010
20+|5.7|5.9|5.8|Benign/Borderline|13422|228810217|Male and Female|Tumors of Sellar Region|2011
20+|0.0|0.0|0.0|Malignant|39|228810217|Male and Female|Tumors of Sellar Region|2011
20+|6.2|6.4|6.3|Benign/Borderline|14558|231491214|Male and Female|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|35|231491214|Male and Female|Tumors of Sellar Region|2012
20+|6.1|6.3|6.2|Benign/Borderline|14667|233954032|Male and Female|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|48|233954032|Male and Female|Tumors of Sellar Region|2013
20+|6.2|6.4|6.3|Benign/Borderline|15059|236459328|Male and Female|Tumors of Sellar Region|2014
20+|0.0|0.0|0.0|Malignant|42|236459328|Male and Female|Tumors of Sellar Region|2014
20+|6.5|6.7|6.6|Benign/Borderline|15917|238880209|Male and Female|Tumors of Sellar Region|2015
20+|0.0|0.0|0.0|Malignant|35|238880209|Male and Female|Tumors of Sellar Region|2015
20+|6.6|6.8|6.7|Benign/Borderline|16331|241210490|Male and Female|Tumors of Sellar Region|2016
20+|0.0|0.0|0.0|Malignant|44|241210490|Male and Female|Tumors of Sellar Region|2016
20+|6.9|7.1|7.0|Benign/Borderline|17229|243333009|Male and Female|Tumors of Sellar Region|2017
20+|0.0|0.0|0.0|Malignant|34|243333009|Male and Female|Tumors of Sellar Region|2017
20+|6.9|7.1|7.0|Benign/Borderline|17516|245243299|Male and Female|Tumors of Sellar Region|2018
20+|0.0|0.0|0.0|Malignant|43|245243299|Male and Female|Tumors of Sellar Region|2018
20+|7.0|7.2|7.1|Benign/Borderline|17954|247052250|Male and Female|Tumors of Sellar Region|2019
20+|0.0|0.0|0.0|Malignant|33|247052250|Male and Female|Tumors of Sellar Region|2019
20+|6.7|6.7|6.7|Benign/Borderline|85961|1252252205|Male and Female|Tumors of Sellar Region|2019-2023
20+|0.2|0.2|0.2|Malignant|2794|1252252205|Male and Female|Tumors of Sellar Region|2019-2023
20+|6.1|6.3|6.2|Benign/Borderline|15808|248691091|Male and Female|Tumors of Sellar Region|2020
20+|0.0|0.0|0.0|Malignant|63|248691091|Male and Female|Tumors of Sellar Region|2020
20+|6.9|7.1|7.0|Benign/Borderline|17881|249886916|Male and Female|Tumors of Sellar Region|2021
20+|0.0|0.0|0.0|Malignant|87|249886916|Male and Female|Tumors of Sellar Region|2021
20+|6.8|7.0|6.9|Benign/Borderline|17851|251903901|Male and Female|Tumors of Sellar Region|2022
20+|0.1|0.2|0.2|Malignant|415|251903901|Male and Female|Tumors of Sellar Region|2022
20+|6.2|6.4|6.3|Benign/Borderline|16467|254718047|Male and Female|Tumors of Sellar Region|2023
20+|0.8|0.9|0.8|Malignant|2196|254718047|Male and Female|Tumors of Sellar Region|2023
20+|9.3|9.6|9.5|Benign/Borderline|20120|211050944|Male and Female|Tumors of the Meninges|2004
20+|0.2|0.3|0.2|Malignant|510|211050944|Male and Female|Tumors of the Meninges|2004
20+|10.4|10.7|10.6|Benign/Borderline|22808|213511339|Male and Female|Tumors of the Meninges|2005
20+|0.2|0.3|0.2|Malignant|502|213511339|Male and Female|Tumors of the Meninges|2005
20+|10.9|11.2|11.1|Benign/Borderline|24314|216055494|Male and Female|Tumors of the Meninges|2006
20+|0.2|0.2|0.2|Malignant|472|216055494|Male and Female|Tumors of the Meninges|2006
20+|11.3|11.6|11.4|Benign/Borderline|25605|218481776|Male and Female|Tumors of the Meninges|2007
20+|0.2|0.3|0.2|Malignant|530|218481776|Male and Female|Tumors of the Meninges|2007
20+|12.0|12.3|12.1|Benign/Borderline|27707|220975702|Male and Female|Tumors of the Meninges|2008
20+|0.2|0.2|0.2|Malignant|475|220975702|Male and Female|Tumors of the Meninges|2008
20+|12.8|13.0|12.9|Benign/Borderline|29943|223491138|Male and Female|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|443|223491138|Male and Female|Tumors of the Meninges|2009
20+|12.4|12.7|12.6|Benign/Borderline|29738|226155501|Male and Female|Tumors of the Meninges|2010
20+|0.2|0.2|0.2|Malignant|408|226155501|Male and Female|Tumors of the Meninges|2010
20+|12.6|12.9|12.7|Benign/Borderline|30496|228810217|Male and Female|Tumors of the Meninges|2011
20+|0.2|0.2|0.2|Malignant|411|228810217|Male and Female|Tumors of the Meninges|2011
20+|12.8|13.1|13.0|Benign/Borderline|31766|231491214|Male and Female|Tumors of the Meninges|2012
20+|0.2|0.2|0.2|Malignant|437|231491214|Male and Female|Tumors of the Meninges|2012
20+|13.1|13.4|13.3|Benign/Borderline|32924|233954032|Male and Female|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|478|233954032|Male and Female|Tumors of the Meninges|2013
20+|13.4|13.7|13.5|Benign/Borderline|34265|236459328|Male and Female|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|484|236459328|Male and Female|Tumors of the Meninges|2014
20+|13.9|14.2|14.1|Benign/Borderline|36350|238880209|Male and Female|Tumors of the Meninges|2015
20+|0.2|0.2|0.2|Malignant|454|238880209|Male and Female|Tumors of the Meninges|2015
20+|14.3|14.6|14.4|Benign/Borderline|37769|241210490|Male and Female|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|432|241210490|Male and Female|Tumors of the Meninges|2016
20+|14.8|15.1|15.0|Benign/Borderline|39890|243333009|Male and Female|Tumors of the Meninges|2017
20+|0.2|0.2|0.2|Malignant|466|243333009|Male and Female|Tumors of the Meninges|2017
20+|15.0|15.3|15.2|Benign/Borderline|41132|245243299|Male and Female|Tumors of the Meninges|2018
20+|0.2|0.2|0.2|Malignant|447|245243299|Male and Female|Tumors of the Meninges|2018
20+|15.8|16.1|16.0|Benign/Borderline|43997|247052250|Male and Female|Tumors of the Meninges|2019
20+|0.1|0.2|0.2|Malignant|425|247052250|Male and Female|Tumors of the Meninges|2019
20+|15.8|15.9|15.8|Benign/Borderline|224801|1252252205|Male and Female|Tumors of the Meninges|2019-2023
20+|0.2|0.2|0.2|Malignant|2194|1252252205|Male and Female|Tumors of the Meninges|2019-2023
20+|14.4|14.7|14.6|Benign/Borderline|40651|248691091|Male and Female|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|443|248691091|Male and Female|Tumors of the Meninges|2020
20+|15.8|16.1|16.0|Benign/Borderline|45226|249886916|Male and Female|Tumors of the Meninges|2021
20+|0.2|0.2|0.2|Malignant|480|249886916|Male and Female|Tumors of the Meninges|2021
20+|16.2|16.5|16.3|Benign/Borderline|47140|251903901|Male and Female|Tumors of the Meninges|2022
20+|0.1|0.2|0.2|Malignant|460|251903901|Male and Female|Tumors of the Meninges|2022
20+|16.1|16.4|16.2|Benign/Borderline|47787|254718047|Male and Female|Tumors of the Meninges|2023
20+|0.1|0.1|0.1|Malignant|386|254718047|Male and Female|Tumors of the Meninges|2023
20+|0.7|0.8|0.8|Benign/Borderline|1603|211050944|Male and Female|Unclassified Tumors|2004
20+|0.6|0.6|0.6|Malignant|1282|211050944|Male and Female|Unclassified Tumors|2004
20+|0.9|1.0|0.9|Benign/Borderline|2011|213511339|Male and Female|Unclassified Tumors|2005
20+|0.6|0.7|0.6|Malignant|1330|213511339|Male and Female|Unclassified Tumors|2005
20+|0.9|1.0|0.9|Benign/Borderline|2013|216055494|Male and Female|Unclassified Tumors|2006
20+|0.6|0.6|0.6|Malignant|1302|216055494|Male and Female|Unclassified Tumors|2006
20+|0.9|1.0|1.0|Benign/Borderline|2110|218481776|Male and Female|Unclassified Tumors|2007
20+|0.5|0.6|0.6|Malignant|1226|218481776|Male and Female|Unclassified Tumors|2007
20+|1.0|1.1|1.0|Benign/Borderline|2299|220975702|Male and Female|Unclassified Tumors|2008
20+|0.6|0.6|0.6|Malignant|1391|220975702|Male and Female|Unclassified Tumors|2008
20+|1.1|1.2|1.1|Benign/Borderline|2542|223491138|Male and Female|Unclassified Tumors|2009
20+|0.6|0.7|0.6|Malignant|1432|223491138|Male and Female|Unclassified Tumors|2009
20+|1.1|1.2|1.2|Benign/Borderline|2663|226155501|Male and Female|Unclassified Tumors|2010
20+|0.5|0.6|0.5|Malignant|1262|226155501|Male and Female|Unclassified Tumors|2010
20+|1.1|1.2|1.2|Benign/Borderline|2762|228810217|Male and Female|Unclassified Tumors|2011
20+|0.5|0.6|0.5|Malignant|1283|228810217|Male and Female|Unclassified Tumors|2011
20+|1.2|1.3|1.2|Benign/Borderline|2872|231491214|Male and Female|Unclassified Tumors|2012
20+|0.5|0.6|0.5|Malignant|1287|231491214|Male and Female|Unclassified Tumors|2012
20+|1.1|1.2|1.2|Benign/Borderline|2798|233954032|Male and Female|Unclassified Tumors|2013
20+|0.5|0.5|0.5|Malignant|1288|233954032|Male and Female|Unclassified Tumors|2013
20+|1.1|1.2|1.1|Benign/Borderline|2801|236459328|Male and Female|Unclassified Tumors|2014
20+|0.5|0.6|0.6|Malignant|1435|236459328|Male and Female|Unclassified Tumors|2014
20+|1.0|1.1|1.1|Benign/Borderline|2652|238880209|Male and Female|Unclassified Tumors|2015
20+|0.5|0.6|0.5|Malignant|1389|238880209|Male and Female|Unclassified Tumors|2015
20+|1.0|1.0|1.0|Benign/Borderline|2498|241210490|Male and Female|Unclassified Tumors|2016
20+|0.5|0.5|0.5|Malignant|1281|241210490|Male and Female|Unclassified Tumors|2016
20+|0.9|1.0|1.0|Benign/Borderline|2433|243333009|Male and Female|Unclassified Tumors|2017
20+|0.5|0.5|0.5|Malignant|1288|243333009|Male and Female|Unclassified Tumors|2017
20+|0.9|1.0|0.9|Benign/Borderline|2442|245243299|Male and Female|Unclassified Tumors|2018
20+|0.5|0.5|0.5|Malignant|1385|245243299|Male and Female|Unclassified Tumors|2018
20+|0.8|0.9|0.9|Benign/Borderline|2280|247052250|Male and Female|Unclassified Tumors|2019
20+|0.5|0.6|0.5|Malignant|1447|247052250|Male and Female|Unclassified Tumors|2019
20+|0.9|0.9|0.9|Benign/Borderline|11737|1252252205|Male and Female|Unclassified Tumors|2019-2023
20+|0.5|0.5|0.5|Malignant|7260|1252252205|Male and Female|Unclassified Tumors|2019-2023
20+|0.9|0.9|0.9|Benign/Borderline|2381|248691091|Male and Female|Unclassified Tumors|2020
20+|0.5|0.6|0.6|Malignant|1559|248691091|Male and Female|Unclassified Tumors|2020
20+|0.8|0.9|0.9|Benign/Borderline|2303|249886916|Male and Female|Unclassified Tumors|2021
20+|0.5|0.6|0.5|Malignant|1488|249886916|Male and Female|Unclassified Tumors|2021
20+|0.8|0.9|0.9|Benign/Borderline|2404|251903901|Male and Female|Unclassified Tumors|2022
20+|0.5|0.5|0.5|Malignant|1445|251903901|Male and Female|Unclassified Tumors|2022
20+|0.8|0.9|0.9|Benign/Borderline|2369|254718047|Male and Female|Unclassified Tumors|2023
20+|0.4|0.5|0.4|Malignant|1321|254718047|Male and Female|Unclassified Tumors|2023
20+|0.1|0.1|0.1|Benign/Borderline|156|211050944|Male and Female|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Unique astrocytoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|159|213511339|Male and Female|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Unique astrocytoma variants|2005
20+|0.1|0.1|0.1|Benign/Borderline|193|216055494|Male and Female|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|50|216055494|Male and Female|Unique astrocytoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|188|218481776|Male and Female|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|50|218481776|Male and Female|Unique astrocytoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|215|220975702|Male and Female|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|57|220975702|Male and Female|Unique astrocytoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|244|223491138|Male and Female|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|67|223491138|Male and Female|Unique astrocytoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|264|226155501|Male and Female|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|47|226155501|Male and Female|Unique astrocytoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|274|228810217|Male and Female|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|62|228810217|Male and Female|Unique astrocytoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|288|231491214|Male and Female|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|59|231491214|Male and Female|Unique astrocytoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|277|233954032|Male and Female|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|69|233954032|Male and Female|Unique astrocytoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|287|236459328|Male and Female|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|79|236459328|Male and Female|Unique astrocytoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|300|238880209|Male and Female|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|52|238880209|Male and Female|Unique astrocytoma variants|2015
20+|0.1|0.2|0.1|Benign/Borderline|336|241210490|Male and Female|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|68|241210490|Male and Female|Unique astrocytoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|323|243333009|Male and Female|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|74|243333009|Male and Female|Unique astrocytoma variants|2017
20+|0.1|0.2|0.1|Benign/Borderline|357|245243299|Male and Female|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|66|245243299|Male and Female|Unique astrocytoma variants|2018
20+|0.1|0.2|0.2|Benign/Borderline|386|247052250|Male and Female|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|58|247052250|Male and Female|Unique astrocytoma variants|2019
20+|0.1|0.2|0.2|Benign/Borderline|2001|1252252205|Male and Female|Unique astrocytoma variants|2019-2023
20+|0.0|0.0|0.0|Malignant|316|1252252205|Male and Female|Unique astrocytoma variants|2019-2023
20+|0.1|0.2|0.1|Benign/Borderline|361|248691091|Male and Female|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|64|248691091|Male and Female|Unique astrocytoma variants|2020
20+|0.1|0.2|0.2|Benign/Borderline|396|249886916|Male and Female|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|52|249886916|Male and Female|Unique astrocytoma variants|2021
20+|0.1|0.2|0.2|Benign/Borderline|412|251903901|Male and Female|Unique astrocytoma variants|2022
20+|0.0|0.0|0.0|Malignant|72|251903901|Male and Female|Unique astrocytoma variants|2022
20+|0.2|0.2|0.2|Benign/Borderline|446|254718047|Male and Female|Unique astrocytoma variants|2023
20+|0.0|0.0|0.0|Malignant|70|254718047|Male and Female|Unique astrocytoma variants|2023
